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These studies were designed to investigate the production of
neuraminidase by a wide range of species of strictly anaerobic
bacteria and to explore the possibility that the enzyme may play a
part in the pathogenic mechanisms of these organisms.
A glycoprotein fraction was prepared from pooled human plasma
for use as substrate in assays for neuraminidase. Sensitive and
reliable procedures were developed for characterisation of
neuraminidase production by Clostridium perfrinaens and Bacteroides
fragilis, and these studies were extended to a survey of well
characterised strains of other species in these genera. There was
variation amongst strains of C. oerfrinaens type A; many heat-
resistant food-poisoning strains did not produce the enzyme whereas
most haemolytic, heat-sensitive strains did. The results were
consistent for all strains of the other clostridial and bacteroides
species examined and it is suggested that tests for neuraminidase
production should be a valuable addition to currently used
biochemical tests in certain areas of taxonomic studies in both
genera.
The ability of various Clostridia to produce experimental
myonecrosis was tested in guinea pigs. Strains classed as
neuraminidase-positive in vitro also produced the enzyme in vivo;
neuraminidase-negative strains did not. Pathogenic Clostridia
produced extensive myonecrosis and death in 24-48 h; virulence was
assessed by the challenge dose required to produce fatal infection
or by the severity of local muscle infection in surviving animals.
Although a number of pathogenic Clostridia produce neuraminidase,
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there was no clear-cut correlation between virulence and ability to
produce the enzyme. Large amounts of neuraminidase were produced
in the tissues by virulent strains of C. oerfrinoens and
C. septicum but none by the equally pathogenic but neuraminidase-
negative C. novyi: at least one neuraminidase-negative strain of
C. perfringens was able to produce fatal infection.
Various equine and rabbit antisera were assessed for their
ability to protect animals challenged with a virulent strain of
C. perfringens: the protective effect was found to correlate with
the content of anti-oe-toxin. C. perfringens neuraminidase proved
to be a poor antigen and it was difficult to produce sera with high
levels of neutralising activity; however, there was no evidence
that anti-neuraminidase contributed to the protective effect of the
antisera tested.
The occurrence and roles of neuraminidase and its substrates
are reviewed, and various ways in which neuraminidase produced
during infection might contribute to tissue damage are discussed.
The pathogenesis of C. perfringens gas gangrene remains
incompletely understood and a number of features of the disease are
not adequately explained by theories that attribute the major role
to oc-toxin. Neuraminidase is one of a collection of digestive
enzymes that are thought to be of value to commensal or saprophytic
C. perfringens strains and it is probable that it has a similar
role during infection; however, there is no evidence that




The enzyme neuraminidase (sialidase; N-acyl neuraminosyl
glycohydrolase; EC 3.2.1.18) is widely distributed in nature, being
found in viruses, bacteria, protozoa and vertebrate tissues, though
not in plants. The enzyme acts to release sialic acids (neuraminic
acid derivatives) from carbohydrates, glycoproteins and glyco-
lipids that have a variety of important roles in various animal
tissues. Sialic acids are thought to contribute to the specific
biological properties of many sialoglycoconjugates, and
neuraminidases have been widely used as tools in studies on their
activities. Mammalian neuraminidase is predominantly packaged as a
lysosomal enzyme and is thought to be involved in the controlled
degradation of sialoglycoconj ugates in normal animals; this may
contribute to the regulatory processes that determine the activity
and turnover of various glycoconjugates and cells.
The enzyme is produced by a number of important pathogenic
micro-organisms and it has been suggested that it may play a role
in pathogenesis of infections produced by some of these organisms.
The enzyme is not directly toxic to experimental animals but it has
been shown to be able to affect a number of important properties of
a variety of cells and glycoproteins in vitro and it seems possible
that the presence of exogenous enzyme during infection might
contribute to the pathogenic process.
The Introduction to this report reviews the occurrence and
roles of neuraminidase and its substrates and the possible role of
the enzyme in a variety of infections. The experimental work
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reported thereafter was undertaken in order to study further the
production of the enzyme by a range of anaerobic bacteria of
clinical interest and to assess the possible contribution of
neuraminidase to the pathogenesis of clostridial myonecrosis.
Discovery and chemistry of sialic acids
The early history of the discovery of sialic acids was
reviewed by Gottschalk (1960); more recent accounts of the
chemistry and biological roles of these amino sugars were given by
Blix & Jeanloz (1969), Tuppy & Gottschalk (1972), Ledeen & Yu
(1976), Corfield & Schauer (1982b) and Schauer (1982). The
accepted nomenclature of the sialic acids was proposed by Blix,
Gottschalk & Klenk (1957). The term neuraminic acid is reserved
for the unsubstituted parent compound whose structure is shown in
fig. Intro/1 (a); this compound is inherently unstable and has not
been isolated. The naturally occurring N-acylated and O-acylated
derivatives are known collectively as sialic acids. Hie commonest
form is N-acetyl neuraminic acid (NANA) whose structure is shown in
fig. Intro/1 (b); this is the precursor from which other sialic
acids are synthesised. Many species of animals, though not man,
have a proportion of sialic acids with an N-glycolyl group in place
of the N-acetyl group at position 5. Diacyl compounds also occur,
with the molecule further substituted with an O-acyl group in
position 4, 7, 8 or 9; triacyl derivatives are also encountered
(Ledeen & Yu, 1976; Schauer, 1982).
The sialic acids occur predominantly in the carbohydrate
























Fig. Intro/1 - (a) Structure of neuraminic acid in the open-chain
(keto) form; (b) representations of structure of N-acetyl








poly-saccharides; only small quantities are found in the free
state. The occurrence of the various sialic acids was reviewed by
Ng & Dain (1976) and Schauer (1982). Human tissues contain only N-
acetyl sialic acids - predominantly NANA itself - but many animal
species also have N-glycolyl and NfO-diacyl derivatives (Ledeen &
Yu, 1976). Sialic acids occur linked with lactose in various forms
of sialyl-iactose, oligosaccharides which are found in high concen¬
trations in mammalian colostrum. Around 80% of the NAN-lactose in
bovine colostrum is in the N-acetylneuramin («2 ->3) linkage but
the («2 6) linkage also occurs (Schneir & Rafelson, 1966).
Colominic acid, a polymer of (<x2—^ 8) linked NANA, is produced by
strains of Escherichia coli type K1 and Neisseria meningitidis
group B (Barry, 1958; Rasper £t al.f 1973; Robbins et al., 1974);
it has been suggested that this unusual capsular material may be a
virulence factor in the production of neonatal meningitis by these
otherwise dissimilar bacteria (Orskov, 1978; Wilfert, 1978).
Group-B streptococci, which may cause neonatal meningitis, also
contain sialic acid in their surface heteropolysaccharide (Baker &
Rasper, 1976).
NANA is a common constituent of mammalian glycoproteins and
was first purified by Blix in 1936 during studies on bovine
submaxillary mucin (see Gottschalk, 1960); the name sialic acid
derives from its detection in salivary gland material. The sialic
acids in glycoproteins occur as terminal sugars bound predominantly
by (2 -^>3) or (2 -9 6) linkages to galactose or N-acetyl D-
galactosamine, or occasionally to N-acetyl D-glucosamine; evidence
for (2 —9 4) and (2 —>9) linkages in glycoprotein: has also been
reported (Schauer, 1982). They also occur bound by (2—^8) linkage
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to another sialic acid in compounds with a terminal disialyl group
(Gottschalk & Drzeniek, 1972). Sialic acids in cell-membrane
glycoproteins are major cell-surface constituents and appear to
have important roles in cell behaviour and interactions.
Sialic acids are also present in glycolipids isolated from
cell membranes and brain tissue (see reviews by Brunngraber, 1979;
Li & Li, 1982). Sialic-acid-containing glycosphingolipids are
called gangliosides; some 15 inter-related gangliosides have been
isolated from brain and other tissues (Fishman & Brady, 1976b).
The term neuraminic acid was first used by Klenk in 1941 for a
substance isolated from human brain, and eventually shown to be
similar to that found by Blix in submaxillary mucin (see
Gottschalk, 1960). Human gangliosides contain only N-acetyl
derivatives whereas those from cell membranes of other mammalian
species may also contain N-glycolyl sialic acids. Virtually all
the ganglioside sialic acid in mammalian brain is NANA, regardless
of species (Ledeen & Yu, 1976). Gangliosides are classified by the
composition of the oligosaccharide chains attached to the ceramide
portion of the molecule (see Ng & Dain, 1976). The carbohydrate
portion of gangliosides may contain up to four neutral sugars and
one, two or three NANA molecules (though minor constituents have
been detected with up to five). NANA usually occurs as the
terminal sugar, bound by (2 —^3) linkage to galactose;
occasionally it occurs as a terminal disialyl (2—?8) group. The
structure is usually branched, with a further NANA linked (2—>3)
to an internal galactose (see table Intro/I). Sequential removal
of sialic acid residues from gangliosides by neuraminidase leads to
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TABLE Intro/I
Oligosaccharide structure of four gangliosides from
vertebrate brain
Ganglioside Structure of oligosaccharide0
GM3
(J31-4) (pi-1)





Gal > GalNAc >
(pi-4) (pi-1)




















Gal > Glc > Cer
(*2-3)
NANA
From Ng & Dain (1976).
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their interconversion as the terminal molecules are removed to
leave monosialyl gangliosides (e.g. GM1 or GM2) with a terminal
galactose residue but retaining the "internal" NANA; this usually
cannot be removed until the carbohydrate chain has been further
degraded (Suzuki, 1976).
The evolution of sialic acids has been discussed by Ng & Dain
(1976), Corfield & Schauer (1982a) and Schauer (1982). They do not
occur in plants, insects and primitive invertebrates, appearing
first in higher invertebrates; conflicting reports of the finding
of trace amounts of sialic acids in various lower species may be
attributable to unrefined assay techniques or to presence of sialic
acids in the diet or gut contents. The presence of sialic acids in
viruses may be ascribed to their close links with higher host
cells. Some bacteria, both Gram-positive and Gram-negative,
contain sialic acids and have enzyme systems for their metabolism;
it has been suggested that these occur mainly in pathogenic
bacteria (Irani & Ganapathi, 1962) and that they too may have been
acquired by contact or association with higher animals (Ng & Dain,
1976). Sialic-acid-containing gangliosides appear in the brain in
fish and amphibia, and increasingly complex sialic acid metabolism
is found in reptiles, birds and mammals. It is striking that the
N-glycolyl derivatives are common throughout earlier species but
have been discarded in man.
Discovery of neuraminidase
Neuraminidase (sialidase) was discovered in the course of
observations on the interaction of influenza virus and red blood
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cells (see Burnet, 1951; Gottschalk, 1960, 1966; Gottschalk &
Bhargava, 1971). The ability of influenza viruses to adsorb to and
agglutinate red cells was discovered independently in 1941 by Hirst
and by McClelland & Hare (Hirst, 1942a). The virus can elute from
the cells again; in the process it destroys the receptors on the
red cell but leaves the virus able to repeat the cycle with fresh
red cells. Hirst (1942b) ascribed this to an enzymic action of the
virus at the surface of the cell. The modern view of influenza
virus with separate haemagglutinin and neuraminidase subunits
occurring as glycoprotein spikes projecting from the virus particle
is reviewed in a later section below.
Burnet, McCrea & Stone (1946) observed that red cells treated
with influenza virus not only lose their receptors for the virus
but also have altered surface antigens such that they become
polyagglutinable (panagglutinable), i.e. agglutinable by antibody
present in normal human sera regardless of ABO specificity.
Similar anomalies in blood-grouping tests had been described by
Thomsen in 1926 and investigated further by Friedenreich (1928,
1930); it was concluded that a new antigen (T antigen) was
produced on the cell surface by enzymic action in samples of red
cells that had been contaminated by various bacteria, and that this
could react with natural anti-T antibody present in most mammalian
sera. Burnet and his colleagues, recognising the parallels, soon
demonstrated the presence of enzymes that were able to induce
polyagglutinability and to destroy influenza-virus receptors of red
cells in culture filtrates of various bacteria, including
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Clostridium perfrinqens (C. welchi) and Vibrio cholerae (Burnet et
al.. 1946). The Vibrio cholerae receptor-destroying enzyme (RDE)
soon became a standard reagent in influenza virus studies.
Ihe biochemical nature of the reaction was more conveniently
studied after the realisation that serum glycoproteins that acted
as inhibitors of influenza virus haemagglutination, e.g. the
Francis inhibitor, were also substrates for the enzyme (Anderson,
1948) and the studies were soon extended to other readily available
glycoproteins such as ovomucin (Gottschalk & Lind, 1949). These
studies resulted in the characterisation of the split product as
NANA and of the enzyme as an cx-glycosidase that was named
neuraminidase, or sialidase (Gottschalk, 1956, 1957).
The enzyme has since been isolated from other viruses (its
presence has been used for classification of this whole group of
viruses as myxoviruses) and it has also been found to be produced
by many other bacteria (see below). Neuraminidases from different
sources all release sialic acids from sialic-acid-containing
substances but their properties may vary considerably, e.g. in MW,
subunit structure, ion requirements, pH optima and specificity for
(2->3), (2—»6) or (2—^8) linkages. Mammalian neuraminidase was
first reported by Warren & Spearing (1960) but these enzymes have
proved much harder to purify and characterise. The role of
mammalian sialidases in normal metabolism of sialic-acid-containing
compounds has been much studied. The initial observations on the
effect of neuraminidase on red cells have been extended and the
blood-group chemistry of the Thomsen-Friedenreich phenomenon is now
understood in detail. Bacterial and viral neuraminidases have been
widely used as tools in studies of carbohydrate structure and
14
function in other sites, e.g. in circulating glycoproteins and in
surface components of white blood cells, tissue cells and tumour
cells. A number of these areas are reviewed below.
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BIOLOGICAL ROLES OF SIALIC ACIDS
One difficulty in ascribing particular functions to the
sialic acid moieties in glycoproteins and other glycoconjugates is
that the overall function of the carbohydrate portion itself is
unknown. A general role for carbohydrate in export of
glycoproteins from the synthesising cells has been suggested
(Eylar, 1965) but appears unlikely, if only because of the wide
variation in carbohydrate content - from a single residue per
molecule to more than 40% by weight of certain glycoproteins - and
the existence of some non-glycosylated extracellular proteins
(Warren, Buck & Tuszynski, 1978). The enormous variety of spatial
configurations that result from different combinations,
conformations and linkages of a relatively small number of sugar
residues suggests that the carbohydrate portions are concerned in
conferring specificity of interaction and may more probably play a
role in determining the destination of glycoproteins in the body
than their export into the circulation (Winterburn & Phelps, 1972;
Clamp, 1975).
No unified view of the biological role of sialic acids has
emerged although it seems reasonable to assume that they are
important in the regulation of a variety of biological processes
because of their peripheral position in many glycoconj ugates and
their frequent external location in cell membranes (see Gottschalk,
1960; Rosenberg & Schengrund, 1976a; Jeanloz & Codington, 1976;
Schauer, 1982). It is widely assumed that the biological
properties of sialic acids are primarily attributable to the strong
negative charge of the carboxyl group although direct evidence for
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this is not always available. Hie influence of the different acyl
substitutions observed in naturally occurring sialic acids is
unknown; glycoproteins with equivalent functions in man and other
mammalian species may be substituted with N-acetyl or N-glycolyl
groups without obvious differences in biological function. Jeanloz
& Codington (1976) have suggested that the polyhydroxylated side
chain (C7-C9) may be of significance, since it is the result of a
rather complex biosynthetic pathway and seems to be the only
covalently bound, flexible, polyhydroxylated structure present on
the surface of cells; there is, however, no direct evidence for
its importance.
The negative charge on sialic acid residues may contribute to
the conformation of glycoconjugates and may confer rigidity both on
these molecules and on cell membranes in which they are
concentrated (Montreuil, 1982; Schauer, 1982). Sialic acid
contributes to the viscosity of glycoproteins in mucous secretions,
which have a protective and lubricating role at mucous surfaces
(Ahmad & McPhie, 1980). The presence of sialic acid residues gives
resistance against proteolytic degradation in a variety of
glycoproteins, predominantly those with a high sialic acid content
(Hoskings, 1978). Sialic acid is characteristically the terminal
sugar in an oligosaccharide; it may therefore be seen as a
terminating signal for biosynthesis (Corfield & Schauer, 1982b).
Catabolism of glycoconjugates is a stepwise process and the
presence of terminal sialic acid residues protects the rest of the
oligosaccharide chain frcm degradation (Suzuki, 1976) .
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The concentration of sialic acid residues at the surface of
red cells and other circulating cells is responsible for the net
negative charge of the cells and the mutual repulsive force that
prevents aggregation (Pollack, 1965; Seaman, 1975). It is
postulated that sialic acids may play a part in keeping various
other types of cell separate and that Ca2+ and other cations may
have a role in forming bridges and allowing cells to come together.
It may be that loss of contact inhibition in transformed cell lines
is similarly mediated by alterations in the net negative charge of
the cells (Schauer, 1982). The trapping of cations by sialo-
glycoconjugates in cell membranes is presumed to influence ion
transport through the membrane although the details are unclear.
The specific role of gangliosides in nerve and brain tissue has
been much studied; it is postulated that they are involved in ion
fluxes associated with action potentials (Brunngraber, 1979, chap.
3).
In general, sialic acids have not been found to contribute to
antigenicity despite their prominence on the surfaces of cells and
molecules. Horowitz (1978) has examined the hypothesis that sialic
acids are so widely distributed that they are "immunological self"
and thus non-antigenic. It has been suggested that a factor in the
production of neonatal meningitis by group-B meningococci and
Escherichia coli K1 is immunological tolerance because of the
similarity of their sialic-acid-containing capsules to polysialyl
glycopeptides in normal brain (Finne, Leinonen & Makela, 1983).
The major sialoglycoprotein of the red cell surface, glycophorin A,
has MN blood-group antigen specificity; however the contribution of
sialic acid to the antigenic determinant now appears to be indirect
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(see below). It is possible, however, to raise antisera against
sialic acid haptens in experimental animals; these distinguish
between the (2-* 3) and (2-* 6) linkages (Smith & Ginsburg, 1980).
N-glycolyl sialic acids are not present in man but may be
potentially immunogenic and have been implicated in human serum-
sickness reactions (Higashi et al., 1977).
In a number of instances sialic acids have been found to mask
antigenic determinants formed by other specific groupings on
glycoproteins or cell membranes, perhaps by steric hindrance or
because of their negative charge. The failure to induce immune
responses has been of particular interest in studies of tumour
cells, some of which have an increased surface sialic-acid content
or altered sialic-acid metabolism (Weiss, 1973; Fishman & Brady,
1976a)# and in studies on the role of the trophoblast in preventing
immunological rejection of the foetus during pregnancy (Currie &
Bagshawe, 1967; Jones & Kemp, 1969). Such studies have produced
many conflicting results and the roles of sialic acids in these
situations remain unclear (Horowitz, 1978).
The following sections review the evidence for the importance
of sialic acids in a number of glycoproteins and cell membranes
that have been studied in detail. In most cases the role of the
sialic acid is deduced by observing the effect of its removal by
neuraminidase action. It may be that this has produced more
information on the fate of neuraminidase-treated glycoproteins and
cells than on the roles played by sialic acids in normal tissues;
however, such studies give an insight into the possible
consequences of the production of neuraminidase during infections
with pathogenic micro-organisms.
Sialic acid and circulating glycoproteins
Most circulating proteins in mammalian plasma are sialo-
glycoproteins, containing one or more sialic acid residues per
molecule (see Rosenberg & Schengrund, 1976a; Montreuil, 1982).
Human plasma sialoglycoproteins have a wide range of biological
roles; they include o^-acid glycoprotein (orosomucoid), alkaline
phosphatase, transferrin, ceruloplasmin, immunoglobulins and
glycoprotein hormones. It seems probable that the carbohydrate
portion of these proteins is involved in giving specificity to
their interactions with membranes and cells. The importance of the
sialic acid residues has been investigated primarily by treatment
with neuraminidase; it should be appreciated that many of the
earlier studies used crude enzyme preparations that might give
variable hydrolysis of molecules with different linkages, or that
might contain other contaminant glycohydrolases that could have
produced other additional effects (Gottschalk & Drzeniek, 1972;
Wadstrcm, 1978).
Human oc^-acid glycoprotein is the major plasma sialoglyco-
protein; it has 14 terminal sialic-acid residues on five branched-
chain oligosaccharides that are attached near the N-terminal end of
the polypeptide (Jeanloz, 1972; Schmid, 1975). Neuraminidase
produces a marked change in the electrophoretic mobility of the
protein but since the function of this protein remains obscure the
effect on its biological activity is unknown. The sialic acid is
not part of an antigenic determinant; partial removal of the
sialic acids increases its antigenicity (Athineos, Thornton &
Winzler, 1962).
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In general, neuraminidase treatment of other sialo-
glycoproteins has similar effects; their electropnoretic mobility
is altered but this does not seem to interfere with their specific
immunological or biological properties In vitro (Winzler & Bocci,
1972; Warren gt al., 1978). Thus, enzymic functions of human
alkaline phosphatase, amylase, atropinase and cholinesterase are
unaffected by neuraminidase, as are the metal-binding properties of
ceruloplasmin and transferrin and antigen binding by immuno¬
globulins (Kristjansson & Cipera, 1963; Johnson £t al., 1970;
Rosenberg & Schengrund, 1976a). Different degrees of sialylation
may be responsible for the microheterogeneity in purified
preparations of some of these glycoproteins, e.g. isoenzymes of
alkaline phosphatase and amylase.
The glycoprotein hormones are a group of structurally related
sialoglycoproteins - luteinising hormone (LH), follicle-stimulating
hormone (FSH) , thyroid-stimulating hormone (TSH) and human
chorionic gonadotrophin (HCG). Despite their diverse target cells
and physiological actions each consists of two subunits (oc and p)
of which the oc-chain is common to all four hormones. The fJ-chains
are different and confer the specificity of adsorption to receptors
on the different target cells. The oc-chains are interchangeable in
vitro: this portion acts to activate adenylate cyclase in the
target cell and switch on the appropriate cell function (see Pierce
& Parsons, 1981; Cooke, 1982; Stadel, De Lean & Lefkowitz, 1982).
Both polypeptide subunits have sialic-acid-containing oligo¬
saccharide chains attached. Many reports have shown that
neuraminidase treatment of these hormones does not alter their
immunological reactions but does produce a major reduction in their
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biological activity in vivo, e.g. with FSH (Gottschalk, Whitten &
Graham, 1960), LH (Braunstein £t al., 1971) and HCG (Barr & Collee,
1967; Van Hall j*t al., 1971). Similar observations were made with
erythropoietin, another sialic-acid-containing glycoprotein hormone
(Lowy, Keighley & Borsook, 1960). These findings were initially
taken to indicate that sialic acid residues were involved in their
specific activities but further investigations have shown that the
loss of activity in vivo is not paralleled in vitro and it is now
clear that the primary effect of neuraminidase treatment is to
reduce the survival time of the hormones in the circulation.
It seems probable that sialic acids play a general role in
determining the fate of a wide range of glycoproteins in mammalian
serum. The initial observations by Morell et al. (1968) were made
with radioactive-labelled desialylated ceruloplasmin. The normal
survival time of native ceruloplasmin in the plasma (2-3 days) was
dramatically reduced after removal of two or more of the 12 sialic
acid residues; it was cleared within a few minutes and was found
to have appeared in the cytoplasm of the hepatocytes in
experimental animals. It was shown that this depended specifically
on the exposure of the subterminal galactose residues after removal
of the terminal sialic acids; removal of the galactose residues by
galactosidase or modification by treatment with galactose oxidase
abolished the effect. Later studies demonstrated that replacement
of sialic acid by the action of sialyl-transferase preparations
restored the normal survival time of the molecules (Hickman £t al.,
1970). The recognition of the desialylated ceruloplasmin is
dependent on the presence of specific galactose-binding receptors
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on the surface of mammalian hepatocytes, and the same mechanism has
been shown to produce the accelerated clearance of the
glycoprotein hormones and of a wide variety of other desialylatea
glycoproteins (see Ashwell & Morell, 1974; Hughes, 1976, chap. 13;
Ashwell & Harford, 1982; Harford & Ashwell, 1982). After binding
of asialyoglycoprotein to the surface receptor the complex is
rapidly internalised by endocytosis (receptor-mediated
endocytosis); the glycoprotein is catabolised in the lysosomes
(Patel, 1978). Only some 10% of the hepatic receptor is present on
the cell surface; the role of the remaining 90% inside the cell is
still conjectural. The receptor molecules themselves are conserved
and recycled in the cell; some of the internal receptor is present
in lysosome membranes, apparently on the cytoplasmic surface, but
much is also present in Golgi and microsomal membrane fractions
(Harford & Ashwell, 1982). Antibody prepared against the hepatic
receptor specifically inhibits uptake of desialylated glycoproteins
by the liver, which demonstrates that the surface receptor
molecules are essential for this process whatever the function of
the internal molecules may be (Stockert et al., 1980).
The hepatic receptor has been purified and characterised; it
is itself a sialoglycoprotein and the presence of the sialic acid
is essential for its ability to bind the exposed galactose
residues. There might appear to be similarities between the
properties of this receptor and of sialyl- or other glycosyl-
transferases, but the isolated receptor cannot be shown to have
such enzymatic activity (Hudgin & Ashwell, 1974). The hepatic
asialoglycoprotein receptor has many of the properties associated
with plant lectins, e.g. binding to a specific sugar moiety,
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ability to agglutinate red cells with this sugar exposed on the
surface (Stockert, Morell & Scheinberg, 1974) and mitogenic
stimulation of desialylated lymphocytes (Novogrodsky & Ashwell,
1977); many authorities now broaden the definition of lectin to
include this and similar receptor molecules on the surfaces of
mammalian and bacterial cells with specific affinities for
particular mono- or di-saccharide residues (Goldstein & Hayes,
1978; Weir, 1980; Barondes, 1981).
The role of the mammalian hepatocyte receptor in removing
injected asialoglycoproteins is clear; the role of this mechanism
in determining the survival time of native sialoglycoproteins in
normal animals is less certain. It is attractive to postulate that
ageing molecules of circulating glycoproteins lose their sialic
acid residues and are preferentially removed from the circulation;
indeed the turnover of sialoglycoproteins might be partially
regulated by the rate of removal of sialic acid, whether
enzymically or by chemical forces. The site of this postulated
desialylation in normal mammals is unknown however, though some
neuraminidase activity may be present in normal plasma (Warren &
Spearing, 1960) and in the surface membranes of hepatocytes and
other cells (Rosenberg & Schengrund, 1976b). Furthermore, this
mechanism for glycoprotein scavenging is restricted to mammals,
which argues against a general role for sialic acid in such a
process. Birds do not have a galactose-specific hepatic receptor
and, in contrast to the situation in mammals, a high proportion of
circulating glycoproteins are already partially desialylated.
Further degradation to expose N-acetyl glucosamine leads to rapid
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clearance from the plasma by an analogous glucosamine receptor in
chicken hepatocytes (Lunney & Ashwell, 1976). Equivalent
mechanisms have not yet been identified in other phylogenetic
groups.
Despite some areas of uncertainty it seems reasonable at
present to assume that the hepatic receptor does have a physio¬
logical role and that it is likely to play a part in determining
the survival time of circulating glycoproteins. Some glycoproteins
do not contain sialic acid but do contain galactose; it may be
that this is normally masked, e.g. by terminal fucose residues, and
that such proteins are also removed when the galactose residues are
exposed (Clamp, 1975). It has been shown that mammalian liver
damage may be associated with detectable amounts of circulating
desialylated glycoproteins (Harford & Ashwell, 1982). Evidence
that an analogous system is involved in determining the lifespan of
circulating erythrocytes is discussed below.
Erythrocyte sialic acid and blood group antigens
A variety of lines of investigation followed from the recog¬
nition of sialic acid as the essential constituent of the
erythrocyte virus receptor in the early studies on interactions of
influenza viruses and red blood cells (see Gottschalk, 1960).
Interest in the broader role of the membrane-associated sialic acid
was stimulated when it was shown that the negative charge of the
erythrocyte is attributable to its sialic acid content (Eylar et
al., 1962). Neuraminidase treatment reduces the electrophoretic
mobility of the red cells, rendering them more easily aggregated or
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agglutinated by antisera under a variety of physico-chemical
conditions (Pollack, 1965). It became apparent that a substantial
part of the erythrocyte sialic acid was present in glycoprotein
rather than glycolipid when Cook, Heard & Seaman (1960)
demonstrated that treatment with proteolytic enzymes releases
sialoglycopeptides from the red cell surface. Early studies on the
human ABOH blood-group substances suggested that they were
predominantly present in glycolipids in the red cell membrane.
Neuraminidase treatment did not affect ABO specificity but did
destroy the MN blood-group antigens (Klenk & Uhlenbruck, 1960;
Cook & Eylar, 1965). Satisfactory techniques for extraction and
analysis of membrane components proved difficult to develop until
the 1970s when a variety of methods were used to produce sialo-
glycoprotein extracts with MN activity (Hamaguchi & Cleve, 1972;
Anstee & Tanner, 1974). Red-cell surface structures have since
been intensively investigated, partly because of the intrinsic
interest of this cell and its clinical importance in blood
transfusion, and partly because of its appeal as a simple model
cell for studies on general problems of mammalian cell-membrane
structure. Although sialic acid has been implicated in many
different processes involving the red cell surface, it remains
difficult to determine its precise biological role.
The immunochemistry of human red-cell antigens was
intensively studied in the 1950s and 1960s with particular
reference to the ABOH, P, I and Lewis family of related antigenic
specificities (see Morgan & Watkins, 1969; Watkins, 1972; Marsh,
1981; Mollison, 1983, chap. 7). These antigens are present in
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cell-surface glycoconjugates that contain fucose as a terminal
sugar but not sialic acid; however, a brief account is given here
because of the influence of these findings on later studies of the
MN system. The initial investigations did not use antigen
extracted from red cells, but glycoproteins in various secretions
that were found also to have ABH blood-group activity. The
antigenic specificities depend on the sequence and linkage of
sugars in the oligosaccharide chains rather than on differences in
the protein part of the molecule; the antigens are synthesised by
sequential addition of sugars to the precursor substance. The gene
products are glycosyl-transferase enzymes, and the specific
antigenic oligosaccharide results from the particular complement of
glycosyl-transf erases specified in the individual's genotype (see
table Intro/II ). The enzymes may act on a variety of precursors
in the cell membrane, or in plasma and secretions, producing the
same antigenic specificity. More recently techniques have been
evolved for studying the erythrocyte membrane components directly
(Marchesi, 1979). Such studies have confirmed the picture that
emerged from the work on blood-group-active glycoproteins in
secretions and have shown that the antigenic oligosaccharides are
attached to several different components in the red cell membrane,
including simple glycolipids, polyglycosylceramides and glyco¬
proteins (see Hakomori, 1981).
The current concept of red-cell membrane structure was
discussed by Lux (1979) and by Mollison (1983, chap. 6). The
general fluid-mosaic model of Singer & Nicolson (1972) postulated a
fluid lipid bilayer with various proteins embedded in it, forming a
dynamic mosaic on the surface of the membrane. Marchesi (1979)
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table; intro/n
Structure of terminal oligosaccharides determining
human blood-group ABH antigenic specificity
Blood-group Gene product Terminal structure of
substance oligosaccharide3
(pi-3)
Precursor - Gal > GlcNAc > R
(J31-3)













a Fran Mollison (1983) .
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proposed a modification of this for the erythrocyte, with a fixed
protein matrix beneath the lipid bilayer. The major structural
protein of the red cell, spectrin, occurs on the inner surface of
the membrane only; it is thought to interact with actin and other
internal proteins to form a supporting layer. Some glycoproteins
at least are thought to be relatively fixed in the red cell
membrane; these are postulated to be transmembrane proteins with a
tail that penetrates the lipid bilayer and may interact with the
structural matrix below.
Hughes (1976, chap. 4) reviewed the evidence that integral
membrane glycoproteins are generally amphipathic, with a hydro¬
phobic portion inserted into the lipid membrane and a hydrophilic
portion, bearing the oligosaccharide chains, that extends into the
aqueous environment. Perhaps the best studied membrane glyco¬
proteins are those of the human red cell. The proteins can be
separated and identified by the SDS-PAGE technique (Marchesi,
1979). Aggregates of one major transmembrane glycoprotein, the so-
called band-3 protein, form the anion channel of the red cell
membrane; this protein does not contain sialic acid and its
external carbohydrate portion carries the ABH and I blood-group
determinants. At least four sialoglycoproteins have been
identified, of which two have been purified and characterised -
glycophorin A (oc-sialoglycoprotein) and glycophorin B (S-sialo-
glycoprotein); various homo- and hetero-dimers and larger
complexes are also observed (Anstee, 1981). These glycoproteins
account for the majority of the total red-cell sialic acid,
although some is also present in glycolipids. Glycophorin A
(MW 31,000) is the major sialoglycoprotein component of the red
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cell surface and carries the MN blood-group specificity; there are
c. 106 molecules of glycophorin A on each red cell. Glycophorin B
also has N-group activity and in addition carries the associated Ss
specificity.
The observation that MN blood-group activity was abolished by
neuraminidase was initially interpreted to suggest that sialic acid
formed part of the antigenic determinant. By analogy with the ABH
system it was argued that the MN gene products were likely to be
glycosyl-transferases. M and N are allelic genes but some N
antigen is often detectable in M cells; this led to the suggestion
that the N substance was a monosialyl oligosaccharide that was the
precursor for M, with the M-gene product a second sialyl-
transferase that was required for complete sialylation of the
glycoprotein (Springer, Tegtmeyer & Huprikar, 1972; Watkins,
1974). Other workers, however, were unable to confirm consistent
differences in the oligosaccharides isolated from M and N cells
(Blumenfeld & Adamany, 1978); the structure of the carbohydrate
side chains of normal glycophorin A is shown in table Intro/III (T
and Tn antigens are discussed below).
More recent studies have disproved this theory and it is now
clear that the primary difference between glycophorin A from M and
N cells lies in the polypeptide part of the molecule (Walker,
Rubinstein & Allen, 1977; Sadler, Paulson & Hill, 1979). The
complete amino acid sequence of the protein was reported by Tomita,
Furthmayr & Marchesi (1978). The polypeptide chain contains 131
amino acids and spans the membrane with its amino terminus outside
the cell and its carboxy terminus inside; about 70 amino acids are
external to the membrane, 20 within it, and 40 in the cytoplasm.
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TABLE Intro/III
Structure of O-glvcosidically linked oligosaccharides
of glvcophorin A in normal. T and Tn red blood cells









Gal > GalNAc > Ser/Har
Tn GalNAc > Ser/Thr
a Fran Anstee (1981).
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The M and N genes specify polypeptide chains that differ only at
positions 1 and 5, as shown in table Intro/IV. Glycophorin A has
a high carbohydrate content (c. 60%); it contains 15 0-
glycosidically linked oligosaccharides, of the structure shown in
table Intro/III, and one N-glycosidically linked oligosaccharide,
of different though still debated structure. The carbohydrate
chains are all attached to the portion of the molecule external to
the membrane; three of the O-glycosidically linked oligo¬
saccharides are attached to amino acids in positions 2, 3 and 4.
The MN antigenic activity is conserved in octaglycopeptides
containing only the terminal eight amino acids and these three
oligosaccharide chains (Dahr & Uhlenbruck, 1978). Glycophorin B
has a different polypeptide chain; the terminal octapeptide is
invariable but the same as that giving N specificity in glycophorin
A (Anstee, 1981).
Although sialic acid is essential for M and N antigenic
activity it does not form part of the antigenic determinant.
Chemical modification either of the sialic acids (Ebert, Metz &
Roelcke, 1972) or of the free amino groups (Lisowska & Duk, 1975)
interferes with MN activity; both components are necessary for the
specific antigenic conformation. Neuraminidase abolishes both M
and N activity; resialylation of glycophorin A with specific
sialyl-transferases restores the original M or N specificity
(Sadler £t al., 1979). Lectins with anti-N activity bind to the
carbohydrate portion of glycophorin A, but to internal sugars and
not to the sialic acids (Dahr & Uhlenbruck, 1971; Anstee, 1981).
It appears that the primary differences in the amino acids at
positions 1 and 5 determine the spatial configurations of the
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TABLE Intro/IV
Amino acid sequences of the amino-terminal octaglvcooeptide
of alycophorin A from human red cells of blood groups M and N
Red cell Structure of terminal octaglycopeptidea
antigen
? 1 f
M Ser - Ser - Thr - Thr - Gly - Val - Ala - Met
? 1 ?
N Leu - Ser - Thr - Thr - Glu - Val - Ala - Met
a Modified from Anstee (1981); ^ = O-glycosidically linked oligo¬
saccharide (see table Intro/III).
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oligosaccharide chains so that different antigenic conformations of
the common internal sugars are exposed; this is thought to depend
on the charge interactions between the amino acids and the carboxyl
groups of the sialic acids (Furthmayr, 1978; Anstee, 1981). Thus
the frequently repeated statement that sialic acid plays a role in
MN blood-group specificity is true, albeit in a less direct way
than was originally envisaged.
T-polvaaalutinabilitv and red cell lifespan
The clarification of the role of sialic acid in MN blood-
group specificity has also allowed a clearer understanding of the
immunochemistry of the Ihomsen-Friedenreich phenomenon. Neura¬
minidase treatment of erythrocytes not only destroys MN antigens
but also exposes the cryptantigen T on the cell surface. It was
originally assumed that T would prove to be the precursor for the M
or N antigens, but it is now evident that this was an over¬
simplification. Bird (1964) described a lectin from peanuts
(Arachis hypoaaea) that has anti-T activity and this has been
widely used in studies of T-polyagglutinability. It binds the
disaccharide galactose (pi —»3) N-acetyl galactosamine; this is
the structure exposed by removal of the two molecules of NANA from
the oligosaccharide of glycophorin A (see table Intro/III). Only a
small proportion of the cell-surface sialic acid is involved in the
MN antigenic determinants - that in the O-glycosidically linked
oligosaccharides attached close to the amino terminus of
glycophorin A (and probably also of glycophorin B). There are many
more potential T-antigen sites on the red cell surface, as T is
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also exposed by removal of sialic acid from any of the other 0-
glycosidically linked oligosaccharides attached to other parts of
the glycophorin molecules or to glycolipids in the cell membrane
(Anstee, 1981).
Panagglutination was the term originally used to describe the
agglutination of red cells by naturally occurring antibodies
independent of the ABO system that are present in a wide range of
normal vertebrate sera. The cells are now more usually described
as polyagglutinable rather than panagglutinable because the
antibodies concerned may be common rather than universal. A
variety of mechanisms other than the T/anti-T system may be
responsible for polyagglutinability, e.g. adsorption of bacterial
antigens to the surface of red cells, or exposure of other crypt-
antigens by the action of other bacterial enzymes, or the presence
of very rare genetic blood groups to which natural antibodies
commonly occur (see Prokop & Uhlenbruck, 1969; Mollison, 1983,
chap. 10). Table Intro/III also shows the structure of the Tn
antigen, which gives rise to a different type of polyagglutin¬
ability; in this case the chain terminates with the N-acetyl
galactosamine residue. Anti-Tn occurs naturally in the serum of
many normal people; a specific anti-Tn lectin from Salvia sclarea
is also available (see Bird, 1981). Tn cells do not arise by
enzymic removal of the distal sugars as do T cells, but rather by a
somatic mutation that gives rise to a clone of cells that lack the
glycosyl-transferases necessary for elaboration of the oligo¬
saccharide (Anstee, 1981).
Anti-T occurs in variable (often low) titres in the serum of
man and other animal species; it is usually IgM in nature, and
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agglutination of neuraminidase-treated cells is best demonstrated
at room temperature or in the cold (Mollison, 1983, chap. 10). Its
origin is debated; presumably it might arise by exposure of T
antigen during synthesis or catabolism of red-cell surface
structures. In general, it is not found in umbilical cord blood
and this argues for external factors in stimulating antibody
production. Springer & Tegtmeyer (1981) have demonstrated the
production of anti-T by chicks in response to administration of
particular strains of commensal Escherichia coli with fortuitous T-
antigen activity; the same mechanism is invoked to explain the
presence of natural anti-A and anti-B associated with the ABO
blood-group system. The presence of natural anti-T in sera used
for testing for other blood-group antigens may give rise to
misleading or conflicting results; however, the anti-T is usually
diluted to insignificant proportions when high-titre immune
diagnostic antisera are used. High-titre IgG anti-T may be
produced in rabbits in order to give a reliable diagnostic reagent
for investigation of polyagglutinability; increasingly the peanut
lectin and a variety of other lectins are used for detection of T
and a number of related variant antigens (see Bird, 1981).
T-polyagglutinability is essentially an in-vitro phenomenon,
where red cells can be shown to have been altered by enzyme
treatment so that anti-T serum or lectins will produce
agglutination. It may also occur in vivo, with red cells from a
patient found to be polyagglutinable during routine cross-matching.
On occasion this has occurred in patients shown to have infections
with myxoviruses or bacteria that can produce polyagglutinability
in vitro; only a small proportion of such cases have shown
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haemolysis or other effects that might be attributable to
interaction of altered red cells with natural anti-T (see
Chorpenning & Hayes, 1959; Bird & Stephenson, 1973; Klein et al.,
1977; Seger _et_al., 1980; Bird, 1981). Unfortunately, several of
the reported cases have not been well documented and, since the
polyagglutinability has been assumed to involve T exposure without
adequate investigation, other mechanisms of polyagglutinability and
of haemolysis might have been involved; in particular, haemolysis
during severe Clostridium perfringens infections might also be
attributed to phospholipase-C (oc-toxin) action.
The significance of possible exposure of T antigen and its
combination with natural anti-T in vivo remains unclear (see
Mollison, 1983, chap. 10). T-activated cells fail to agglutinate
in their own serum. It is possible that the patient's anti-T
is absorbed by his own cells, though the cells give a negative
direct antiglobulin reaction. Anti-T is often a cold-reactive
agglutinin, apparently ineffective at 37°C. Other red cell
autoantibodies are known that react predominantly in the cold and
that do not appear to cause damage in vivo, e.g. anti-I cold
agglutinins in normal sera; there are also a few instances of
harmless warm autoagglutinins. Tn cells (see above) are genetic
variants with an exposed cryptantigen related to the T antigen.
Anti-Tn is present in many normal people though not in patients who
are producing these cells; they do not appear to have a reduced
survival time in plasma unless transfused into a person with
circulating anti-Tn (Myllyla et al., 1971). There are conflicting
reports about the effect of infusion of blood containing natural
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anti-T into patients whose cells have T antigen exposed; only in a
few cases has haemolysis been reported (Seges et al.. 1981).
Red cells treated with neuraminidase in vitro have been shown
to be rapidly eliminated when reinjected. It should be borne in
mind that early experiments used crude enzyme preparations that
might remove variable amounts of sialic acid and that might contain
other enzymes that could produce other effects at the red cell
surface (Wadstrom, 1978). Similarly it should be appreciated that
other changes may be produced, e.g. neuraminidase or other
bacterial antigens may be adsorbed to the cell surface during such
treatment (Sedlacek & Seiler, 1974; Schauer, 1982). The mechanism
of elimination of neuraminidase-treated red cells, and the relative
significance of cryptantigens, antibody or altered surface charge
in this process have been debated (see Jancik et al., 1978).
Lee (1968) showed that neuraminidase-treated red cells were
more susceptible to phagocytosis by peritoneal macrophages; serum
factors were required for opsonisation. Kay (1975) demonstrated a
requirement for antibody for phagocytosis of treated red cells.
Since IgG antibody could be demonstrated adsorbed to the surface of
old cells but not young cells in normal blood, she argued that this
was the normal mechanism for elimination of ageing red cells.
Durocher, Payne & Conrad (1975) found that after neuraminidase
treatment red cells were sequestered in the liver and suggested
that they might be recognised by a mechanism similar to that
described for desialylated glycoproteins.
Although glycoproteins may be removed by hepatocytes, red
cells do not come in contact with hepatocytes and would be more
likely to be removed by Kupffer cells. Aminoff et al. (1977) found
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that removal of 10% of the surface sialic acid produced rapid
sequestration of red cells in the liver and the spleen. There was
specific adhesion of treated red cells to liver Kupffer cells and
to spleen macrophages though not to hepatocytes; they noted a
number of differences between the Kupffer-cell receptors and the
classic hepatocyte receptor. These results contrast with those of
Kolb et al. (1978b), who demonstrated that both Kupffer cells and
hepatocytes have galactose-specific receptors; further analysis of
the receptors by inhibition studies failed to show any difference
in specificity between the receptors on the two types of cell (Kolb
et al.. 1980). The uptake of neuraminidase-treated red cells by
the liver can be inhibited in vivo by injection of substances with
exposed galactose residues (Kolb, Friedrich & Suss, 1981; Muller,
Franco & Schauer, 1981); this confirms the importance of the
galactose receptor in vivo and argues against the involvement of
antibody in this process. Kuster & Schauer (1981) demonstrated
that the initial binding of treated red cells to Kupffer cells
occurs in buffer but that serum components, probably complement,
are required for phagocytosis thereafter.
Thus, although there remain a number of inconsistencies and
uncertainties, there is reasonable evidence to suggest that
neuraminidase-treated red cells are removed by phagocytic cells in
the liver and spleen following recognition of galactose residues
exposed on the red cell surface. The question arises whether this
mechanism might also be responsible for removing ageing red cells
in the normal situation (see Schauer, 1982). The red cell has a
lifespan of c. 120 days, during which it travels some 300 miles.
Every day c. 2 x 1011 cells (c. 1% of the total) are removed from
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the circulation, primarily in the spleen but also by the liver
(which can take over completely after splenectomy). There is a
little random destruction but in general the oldest cells are
removed preferentially. One suggested mechanism is that as these
non-nucleated cells age various biochemical processes begin to
"wear out" and the cells become more rigid. This loss of
deformability is postulated to lead to more damage while passing
through the capillaries and eventual trapping in the spleen; the
reduced lifespan in some hereditary red-cell abnormalities lends
support to this hypothesis (Berlin & Berk, 1975; Chien, 1975;
Lux, 1979).
An alternative hypothesis suggests that ageing red cells lose
sialic acid and that the liver and spleen provide a quality-control
mechanism so that after a critical amount has been lost the cells
are removed from the circulation. Such a mechanism might act non-
specifically, i.e. the loss of sialic acid in itself alters
membrane charge or other properties so that the cells can be
recognised, or it might require specific exposure of the sub-
terminal galactose residues for interaction with the specific
phagocyte receptors in spleen or liver. It has proved difficult to
demonstrate that there is specific loss of sialic acid from ageing
red cells. Erythrocytes can be fractionated on the basis of their
density (Berlin & Berk, 1975); the oldest cells are the most dense
and studies have been made to determine their relative surface-
charge density and sialic acid content (see Schauer, 1982).
Although such cells do contain 10-20% less sialic acid it appears
that they have also lost other membrane components in the same
proportions (Seaman et al., 1977) and there is no evidence for
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reduced sialylation of glycophorin A in older cells (Lutz & Fehr,
1979). Thus sialic acid loss may be by loss of whole membrane
fragments rather than by selective hydrolysis to expose the
subterminal galactose residues, and it appears unlikely that ageing
red cells resemble neuraminidase-treated cells in this way.
Discussions of the non-specific role of sialic acid at the
red cell surface focus on the importance of the net negative
surface charge of these circulating cells. Many studies have
demonstrated increased agglutinability by "incomplete" antibodies
after removal of sialic acid by neuraminidase or protease
treatment; the agglutinability of the red cell correlates with its
sialic acid content, its electrophoretic mobility and the effective
zeta potential under the test conditions (see Pollack, 1965;
Seaman, 1975). It is less clear, however, whether the surface
sialic acid is important in preventing aggregation or phagocytosis
in vivo. One line of argument against an important role for sialic
acid in the normal red cell is the existence of a number of rare
red cell types that are relatively deficient in sialic acid. The
normal lifespan of Tn cells was mentioned above. A very rare type
of red cell, called En(a-), has been shown to be associated with
complete absence of glycophorin A; there is a little compensatory
increase in sialylation of other red-cell surface components but
the cells have only 40% of the normal NANA content (Tanner &
Anstee, 1976). The even rarer homozygous M^ cells lack both
glycophorins A and B and have only 25% of the normal NANA. These
cells are first recognised during cross-matching or because of
transfusion reactions but they may be found with apparently normal
lifespan in perfectly healthy people in the few families in which
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they have been recognised (Anstee, 1981). These observations,
though involving a very few people with very rare genetic
abnormalities, make it difficult to postulate an important general
role for sialic acid in the life of the erythrocyte.
Although we do not yet have an adequate picture of the role
of sialic acids in the normal economy of the red cell, the evidence
discussed above suggests that removal of sialic acid by
neuraminidase during the course of an infection might have adverse
effects on the patient's red cells, producing antigenic changes,
adsorption of antibody, haemolysis or enhanced clearance from the
circulation. The following section discusses other systems that
might be affected by exogenous neuraminidase.
Other roles for sialic acids
The roles of sialic acids in circulating glycoproteins and on
the erythrocyte membrane have been intensively investigated as
reviewed above; studies on a number of other biological systems
and cell types have also suggested that sialic acids may play
important roles although, in general, the evidence is still
incomplete.
Reutter .gt al. (1982) have reviewed the involvement of sialic
acid in blood clotting. Neuraminidase treatment of thrombocytes
removes sialic acid, exposes T antigen and leads to rapid removal
from the cirulation as with erythrocytes (Choi, Simone & Journey,
1972). Membrane-bound sialic acid is thought to play a role in
adhesion and aggregation of thrombocytes. Several of the plasma
factors involved in blood clotting, e.g. plasminogen, fibrinogen
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and Von Willebrand factor, are sialylated and there is evidence
that removal of the sialic acid groups affects their functions.
Lymphocytes also have sialic acid on their surface and it has
been shown to be important in the distribution and processing of
these cells in the body. Neuraminidase-treated lymphocytes are
selectively trapped in the liver rather than in the spleen or lymph
nodes (Woodruff & Gesner, 1969). Unlike neuraminidase-treated
erythrocytes, they are not destroyed there; after c. 24 h their
surface sialic acid has been regenerated and they re-emerge to
resume the normal pattern of recirculation (Woodruff & Woodruff,
1974, 1976a and b). Kolb £t al. (1978a) showed that the trapping
of lymphocytes was effected by the hepatocyte galactose-specific
asialoglycoprotein receptor. Rose (1982) discussed the possibility
that immature lymphocytes have exposed T antigen that binds peanut
agglutinin and suggested that the lectin-binding properties of
lymphocytes may reflect their tendency to recirculate or be
sessile. Sialic acid may not play a part in the normal pattern of
mature lymphocyte recirculation and processing but it is clearly
important in preventing temporary trapping in the liver.
Novogrodsky & Ashwell (1977) and Kolb-Bachofen & Kolb (1979) have
discussed the importance of this effect in vivo during myxovirus
infections and the possible induction of autoimmune cytotoxic
reactions in the liver following mitogenic stimulation of trapped
lymphocytes by contact with the hepatic receptor (lectin).
Sialic acids are prominent surface structures on many other
cells in the body besides the circulating blood cells described
above and it is thought that they play a role in a wide range of
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surface-dependent phenomena, e.g. adhesiveness or mutual repulsion
of like cells, cell differentiation, or interactions between
different cell types (see Reutter et al., 1982). Neuraminidase
treatment of many types of cell leads to enhanced cell destruction,
often mediated by serum factors; Ray (1977) discussed the role of
such mechanisms in immune surveillance for clearing defective,
aged, mutated or malignant cells. Variations in the amount of
sialic acid on the surface of transformed cells and tumour cells
have been extensively investigated but no general role can
confidently be ascribed to sialic acid in these phenomena (Jeanloz
& Codington, 1976; Ray, 1977; Glick & Flowers, 1978; Horowitz,
1978; Reutter et al.. 1982). Sialic acid is postulated to have a
masking effect at the cell surface, either directly, when removal
of sialic acid creates a new antigen involving the subterminal
sugar as with T antigen, or indirectly, when the bulky, charged
sialic-acid residue is presumed to block access to less superficial
groupings (Jeanloz & Codington, 1976). It appears that certain
tumours with reduced surface sialic acid express T antigen or other
cryptantigens although this fails to provoke an effective immune
response; immunotherapy with neuraminidase-treated cells may lead
to tumour regression or reduce metastasis (see Ray, 1977; Bird,
1981; Springer & Tegtmeyer, 1981; Reutter et al., 1982).
In general, sialic acid has not been found to be part of
antibody receptors on tissue cells although the charge effects of
these molecules might affect the antigenic conformation of other
cell-surface components indirectly as with erythrocyte MN antigens.
The major histocompatibility antigens on lymphocytes and other
tissue cells are sialoglycoproteins but the antibody receptor
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appears to lie in the protein part of the molecule (Hughes, 1976,
chap. 6; Horowitz, 1978). On the other hand, sialic acid is known
to be part of cell-surface receptors for a variety of other agents
(see Jeanloz & Codington, 1976; Schauer, 1982). A number of these
examples have been studied primarily with erythrocytes but similar
surface structures occur widely in membrane glycoproteins and
gangliosides of other cells.
The importance of sialic acid in myxovirus receptors is well
established. The detailed structure of glycophorin A, the major
virus receptor on the erythrocyte surface, was discussed above, and
similar NANA-containing glycoconjugates act as virus receptors on
other types of cell. The inter-related reactions of viral
haemagglutinin and neuraminidase with the virus receptors are
discussed below. Polyoma viruses also bind to sialic acid
receptors on red cells; this is not merely attributable to charge
interactions as there is specificity for (2—>3) linked but not
(2 —* 6) linked molecules (Cahan & Paulson, 1980). A similar
receptor has also been described for a number of mycoplasmas, e.g.
Mycoplasma pneumoniae, which adsorb to erythrocytes and other cells
using receptors that contain sialic acid (Sobeslavsky, Prescott &
Chanock, 1968; Glasgow & Hill, 1980).
Two lectins, from the horseshoe crab (Limulus polyphemus) and
from wheat germ (Triticum vulgaris). attach to receptors with
terminal sialic-acid residues (see Jeanloz & Codington, 1976;
Schauer, 1982). Although these lectins do not normally come in
contact with human cells, it is assumed that lectins frequently
bind to physiologically important receptors on the cell surface as
they may stimulate a variety of important cell reactions (Barondes,
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1981); the lymphocyte mitogenic response to purified hepatocyte
galactose receptor (lectin) was cited above.
Jeanloz & Codington (1976) evaluated the evidence for sialic
acid residues in the receptor sites for a number of hormones,
including insulin, adrenocorticotrophic hormone and serotonin (see
also Van Heyningen, 1974; Fishman & Brady, 1976b). The importance
of sialic acid in the hepatocyte galactose receptor was mentioned
previously. Sialic acid has also been found to be important in
ganglioside receptors for interferon (Besancon & Ankel, 1974). In
all these cases, neuraminidase treatment interferes either with
binding or with later stages in the transfer of information across
the cell menbrane.
Gangliosides have been identified as receptors for a number
of bacterial toxins (see Reutter £t al., 1982). Van Heyningen
(1959) demonstrated the binding of tetanus toxin to gangliosides
extracted from nervous tissue and showed the importance of the NANA
residues in this interaction (Bernheimer & Van Heyningen, 1961).
The toxin is bound to the monosialoganglioside GM1 (see table
Intro/I); binding is lost in the absence of the NANA residue and
very much increased with di- and tri-sialogangliosides (Van
Heyningen, 1974). Brunngraber (1979, chap. 3) summarised the
current concepts of tetanus-toxin-binding to peripheral nerve,
intra-axonal retrograde transport to the spinal cord, and action at
the motor synapse. It is probable that the ganglioside receptor is
involved only in the initial transport of the toxin into the nerve
cell rather than in its final action in the central nervous system
(Stephen & Pietrowski, 1981, chap. 2).
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Cholera toxin also binds to a ganglioside receptor at the
cell surface (see Finkelstein, 1976; Fishman & Brady, 1976b; Van
Heyningen, 1977). Cholera toxin consists of two types of subunit;
the B subunits are responsible for binding to the cell surface
while the A subunit is responsible for activation of adenylate
cyclase and the toxic effects on the target cell. The toxin binds
specifically to ganglioside GMl and is neutralised by it; di- and
tri-sialogangliosides are ineffective (Van Heyningen, 1974). The
susceptibility of various cells to cholera toxin is proportional to
the amount of GMl that is naturally present or that can be intro¬
duced into their surface membrane (Cuatrecasas, 1973; Hollenberg
et al„ 1974); the number of available receptors can be increased
by neuraminidase treatment, which removes NANA from various tri-
and di-sialogangliosides to produce GMl (Haksar, Maudsley & Peron,
1974). Moss, Manganiello & Fishman (1977) produced evidence that
both the terminal galactose and the "internal" sialic acid are
important in binding of cholera toxin B subunit by GMl. The
mechanism of activation of adenylate cyclase by subunit A is still
not completely understood, but it seems that the A subunit has to
be transported to the inner surface of the cell membrane where it
has an enzymic action (ADP-ribosyl transferase) that inactivates a
component of the adenylate cyclase complex; this prevents GTPase
activity and traps the adenylate cyclase in the active form (see
Holmgren, 1981). The role of the ganglioside in the initial
binding of the B subunit is well established; it is not known what
part it plays in the subsequent transfer of the A subunit through
the membrane.
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Thus, sialic acids are known to form an essential part of a
number of cell-surface receptors for various agents. Although it
is hard to claim a physiological role for some of the systems that
have been studied, e.g. with toxins and lectins, it seems probable
that these agents are interacting with systems that do have a
normal role in information transfer over cell membranes that can
lead to changes in the behaviour of the cell. A physiological role
is more directly demonstrated with the hepatocyte galactose-
specific receptor and receptors for hormones and interferon.
Viruses and bacterial toxins may exploit the presence of receptors
that have a quite separate role and turn this to their own
advantage. In some cases the sialic acid may be involved only in
primary binding of the agent but this may initiate a chain of other
interactions that alters the behaviour of the cell. The evidence
from studies of this sort supports the suggestion that sialic acids
are essential constituents in a variety of sialoglycoconjugates
that have important regulatory roles at cell surfaces; this in
turn suggests that neuraminidase produced during infection by
pathogenic micro-organisms might interfere with important functions
in the host's tissues.
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MAMMALIAN NEURAMINIDASE
Neuraminidases that occur in mammalian tissues have proved
very much more difficult to purify and have been very much less
well characterised than the enzymes from bacterial or viral
sources. The presence of the enzyme in mammals was first reported
by Warren & Spearing (1960) who detected activity in concentrated
fractions prepared from pooled human plasma, but the levels of free
enzyme in plasma and other body fluids, e.g. saliva and milk, are
usually very low (Schauer et al., 1976). Neuraminidase activity
has since been detected in a wide range of mammalian and avian
tissues, where it is mainly associated with lysosomes and other
membrane fractions (Carubelli, Trucco & Caputto, 1962; Mahadevan,
Nduaguba & Tappel, 1967; Tuppy & Palese, 1968; Patel, 1978). The
intracellular distribution of the enzyme has been studied
particularly in liver, kidney and brain tissue where the levels are
highest, and evidence has been found for the presence of more than
one type of enzyme, with different pH optima and substrate
specificities. Many conflicting results have been obtained,
largely attributable to differences in fractionation procedures,
the use of crude preparations and inappropriate assay conditions,
but the general picture is becoming a little clearer.
Many of the enzymes studied have the acidic pH optimum (4.0-
4.5) characteristic of lysosomal enzymes, while others have a
higher pH optimum (5.0-6.0) that may be more appropriate for
enzymes active elsewhere in the cell or on the cell surface (see
Rosenberg & Schengrund, 1976b). The lysosomal enzymes do not
usually show the dependence on calcium and other ion concentrations
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that is characteristic of a number of microbial enzymes, though
this may vary with the substrate involved; for example, Schengrund
& Nelson (1975) found a requirement for added Ca2+ with bovine
brain neuraminidase acting on exogenous ganglioside substrates but
not on endogenous gangliosides. Varied susceptibilities to
inhibition by metallic ions, e.g. Hg2+ and Cu2+, and to enhancement
by detergents have also been reported (Rosenberg & Schengrund,
1976b); these have been useful in distinguishing the presence of
different enzymes in various tissues but it is difficult to
generalise from the results because of the varying degrees of
purification involved.
Activity against different substrates also varies markedly.
Mammalian enzymes can be roughly characterised either as glyco¬
protein enzymes, that give rapid hydrolysis of glycoproteins and
oligosaccharides (e.g. sialyl-lactose) but that have little
activity against gangliosides, or as glycolipid enzymes that have
the converse substrate affinities (Schauer, 1982). When defined
substrates are used, variations in relative activity against (2
3), (2 —> 6) and (2 —? 8) linkages have been shown, but it appears
that the lysosomal enzymes can commonly hydrolyse all three types
(Corfield & Schauer, 1982b). Few enzymes have significant activity
against the "internal" NANA in intact gangliosides; this residue
is usually protected until the distal part of the oligosaccharide
has been removed fcy sequential action of the appropriate enzymes
(Suzuki, 1976; Li & Li, 1982).
The subcellular distribution of neuraminidase activity has
been studied in a variety of tissues but the picture remains
unclear. Most of the enzyme is membrane-bound and it has been
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shown in membrane fractions thought to represent constituents of
several different cell structures, e.g. in rat liver it has been
found in lysosomes (Horvat & Touster, 1968), Golgi apparatus
(Kishore _et al., 1975) and plasma membrane (Visser & Emmelot,
1973). Studies on neuraminidase distribution in brain tissue have
proved difficult; the enzyme is found mainly in the grey matter
and is particularly associated with synaptosomal membrane fractions
(Patel, 1978). Synaptosomal neuraminidase is active against
endogenous gangliosides present in brain fractions and it is
postulated to play a role in synaptic transmission (Brunngraber,
1979, chap. 12). It is unclear whether reports of soluble enzyme
activity (e.g. Tulsiani & Carubelli, 1970) indicate a true cytosol
enzyme or a membrane-associated enzyme that is easily solubilised
during tissue extraction procedures; the pH optimum is usually
higher than for lysosomal enzymes. Recently Michalski, Corfield &
Schauer (1982) demonstrated two forms of neuraminidase in human
liver lysosomes; one was membrane-bound and insoluble but the
other could be solubilised in the presence of Triton X-100 and
purified. The latter enzyme, one of the best purified mammalian
neuraminidases, had MW 70,000, pH optimum 4.0-4.5 and activity
primarily against gangliosides; the enzyme remaining firmly bound
to the lysosomal membrane fraction was of the glycoprotein type.
Disease due to neuraminidase deficiency
Further insight into the role of human neuraminidase has come
with the demonstration that certain rare genetic diseases are
associated with defects in neuraminidase production. A large
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number of metabolic diseases have been identified and classified by
various schemes, initially on clinical grounds by eponyms (Gaucher
disease, Tay-Sachs disease, etc. ) but more recently by biochemical
criteria in evolving and overlapping categories such as glyco-
sphingolipidoses, gangliosidoses, mucolipidoses, oligosaccharidoses
or sialidoses (see Tallman & Brady, 1976; Brunngraber, 1979, chap.
14; Brady, 1982). They are characterised by excessive tissue
accumulation and/or urinary excretion of gangliosides or glycocon-
jugate-derived oligosaccharides; in a number of cases they can be
attributed to a primary defect in a specific lysosomal hydrolase.
Cantz, Gehler & Spranger (1977) first identified a primary defect
in neuraminidase production as the cause of a sialidosis when they
showed an almost complete lack of the enzyme in fibroblasts
cultured from the skin of a patient with mucolipidosis I. Further
studies have identified at least two syndromes associated with
primary neuraminidase deficiency (Cantz, 1982). One group of
patients present in infancy with severe progressive neuro¬
degenerative disease and a dysmorphic syndrome similar to Hurler
disease; there may be associated renal damage. Others have a
milder form with normal physical appearance and the onset of
neurological and ophthalmic signs delayed till adolescence. These
syndromes are thought to result from defects in neuraminidase
production, probably due to allelic mutations in the same
neuraminidase gene giving rise to different degrees of lysosomal
neuraminidase deficiency.
The biochemical diagnosis of these conditions depends on
analysis of the oligosaccharides stored in the tissues and excreted
in the urine, and on demonstration of lysosomal enzyme defects in
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cultured fibroblasts or amniotic cells. The analysis of these
defects has been complicated by lack of knowledge about the
activities and distribution of the different enzymes present in
normal cells from these sites and how the findings relate to enzyme
levels in other tissues. The deficiency is in the lysosomal
glycoprotein neuraminidase; by contrast the glycolipid enzyme
activities appear to be normal (Cantz, 1982). Strecker & Michalski
(1978) suggested that separate enzymes were responsible for
hydrolysing (2—^3) and (2-^6) linkages and presented evidence in
support of the theory that mucolipidosis I was due to a specific
deficiency in a (2 —?6) enzyme whereas mucolipidosis II was
associated with lack of both enzymes; it now appears more
probable, however, that both activities are due to the same glyco¬
protein enzyme (Cantz, 1982).
In addition to these primary defects a number of other
conditions have been found where the neuraminidase deficiency
occurs in association with deficiency of other lysosomal enzymes.
Some patients have a combined deficiency of neuraminidase and p-
galactosidase that may be due to defective post-translational
modification of both these enzymes rather than to separate primary
enzyme defects (Hoogeveen et al., 1980). The neuraminidase
deficiency in patients with mucolipidosis II (I-cell disease) and
mucolipidosis III (pseudo-Hurler polydystrophy) is part of a
general picture of deficiency of many lysosomal hydrolases,
secondary to a general defect in lysosomal enzyme compartment-
alisation (Brady, 1982). A partial deficiency of lysosomal
ganglioside neuraminidase has been reported in mucolipidosis IV
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(Bach, Zeigler & Kohn, 1980) but the biochemical lesion has not yet
been fully characterised.
These studies demonstrate the importance of mammalian
neuraminidases in catabolism of sialoglycoconjugates and offer
prospects for further studies to determine their normal roles in
greater detail. Different lysosomal neuraminidases have been shown
to be involved in the primary stages of degradation of sialo-
glycoproteins and of gangliosides and the outline of these
degradative processes is now clear (see Suzuki, 1976; Patel,
1978). The overall co-ordination of sialoglycoconjugate synthesis
and catabolism and its role in regulating biological processes
remain unknown, as do the roles of neuraminidases at other cellular
sites or in cell-surface membranes. Presumably, many different
types of cell have mechanisms for the controlled turnover of
endogenous sialoglycoconjugates; some tissues, e.g. liver, may
have further roles in scavenging cells and sialoglycoconjugates
from the circulation. Neuraminidase may well have particular roles
in brain tissues. The evidence for a variety of enzymes with
different properties in various tissues and cell fractions makes it
probable that mammalian tissues contain multiple enzymes with a
variety of specific roles in sialoglycoconjugate metabolism; this
may be contrasted with the broad substrate range of many bacterial
neuraminidases, e.g. that from Clostridium perfrinqens. which may
be thought to have a broader digestive function.
VIRAL NEURAMINIDASE
Early studies on the interactions of influenza A virus and
red blood cells led to the identification of neuraminidase as a
structural component of the virus (see Gottschalk, 1960). It seems
probable that this unique virus-coded enzyme has an important
biological role and the following section reviews the evidence for
this. The general term myxovirus (myxo = mucin) was introduced to
embrace other viruses that behave in the same manner as influenza
viruses, i.e. with haemagglutinating and neuraminidase activities.
The current classification (see Stuart-Harris & Schild, 1976;
Ginsberg, 1980) distinguishes the orthomyxoviruses, which comprise
influenza viruses A, B and C, and the paramyxoviruses, which
include parainfluenza viruses, mumps virus and Newcastle disease
virus. All are enveloped single-strand (negative-strand) RNA
viruses of similar structure. Measles virus and respiratory
syncytial virus are classified with the paramyxoviruses but are
less closely related and do not contain neuraminidase.
Ortho- and para-myxoviruses are distinguished by a number of
features. The typical oval viral particles of orthomyxoviruses are
smaller (diameter 80-120 nm) than those of the paramyxoviruses
(150-250 nm); the ribonucleoprotein core is also proportionately
smaller. Influenza viruses have a fragmented genome, with separate
segments of ribonucleoprotein corresponding with individual viral
genes, whereas paramyxoviruses have one long continuous unsegmented
genome. The haemagglutinin and neuraminidase are present in
separate glycoprotein spikes on the surface of influenza viruses
but the two activities are associated with a single subunit in
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paramyxoviruses (Scheid & Chcppin, 1973). Much less is known about
paramyxovirus structure and pathogenesis and the present discussion
of viral neuraminidase is based on the influenza viruses.
Influenza A is a major cause of respiratory infection in man;
related strains are found in some domestic animals and in a wide
range of domestic and wild birds (for a comprehensive monograph on
influenza A virus see Stuart-Harris & Schild, 1976). Influenza A
causes epidemics which recur every few years in various parts of
the world, and which occasionally sweep round the world as
pandemics. This fluctuating pattern is associated with changes in
the surface antigens, the so-called antigenic shift and drift of
influenza A virus. By contrast influenza B and C viruses show less
antigenic variation than type A and do not cause epidemics; each
is found only in man and no animal reservoir has been identified.
Influenza B is responsible for less severe, endemic, respiratory
tract infections; influenza C viruses are seldom associated with
clinical symptoms and appear to be widespread but relatively
avirulent (see Palese & Young, 1982). Influenza C viruses differ
in that they lack neuraminidase activity (Kendal, 1974); it is
tempting to associate the greater virulence of A and B viruses with
their possession of the enzyme. The pathogenicity of influenza
viruses has been reviewed by Sweet & Smith (1980); little is known
about the determinants of virulence in these viruses but there is
genetic evidence that both the haemagglutinin and the neuraminidase
are important.
Pandemics of influenza A such as occurred in 1918, 1957 and
1968 are thought to be related to major shifts in antigenic pattern
such that antibody produced in response to previously circulating
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strains gives very little protection. The haemagglutinin (H) is
clearly the most important antigen; anti-H antibody is neutra¬
lising and protective. However, there is evidence that the neura¬
minidase (N) also plays a part and that anti-N confers a
significant degree of protection (see below). Influenza A virus
was first cultured from swine in 1931, and from man in 1933; since
then many isolates have been collected and compared in world-wide
surveys. Earlier attempts to classify the major antigenic changes
in influenza viruses have been revised in recent years; the
following outline is drawn from the discussions in Stuart-Harris &
Schild (1976), Ginsberg (1980), Palese & Young (1982) and Webster
et al. (1982).
Three major antigenic types of haemagglutinin (H-^, H2 and H3)
have been identified in human infections, but some nine others have
been recognised in animals and birds. There is considerable
interest in the possibility that human influenza A viruses may
occasionally infect animals and that new H antigens from animal
viruses may be picked up by human strains during mixed infection;
a number of animal strains have H antigens similar to those of
human strains, and there is evidence that the H antigen of the
swine virus isolated in 1931 (Hsw) had been present in human
strains in 1918. Two major N antigens have occurred in human
strains, before and N2 after 1957; these also occur in avian
strains and a further seven N antigens have been found in birds and
horses.
The antigenic make-up of strains prevalent between 1947 and
1957 was HjNj; the 1957 pandemic resulted from a major shift in
both antigens to H2N2 and in 1968 there was a further shift to H3N2
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strains. Serological evidence suggests that the strains prevalent
at the end of the 19th century were also H3N2 and that the 1918
pandemic was due to strains. The earliest available human
isolates, from 1933-47 have been classified as HqNj but it is less
certain that a major shift in H antigen occurred in 1947 and they
are often now included with the group.
The appearance of a new pandemic strain has usually been
associated with the disappearance of the previous epidemic strain,
although the reasons for this are not clear. In 1976 there was a
small localised outbreak of influenza in the USA due to a HSWN^
virus. This did not spread and rapidly disappeared again; it may
have had an animal origin. The following year saw the reappearance
of strains in China and Russia. They were very similar to
strains last seen 20 years previously in man and no animal
reservoir has been shown; it is possible that the origin was a
laboratory strain or that there are mechanisms by which such
strains can lie latent in man for long periods (Laver & Webster,
1979). Since 1977, for the first time in 40 years experience, two
antigenic types (H^N^ and H3N2) have circulated together in the
world. It seems that antibody to H^N-^ strains in the older group
of the population has helped to contain this strain and modify the
pandemic pattern otherwise expected after a major shift in both
antigens. The unpredictability of the antigenic patterns that may
emerge presents a very serious problem for the formulation of
vaccines that might give effective protection in future pandemics.
Against this background of major antigenic shift there is a
constant pattern of minor antigenic drift, an accumulation of small
changes in both H and N antigens that gradually produces strains
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that are less effectively inhibited by antibodies produced against
previously circulating strains and that may then cause local
epidemics. The genetic basis of shift and drift was originally
deduced from analysis of epidemiological and antigenic changes but
has recently been confirmed by detailed structural analyses of
representative haemagglutinin and neuraminidase molecules (see
Webster et al., 1982). Antigenic drift occurs by accumulation of
point mutations affecting the antigenic determinants of the
molecules, which are closely related within the whole serological
group; shift, however, represents a much more major change that
must be due to acquisition of a gene for a more distantly related
protein from another strain of virus. The influenza virus genome
consists of eight separate ribonucleoprotein segments, each
corresponding to a specific viral polypeptide. During experimental
mixed viral infections, such recombinants with reassortments of
these fragments from the parental strains can be produced.
The structure of influenza A viruses as revealed by electron
microscopy was reviewed by Wrigley (1979). Two types of protein
spike can be identified on the surface of the viral particles;
these are morphologically distinct and correspond to the
haemagglutinin and neuraminidase. There is a variable excess of
haemagglutinin spikes, usually in the proportion of c. 5 to 1. The
structure of the haemagglutinin has been investigated in detail
(see Ward, 1981). The gene product is a polypeptide of MW
c. 80,000 that is cleaved during maturation into two polypeptides,
HA-l (50,000) and HA2 (30,000), which remain bound together by
disulphide bonds. The haemagglutinin spike is a trimer of this
molecule arranged with a large glycosylated hydrophilic portion on
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the outside of the host-derived lipid envelope and a hydrophobic
portion at the base, inserted into the envelope. The tertiary and
quaternary structure of this unusual protein have been resolved in
considerable detail (Waterfield et al.r 1979; Wilson, Skehel &
Wiley, 1981; Webster et al., 1982). There are highly conserved
amino-acid sequences in a pocket at the end of the spike that is
thought to be the NANA-binding site. The antigenic sites are in
variable sequences on loops of the polypeptide chain exposed in the
superficial globular part of the spike (Wiley, Wilson & Skehel,
1981). Drift and shift are reflected in minor and major sequence
differences in these regions of the polypeptide; a dendrogram
charting the degree of relatedness within and between H-antigen
groups was given by Webster et al. (1982).
Similar information is now available for the N antigens. The
neuraminidase spikes are mush room-shaped on electron microscopy,
with the slender stalk inserted into the membrane (Wrigley, 1979).
Each spike is a tetramer of the gene product, an uncleaved poly¬
peptide of MW c. 60,000. Amino acid sequences have been determined
for the enzyme from several strains (Fields, Winter & Brownlee,
1981) and the three-dimensional structure of the spike has recently
been reported (Jackson & Webster, 1982; Varghese, Laver & Colman,
1983). The neuraminidase, like the haemagglutinin, is a trans¬
membrane glycoprotein with a short hydrophilic tail beyond the
hydrophobic intramembrane portion; the slender glycosylated stem
is relatively unfolded and flexible. The catalytic sites are
located on the upper corners of the box-shaped tetramer that forms
the head of the spike; the antigenic determinants are in variable
loops that form a nearly continuous surface across the top of the
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subunit, encircling the catalytic sites (Colman, Varghese & Laver,
1983). Comparison of amino acid sequences of variants between 1968
and 1975 confirmed the clustering of point mutations in these sites
during this period of antigenic drift. It is clear that the
haemagglutinin and the neuraminidase of influenza A virus have very
different structures and that the NANA-recognising pockets on the
two subunits are also dissimilar; this runs counter to an earlier
theory that the two molecules might have a common evolutionary
origin (Gottschalk, 1960; Wiley, 1983).
Hie properties of viral neuraminidases have been reviewed by
Drzeniek (1972), Rosenberg & Schengrund (1976b) and Schauer (1982).
The enzyme spikes can be released from the viral particles by
detergent disruption of the lipid envelope or by protease digestion
of the subunit stalk, and pure preparations are readily produced.
In general, viral neuraminidase is much more active against (2—>3)
linked substrates than the (2 6) forms; this can be used in
analysis of sialic acid linkage under carefully standardised
conditions when only the (2 -?3) linkage is hydrolysed (Gottschalk
& Drzeniek, 1972). Neuraminidases from different myxoviruses vary
greatly in their ability to hydrolyse (2 —* 8) linkages (Corfield &
Schauer, 1982b). The pH optimum, temperature optimum and Km
values, as with bacterial neuraminidases, may vary with different
substrates, buffers and ionic strengths; the pH optimum is usually
9+
in the range 4.5-6.5. Most viral neuraminidases are strongly Ca
dependent.
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Biological role of viral neuraminidase
The replication cycle of influenza virus in cell cultures was
reviewed by Stuart-Harris & Schild (1976) and Ginsberg (1980). The
roles of the haemagglutinin and the neuraminidase have been
investigated in a variety of ways, including the use of specific
antisera prepared against each subunit. It appears that they have
inter-related roles, with the haemagglutinin primarily involved in
initiation of infection whereas the neuraminidase is more important
in viral release and spread. The haemagglutinin is responsible for
initial attachment of the virus to sialic-acid-containing molecules
(receptors) on the host-cell surface; anti-H antibody neutralises
the virus, preventing attachment and infection. Neuraminidase is
not thought to play a direct role in this process as anti-N does
not interfere with infectivity.
After adsorption the viral ribonucleoprotein enters the cell
cytoplasm, although the detailed process by which initial binding
of NANA receptors by the tips of the haemagglutinin spikes leads to
fusion of the viral envelope with the cell membrane remains
unclear (see Kaariainen & Pesonen, 1982). When influenza virus
binds to red cells there is no fusion or infection and the virus
soon elutes again from the cells as neuraminidase splits the NANA
from the cell-surface glycoconjugates, destroying the receptors.
When virus adsorbs to susceptible host cells, fusion occurs before
neuraminidase action can elute the particles again. The relative
proportions of the two viral subunits and their relative affinities
for particular types of surface sialoglycoconjugate presumably
determine the balance between binding and elution; this is
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reflected in the classic studies demonstrating a receptor gradient
on red cells for different types of myxovirus (Burnet et al., 1946;
Ginsberg, 1980). A similar process is thought to occur in natural
infection when influenza virus encounters glycoproteins in the
mucus that overlies the respiratory epithelial cells; after
initial unproductive binding the virus is released again. It
appears that this is one of the major roles of the viral enzyme,
enabling the particles to penetrate the protective mucus layer that
lies between the inhaled virus and the target epithelial cells
(Gottschalk & Bhargava, 1971).
Neuraminidase is not thought to have an essential role during
intracellular replication of myxoviruses (see Drzeniek, 1972);
influenza C virus and a number of paramyxoviruses either lack or
have very weak neuraminidase activity, and neuraminidase-defective
mutants of influenza A virus have been isolated (Palese et al.,
1974). It may be, however, that neuraminidase is a virulence
factor for influenza A virus, processing viral glycoproteins by
preventing addition of sialic acid during their production in the
infected cell. Nakajima & Sugiura (1980) demonstrated that in at
least certain experimental infections this action is required in
order to expose the site for proteolytic cleavage of haemagglutinin
to HAj and HA2, a step that is essential for infectivity. Palese
et al. (1974) suggested that if viral glycoproteins are not
desialylated before viral release there is aggregation of the
progeny virus due to interaction of haemagglutinin with NANA on
other virions.
A number of lines of evidence have suggested that
neuraminidase is important in viral release and spread and that
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anti-N is protective at this point in the replication cycle.
During infection haemagglutinin and neuraminidase subunits are
produced and inserted into localised areas of host-cell membrane;
the mature virus is produced by budding, the ribonucleoprotein core
picking up its envelope complete with spikes as it passes through
the altered cell surface. Rosenberg & Schengrund (1976b) suggested
that the localised removal of sialic acid from these areas of host-
cell membrane may alter the physico-chemical properties of the
membrane so as to permit budding and viral release. Removal of
cell-surface sialic acid is also important to prevent emerging
virus from readsorbing to the host cell. The effect of specific
anti-N on replication of influenza virus was investigated by Seto &
Rott (1966) and by Dowdle, Downie & Laver (1974); the number of
plaques was not affected but the size of the plaques was markedly
reduced, suggesting interference with viral release. This was
initially ascribed to inhibition of enzyme activity at the cell
surface but later studies suggested that this might not be the only
mechanism. Divalent antibody may limit viral release by
aggregating viral particles or by bridging between neuraminidase
subunits in the emerging virus and in the infected host-cell
membrane; univalent Fab fragments that could inhibit the enzyme
activity did not reduce virus release (Becht, Hammerling & Rott,
1971).
Antibody to both haemagglutinin and neuraminidase is easily
produced in man and in laboratory animals in response to natural or
experimental infection or to administration of killed whole virus
or purified subunit vaccines. Hie viral enzyme is a good antigen,
perhaps because of its particulate form in the viral envelope.
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Anti-N may be detected by its ability to inhibit enzyme activity,
though immunodiffusion techniques may be more convenient (see
Stuart-Harris & Schild, 1976). The degree of inhibition of the
enzyme by antibody depends on the test substrate; anti-N gives
complete inhibition with high-MW glycoproteins but only partial
inhibition with smaller glycopeptides and an insignificant effect
with sialyl-lactose as substrate (Fazekas de St Groth, 1963). The
structural data reviewed above confirm that the catalytic site is
distinct from the antigenic determinants, so that inhibition is by
steric hindrance and is more efficient with larger substrate
molecules.
Most studies have used serum antibody levels in assessing the
immune response to influenza viruses, and there is good correlation
between these and immunity. It may be argued that secretory
antibody in respiratory tract mucus, perhaps largely IgA, is more
likely to mediate the protective effect in this disease where virus
remains localised and very seldom spreads to blood or other
tissues; however, secretory antibody is much more difficult to
study directly and may often correlate reasonably with serum
antibody responses. Although there is evidence that cell-mediated
immunity is important in experimental mouse infection (Virelizier,
Allison & Schild, 1979) the importance of this aspect of the immune
response in natural human infection remains in some doubt (Potter &
Oxford, 1979).
The availability of sera with high specific anti-N activity
but lacking anti-H effective against a particular challenge strain
of influenza virus allowed assessment of its protective effect in
experimental infections. Schulman, Khakpour & Kilbourne (1968)
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showed passive protection by anti-N in mice, and Rott, Becht &
Orlich (1974) confirmed this in chicks. Various studies have shown
the protective effect of anti-N for experimental infection in human
volunteers (e.g. Murphy, Kasel & Chanock, 1972; Couch et al.,
1974). A protective effect during natural infection was
demonstrated by Monto & Kendal (1973) who related attack rates with
the new H3N2 pandemic strain to the presence or absence of serum
anti-N2 produced by previous exposure to H2N2 infection. It is now
generally accepted that anti-N does give useful protection in man
and both haemagglutinin and neuraminidase are included in most
human vaccines (see Tyrrell & Smith, 1979). A case has also been
made for the use of purified neuraminidase subunit vaccine in order
to modify subsequent natural infection and produce long-lasting
immunity to both antigens (Couch et al., 1974; Arora, 1979).
Thus there is no doubt of the importance of neuraminidase in
the natural history of influenza A virus and of anti-neuraminidase
in helping to limit its spread. The enzyme probably has a direct
role in hydrolysing glycoproteins and helping the virus to
penetrate protective mucus layers. The viruses have evolved a
specific adhesion mechanism, the haemagglutinin, that greatly
increases their ability to bind to and infect the target cells in
the host's respiratory tract epithelium. However, this mechanism
also brings disadvantages because it would lead to non-specific
binding to NANA residues present on mucus glycoproteins, etc., and
without the enzyme this would lead to enhanced trapping by non¬
specific inhibitors. Similarly, during release of the virus the
haemagglutinin would tend to readsorb to NANA residues on the
host-cell surface, with reduced viral dispersal. For dissemination
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from the host the virus must not only be able to spread locally to
other cells in the upper and lower respiratory tract but must also
be able to penetrate the mucus and be dispersed in active form in
respiratory droplets; here again the enzyme is required to prevent
neutralisation of the virus by adsorbed sialoglycoprotein.
There are some parallels between these processes in influenza
virus infection and those involved with bacteriophage infection of
capsulate host strains. In a number of cases specific enzymes able
to hydrolyse the capsular polysaccharide have been shown to be
associated with the bacteriophage tail and to facilitate
penetration and release. The presence of neuraminidase has
recently been demonstrated in two bacteriophages that infect
strains of Escherichia coli of capsular type Kl; this capsular
material is colominic acid, the (2 —> 8) linked polymer of NANA, and
the bacteriophage enzyme is unusual in giving good hydrolysis of
this material (Kwiatkowski et al., 1983).
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BACTERIAL NEURAMINIDASE
Bacterial neuraminidase was initially detected during inves¬
tigations of the interactions of influenza viruses with red blood
cells by Burnet and co-workers in the 1940's. The enzyme was first
demonstrated in culture supernates of Clostridium perfrinapns and
Vibrio cholerae (Burnet et al.. 1946; Burnet & Stone, 1947; McCrea,
1947); these remain the most intensively studied and widely used
bacterial neuraminidases. Hie production of the enzyme by various
other micro-organisms was reviewed by Drzeniek (1972) and Muller
(1974a); table Intro/V lists species representative of the main
groups of neuraminidase-producing organisms, which include cocci
and bacilli, aerobes and anaerobes, Gram-positive and Gram-negative
species. It should be appreciated that in many cases only a small
number of strains have been examined and that in some cases only a
proportion of these could be shown to produce the enzyme.
Several different groups of Gram-positive bacteria have been
shown to contain neuraminidase-positive species. Chu (1948)
reported receptor-destroying enzyme activity in Streptococcus
pneumoniae: the neuraminidase was later characterised and shown to
be produced by many clinical isolates (Kelly, Greiff & Farmer,
1966; Kelly, Farmer & Greiff, 1967). Strains from a variety of
other streptococcal species also produce neuraminidase, including
various oral strains of the viridans group, e.g. of Streptococcus
sanguis and Streptococcus mitis (Laurell, 1959; Hayano & Tanaka,
1969; Hayano, Tanaka & Okuyama, 1969). Only a few strains of
Lancefield group-A streptococci produce the enzyme (Davis, Baig &
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be neuraminidase-positive (Mattingley et al., 1980); other positive
strains have been found in serogroups C, E, Gf H, K and L (see
Muller, 1974a). The enzyme is also produced by Bifidobacterium
bifidum (Lactobacillus bifidus). a commensal found in large numbers
in the gut in breast-fed infants, but has not been found with other
lactobacilli (Shilo,1957; Von Nicolai & Zilliken,1972); these
organisms are sometimes grouped with the streptococci in the
broader category of Lactobacillaceae.
Many species of Clostridia besides Clostridium perfrinaens
produce the enzyme; these are reviewed in the Discussion section.
The original investigations of panagglutinability found that
diphtheroid strains could produce the Thomsen-Friedenreich
phenomenon (Friedenreich, 1930). Later studies (Blumberg & Warren,
1961; Warren & Spearing, 1963) detected neuraminidase activity in
crystalline preparations of diphtheria toxin; Moriyama & Barksdale
(1967) demonstrated its production in cultures of Corynebacterium
diphtheriae and confirmed that it was quite distinct from the
toxin. A number of other corynebacterial strains have also been
found to produce the enzyme, including Corynebacterium
haemolyticum. Corynebacterium pyogenes. Corynebacterium ulcerans.
Propionibacterium acnes and commensal diphtheroids now classified
as Brevibacterium species (Muller, 1974a; Tisserand-Jochem, 1974;
Von Nicolai, Muller & Zilliken, 1975; Vertiev & Ezepchuk, 1981).
Various other Gram-positive bacteria may be broadly related to the
corynebacteria, whose classification remains difficult. Neura¬
minidase production has been found with Arthrobacter species
(Uchida, Tsukada & Sugimori, 1977; Wang et al.. 1978) and with
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Erysipelothrix rhusiopathiae (insidiosa) (Muller, 1974c; Von
Nicolai, Muller & Zilliken, 1978). Arden, Chang & Barksdale (1972)
surveyed a representative range of corynebacteria and related
Mycobacterium and Nocardia species but found the enzyme only in the
genus Corvnebacterium.
Neuraminidase is also produced by several Gram-negative
bacterial species. In addition to Vibrio cholerae. a number of so-
called non-agglutinable vibrios and some animal strains of
Campylobacter (Vibrio) foetus have been reported to produce the
enzyme (Morris & Park, 1971; Muller,1973a,1974a). A number of
early reports using indirect techniques have not been confirmed,
e.g. those of Shilo (1957) for various Pseudomonas species and
Laurell (1959) for Pasteurella pseudotuberculosis. However, the
enzyme has been clearly demonstrated in Pasteurella multocida and
Pasteurella haemolytica (Scharmann, Drzeniek & Blobel, 1970). Oral
strains of Haemophilus influenzae and Haemophilus parainfluenzae
have been found to produce neuraminidase (Tuyau & Sims, 1974)
though it has not been reported in strains causing systemic
infections (CTToole, Goode & Howe, 1971). Amongst the
Enterobacteriaceae it has been detected only in
Klebsiella aeroaenes (Pardoe, 1970). Muller & Werner (1970b)
described neuraminidase production by Bacteroides fragilis and some
other strictly anaerobic species of Gram-negative bacilli; this
group of organisms is reviewed in the Discussion section.
A number of other microbial sources of the enzyme have been
reported. Several Mycoplasma species adsorb to NANA-containing
receptors on host cells but only Mycoplasma gallisepticum has been
reported to produce a neuraminidase (Sethi & Muller, 1972); this
67
might imply parallels with myxoviruses, although later workers have
failed to confirm the original report (Glasgow & Hill, 1980). The
enzyme has been detected in cultures of a few species of
Streptomyces (Myhill & Cook, 1972; Kunimoto et al., 1974) and also
in some eukaryotic fungal species of Sporotrichum and Penicillium
(Uchida, Tsukada & Sugimori, 1974). Neuraminidase production has
also been reported in the protozoal pathogens Trichomonas foetus
(Watkins & Morgan, 1954; Romanovska & Watkins, 1963) and
Trypanosoma cruzi (Muller, 1974a).
A number of reviews have covered various aspects of bacterial
neuraminidases (Rafelson, Schneir & Wilson, 1966; Gottschalk &
Bhargava, 1971; Drzeniek, 1972, 1973; Gottschalk & Drzeniek, 1972;
Rosenberg & Schengrund, 1976b; Corfield & Schauer, 1982b; Schauer,
1982). The present account is limited to a general outline; a
fuller assessment of the neuraminidases produced by anaerobic
bacteria and their possible role in pathogenesis is reserved for
the Discussion section.
Neuraminidase remains cell-associated in some bacterial
species, e.g. Corynebacterium diphtheriae (Moriyama & Barksdale,
1967) and Pasteurella multocida (Drzeniek, Scharmann & Balke,
1972), but there may be variable release into the culture medium
with a number of bacteria; the high levels of exoenzyme production
found with Vibrio cholerae (Rosenberg, Binnie & Chargaff, 1960),
Clostridium perfrinaens (Cassidy, Jourdian & Roseman, 1966) and
pneumococci (Kelly et al., 1966) have provided the most convenient
starting material for preparation and purification of the enzyme.
Enzyme production depends on the culture medium and in a number of
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cases has been found to be inducible when various substrate
preparations or sialic acid derivatives are added to a basal medium
that lacks glucose (see Pardoe, 1974). This has been shown for
Vibrio cholerae (Ada & French, 1959; French & Ada, 1959), pneumo-
cocci (Kelly et al., 1966), Pasteurella multocida (Drzeniek et al.,
1972), Klebsiella aerocenes (Pardoe, 1970), Clostridium oerfrincens
(Nees & Schauer, 1974a) and Arthrobacter sialoohilus (Wang et al..
1978).
The split product of neuraminidase activity, NMA, may tend
to inhibit the enzyme's activity but it may also induce production
of N-acylneuraminate pyruvate-lyase (NAN-lyase; EC 4.1.3.3), an
enzyme that degrades free NANA to pyruvate and N-acetyl
mannosamine; the latter may act to induce neuraminidase production
in some bacterial species so that production of both enzymes is co¬
ordinated (see Pardoe, 1974; Rosenberg & Schengrund, 1976b). The
Clostridium oerfrinaens NAN-lyase has been most intensively studied
(Comb & Roseman, 1960; Brunetti, Swanson & Roseman, 1963; Nees et
al.. 1976) but it has also been detected in many other
neuraminidase-producing organisms (Arden et al., 1972; Drzeniek et
al.. 1972; Muller, 1974a). NAN-lyase activity is also found in
various mammalian tissues, where it may have a regulatory role in
sialic acid metabolism; the reaction is reversible but a catabolic
role is favoured (Corfield & Schauer,1982b). The combination of
neuraminidase and NAN-lyase is thought to enable bacteria not only
to degrade sialoglycoconjugates but also to take up the released
NANA and use its constituents as a source of energy (Schauer,
1982).
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Methods for purification of bacterial neuraminidases have
been reviewed by Rosenberg & Schengrund (1976b) and Wadstrom
(1978); it should be appreciated that purification and character¬
isation has been undertaken with only a few of the bacterial
species listed above. In general, conventional methods of protein
purification have been used, usually with ammonium sulphate
fractionation followed by chromatographic separation, but this
often gives preparations that are still contaminated with other
bacterial enzymes or toxins (Kraemer, 1968; Den, Malinzak &
Rosenberg, 1975). More recent techniques such as affinity
chromatography, polyacrylamide gel electrophoresis and isoelectric
focusing have yielded very pure preparations (see Rosenberg &
Schengrund, 1976b; Schauer, 1982).
Determinations of MW of bacterial neuraminidases have usually
given results between 50,000 and 90,000 (see Wadstrom, 1978). In a
number of cases there is evidence for multiple forms of the enzyme
with different MW, perhaps partly attributable to proteolytic
digestion (Rosenberg et al., 1960; Rood & Wilkinson, 1976a;
Uchida, Tsukada & Sugimori, 1979; Corfield & Schauer, 1982b); no
definite evidence for subunit structure is available. A number of
H * .
isoenzymes of similar MW but different charge were found in studies
of pneumococcal neuraminidase (Tanenbaum & Sun, 1971); micro-
heterogeneity of neuraminidase molecules was also detected by
Moriyama & Barksdale (1967) and Nees et al. (1975).
The pH optimum of a particular neuraminidase may vary
considerably when tested with different substrates (Rafelson,
Schneir & Wilson, 1963; Schauer, 1982), with different buffer
ions (Cassidy et al., 1966) or at different ionic strengths
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(Barton, Vaskresenija & Rosenberg, 1975). Optimal pH values quoted
for bacterial neuraminidases are usually in the range 4.5-6.5
(Drzeniek, 1972). Neuraminidases may also vary in their calcium
dependence and sensitivity to EDTA (Boschman & Jacobs, 1965;
Drzeniek, 1972); the enzyme produced by Vibrio cholerae is very
calcium-dependent but most other bacterial neuraminidases are not
markedly so.
The specificity of various bacterial neuraminidases was
reinvestigated by Schauer (1982) using a range of well-defined
substrates. Glycoconjugates containing N-glycolyl sialic acids are
hydrolysed less well than N-acetyl forms, and the presence of the
4-0-acetyl group markedly reduces hydrolysis by most neura¬
minidases. Most bacterial enzymes have a broad range of activity
and are able to hydrolyse (2—*3), (2—»6) and ( 2->8) linkages in
oligosaccharide and glycoprotein substrates. Generally, bacterial
neuraminidases have greatest activity with (2—*3) and least with
(2 —* 8) linkages but a number of bacterial enzymes have been found
with different affinities, e.g. the Arthrobacter ureafaciens enzyme
is most active against the (2—>6) linkage (Uchida et al., 1979).
Bacterial enzymes can remove the external NANA residues from
gangliosides; the internal NANA is resistant to Vibrio cholerae
and most other bacterial neuraminidases but can be slowly hydro¬
lysed by the Clostridium oerfrinaens enzyme in the presence of bile
salts (Gatt, Gazit & Barenholz, 1981). The broader substrate range
of bacterial neuraminidases may be related to their occurrence as
soluble exoenzymes of relatively low MW in contrast to the higher
MW of the tetrameric viral enzyme subunits and the particulate
membrane-associated mammalian enzymes.
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Biological role of bacterial neuraminidase
The biological role of bacterial neuraminidase is not fully
understood but it seems probable that it is basically a digestive
and nutritional enzyme. It is unlikely that it has a primary
intracellular role in normal bacterial metabolism as the enzyme
occurs much more widely than do sialic acids, which are relatively
uncommon in bacterial species. It is often associated with NAN-
lyase, although either enzyme may occur alone in various species
(Arden et al., 1972; Muller, 1974a). Production of both enzymes
allows release of sialic acids from sialoglycoconjugates and
subsequent use of the constituents as a source of energy; Schauer
(1982) discussed the co-ordination and induction of this pathway,
which may also require a permease for uptake of NANA since NAN-
lyase is an intracellular enzyme. Even in species where
neuraminidase is predominantly cell-associated it appears that at
least a proportion of the enzyme is available on the cell surface
to interact with exogenous substrate (Pardoe, 1974).
The broad substrate specificity of most bacterial neuramini¬
dases also tends to support a general role as a digestive enzyme.
Removal of terminal NANA residues is an important first step in the
degradation of glycoproteins and glycolipids; in some cases
neuraminidase treatment may be necessary before protease can attack
glycoproteins (Schauer, 1982). A number of neuraminidase-producing
bacteria, e.g. streptococci and Clostridia, produce a range of
other extracellular enzymes that can degrade glycoproteins or
attack cell-surface constituents, e.g. protease, hyaluronidase,
phospholipase and various glycosidases; it seems probable that
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neuraminidase may be a useful addition to this family of digestive
enzymes and will play a role in nutrition of the bacteria in
various natural environments.
As previously outlined, substrates for neuraminidase action
are common in nature, being widespread in vertebrates and higher
invertebrates although not occurring in lower eukaryotes, plants
and most prokaryotes. Saprophytic bacteria have an important
scavenging role and neuraminidase is likely to be of assistance in
breaking down mucous secretions, faecal material and dead tissues.
Some saprophytic organisms live primarily in soil but others are
also commensals of higher animals, colonising epithelial surfaces
and being constantly shed from the body to the environment along
with dying cells, faeces, etc. Commensal organisms live in a
symbiotic association with the host, having a protected environment
and deriving nutrition from it, sometimes carrying out biochemical
transformations of value to their host, and helping to exclude more
pathogenic species from various ecological niches in the host. The
distinction between commensal and pathogen is a fine one and many
bacteria may be on either side of the boundary, depending on the
biochemical attributes of particular bacterial strains and on the
defence mechanisms of the individual host. At death, the commensal
flora are no longer controlled and play their part as saprophytes
in digesting the tissues of the corpse.
The list of neuraminidase-producing organisms (see table
Intro/V) contains many bacteria that are commensals of man and
animals; even such well-known pathogens as Clostridium perfrin-
qens. Vibrio cholerae and Corvnebacterium diphtheriae may also have
a commensal role or be associated with long-term symptomless
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carriage. A variety of species of Clostridia, corynebacteria,
streptococci, bifidobacteria and bacteroides organisms are
prominent in the commensal flora of human epithelial surfaces, on
the skin, in the mouth, throat, gut or vagina. In all these sites
there are sialoglycoconj ugates in mucous secretions and on
epithelial cell surfaces and it seems probable that neuraminidase-
producing bacteria will play a part in their breakdown (Gottschalk,
1960; Collee, 1965b; Muller, 1974a).
The lower gut in particular contains large numbers of
bacteria that thrive on the nutrients available in the dietary
debris, the intestinal secretions and the large number of cells
that are shed daily from the intestinal epithelium. The absorptive
power of the lower gut is limited and most of the nutrients
reaching the colon are utilised by the bacterial flora. Hoskings
(1978) discussed the role of bacteria in degradation of
glycoproteins in saliva and intestinal secretions. Studies with
germ-free rats confirmed that bacterial glycosidases are required
for degradation of the oligosaccharide portion of the intestinal
mucus, although host mechanisms may be largely responsible for
proteolysis. Neuraminidase activity in the gut and saliva is
almost entirely contributed by bacteria; a considerable amount of
sialoglycoconjugate remained in the faeces of germ-free animals
whereas almost none was detectable in normal faeces.
When this broad picture is considered it is not surprising
that a number of saprophytic and commensal bacteria can produce
neuraminidase as a digestive and nutritional enzyme; medical
interest in bacterial neuraminidase derives from the possibility
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that the enzyme may also be a virulence factor for some pathogenic
species, contributing to damage of host tissues or the evasion of
host defences even though it is not itself directly toxic. For
many years the main advances in analysing bacterial pathogenesis
lay in the detection and characterisation of specific toxins that
could reproduce the main features of clinical disease. This
approach has had many successes, e.g. with diphtheria, tetanus and
cholera toxins, but it is apparent that even in these diseases
other factors are also important, while there are many diseases
where the damage to the host cannot be attributed to individual
toxic products.
Possible roles of neuraminidase in bacterial pathogenicity
Pathogenicity is the result of interaction between micro¬
organisms and the host. Both sides of the equation are important;
the majority of infections occur in people who are in some way
compromised - the old, the very young, those with previous injury
or surgery, tumours, immunosuppression, etc. Only a proportion of
those exposed to bacterial challenge develop clinical infection and
the severity of infection varies considerably; this reflects
differences in the individual's specific and non-specific defence
mechanisms as well as factors in the challenge organism. A few
bacteria are clearly virulent organisms capable of causing severe
infection in healthy people but many also have a commensal role and
only occasionally invade and cause disease. Related strains and
species of bacteria can be shown to be of different virulence in
experimental models of infection. Some bacteria are almost
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incapable of producing infection. The factors that distinguish
pathogens and potential pathogens from non-virulent organisms are
of great interest as the identification of such virulence
determinants may suggest additional therapeutic strategies for
control of infection. It seems probable that neuraminidase will
continue to play a digestive and nutritional role for bacteria that
can invade the tissues and produce disease; it is less certain
whether it may be a virulence determinant contributing to the
ability of particular bacteria to cause infection.
The broad picture of bacterial pathogenesis has been
discussed by Smith (1978) and Mims (1982). Pathogenicity can
seldom be understood in terms of a single virulence factor as
different factors are likely to be important at different stages in
the process of infection. Successful pathogens have to enter the
host and reach the target area; bacterial adhesion and other
mechanisms of localisation are the subject of much current interest
(see Arbuthnott & Smyth, 1979; Ofek & Beachey, 1980). Many
bacteria have to be able to evade the host's non-specific defence
mechanisms by penetration of protective mucus and inhibition of
phagocytosis or intracellular killing; bacterial capsules and other
surface components may be important for these processes (Smith,
1977). Pathogenic bacteria must be able to obtain nutrients in or
on the host tissues and to compete for essential factors, e.g. iron
(Bullen, Rogers & Griffiths, 1978). Damage to the host tissues may
be direct, by toxins and exoenzymes, or indirect, leading to damage
by inflammation, hypersensitivity or autoimmune reactions (see
Arbuthnott, 1978a; Stephen & Pietrowski, 1981). In chronic
infections, pathogenic organisms may require mechanisms for
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avoiding elimination by the host's specific humoral or cell-
mediated immune responses.
Neuraminidase is produced in vitro by a number of important
pathogenic bacteria and it might be postulated that it plays a role
in some of these processes if it is also produced in vivo during
infection. Pardoe (1974) showed that the enzyme can be induced in
vitro by a wide range of sialic-acid-containing substances present
in mammalian secretions and tissues, and argued that this also
occurs in vivo. The presence of bacterial neuraminidase in blood
or tissues during natural or experimental infection has been
demonstrated directly on a number of occasions (e.g. Gadalla &
Collee, 1968; Seger et al., 1980; Hof & Loegering, 1982;
Schauer, 1982), although the difficulties in distinguishing
bacterial and mammalian neuraminidase with confidence must be borne
in mind. Production of the enzyme in vivo has also been deduced by
the demonstration of alterations attributable to neuraminidase in
serum or exudate proteins during infection (e.g. Muller, 1970b,
1974a; Muller & Werner, 1970a) or by demonstration of exposed T
antigen on red blood cells or in other tissues (Klein et al., 1977;
Seger et al., 1980; Seges et al., 1981).
The original evidence for the importance of neuraminidase in
infection came from analyses of its role in myxovirus infection
(see Drzeniek, 1972). It was initially thought that the production
of both haemagglutinins and neuraminidases by some bacterial
species might indicate similarities with the process of influenza
virus infection. The occurrence of bacterial haemagglutinins was
reviewed by Neter (1956); it soon became clear that they might be
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either structural or soluble factors (Duguid et al., 1955). The
structural haemagglutinins of various bacteria are common fimbriae
or related filamentous structures such as the K88 antigen of
Escherichia coli (see Duguid & Old, 1980); such surface structures
may play an important role in bacterial adhesion to their target
cells but the receptors are different from the NANA-containing
receptors for myxoviruses (see Ofek & Beachey, 1980) and there is
no correlation with neuraminidase production. Soluble haemag¬
glutinins are bacterial products that can adhere to red cells and
alter their sedimentation pattern. In general there is little
correlation between the production of soluble haemagglutinins and
neuraminidase by bacteria (Muller, 1974a; Tuyau & Sims, 1974) and
their biological significance remains in doubt (Tavendale et al.,
1983).
The closest parallel has been found with clostridial haemag¬
glutinins. Collee (1961, 1962, 1965a and b) was able to
distinguish the haemagglutinin of Clostridium perfringens from the
phospholipase-C and most of the other soluble products of the
organism. It was very closely associated with the neuraminidase,
although not identical; freshly isolated neuraminidase-positive
strains were haemagglutinin-negative. He concluded that the
haemagglutinin may be an inactive form of the enzyme. Similar
findings were made for the haemagglutinin and neuraminidase of
Clostridium seoticum although with this species the haemagglutinin
was also produced by freshly isolated strains (Gadalla & Collee,
1967, 1968). The relationship between the haemagglutinin and
neuraminidase of Clostridium perfrinaens was further investigated
by Rood & Wilkinson (1975, 1976a and b). Mutants defective in
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haemagglutinin production were also defective for neuraminidase; a
revertant that regained haemagglutinin production also regained
enzyme production. These workers purified the enzyme and found at
least two apparently unrelated molecular species; chromatographic
methods failed to separate the haemagglutinating and enzymic
activities. These studies provide further genetic evidence that
the haemagglutinin is likely to be an altered form of the enzyme
with affinity for erythrocyte receptors but unable to complete its
enzymic action (see Wadstrom, 1978); studies by Tatsuki et al.
(1981) with a different strain of C perfringens, however, did not
confirm that production of the two products was regulated by a
common genetic mechanism.
There is no evidence that clostridial haemagglutinin plays a
part in bacterial adhesion in vivo and there are obvious
differences between the situation with these bacteria and with
influenza viruses. It is unlikely that bacterial neuraminidase
will play a role similar to that of viral neuraminidase in the
complex inter-relationship outlined above where the enzyme appears
to be necessary to compensate for the presence of a powerful
attachment factor. However, bacterial neuraminidase may well have
a comparable role in attacking protective mucous layers and
reducing viscosity, preventing bacterial entrapment and allowing
access to target cells for bacteria or their toxins. As Gottschalk
(1960, p. 102) suggested, the enzyme may have evolved "as part of a
vital mechanism to guard the organism against separation from its
environment by layers of mucin covering its surface".
79
It appears that mammalian neuraminidase is predominantly an
intracellular enzyme, with carefully regulated activity required
for the controlled metabolism of sialoglycoccnj ugates. The intro¬
duction of exogenous bacterial neuraminidase during infection is
likely to hydrolyse MA residues from important circulating glyco¬
proteins and cell-surface components, which may profoundly affect
their function, distribution and lifespan in the body. Studies of
the effect of injecting bacterial neuraminidases into experimental
animals have not shown it to have direct toxic effects (e.g.
Burton, 1963) unless large amounts are given, when effects on
plasma proteins, red cells and thrombocytes can be shown (Ejby-
Poulsen, 1954b; Choi jgt al., 1972; Gregoriadis j=t al., 1974;
Ronnenberger, 1974). Although neuraminidase is not a classical
bacterial toxin, it might be an aggressin, contributing to the
pathogenic effect produced by other bacterial factors, and it might
occasionally produce the haemolytic or coagulation disorders that
may be late complications in a number of severe infections (Seges
3t .al., 1981).
The general proposition that neuraminidase plays a role in
bacterial pathogenesis has been supported by two main lines of
argument. Muller (1974a) claimed that there is a strong
correlation between pathogenicity and neuraminidase production. He
argued that in several groups of bacteria the enzyme was produced
by the more virulent strains and species, whereas less virulent
commensals produced much lower levels or failed to produce it at
all. He suggested that the enzyme was commonly inducible in
pathogenic bacteria but less so in commensal strains; the ability
to boost production of neuraminidase to high levels _in vivo would
80
be a virulence determinant for such strains. Furthermore he argued
that the enzyme produced by pathogenic bacteria was more active,
with a wider range of substrate specificity, and that this
explained the greater virulence of these strains.
The other main line of argument has been the enumeration of
biological effects of the enzyme in various test systems.
Rosenberg & Schengrund (1976b) listed 123 reports of the effect of
neuraminidase on a wide range of glycoconjugates, circulating blood
cells and normal or abnormal tissue cells, and argued that such
findings, though incomplete, "are suggestive of a role for
bacterial sialidase in the aggressive survival of bacterial
pathogens". Many such examples of possible effects of exogenous
neuraminidase produced during infection have been indicated in this
Introductory Review; the possible role of the enzyme in the patho¬
genicity of particular groups of bacteria is considered in more
detail in the following pages.
Pathogenicity of various neuraminidase-producina bacteria
Pneumococci. Pneumococcal strains are commonly present as
commensals in the nasopharynx but may become involved in lower
respiratory tract infection in people with chronic respiratory
disorders or following viral infections. Some strains are more
virulent and can produce outbreaks of pneumonia (classically lobar
pneumonia) in previously healthy young people. Pneumococci are an
important cause of meningitis and can produce serious septicaemia;
haemolytic-uraemic syndrome has also been associated with
pneumococcal infection. The pathogenesis of pneumococcal
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infection remains poorly understood; no conventional exotoxins
have been demonstrated and attention has focused on neuraminidase
as a probable toxic factor. Kelly and his colleagues (Kelly &
Greiff, 1970; Kelly et al., 1966, 1967) found that the enzyme was
produced by all of 77 recent clinical isolates although it was
lacking in several laboratory-adapted strains. Sterile extracts of
neuraminidase-producing strains proved lethal on intraperitoneal
injection into weanling mice; the toxicity was related to the
neuraminidase content. They further demonstrated that purified
neuraminidase from these cell extracts was lethal when given either
by the intraperitoneal route or by direct intracerebral injection.
The enzyme has been shown to be produced during experimental
infections (e.g. Ejby-Poulsen, 1954a), and there is good evidence
for its production and activity during severe human infections, in
meningitis (Muller, 1970c; O'Toole et al., 1971; Vierbuchen &
Klein, 1983) and also in fatal haemolytic-uraemic syndrome, when T-
antigen exposure has been shown both on red cells and in the
glomeruli (Klein et al.. 1977; Seger et al., 1980). The detailed
mechanism of action of neuraminidase in pneumococcal respiratory
tract infection remains unclear although it seems probable that it
will play a part in combating the normal protective role of
respiratory mucus. The role of the enzyme in meningitis is also
uncertain. The enzyme can be detected in the CSF in pneumococcal
but not meningococcal or Haemophilus meningitis and it has been
suggested that its presence may correlate with coma and brain
damage (O'Toole et al., 1971); however, no effect on brain
gangliosides could be shown in experimental pneumococcal meningitis
in dogs (Carruthers & Kanokvechayant, 1973). Vierbuchen & Klein
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(1983) demonstrated T-antigen exposure in the choroid plexus in
three fatal cases of pneumococcal meningitis and attributed this to
bacterial enzyme in the CSF; adsorption of natural anti-T to the
altered choroid plexus endothelium might contribute to the
pathology. In haemolytic-uraemic syndrome the exposure of T
antigen on red cells, thrombocytes and renal glomeruli is
postulated to lead to adsorption of anti-T, haemolysis, glomerular
damage and the other features of the disease (Klein et al., 1977;
Seger etal., 1980).
Other factors are also of importance in pneumococcal
infection; Kelly & Greiff (1970) observed that a non-neuraminidase-
producing pneumococcal strain was also highly virulent for mice
although the cell extract from this strain was non-toxic. The
critical importance of the pneumococcal capsule has been recognised
for many years; the capsular material itself is non-toxic but it
protects the organism from phagocytosis (see Smith, 1977).
Nevertheless it is generally accepted that neuraminidase does
contribute to the pathogenicity of the organism and is a
significant virulence factor in severe pneumococcal infections.
Other streptococci. Muller (1974b) found high levels of
neuraminidase activity in isolates of Streptococcus sanguis and
other viridans streptococci isolated from patients with bacterial
endocarditis. The enzyme was shown to have been active in vivo,
producing characteristic changes in the electrophoretic pattern of
the serum proteins, and he argued that the virulence of these
strains correlated with their ability to produce higher levels of
the enzyme than were found with most commensal viridans
streptococci.
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Neuraminidase is also produced by some strains of group-B
streptococci (Streptococcus agalactiae). Milligan et al. (1978)
reported that high levels of the enzyme were produced by clinical
isolates of type-Ill group-B streptococci, which are particularly
associated with late-onset neonatal infections; interestingly,
group-B streptococci also have sialic-acid-containing surface
antigens (Baker & Rasper, 1976; Rasper et al., 1979; Doran,
Straus & Mattingley, 1980). Mattingley et al. (1980) surveyed a
range of type-Ill strains recently isolated from infected patients
and found that the majority, but not all, of the strains did
produce the enzyme. Durham e£ aJL. (1981) , investigating
neuraminidase production and virulence of type-Ill strains in
experimental infection of mice, found that although the enzyme was
produced by some virulent strains there was no general correlation
with virulence. The evidence for an association between virulence
and neuraminidase production in group-B streptococci is still
incomplete.
Davis et al. (1979) studied laboratory strains of group-A
streptococci (Streptococcus pyogenes). Neuraminidase-positive
strains were found only in particular serotypes (Tl, T4 and T12)
that have been associated with production of acute glomerulo¬
nephritis, a late complication of Streptococcus pyogenes infection
attributed to immune-complex formation. Hiey related their finding
to the observation by Mcintosh et al. (1972) that serum immuno¬
globulin treated with neuraminidase from a nephritogenic group-A
streptococcus could produce glomerular lesions in experimental
animals, and suggested that neuraminidase might be responsible for
generating an autoimmune response. However recent studies by
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Potter .et al. (1982) have not supported a link between neuramini¬
dase and post-streptococcal nephritis; none of 23 strains of T4
and T12 serotypes actually isolated from patients with glomerulo¬
nephritis produced the enzyme.
Oral bacteria. There is considerable interest in the oral
bacterial flora, partly because of the possible role of various
bacterial species in dental caries and gingival infections.
Neuraminidase activity in saliva and dental plaque is attributed to
their bacterial content (Rogers, Newbrun & Tatevossian, 1979). The
enzyme has been shown to be produced by some oral strains of
Streptococcus sanguis and Streptococcus mitis (Fukui, Fukui &
Moriyama, 1971) and by oral Haemophilus strains (Tuyau & Sims,
1974, 1975) but not by most other oral commensals. At one time it
was thought that neuraminidase action on salivary glycoproteins
might play a part in their precipitation on teeth and the formation
of dental plaque (Leach, 1963). However, no positive correlation
between neuraminidase levels and dental caries or periodontal
disease has been demonstrated (Perlitsh & Glickman, 1967) and
neuraminidase-treated salivary proteins cannot be shown to adhere
to teeth (Briscoe, Pruitt & Caldwell, 1972). Attention is now
focused primarily on the role of polysaccharides and dextran
production by Streptococcus mutans in the build-up of dental plaque
(see Gibbons & Van Houte, 1975; MoGhee & Michalek, 1981).
Corynebacterium diphtheriae. Neuraminidase production is
closely associated with diphtheria toxin production, and commercial
antitoxin against diphtheria toxin also contains anti-neuraminidase
antibody (Warren & Spearing, 1963). This raised the possibility
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that neuraminidase might have been responsible for some of the
observed effects of the toxin and that anti-neuraminidase might
contribute to the protective effect of the antiserum. However,
later studies with purified toxin have very successfully elucidated
the molecular mode of action of the toxin, which is clearly
responsible for the major features of the disease (see Murphy,
1976).
It remains possible that neuraminidase plays a role in the
local establishment of infection in the throat; little is known
about this process although successful colonisation must be a
prerequisite for the production of toxin and its clinical effects.
Ronnenberger (1974) showed that subcutaneous or intramuscular
injection of purified Vibrio cholerae neuraminidase into rabbits or
guinea pigs produced transient localised inflammatory signs.
Ezepchuk & Vertiev (1974) demonstrated similar findings with
purified neuraminidase from a non-toxigenic strain of
Corynebacterium diphtheriae and claimed that it might be
responsible for some of the oedema and spreading of the local
lesion in diphtheria. However, diphtheria toxin has marked
dermonecrotic activity and, since mass immunisation with diphtheria
toxoid has led to virtual disappearance of the organism rather than
its transmission in the immunised population as a throat commensal,
it seems probable that the toxin itself plays a critical part in
the colonisation of the throat and subsequent dissemination.
Neuraminidase may play a part in attacking pharyngeal secretions
but any more central role in the pathogenesis of diphtheria remains
hypothetical.
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Vibrio cholerae. The pathophysiology of cholera is now
understood in considerable detail but the importance of the large
amounts of extracellular neuraminidase that Vibrio cholerae
produces remains uncertain. There appears to be a correlation
between virulence and neuraminidase production in Vibrio species;
large amounts are produced by virulent strains isolated from human
infections but much lower levels by environmental strains and non-
cholera vibrios (Solovev et al.. 1972; Muller, 1973a).
Gastrointestinal infections similar to cholera are produced
in young animals and human neonates by strains of Escherichia coli:
there are many parallels with cholera but these species do not
produce neuraminidase. In each case the organisms penetrate the
protective mucous secretions and localise in the upper small bowel,
resisting the host's normal defences against bacterial colonisation
and the mechanical cleansing produced by peristalsis and the high
flow rate of intestinal contents (see Savage, 1980). They then
produce enterotoxins, which adsorb to receptors on the epithelial
cells; the toxin activates adenylate cyclase inside the cell and
switches on the secretion of fluid and electrolytes into the gut
that is responsible for the clinical syndrome (see Holmgren, 1981).
For enterotoxigenic strains of Escherichia coli. attachment to the
intestinal epithelium is mediated by surface bacterial structures
such as the K88 antigen found in strains that infect piglets (see
Smith & Linggood, 1971; Arbuthnott & Smyth, 1979). Localisation is
also essential for Vibrio cholerae infection but occurs by a
different mechanism. Freter (1981) has shown that active motility
is essential in order to allow the vibrios to penetrate the mucous
layer and approach the intestinal villi; it appears that they may
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not require to attach to the epithelial surface as do entero¬
toxigenic Escherichia coli.
Neuraminidase may play a part in this process by reducing the
viscosity of the intestinal mucus and assisting penetration by
motile vibrios and by toxin. The actual receptor for cholera toxin
is GM1 ganglioside on the epithelial cell surface. Studies of
neuraminidase action with other cell types showed an increase in
the number of receptors for cholera toxin as di- and tri-
gangliosides were hydrolysed to produce more of the monosialo-
ganglioside GM1 (Haksar et al.. 1974). It was suggested that
cholera neuraminidase might act similarly in the gut but further
studies have not been able to show an increased concentration of
GM1 receptors following neuraminidase treatment of intestinal
epithelium; it appears that there is already an adequate
concentration of GMl in the normal gut (Holmgren, 1981).
Pasteurella species. Muller (1974a) reported changes in the
electrophoretic pattern of serum proteins that confirmed the
production of neuraminidase during fatal infection of a guinea pig
with Pasteurella multocida. Drzeniek et al. (1972) failed to find
a correlation between neuraminidase production and virulence of
Pasteurella multocida strains, for mice. Krasemann & Muller (1974)
also found an imperfect correlation between neuraminidase
production in vitro and mouse virulence for 25 strains of this
organism although some of the most virulent strains produced high
levels of the enzyme; they concluded that other factors were
important. Frank & Tabatabai (1981) discussed the possible role of
neuraminidase in the pathogenicity of Pasteurella haemolvtica
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strains in sheep and cattle but were unable to demonstrate a good
correlation; little is known about the virulence of this species.
Anaerobic bacteria. It is apparent that neuraminidase is
produced in vivo during infection by a number of significant
bacterial pathogens and that it can be expected to act on a variety
of important glycoconjugates on mucous surfaces and in the tissues,
but persuasive evidence for a role as a critical virulence
determinant in the infections reviewed above is still lacking (with
the possible exception of the pneumococcus). The experimental work
reported in this thesis was designed to investigate neuraminidase
production by a variety of species of Clostridium and Bacteroides
and to assess its possible contribution to clostridial myonecrotic
infections; the pathogenesis of these infections is discussed in
the next section.
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CLOSTRIDIAL MYONECROSIS (GAS GANGRENE)
Gas gangrene came into prominence in 1914-18 as an important
cause of death due to infection developing after war injury;
Clostridium perfrinoens (C. welchi), C. seoticum and C. nowi
(C. oedematiens) are the organisms most commonly involved. The
infection is rare in peace-time and most of the literature on
clinical and bacteriological aspects comes from military experience
in World Wars I and II; comprehensive reviews of clostridial wound
infection were provided by Oakley (1954), MacLennan (1962) and
Willis (1969).
Classically, the clinical syndrome of gas gangrene develops
in penetrating wounds of muscle and soft tissue contaminated with
clostridial spores borne on fragments of soil, clothing, metal,
etc. Strict anaerobes are unable to grow at the Eh values found in
normal well oxygenated tissues. The basic prerequisite for
anaerobic infection is the development of a low Eh following
disruption of the blood supply with associated haemorrhage, oedema,
hypoxia and necrosis in the damaged tissue; Eh may be particularly
low at the surface of particles of foreign material. Clostridial
spores germinate and start to grow in the rich nutrients provided
by the necrotic tissue; bacterial growth lowers the pH and Eh
further. Host defences are compromised, since cells, antibody and
antibiotics cannot penetrate the necrotic area, and phagocytosis
and intracellular killing are impaired under anaerobic conditions.
Pathogenic Clostridia survive and are able to exploit this
situation, producing a battery of toxins and enzymes that are
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thought to contribute to tissue digestion and killing of
phagocytes. Increased pressure due to oedema, haemorrhage and gas
produced by the bacteria further restricts blood perfusion and
helps to spread infection into adjacent healthy tissue. In severe
infections systemic illness with prostration, shock and death may
rapidly follow; this is conventionally attributed to toxaemia as
it may occur without bacterial invasion of the blood, though the
toxin(s) involved have not been well characterised (see below).
In civilian practice clostridial wound infection is
relatively rare and, although it remains a dramatic and life-
threatening disease, the full picture of gas gangrene is seldom
seen (see Willis, 1977, chap. 9). The old name persists in common
use although gas production is a late and relatively uncommon
feature; clostridial myonecrosis describes the disease more
accurately. The critical factor in the development of gas gangrene
is the anaerobic condition of the wound, which allows contaminating
spores to germinate and grow. Clostridial spores are widespread in
dust, soil, clothing and skin, and contamination of accidental or
operative wounds continues to occur; however, infection is
prevented by prompt cleansing with removal of devitalised tissue
and restoration of adequate oxygenation. Antibiotics may have
played some part in limiting the disease but early effective
surgery is much the most important factor in prevention and
treatment of gas gangrene. In this connection it should be
appreciated that C. perfrinaens and other anaerobic species are not
uncommonly present in the exudate from surgical wounds but that
they do not cause infection or delay healing if there is adequate
drainage and oxygenation (Gorbach & Thadepalli, 1975; Smith, 1975,
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chap. 18); similarly, anaerobic cellulitis is a localised soft-
tissue clostridial infection that does not go on to invade muscle
tissue or produce gas gangrene (MacLennan, 1962; Finegold, 1977,
chap. 13). Gas gangrene in Britain now occurs more usually after
elective surgery than following injury; the importance of special
precautions in operations on the hip and thigh muscles of the
elderly, diabetics or others with relative arterial insufficiency
is well recognised (Parker, 1969).
Although the present discussion concentrates on clostridial
gas gangrene, a variety of other organisms may be involved in
severe necrotising soft-tissue infections (see Finegold, 1977,
chap. 13; Dellinger, 1981). The emphasis on the classical
clostridial infections may distract attention from anaerobic cocci,
fusobacteria and other Gram-negative anaerobes that are
increasingly cultured from such conditions. It is salutary to bear
in mind that clostridial myonecrosis may have parallels with less
well defined infections involving other strict anaerobes, and that
some of the features of infection may be attributable generally to
the anaerobic condition of the tissues rather than specifically to
properties of the invading micro-organism. Not uncommonly, more
than one organism can be isolated; it appears that there may be
pathogenic synergy between a variety of different anaerobic
species. It is also well recognised that facultative anaerobes may
help to create conditions appropriate for strict anaerobes by
reducing the oxygen levels in the affected tissue, e.g. in
Meleney's synergistic gangrene and related conditions (see
Finegold, 1977, chap. 13; Willis, 1977, chap. 6). In mixed
infections it is difficult to determine which organisms are primary
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pathogens and which merely contaminants, able to multiply in the
wound but not to cause infection on their own. This situation has
been most extensively explored with the Clostridia; the pathogenic
potential of other strict anaerobes, alone or in combination, is
still poorly understood, and progress will depend on further
application of the recently developed techniques for reliable
culture and identification of these species.
Hie Clostridia responsible for gas gangrene infections were
reviewed by MacLennan (1962) and Willis (1969, chap. 9). There is
general agreement that the majority of infections can be attributed
to C. perfrinaens type A, C. septicum and C. novyi type A, either
alone or in combination. C. perfrinaens is most commonly
implicated (50-80% of cases in various surveys), with the other two
competing for second place (c. 20-40%). C. oerfrinaens and
C. septicum are comparatively easy to culture and identify; it may
be that C. novyi has been overlooked and is relatively under-
reported in some surveys. Each of these three species is
undoubtedly pathogenic in its own right, and this is supported by
their ability to reproduce the infection when pure cultures are
inoculated into experimental animals. A number of other
clostridial species that are non-pathogenic for laboratory animals
may also be isolated from gas gangrene wounds, e.g. C. sporooenes
and C. bifermentans: these are assumed to be contaminants and of
little significance in the infection. Other Clostridia may
occasionally contribute to gas gangrene, e.g. C. sordelli.
C. histolyticum, C. fallax? these may be pathogenic in experimental
infections but are seldom encountered in gas gangrene, and very
rarely as the sole isolate.
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General considerations of bacterial pathogenicity and
virulence determinants were outlined above. Clostridia are
primarily commensals in the gut or saprophytes in soil and cause
gas gangrene only when introduced into the tissues by injury;
mechanisms of adhesion or localisation are not important because
the organisms are implanted directly into susceptible tissues. The
ability to form spores may be considered of significance for
clostridial wound infection since these resistant, dormant forms
survive better than vegetative anaerobes in the environment or on
skin and this increases their chances of gaining access to injured
tissue. Pathogenic Clostridia owe their virulence to factors that
enable them to evade host defences, grow in the tissues and cause
infection. C. perfrinaens is the only pathogenic clostridial
species that produces a capsule; there is evidence that capsules
are produced in vivo by virulent strains and that this correlates
with their ability to resist phagocytosis and to cause infection
(Butler, 1945; Willis, 1969, chap. 2). On the other hand, Keppie
& Robertson (1944) found an inverse relationship between the
thickness of the capsule and the amounts of toxins produced by
strains of C. perfrinaens. and most studies have found a general
correlation between virulence and toxigenicity (see below). Many
clostridial toxins are haemolysins or more general cytolysins and
it is probable that such products also act against the host's
phagocytic cell response at the site of infection. However, such
antiphagocytic factors may be of only minor significance in
severely damaged necrotic tissues, where inability to penetrate and
lack of oxygen may present much more serious problems (Oakley,
1954).
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Other areas in which virulence determinants are likely to be
of importance in these acute infections are in the initiation of
local tissue damage, the extension of the local lesion, and the
production of generalised illness and death. The exotoxins and
exoenzymes of Clostridia have been extensively studied for many
years and it is assumed that they play a role in gas gangrene.
MacLennan (1962, p. 180) suggested that "the Clostridia are
primarily and essentially saprophytes, whose toxins are quite as
incidental and quite as unimportant to their economy as morphine to
the poppy plant or digitalis to the foxglove". Although the
ability to cause wound infection is unlikely to be of direct
importance in their ecology, it might parallel their ability to
digest dead tissue or organic waste in soil. Willis (1969,
chap. 9) summarised the classical view of the likely roles of
clostridial products, while noting the lack of firm evidence. Thus
phospholipase-C (C. perfrinoens, C. novyi) may damage cell
membranes and increase capillary permeability; collagenase
(C. perfrinaens. C. histolyticum) may break down collagen barriers
in the tissues; hyaluronidase (C. perfringens) may facilitate
spread of organisms through the tissues; and toxic or digestive
roles can easily be suggested for other products such as DNA-ase
fC. perfrinaens. C. septicum), lipase (C. nowi) and protease
(C. histolvticum) in the local destruction of the tissues. Several
Clostridia produce toxins that are lethal when injected into
experimental animals, e.g. the oc-toxins of C. perfrinoens.
C. novyi. C. septicum and C. haemolyticum (all quite distinct
toxins); these may contribute to the local damage and it is
tempting to attribute the systemic illness and fatal outcome to
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toxaemia with these products. Willis (1969, p. 300) cautiously
concluded that "while there is much evidence to suggest that the
exotoxins produced by Clostridia are largely responsible for the
nature of the lesion and the systemic manifestations, the modes of
action of the toxins and the individual importance of each are
complex and uncertain, and not infrequently unknown except in the
most general terms".
Toxins and other products of C. oerfringens type A
Clostridia produce a variety of exotoxins and other exo-
proteins; these still play a major part in current schemes of
identification along with biochemical characterisation (see
Holdeman, Cato & Moore, 1977; Willis, 1977, chap. 4). The
extracellular products are identified serologically and by their
biological activities, e.g.lethal, dermonecrotic, haemolytic or
enzymatic properties. They have traditionally been called toxins
and distinguished by different letters of the Greek alphabet;
however, it should be appreciated that this was a convention of
nomenclature and that their toxic role in vivo is often highly
speculative. The toxins produced by C. perfringens were listed by
Willis (1969, chap. 2); all types produce the oc-toxin but type-A
strains are distinguished from types B-E by the other toxins
produced. In addition to oc-toxin, type-A strains produce an
oxygen-labile haemolysin (0-toxin), collagenase (K-toxin),
hyaluronidase (ja-toxin), DNA-ase (v-toxin) and neuraminidase; in
addition food-poisoning strains produce the enterotoxin. The
K-toxin is the major lethal toxin produced by type-A strains,
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though strains of types B-E also produce other lethal toxins;
these organisms may be associated with a variety of veterinary
infections but are not involved in human myonecrotic infections
(see table Intro/VI).
Aloha toxin. There is general agreement that the oc-toxin is
the most significant factor in production of gas gangrene by
C. perfrinaens type A, although it is recognised that the evidence
is incomplete (MacLennan, 1962; Willis, 1969, chap. 2;
Ispolatovskaya, 1971; Smith, 1979; Stephen & Pietrowski, 1981,
chap. 3). The oc-toxin was characterised as a lecithinase or
phospholipase-C by MacFarlane & Knight (1941), the first bacterial
toxin to be shown to have an enzymic action. It also has lethal,
dermonecrotic, haemolytic and cytolytic activites; early studies
were complicated by difficulties in separating the phospholipase
from other toxic or membrane-damaging products of the organism
(Wadstrom, 1978) but recent studies with highly purified
preparations have confirmed that these different biological
activities are associated with a single molecular species (Smyth &
Arbuthnott, 1974; Avigad, 1976; Mollby, 1978; Takahashi, Sugahara
& Ohsaka,1981).
The structures of some common phospholipids and the point of
action of various phospholipases and sphingomyelinases are shown in
fig. Intro/2. The phospholipids found in greatest amounts in cell
membranes are phosphatidylcholine (lecithin), phosphatidylethano-
lamine, phosphatidylserine and sphingomyelin. The C. perfrinaens
oc-toxin is a phospholipase-C, hydrolysing phosphatidylcholine to
produce soluble phosphorylcholine and insoluble diglyceride; this
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Table Intro/VI
Disease conditions produced bv different types
of Clostridium perfrinaens
Type Disease3
A Gas gangrene of man and animals
Food poisoning
Equine grass sickness
Necrotising colitis and enterotoxaemia of
horses
B Lamb dysentery
Enterotoxaemia of foals, sheep, goats
C Enterotoxaemia of sheep (struck), calves,
lambs, piglets
Necrotic enteritis (Pig-Bel)
D Enterotoxaemia of sheep, lambs (pulpy
kidney), goats, cattle
E Role in pathogenicity unclear, found in sheep
and cattle

























Fig. Intro/2 - Structure of common cell-membrane phospholipids; the
position of hydrolysis by phospholipases Alf A2, C and D is
indicated (from Mollby, 1978).
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is the basis of the Nagler reaction used for identification of
phospholipase-producing Clostridia on serum or egg-yolk agar
(Willis, 1977, chap. 3). Although Pastan, Macchia & Katzen (1968)
suggested that activity against lecithin and against sphingomyelin
was attributable to the presence of two separate enzymes, later
studies (Smyth & Arbuthnott, 1974; Mollby, 1978) have not confirmed
this and have shown that purified phospholipase-C is active against
both substrates. Substrate specificity has been investigated with
purified phospholipids; activity is markedly dependent on the
physical state of the preparation, e.g. the degree of bilayer
formation, and activity may be greater against phospholipids on
intact cells or membrane preparations (Mollby, 1978).
The mechanism of membrane damage by C. perfringens phospho¬
lipase-C has been intensively investigated (see Avigad, 1976; Freer
& Arbuthnott, 1976; Mollby, 1978; McDonel, 1980). Membrane
damage may occur without actual red-cell lysis; this is
illustrated in the phenomenon of hot-cold lysis, which does occur
with purified C. perfringens phospholipase-C although it is not as
marked as with a specific sphingomyelinase-C produced by
Staphylococcus aureus (see Arbuthnott, 1978b). The enzyme requires
Ca2+ for activity; it is now thought that its influence is
predominantly on the substrate rather than directly on the enzyme
itself. Zinc is also required, primarily to stabilise the enzyme
and protect it against proteolytic destruction in the culture
medium (Sato et al., 1978). The exact mechanism by which enzymic
hydrolysis of surface phospholipids destabilises the erythrocyte
membrane is still debated, but it is quite distinct from that of
the oxygen-labile $-haemolysin (see below); many of the earlier
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studies were invalidated by the use of contaminated preparations.
Most studies have used red cell membranes, either in intact cells
or as erythrocyte ghosts, but similar effects may occur with
membranes of other cell types. The effect of the enzyme depends on
many variables, including the relative concentrations of different
types of phospholipids in the membrane of the target cell, their
relative distributions on the inner and outer surfaces of the
membrane and their accessibility to the enzyme. Factors such as
these, and differences in substrate specificity for various
phospholipids and sphingomyelins, presumably explain differences in
haemolytic and toxic activities for phospholipase-C enzymes
produced by other bacteria, e.g. C. sordelli. C. bifermentans.
C. novyi. Bacillus cereus and Pseudomonas species; the
C. oerfrinaens enzyme has a broad substrate range and is much the
most toxic (see Mollby, 1978).
The oc-toxin can damage a variety of other cells besides red
cells. The original studies of the effects on muscle (e.g. Robb-
Smith, 1945) were made with impure toxin preparations but many of
the observations of the relative effects of different bacterial
products have since been confirmed with pure preparations. Aikat
and Dible (1956) showed that the x-toxin was the main factor
responsible for digestion of muscle, either in vitro or when
injected into experimental animals; they demonstrated that neither
collagenase nor hyaluronidase was necessary for the action of k-
toxin. The membrane-damaging effects of purified C. perfrinaens
phospholipase-C acting on muscle fibres has been confirmed by
Strunk, Smith & Blumberg (1967) and Boethius et al. (1973) and has
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also been demonstrated with fibroblasts (Mollby, Thelestam &
Wadstrom, 1974). Phospholipase-C damages leucocytes and platelets;
platelet damage leads to aggregation and thrombus formation which
may contribute further to haemostasis and Eh reduction during
infection (Mollby, 1978; McDonel, 1980). C. perfrinaens ot-toxin
damages endothelial cells and produces increased capillary
permeability, conveniently demonstrated by extravasation of dye at
the site of intradermal injection in experimental animals (Willis,
1969, chap. 2); release of histamine from mast cells and mediators
from damaged platelets may also contribute to the massive oedema
that is a striking feature of gas gangrene (McDonel, 1980).
The effects of injection of C. perfrinaens oc-toxin into
experimental animals have been reviewed by Willis (1969, chap. 2),
Smith (1975, chap. 7) and McDonel (1980). The results depend
markedly on the route of injection. Intravenous injection produces
haemolysis, destruction of platelets, widespread capillary damage,
oedema, shock and death. The toxin quickly disappears from the
blood; Ellner (1961) found that it was not taken up by skeletal
muscle or brain but appeared largely in the liver and other
internal organs and was rapidly metabolised. Conversely, oc-toxin
injected by the intramuscular route remains bound to muscle; very
little appears in the blood and there are no systemic effects
unless very large doses are given. There is oedema and necrosis in
the injected muscle; the amount of tissue swelling and disruption
is increased by the presence of hyaluronidase, though collagenase
appears to have little direct effect (Aikat & Dible, 1956). It
seems that oc-toxin is rapidly adsorbed to phospholipids and
lipoproteins in the local lesion and that little is detectable in
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the tissue fluids; free toxin has occasionally been demonstrated
in the exudate from rapidly deteriorating gas gangrene wounds but
only very rarely from the blood in such cases (see Willis, 1969,
chap. 2; McDonel, 1980). Haemolysis is a late and uncommon
clinical feature in clinical gas gangrene, though it occurs more
commonly with post-abortal clostridial uterine infections. Oakley
(1954) argued that small amounts of cx-toxin absorbed into the
bloodstream might produce serious changes in vital organs in the
absence of haemolysis, but it seems unlikely that there is
significant oc-toxin in the blood in the majority of "toxaemic" gas
gangrene patients (Willis, 1969, chap. 9).
Theta toxin. Other C. perfrinoens products may be involved
in production of the local lesion in infected muscle but the
evidence suggests that they play a subsidiary role to the oc-toxin.
The 6-toxin has been purified and characterised (Smyth, 1975). It
is one of a group of oxygen-labile haemolysins that are now more
commonly described as sulfhydryl- or thiol-activated cytolysins
(Bernheimer, 1976; Smyth & Duncan, 1978) because they may affect a
range of different cell types; since they may produce significant
damage in sub-lytic doses they are more accurately described as
membrane-damaging toxins (Arbuthnott, 1978b). Related thiol-
activated haemolysins are produced by a number of other pathogenic
and saprophytic Gram-positive bacterial species, e.g. C. tetani and
several other Clostridia, Streptococcus pyogenes. Bacillus cereus.
Bacillus thurinaiensis: there is cross-neutralisation by antisera
within the whole group despite their diverse origins. All are
heat-labile and thiol-activated proteins that can be neutralised by
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cholesterol, which is the natural receptor in cell membranes.
Binding of toxin to cholesterol leads to redistribution of the
sterol in the membrane and the formation of functional pores
permeable to potassium ions, and eventually haemoglobin. These
toxins also produce membrane damage with various other types of
cell, including leucocytes, and are lethal on intravenous injection
into experimental animals (see Bernheimer, 1976; Smyth & Duncan,
1978). However, there is no evidence that much (3-toxin is produced
in vivo or that it plays a significant part in the pathogenesis of
gas gangrene (Oakley, 1954) and anti-0-toxin is not protective in
experimental infections (Evans, 1943a).
Other toxins. The collagenase, hyaluronidase and DNA-ase of
C. perfrinoens have not been well characterised and their role in
muscle damage remains uncertain (see Oakley, 1954; MacLennan, 1962;
Willis, 1969, chap. 2; McDonel, 1980). There is no clear
correlation between virulence and in-vitro production by different
strains (Ispolatovskaya, 1971). MacFarlane & MacLennan (1945)
identified the collagenase and suggested that it played a major
role in the disintegration of infected muscle, but Evans (1947) was
unable to show a protective effect of anti-collagenase in
experimental infection. Aikat & Dible (1956) found that (x-toxin
was predominantly responsible for muscle damage and were unable to
detect any additional effect attributable to collagenase; however,
their experiments were criticised by MacLennan (1962) who argued
for a role for collagenase in destroying the structure of muscle
and helping the spread of infection. Hyaluronidase attacks the
matrix material of connective tissue and has been shown to increase
the muscle damage produced by oc-toxin (Robb-Smith, 1945; Aikat &
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Dible, 1956); it, too, is generally postulated to play a role in
the spread of damage through infected muscle (Willis, 1969,
chap. 2). The DNA-ase of C. oerfrinaens is a non-lethal product
that does not produce muscle damage but has been suggested to have
leucocidal activity (Robb-Smith, 1945). It might contribute to the
poor leucocyte response that is typical of serious myonecrotic
infection (Butler, 1945) although other factors such as cx-toxin and
6-toxin might equally be incriminated (Oakley, 1954; Willis, 1969,
chap. 2).
Enterotoxin. The enterotoxin of food-poisoning strains of
C. perfringens type A is a sporulation-specific product, perhaps an
actual spore-coat component that is overproduced by food-poisoning
strains and may become visible as a parasporal semi-crystalline
accumulation in the cell (Duncan, King & Frieben, 1973; Frieben &
Duncan, 1973; Labbe & Duncan, 1977). The precise mechanism by
which it produces secretion of fluid and electrolytes in the small
intestine is still to be elucidated; it is clearly different from
the cyclic-AMP-mediated stimulatory mechanism of cholera toxin.
C. perfrinaens enterotoxin produces necrosis of the tips of the
ileal villi in experimental animals, probably by direct cell-
membrane damage to the brush border of the epithelial cells
(McDonel, 1979, 1980). Although the enterotoxin can also produce
increased capillary permeability on intradermal injection
(Hauschild, 1970) and is lethal when large doses are given by
intravenous injection (Stark & Duncan, 1971), it is not thought to
play a part in the pathogenesis of gas gangrene. It is produced in
large amounts only by food-poisoning strains, many of which are not
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virulent on intramuscular injection (Hauschild & Thatcher, 1968).
Furthermore, C. perfringens in wound infection is present as
rapidly growing vegetative cells with insignificant spore
formation; this contrasts with the situation in the gut where
vegetative cells in food reaching the small intestine rapidly
sporulate, releasing enterotoxin.
Other products. A variety of other bacterial products have
been reported in culture supernates of C. oerfrinaens strains, e.g.
enzymes that destroy various blood-group substances, fibrinolysin,
non-oc06-haemolysins, "bursting factor" (Fredette, Forget & Vinet,
1962) and "circulating factor" (Ganley, Merchant & Bohr, 1955).
These were reviewed by Willis (1969, chap. 2); they are in general
poorly characterised and of dubious importance in clostridial
myonecrosis. The haemagglutinin of C. perfrinaens type A was
mentioned in an earlier section; since it is produced by
laboratory strains but not by fresh isolates (Collee, 1961) it
seems unlikely to be related to virulence. The possible role of
neuraminidase in clostridial myonecrosis is considered in the
Discussion section of this report.
Pathogenesis of C. perfringens type A
gas gangrene
Although C. perfringens type A may be involved in a number of
other types of infection (see Willis, 1969, chap. 9), gas gangrene
is the most important and dramatic condition produced and studies
on the pathogenicity of the organism have focused on this. Muscle
infection can be produced experimentally in a variety of animals;
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the guinea pig has been most widely used, e.g. in the classical
studies of Evans (1943a and b) and the more recent investigations
by Bullen and his colleagues (Bullen & Cushnie, 1962; Bullen,
1970). Experimental myonecrotic infection of the guinea pig thigh
muscles reproduces many of the features of clinical gas gangrene,
although it has been suggested that the muscle mass may be too
small to provide a full parallel with human infection (Oakley,
1954). For obvious reasons, observations on larger animals, e.g.
with experimental gunshot wounds in sheep, have been limited (but
see Owen-Smith & Matheson, 1968; Boyd, Thomson & Walker, 1972a;
Boyd, Walker & Thomson, 1972b).
The importance of the route of administration, the state of
the tissues and the presence or absence of pre-formed toxin in the
inoculum administered to experimental animals was established in
early studies and was reviewed by Willis (1969, chap. 2).
Injection of washed cells of C. perfrinaens into muscle does not
produce infection unless there is a nidus of ischaemic or necrotic
tissue. Infection may be initiated by inoculation of whole broth
culture into healthy muscle; the amount of pre-formed toxin
present in the culture is often sufficient to produce local damage
and allow establishment of the organism. However, this procedure
does not mimic natural infection, when spores are assumed to
initiate infection in the absence of exogenous toxin; furthermore,
variations in virulence of organisms in such experiments might
reflect variations in their production of toxin(s) in vitro that
might not parallel their virulence in vivo.
Calcium chloride has been identified as the agent responsible
for early tissue necrosis in wounds contaminated with soil, and it
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has been used as standard sclerosing agent in many studies. It
should be appreciated that it might also act in other ways, e.g.
Ca^+ might stimulate the activity of C. perfrincens phospholipase-C
in vivo as well as in vitro. Princewill (1965) showed that Ca^+
might also stimulate germination and outgrowth of clostridial
spores; however, the use of washed suspensions of log-phase cells
as inoculum avoids variations that might be due to factors
influencing spore dormancy and activation. An alternative method
for initiation of infection is to mix the bacterial inoculum with
adrenaline (Evans, Miles & Niven, 1948); the adrenaline gives
transient intense vasoconstriction and a local fall in Eh for
c. 2 h without apparent residual damage, but it produces greatly
increased susceptibility to infection. Clinical gas gangrene has
occurred after intramuscular injection of adrenaline in man; the
risks of introduction of clostridial spores from skin along with
vasoconstricting substances in this way are well established (e.g.
see Leading Article, 1968).
When virulent organisms are inoculated with either of these
initiating agents, infection is established and rapidly progresses
to produce extensive necrosis and digestion of the thigh muscle
mass with collapse and death occurring in 24-48 h. Less virulent
organisms may be able to cause local infection but this is
contained and the animal survives. The clinical features of human
clostridial wound infections were reviewed by MacLennan (1962) who
noted that gas gangrene developed in only a proportion of wounds
contaminated by Clostridia, but in these cases the onset of illness
was often sudden and its progress very rapid. The course of
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infection depends both on the nature of the wound, in particular
the degree of tissue damage and Eh reduction that is produced (see
above), and on the virulence of the infecting strain. In
experimental infection the initial tissue compromise can be
standardised, so that virulence of the challenge strain can be
assessed by the size of inoculum required to initiate infection.
Other measures of virulence in this model are the severity of local
infection and the ability to produce the systemic disease and rapid
fatal outcome that parallel the toxaemic phase of human infection.
Various approaches have been developed for analysis of
virulence factors that may operate at different stages of
infection. As previously described, many of the features of the
local tissue damage can be reproduced by exposure of muscle to
culture filtrates of C. perfrinaens strains, either In vitro or in
vivo: experiments with preparations containing different
proportions of various toxins suggested a major role for the «-
toxin, with the possibility of some further contribution from
collagenase, hyaluronidase and 0-toxin. In a complementary
approach, Evans (1943a and b, 1947) studied the protective effect
of antisera containing different proportions of various antibodies
for guinea pigs challenged with C. perfrinaens: there was a
general correlation between protection and anti-cc-toxin titres, but
he was unable to show any protective effect attributable to anti-0-
toxin, anti-collagenase or anti-byaluronidase, either alone or in
combination with anti-oc-toxin (see also Kameyama, Sato & Murata,
1972).
The protective effects of antitoxic sera are limited, and the
guinea pig appears to provide a good parallel with human infection
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in this regard too. Antiserum gives passive protection only when
administered before or very shortly after experimental challenge.
Its effect is primarily to prevent or abort infection rather than
to modify the course of established infection; it is ineffective
when given therapeutically in an attempt to prevent systemic
collapse and the toxaemic phase of the disease (Evans, 1945a;
Bullen, 1970). There is evidence that active immunisation of
various animals with clostridial toxoids gives similar protection
against the development of gas gangrene on later challenge (Willis,
1969, chap. 9; Boyd £t al., 1972b). Active immunisation of
soldiers has not been practised on a wide scale but clinical
experience of the value of antitoxin in preventing gas gangrene in
military casualties was evaluated by Oakley (1954) and MacLennan
(1962). Standard preparations of antitoxin are polyvalent,
containing antibody to a variety of toxins produced by
C. oerfrinaens and also by C. septicum and C. novyi; although the
potency of C. perfrinaens anti-oc-toxin could be standardised, the
content of antibody to other products of the organism might vary.
The difficulties of assessing results obtained under wartime
conditions are considerable, with different types and degrees of
injury and contamination, and the problem of disentangling the
effects of surgery, antitoxin and, latterly, antimicrobial therapy.
The most satisfactory studies (e.g. MacLennan & MacFarlane, 1944;
MacLennan & MacFarlane, 1945) suggested that antitoxin was of some
value if administered within c. 6 h of injury; given later,
however, it was ineffective in preventing extension of established
disease and ultimate death. These conclusions have been borne out
in civilian practice; treatment with antitoxin or antibiotics is of
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very limited efficacy unless necrotic tissue can be completely
removed by surgery and full oxygenation is restored (Willis, 1969,
chap. 9; Weinstein & Barza, 1973; Hitchcock, Demello & Haglin,
1975; Darke, King & Slack, 1977; Finegold, 1977, chap. 19; Garrod,
Lambert & O'Grady, 1981, chap. 16).
Many studies have sought to correlate pathogenicity and toxi-
genicity in C. perfringens. Strains isolated from gangrenous
wounds generally produce good levels of a-toxin in vitro; yields
of other toxins may be much more varied. A number of studies have
shown that commensal and environmental strains may produce oc-toxin
levels as high as or higher than those produced by known pathogenic
strains (e.g. Keppie & Robertson, 1944; Price & Shooter, 1964;
Mollby et al.. 1976). Butler (1943) found that laboratory strains
of C. perfrinoens may lose virulence during subculture and regain
it after animal passage; this may not be important in nature since
infection is normally with environmental strains. Bullen (1970)
drew attention to discrepancies between oc-toxin production and
virulence for individual strains in a number of published accounts
that in general supported a correlation of the two, e.g. Keppie &
Robertson (1944), Evans (1945b). Bullen, Wilson & Cordiner (1961)
studied two strains of C. perfrinaens that were of similar
virulence, with a minimum lethal dose of c. 102 cells, and showed
that one produced very much higher levels of various toxins than
the other in vitro. Bullen (1970) also emphasised discrepancies
between anti-oc-toxin titres and protection against different
challenge strains in the studies of Evans (1945a) and suggested
that factors other than K-toxin were of major significance in the
pathogenesis of gas gangrene.
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Bullen & Cushnie (1962) studied the growth of a virulent but
poorly toxigenic strain of C. perfrinaens when injected into
guinea pig thigh muscles in experiments designed to assess whether
invasiveness of the organism might be distinct from toxigenicity.
When muscle was damaged by CaCI^ injection, the presence of anti-oc-
toxin did not reduce the rate of growth of the inoculum in the
muscle, and did not prevent extension of the lesion into healthy
tissues; this was not due to failure of penetration of antibody as
large amounts were demonstrable in the damaged tissues. By
contrast, when adrenaline was used as initiating agent passive
immunisation was much more effective in halting bacterial growth
and protecting the animals. Thus the invasiveness of the organism
was not solely due to its toxins, but was also dependent on the
state of the host's tissues. Later studies on the efficacy of
anti-ot-toxin identified other factors that may affect the balance
between host and pathogen. Bullen, Cushnie & Rogers (1967) showed
that intravenous injection of ferric ammonium citrate abolished the
protective effect of antiserum in animals given adrenaline as
initiating agent. It is now appreciated that the ability to obtain
O _L
Fe from the tissues is a decisive factor for virulence in a
variety of bacterial species, including Pasteurella septica.
Escherichia coli and mycobacteria as well as C. perfringens
(Rogers, Bullen & Cushnie, 1970; Bullen ^t al., 1978). Virulent
strains produce iron-binding proteins that can successfully compete
with the host's transferrin for the small amounts of free FeJ in
the tissues; the balance is complex as the availability of iron is
also important for the host's phagocytic cells. It appears that
the bacteriostatic effect of partially saturated transferrin is an
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important component in the host's defence against challenge with
C. perfrinoens: an increase in available Fe^+ removes the
limitation on bacterial growth and allows infection to progress
despite the presence of antitoxin.
Bullen (1970) argued that the invasiveness of C. perfrinaens
is largely independent of toxin production but depends on the
ability of normal muscle tissue to produce bacteriostasis. This is
not solely due to the Eh in the tissues, as injection of iron some
hours after the effects of adrenaline have worn off can still
stimulate bacterial growth again (ferric iron itself does not lower
the Eh as it remains in the oxidised form). However, the bacterio¬
static effect of serum at normal Eh values (c. +200 mV) is much
reduced if the Eh falls to zero or negative values (Bullen, Dobson
& Wilson, 1964). C. perfrinoens is not a very strict anaerobe as
it can grow at an Eh value as high as +60 mV and can remove oxygen
from its environment; in severe clostridial infection the Eh falls
to -400 mV (Bullen, Cushnie & Stoner, 1966). Bullen (1970)
proposed that extension of the gangrenous lesion is due to
bacterial removal of oxygen from the neighbouring healthy tissue at
the edge of the lesion so that Eh falls and the normal
bacteriostatic mechanisms are compromised.
Hyperbaric oxygen has been advocated for treatment of gas
gangrene (Brummelkamp, 1965; Gottlieb, 1971; Darke etal., 1977;
Willis, 1977, chap. 9); opinions vary on its place in modern
therapy but there is no doubt that oxygen administration can arrest
the progress of the local lesion and gain time before surgical
excision proceeds. It was initially suggested that the effect
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depends upon inhibition of toxin production or of clostridial
growth, but it is also possible that increased oxygen supply to the
extending edge of the lesion may act to balance oxygen removal by
the bacteria and restore normal bacteriostasis (Bullen £t al..
1978) .
There is little agreement about the mechanisms that produce
the toxaemic phase and death in gas gangrene (e.g. see Oakley,
1954; MacLennan, 1962; Willis, 1969, chap. 9; Bullen, 1970; Smith,
1979; Stephen & Pietrowski, 1981, chap. 3). The failure to
demonstrate oc-toxin in the blood and the relative rarity of
haemolysis in fatal clinical infections (mentioned above) throw
considerable doubt on early suggestions that death is due to the
lethal effect of circulating oc-toxin. The limited protective
effect of antitoxin in established disease in animals or man adds
to the evidence that oc-toxin is not the major factor. MacFarlane &
MacLennan (1945) suggested that the toxaemia was due not to oc-toxin
but to some other toxic substance produced by its action on muscle;
it is not due simply to release of products from anoxic muscle as
it is not seen with sterile necrotic lesions or other muscle
infections (see Oakley, 1954). Production of massive oedema and
exudate may be the mechanism at least partly responsible for
systemic collapse and the development of shock. Local effects of
clostridial toxins on muscle cells and on capillary permeability
may be involved, though the failure of antitoxins to prevent death
unless necrotic tissue is removed surgically suggests that none
plays a major part. Experiments with fatal C. oerfringens
peritonitis in passively immunised guinea pigs (Bullen & Cushnie,
1963; Bullen et al-r 1966) indicated that shock and death followed
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a massive loss of fluid and protein into the peritoneum. This was
not attributable to recognised toxins or mediators such as
histamine and it was ascribed directly to the removal of oxygen by
the metabolic activity of the organism; however, the differences
between experimental peritonitis and muscle infection should be
borne in mind.
It is apparent that the pathogenesis of C. oerfrinaens gas
gangrene remains incompletely understood. It seems reasonable to
postulate an important role for x-toxin in the initial stages of
infection and in the local tissue damage, and it is probable that
anti-oc-toxin has some protective effect at this stage; however,
the role of X-toxin in extension of established infection is much
more debatable and there is little evidence to support the original
concept of toxaemia with «-toxin as the mechanism leading to death.
Most authorities conclude that oc-toxin plays an important part, but
views range from "It is difficult to escape the conclusion that the
syndrome of fatal human or experimental gas gangrene caused by
C. perfrinaens is the integrated sum of all the deranged metabolic
events initiated by <x-toxin" (Stephen & Pietrowski, 1981, p. 45) to
"There is little evidence to suggest that x-toxin, or any other
toxin, has any essential role in the pathogenesis of this disease"
(Bullen, 1970, p. 274).
It seems that the recognised toxic products of C. perfrinaens
do not account completely for the pathogenicity of the organism.
The studies discussed earlier in this Introductory Review suggest a
variety of mechanisms, direct and indirect, by which neuraminidase
produced by C. perfrinaens might contribute either to the local
tissue damage or to systemic derangements and collapse; such a
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role has been suggested on a number of occasions (e.g. Collee,
1962, 1965b; Muller, 1970a, 1974a) although few studies have been
designed to test the possibility. Antisera prepared against
C. perfrinaens products have been assessed primarily on the basis
of their content of various antitoxins but they may also contain
anti-neuraminidase (Warren & Spearing, 1963); the extent to which
this component might contribute to their protective effects is not
known. The present studies were undertaken in order to clarify the
roles that neuraminidase and anti-neuraminidase might play in the




Source and maintenance of cultures. All strains were held in
the collection of Prof. J.G. Collee, Microbial Pathogenicity
Research Laboratory, Department of Bacteriology, University of
Edinburgh. Hie source of strains that were recently obtained from
the National Collection of Type Cultures, Colindale Avenue, London
NW9 5HT is shown as NCTC. Other strains were originally obtained
from the NCTC and have been held in Prof. Collee's collection for
many years; their source is indicated as Prof. Collee and the NCTC
numbers are quoted. Hie remainder of the strains, including some
NCTC strains and clinical isolates from a variety of infections,
were obtained from various sources at various times and have been
held here, sometimes for many years and with many subcultures; the
donors of the strains are cited. All strains were maintained as
lyophilised stock with periodic subculture in cooked-meat broth
(CMB) and relyophilisation. For the present studies all strains
were preshly grown in CMB from lyophilised stock and their purity
and identity were carefully checked in microscopic, cultural and
biochanical studies.
Strains of Clostridium perfrinoens (C. welchih Hie standard
strain used in these studies (L2Ab) was a laboratory sub-strain
derived from a classical haemolytic type-A strain obtained from the
late Prof. C.L. Oakley, School of Medicine, University of Leeds.
Other classical type-A strains were: strain L3A, also from Prof.
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Oakley; NCTC8237, from the NCTC; and strains CI and 032, isolated
from wound infections in Edinburgh by Prof. Collee. All strains
were characterised biochemically by the tests listed by Willis
(1977, p.113) and their identity was confirmed by production of
opalescence on half-antitoxin egg-yolk agar (EYA) plates that was
inhibited by C. perfrincens type A antitoxin (see below). In
addition, strain L2Ab was typed by toxin-antitoxin neutralisation
tests in a guinea pig (Cruickshank et al., 1975, p.475). Strains
CW6 and CW7 were strains of C. oerfrinaens isolated from human
wound infections and identified biochemically in this laboratory
but found not to produce phospholipase-C (x-toxin); they were
submitted to Dr A.T. Willis, Central Public Health Laboratory,
( Colindale, London, who confirmed their identity. Strain NCTC11144
is a phospholipase-negative strain obtained from the NCTC.
Typical non-haemolytic, heat-resistant, food-poisoning type-A
strains of Hobbs' types 1-4 (Nos 8359 , 8238 , 8239 and 8247 respec¬
tively) were obtained from the NCTC; strains of Hobbs' types 5-24
were provided by Dr Betty Hobbs, Central Public Health Laboratory,
Colindale, London. Strains 029 and 153 were typical food-poisoning
strains isolated from separate food-poisoning outbreaks in
Edinburgh (Collee, 1965b); they were submitted for serotyping to
Dr Hobbs who reported that they were both type-13 strains. Strains
611 and 4621 were provided by Dr Hobbs: these were non-haemolytic
type-13 strains but were not responsible for actual food-poisoning
outbreaks; strain 611 was isolated post mortem from a patient with
colitis and strain 4621 from a patient who died during a food-
poisoning outbreak attributed to a different strain of C. per-
fringens. Reference food-poisoning strains of C. perfringens type
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A that do not produce heat-resistant spores (types i-iii, v-xviii)
were provided by Dr Hobbs and are referred to as heat-sensitive
strains. The identity of all the food-poisoning strains of
C. oerfrinaens type A was confirmed by culture on half-antitoxin
EYA plates. The haemolytic reactions were tested on horse-blood
agar (HBA) as detailed below, but the heat-resistance of the spores
was not retested in this laboratory.
A collection of strains of C. oerfrinaens type A that were
reported to have altered neuraminidase production (Rood &
Wilkinson, 1975) were obtained as follows: strain CN3870 (wild-
type) and the mutant strains CM156, CM165, CM198, CM206 and CM209
from Dr R.G. Wilkinson, School of Microbiology, University of
Melbourne, Parkville, Victoria 3052, Australia; strains CM173 and
CM218 were from Dr J.I. Rood, Food Research Institute, 1925 Willow
Drive, University of Wisconsin, Madison 53706, USA. The characters
of these strains are reported in Section IIIc and table III/XIV.
Strains of C. perfrinaens types B-E were as follows: NCTC3110
(type B), NCTC3180 (type C) and NCTC8084 (type E) were from Prof.
Collee's collection; strain L8 (type D) was originally obtained
from Prof. Oakley. All were identified biochemically and by
culture on half-antitoxin EYA plates. In addition, strains
NCTC3180 and L8 were retyped by toxin-antitoxin neutralisation
tests in guinea pigs.
Strains of other clostridial species. The following strains
were obtained directly from the NCTC: C. chauvoei NCTC8070;
C. tertium NCTC541; C. sordelli strains 1340, 2914, 6800, 6801,
6927, 6929 and 8780; C. bifermentans strains 1341 and 6928;
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C. novyi (c. oedematiens) strains 9746 and 9692; C. tetani strains
279, 5405 and 9569; C. botulinum strains 7272, 7273, 3732 and
8266; C. difficile NCTC11223; C. sphenoides NCTC507: C. fallax
NCTC8380; and C. tetanomorphum NCTC2909.
C. tertium strain CT1, C. sordelli CB4 and C. subterminale
CS1 were obtained from Dr B. Watt, Bacteriology Laboratory, City
Hospital, Edinburgh. C. absonum strains HA7103, HA7107 and HA9103,
and C. oaraoerfrincens 2227, 3-3, G and 9 were from Prof. S.
Nishida, Department of Bacteriology, School of Medicine, Kanazawa
University, Japan. C. sordelli strains 1734 and P3, and
C. bifermentans B4 and 1617 were from Prof. Oakley. C. difficile
strains N3 and N6 were from Dr S. Hafiz, University of Sheffield
Medical School. C. sporoaenes strains 23, 24, 26 and 28 were from
Dr Nancy Hayward, Monash University Medical School, Australia.
The remaining strains of Clostridia were from Prof. Collee's
collection: C. chauvoei CC2; C. sordelli CB2 and CB3;
C. bifermentans NCTC506; C. tetani NCTC540, NCTC5404 and NCTC5413;
C. difficile MPRL2, MPRL105 and MPRL174 (recent isolates from the
stools of patients with diarrhoea); C. histolvticum NCTC503,
NCTC7123, NCTC7124 and CH2; and C. butvricum NCTC7423.
C. septicum strains NCTC547, 688/52, 1376/53, 2029/53 and CN3204
were described by Gadalla & Collee (1967). C. novyi strains
NCTC538 (GR1A), NCTC6737 (GP3A), GR2A, GR4A, GR1B, NCTC9747 (GR1C),
NCTC8145 (GR2D) and NCTC8350 (GRID) were described by Rutter &
Collee (1969).
Unless otherwise stated, all strains were identified to
species level by the biochemical criteria given by Willis (1977,
p.113). C. tetanomorphum NCTC2909 is thus named in the NCTC
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catalogue but has teen reclassified as C. cochlearium (Holdeman et
al., 1977, p. 97; Nakamura et al., 1979). The biochemical
reactions of C. butvricum NCTC7423 were confirmed to be as given by-
Willis (1969, p.14). C. subterminale CS1 was identified by the
biochemical criteria, including gas-liquid chromatography (GLC), of
Holdeman et al. (1977, p.80); this strain was also submitted to Dr
Willis who confirmed its identification. The identity of the
strains of C. septicum and C. chauvoei was further confirmed with
immunofluorescent diagnostic antisera (anti-C septicum, code FC07;
anti-C. chauvoei. code FC04: Wellcome Diagnostic Reagents Ltd, 303
Hither Green Lane, London SE13 6TL). The strains of C. sordelli
and C. bifermentans were also tested on half-antitoxin EYA plates
> as for C. perfrinaens: all strains produced opalescence that was
inhibited by the antitoxin (Willis, 1977, p.82). The biochemical
distinction between C. sordelli and C. bifermentans was further
investigated by tests for fermentation of mannose and sorbitol, and
for growth inhibition by mannose (see table IV/IV). The identity
of C. tetani strains was confirmed by neutralisation tests in mice
(Willis, 1977, p.116). C. difficile strains were further
characterised by production of typical colonies on CCFA medium
(George et al., 1979) and by GLC (Holdeman et al., 1977, p.80).
C. botulinum strains were not retested for biochemical reactions
but their identity and type was confirmed with immunofluorescent
diagnostic antisera (anti-type A, code FC01; anti-type C, code
FC02; anti-type E, code FC03: Wellcome Diagnostic Reagents Ltd).
The strains of C. absonum and C. paraperfrinaens were not
reidentified biochemically but their reactions were checked on
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half-antitoxin EYA plates; C. absonum strains produced a broad
zone of opalescence that was partially inhibited by the C. oerfrin-
aens antitoxin and C. paraperfrinaens strains produced a narrow
zone that was completely inhibited by the antitoxin (Nakamura et
al., 1973). Cato, Holdeman & Moore (1982) have suggested that
C. oaraoerfrinaens strains are identical with C. barati and should
be reclassified under the latter name.
Strains of Bacteroidaceae. Many of the strains were charac¬
terised in this laboratory and described by Duerden et al. (1976)
or Deacon, Duerden & Holbrook (1978). The GNAB and WPH strains
were isolated from various sites in healthy adults in this
laboratory, or from clinical material by colleagues in the
' diagnostic laboratories in the Bacteriology Departments of the
Royal Infirmary and the Western General Hospital, Edinburgh. The
other strains studied were as follows: Bacteroides eggerthi
NCTC11155, B splanchnicus NCTC10825 and NCTC10826, B. asaccharo-
lyticus NCTC9337 and Fusobacterium varium NCTC10560; these were
all obtained directly from the NCTC. B. uniformis VPI11227,
B. variabilis VPI11368 and B. melaninogenicus ss. levi VPI3300 were
obtained from Dr Lillian V. Holdeman, Virginia Polytechnic
Institute and State University, Blacksburg, Virginia 24060, USA.
B. oralis VPI9958, B. oralis (B. buccalis) VPI8906D, B. bivius
VPI5540, VPI6318, VPI6822 and VPI7880, and B. disiens VPI7852 and
VPI8057 were provided by Dr Ella M. Barnes, Agricultural Research
Council, Food Research Institute, Colney Lane, Norwich NOR 70F.
B. ruminicola strains B38024, B38080 and B56029 were provided by Dr
T. Mitsuoka, Animal Pathology Laboratory, Institute of Physical and
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Chemical Research, Wako, Saitama 351, Japan. B. corrodens strains
143A and 151RV were provided by Dr A.L. James, Department of
Chemistry, Faculty of Science and Technology, Newcastle upon Tyne
Polytechnic.
The classification of the Bacteroidaceae has been much
altered and refined over the past decade; current schemes are
based mainly on the biochemical activities of the organisms
(Holdeman .et al.r 1977). The strains used in the present study
were all identified to species level by the identification scheme
developed in this laboratory (Duerden .et al., 1976, 1980),
including GLC as described by Deacon et al. (197 8). A number of
the strains have been reclassified in recent years. The former
subspecies of B. fraailis are now given separate species status.
B. thetaiotaomicron is further subdivided into the species
B. thetaiotaomicron. B. eaoerthi and B. uniformis: Werner (1974)
demonstrated that sugar fermentation tests discriminated reliably
between the various species in this group and further distinguished
B. variabilis from B. uniformis by differences in fermentation of
rhamnose and trehalose. Strain ATCC8492, originally the reference
strain of B. thetaiotaomicron. is now classified as B uniformis.
The classification of the B. melaninogenicus - B. oralis group of
strains has also been considerably revised, with less emphasis
placed on pigment production as the criterion for classifying
strains as B. melaninogenicus. Because of the basic difference in
sugar utilisation, B, melaninogenicus ss. asaccharolvticus has been
given separate species status as B. asaccharolyticus (Finegold &
Barnes, 1977) while B. melaninogenicus is now subdivided into the
subspecies melaninogenicus, levi and intermedius. Strain ATCC15930
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was originally a reference strain of B. oralis but has been
reclassified as B. melaninogenicus ss. melaninogenicus (Holbrook &
Duerden, 1974). Strain NP333, originally described as B. oralis,
was provisionally reclassified as B. ruminicola on the basis of
xylose fermentation (Duerden et al.. 1980) but Shah & Collins
(1981) re-examined a range of former B. oralis strains and
reallocated strain NP333 to the new species B. oentosaceus: in
the same study they reallocated B. oralis VPI8906D to the new
species B buccalis. Strain WFH15, previously B. asaccharolvticus.
is now reclassified as B. ginaivalis by the GLC criteria of
Kaczmarek & Coykendall (1980; Coykendall, Kaczmarek & Slots,
1980). B. corrodens strains 143A and 151RV were confirmed to be
; strictly anaerobic and urease-positive; Jackson & Goodman (1978)
have suggested that such strains should be renamed B. ureolvticus
to distinguish them clearly from the GC^-dependent urease-negative
strains now classified as Eikenella corrodens. The strains
previously classified as B. ochraceus are not strictly anaerobic
but require CC>2 for growth; they are now classified in a separate
genus, Capnocvtoohaga (Newman et al.. 1979; Williams, Hollis &
Holdeman, 1979).
Culture Media
Nutrient broth (NB) was prepared according to the manufac¬
turer's recommendations (Nutrient Broth No. 2, Oxoid Ltd, Wade
Road, Basingstoke, Hampshire RG24 OIW).
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Cooked-meat broth (CMB) was prepared as described by
Cruickshank et al. (1975, p.122), but with Nutrient Broth No. 2
(Oxoid Ltd) replacing the peptone infusion broth.
Todd-Hewitt broth (THB) was prepared according to the manu¬
facturer's recommendations (Oxoid Ltd). In early experiments the
pH was adjusted to 7.4 before autoclaving but it was found that the
pH of THB sometimes rose considerably on storage. In later
experiments the pH was adjusted after autoclaving, by the addition
of membrane-filtered 1.0M HC1 to the sterile broth before use.
Proteose peptone water (PPW5) contained (g/litre): Proteose
Peptone (Difco Laboratories, PO Box 14B, Central Avenue, West
Molesey, Surrey KT8 OSE; code 0120) 50 g and NaCl 5 g. It was
adjusted to pH 7.0 and was clarified by filtering through Whatman
No. 1 paper before autoclaving at 121°C for 15 min. To improve the
growth of strains of C. nowi. L-cysteine (Koch Light Laboratories
Ltd, Poyle Estate, Willow Road, Colnbrook, Slough, Berkshire SL3
OBZ) and dithiothreitol (BDH Chemicals Ltd, Poole, Dorset BH12 4NN)
were added (Moore, 1968); the supplemented broth is referred to as
PPW5S. A freshly prepared concentrated (x 50) solution containing
cysteine and dithiothreitol was passed through a membrane filter
(0.2-^um pore) and added aseptically to the steamed medium just
before inoculation with the test organism. The final concen¬
trations were: cysteine, 1 mg/ml; dithiothreitol, 90 ^g/ml.
Supplements for broth cultures of Bacteroides strains. CMB
was used without added growth factors, but all other broth media
used for culture of Bacteroides strains were supplemented with
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haemin (BDH Chemicals Ltd) and menadione (Sigma London Chemical Co.
Ltdf Fancy Road, Poole, Dorset BH17 7NH) as a routine. Membrane-
filtered solutions were added aseptically to the steamed media just
before inoculation as described by Deacon £t al. (1978). The final
concentrations were: haemin, 5 /jg/ml; menadione, 1 jug/ml.
Thioglvcollate broth (TGB) was prepared according to the
manufacturer's recommendations (Thioglycollate Medium, fluid,
without dextrose or Eh indicator, code 11727; BBL, supplied by
Becton, Dickinson UK Ltd, York House, Empire Way, Wembley,
Middlesex HA9 OPS) with the addition of yeast extract (Oxoid Ltd)
and sodium succinate (BDH Chemicals Ltd). The final concentrations
were: yeast extract, 0.25% (w/v); sodium succinate, 0.25% (w/v).
Digest broth (DB) was prepared as described by Cruickshank
et al. (1975, p.lll) but with best beef steak in place of horse
flesh; the NaHCO^ was omitted and the final pH was adjusted with
NaOH to 7.4-7.6 before sterilisation by autoclaving.
PPY broth medium was prepared as described by Deacon £t al.
(1978).
BM broth medium was prepared as described by Deacon et al.
(1978) but 0.25% (w/v) sodium succinate was added and horse serum
was omitted.
Trvoticase glycogen medium (TGM). The broth medium for
production of phospholipase-C by C. oerfrinoens contained:
Trypticase Peptone (BBL), 15 g; Na2HPO4.12H20, 5.6 g; KH2P04,
0.5 g; and MgSO4.7H20, 0.2 g. These were dissolved in 1 litre
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distilled water and autoclaved at 121 °C for 20 rain; the pH after
autoclaving was 7.1. To this was added 50 ml of autoclaved 20%
(w/v) glycogen solution (BDH Chemicals Ltd; 38042).
Horse-blood agar (HBA) was used for characterisation of the
haemolytic patterns of food-poisoning strains of C. oerfrinaens:
it contained Columbia Agar Base (Oxoid Ltd) with 10% (v/v)
Defibrinated Horse Blood (Oxoid Ltd). For routine cultures and
purity checks, blood agar (BA) containing 5% (v/v) outdated human
blood was used.
Egg-yolk agar (EYA) was prepared as described by Cruickshank
et al. (1975, p.186) using 5% (v/v) Egg-yolk Emulsion (Oxoid Ltd)
in Columbia Agar Base (Oxoid Ltd).
Bacterial Culture Studies
Method of anaerobic culture. BTL jars (Baird & Tatlock Ltd,
Chadwell Heath, Essex) were used with room-temperature-active
catalyst sachets supplied by BTL. Jars were filled with hydrogen
and 10% (v/v) C02 according to the standardised procedure described
by Collee, Rutter & Watt (1971). Broth media were held in a
steamer at 100°C for 30 min (pre-steamed) and promptly cooled to
37°C just before inoculation. The caps of bottles were loosened
when they were put into anaerobic jars. Unless otherwise stated,
all cultures were incubated at 37°C.
Strains were held as lyophilised stock with periodic
subculture in CMB and relyophilisation. For the present studies,
all strains were freshly grown in tubes (10 ml) of CMB and their
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purity and identity were carefully checked in cultural and
biochemical studies. In general, subcultures were made in tubes
(10 ml) of the test culture medium. The initial inoculum was
derived from a culture in CMB incubated anaerobically at 37°C for
18 h; the broth was shaken to resuspend the organisms and the
cooked-meat particles were allowed to settle before the inoculum
was taken.
Observation of haemolytic effect with strains of C. oerfrin-
aens. Strains were grown anaerobically on HBA plates for 18 h at
37°C with 10% CC^. Strains graded as haemolytic produced clear
haemolysis, with or without a surrounding zone of incomplete
haemolysis? non-haemolytic strains produced no effect, or only a
zone of faint, incomplete haemolysis (see Section Hid).
Biochemical characterisation of Clostridia. Fermentation
reactions were tested in tubes (10 ml) of CMB with the addition of
1% (w/v) of the appropriate substrate (glucose, maltose, lactose,
sucrose and, for C. bifermentans/C. sordelli strains, mannose and
sorbitol). The inoculum was c. 0.02 ml of a 24-h CMB culture of
the test organism. Cultures containing the appropriate substrates
were incubated anaerobically at 37°C for 24 h along with a control
culture in CMB with no added substrate. Hie pH of the cultures was
measured with a pH meter and the value obtained with each test
substrate was compared with that in the substrate-free control. A
fall in pH of >0.5 units was accepted as a positive fermentation
test result (see Rutter, 1970). For detection of urease
production, similar tests were performed in CMB containing 1% (w/v)
urea; a final pH of >8.0 was regarded as positive. Indole
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production was detected with xylene extraction of the CMB culture
before addition of Ehrlich's reagent (Holdeman .££ al., 1977,
p.127). Gelatinase activity was demonstrated with gelatin charcoal
disks (Cruickshank et al., 1975, p.178) in CMB cultures. For
differentiation of C. sordelli and C. bifermentans. tests for
growth inhibition by mannose were performed as described by
Nakamura et al. (1975) with 24-h cultures in PPY broth containing
1% (w/v) mannose.
Plate tests for phospholipase-C production bv Clostridia.
Strains were cultured anaerobically for 18 h at 37°C on EYA plates.
Strains that produced a broad zone of opalescence in the medium
surrounding the area of growth were recorded as phospholipase-
positive. A few strains that produced only a small zone of opaci¬
fication beneath the area of the colonies were regarded as weak
phospholipase producers. Phospholipase-negative strains produced
no effect in the EYA medium. The phospholipase produced by various
Clostridia was further characterised by observing inhibition of
phospholipase action on half-antitoxin EYA plates (Cruickshank £t
al.. 1975, p.474) with C. oerfrinaens type A antitoxin (Clostridial
Diagnostic Serum, code CD01; Wellcome Diagnostic Reagents Ltd).
Bacterial counts. Counting methods were as described by
Cruickshank et al (1975, pp.306-307). Samples were diluted as
appropriate in 10- or 100-fold steps in NB medium that had been
pre-reduced by steaming and promptly cooling to 37°C just before
use. Total counts were made microscopically in a cell-counting
chamber of 0J. mm depth with Thoma ruling (Gelman Hawksley Ltd, 10
Harrowden Rd, Brackmills, Northampton NN4 OEB). Separate counts
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were made of total bacteria and of colony-forming units (cfu); in
practice these were very similar as few bacteria were in clumps of
2 or more units even in early log-phase cultures. Viable counts
were performed in triplicate with 0.02-ml samples spread with
disposable glass spreaders over BA plates and incubated
anaerobically at 37°C for 18 h. Spore counts were made using
0.5-ml samples that had been heated in glass tubes (75 x 13 mm) in
a waterbath at 70°C for 20 min and rapidly cooled before performing
the viable count.
C. perfrinaens growth-curve experiment. A fresh batch of
PPW5 broth (600 ml) was prepared in a conical glass flask, a
magnetic stirrer bar (PTFE-covered) was added, and a fine-bore
(0.75 mm) PVC sampling tube was passed from the bottom of the flask
through the cotton-wool bung. This apparatus was autoclaved at
121°C for 15 min. The flask was then put in an anaerobic jar with
the sampling tube passing through the side-arm; an air-tight seal
was made at the side-arm with a rubber bung. The sampling tube was
clamped, the lid of the jar was sealed and an anaerobic environment
was produced with a Gaspak H2 and CO2 generator envelope (BBL,
supplied by Becton, Dickinson UK Ltd). The jar was placed on a
magnetic stirrer (200-250 rpm) in an incubator and the sampling
tube was led to the outside of the incubator so that the door did
not have to be opened thereafter; the temperature of the incubator
was maintained at 37.0-37.2°C throughout the experiment. The use
of the Gaspak system produced a positive pressure in the culture
flask that allowed samples to be taken through the tube into a
syringe at intervals. The dead space in the tubing was <0.5 ml,
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and the first 2 ml of fluid withdrawn was discarded in order to
wash out the tube before each sample was taken.
After holding the culture medium uninoculated for a
preliminary period of 18 h at 37°C, an inoculum of C. perfrinaens
strain L2Ab was introduced through the sampling tube with
precautions to ensure that all of the inoculum was washed through
into the culture flask. The inoculum contained 4 ml of a 10-5
dilution of a 24-h anaerobic culture in CMB medium; this contained
c. 1.5 x 104 organisms (total count) and was calculated to produce
an initial count of c. 20 organisms/ml in the bulk PPW5 culture.
At intervals after inoculation, 10-ml samples of culture were
withdrawn and used immediately for bacterial counts; they were
then cooled quickly to 4°C and 5-ml samples of supernate (800 g. for
1 h at 4°C) were stored at -20°C until assayed for neuraminidase.
Intermediate samples of 2-ml volume were used for bacterial counts
when it was not desired also to test for neuraminidase. A sample
of broth taken just before inoculation of the culture was
subcultured aerobically and anaerobically on BA plates for 24 h at
37°C to confirm that the original medium was sterile. Thereafter,
purity checks were made in the same way at 12-h intervals.
Stock neuraminidase preparations from bulk culture supernate
of C. oerfrinaens strain L2Ab in PPW5 broth (P9). A bottle con¬
taining 100 ml of pre-steamed PPW5 broth was seeded with 1.0 ml of
an overnight CMB culture of strain L2Ab and incubated anaerobically
at 37°C for 48 h; 20 ml of this starter culture was then used as
inoculum for each of three 600-ml narrow-mouthed Winchester bottles
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containing 500 ml pre-steamed PPW5 broth. After anaerobic
incubation at 37°C for 48 h, the cultures were centrifuged (1700 £
for 1 h at 4°C) and the culture supernates were pooled and stored
at 4°C. The pooled supernate was passed through a Seitz filter and
the filtered supernate (P9) was stored at -20°C for some months.
A sample (82 ml) of P9 material was thawed and, after centri-
fugation (2400 g. for 30 min at 4°C) to remove a slight precipitate,
the supernate was dialysed at 4°C in 25-mm Visking Cellophane
tubing for 72 h against running tap water, and then against a large
excess of distilled water for 24 h; the final volume after
dialysis was 100 ml. This dialysed preparation (P9D2) had strong
neuraminidase activity and was stored in 5-ml "bijou" bottles at
-20°C. No phospholipase-C (oc-toxin) activity was demonstrable in
tube tests when incubated with lecithovitellin substrate at 37°C
for 1 h (Holding & Collee, 1971). Two further dialysed samples
were similarly prepared and membrane-filtered before storing at
-20°C. Preparation P9D3 (final volume 218 ml) was made from 200 ml
of P9, and P9D4 (385 ml) from 345 ml of P9. For the neuraminidase
activity in these stock enzyme preparations, see Section Ilf.
Serial culture of clostridial strains for detection of neura¬
minidase production. In standard tests with strains of C. oer-
fringens and other clostridial species, the supernate of the second
serial 48-h culture in the test medium was used. An inoculum
(0.1 ml) of the CMB culture was added to 10 ml of pre-steamed test
medium and incubated anaerobically at 37°C for 48 h. The second
serial culture was made similarly, with an inoculum (0.1. ml) from
this culture. When desired, further serial cultures were made in
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the same manner. All strains of C. perfrinaens grew well in the
test media but when strains of other clostridial species did not
grow, or grew very poorly, in a particular medium, a further
attempt was made with a larger inoculum (1.0 ml) and incubating
each serial culture for 96 h.
Growth was estimated visually and was recorded as follows:
+++, dense turbidity; ++, moderate turbidity; +, light turbidity,
or faint turbidity with many cells seen by microscopy in a wet
film; -, faint turbidity with few cells present on microscopy;
-, no turbidity, or no cells seen on microscopy.
The purity of growth in each culture was carefully checked by
subculture aerobically and anaerobically for 18-24 h at 37°C on BA
plates. When the culture supernate was to be tested for
neuraminidase activity, cultures were centrifuged (800 g. for 1 h at
4°C) and 5-ml samples were stored at -20°C until the assay. In
addition, the centrifuged supernates of C. botulinum cultures were
membrane-filtered (0.2 /im pore) to ensure removal of all organisms.
Serial culture of C. perfrinaens strains for detection of
cell-associated neuraminidase. For the experiment presented in
table III/X, five serial anaerobic cultures of C. oerfringens
strains L2Ab and Hobbs1 type 2 were made in PPW5 broth, incubated
on each occasion for 48 h at 3 9°C. Cultures 1, 2 and 3 were made
by transferring 0.1 ml into 10 ml medium as for standard serial
cultures. For the fourth culture a 1.0 ml inoculum was added to
100 ml medium and, for the fifth, 10 ml was added to 500 ml.
Samples (5 ml) of centrifuged supernates (800 g. for 1 h at 4°C)
from cultures 1-4 were stored at -20°C. After centrifugation
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(2000 ^ for 1 h at 4°C), the supernate of the fifth serial culture
was stored at -20°C and the packed cells were resuspended in 20 ml
sterile normal saline. The cells were washed three times in saline
(2000 5 for 1 h at 4°C) and the washed cells were resuspended in
20 ml saline. The resuspended washed cells and samples of
supernate from each washing were held at -20°C.
Samples (100 ml) of the supernate of the fifth serial
cultures were concentrated in 2.5-cm Visking Cellophane tubing
exposed to polyethyleneglycol MW 6000 for 20 h at 4°C, and there¬
after dialysed against large quantities of distilled water for 72 h
at 4°C.
For preparation of cell extracts, the washed cell suspension
was thawed and four 3-ml samples of each organism were subjected to
ultrasonic disruption (Ultrasonic Disintegrator; MSE Scientific
Instruments, Manor Royal, Crawley, Sussex RH10 2QQ) for 1 h with
the samples held at 0-1 °C in an ice bath. This produced a great
decrease in turbidity in the samples, and phase-contrast microscopy
confirmed a reduction in the number of intact cells to <1% of the
original. The treated samples were pooled and the centrifuged
supernate (20,000 g. for 1 h at 4°C) was stored at -20°C.
Stock preparation of cell extract of C. perfrinaens strain
L2Ab in PPW5 broth fPIO). An inoculum (0.1 ml) of overnight CMB
culture of strain L2Ab was added to 10 ml PPW5 broth and incubated
anaerobically at 37°C for 48 h; 1 ml of this culture was then used
as inoculum for 100 ml pre-steamed PPW5 broth. After anaerobic
incubation at 37°C for 48 h the culture was centrifuged (12,000 g
for 10 min at 4°C) and the packed cells were resuspended in 20 ml
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sterile saline; the cells were washed three times in saline
(12,000 3 for 10 min at 4°C) and resuspended in 20 ml saline. The
resuspended cells were subjected to ultrasonic disintegration at 0-
1°C for 30 min in 3-ml volumes and the pooled cell extract was
stored, uncentrifuged, at -20 °C.
Preparation of cell extracts of clostridial species. Cell
extracts were prepared from the centrifuged cell deposits of the
second serial cultures (10-ml volumes) of a number of strains of
clostridial species grown in PPW5 or CMB medium. Cooked-meat
particles were allowed to settle before the broth was removed from
CMB cultures. All the supernate was removed from the packed cell
deposit after centrifugation (1200 3 for 90 min at 4°C) and the
cells were resuspended in 2 ml sterile normal saline. The
resuspended cells were subjected to ultrasonic disintegration for
15-30 min at 0-1 °C until the sample was no longer turbid. These
uncentrifuged cell extracts were stored at -20°C until assayed for
neuraminidase.
Culture of Bacteroides strains in broth media. For standard
tests of neuraminidase production by Bacteroides strains, an
inoculum (0.2 ml) of overnight CMB culture was added to 10 ml of
pre-steamed medium and incubated for 48 h at 37°C. Growth was
estimated visually and recorded as +++, ++, +, - or - as for
cultures of clostridial species (see above). Incubation was
continued to 96 h to improve growth when there was <+ turbidity at
48 h. In general, the cell extract of such cultures was tested for
neuraminidase.
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Preparation of cell extracts of Bacteroides species. In
standard tests for neuraminidase production by Bacteroides species
the 48-h or 96-h cultures were centrifuged (800 g for 60 min at
4°C). When it was desired to test the culture supernates, 5-ml
samples of the centrifuged supernate were removed and stored at
-20°C. Hie rest of the supernate was then removed from the packed
cell deposit and the cells from the 10 ml culture were resuspended
in 2 ml sterile normal saline. The resuspended cells were
subjected to ultrasonic disintegration for 15-20 min at 0-1°C and
these uncentrifuged cell extracts were stored at -20°C until
assayed for neuraminidase.
A more concentrated bulk cell extract (P15) was prepared for
tests of the effects of pH and Ca^+ on activity of B. faailis
NCTC9344 neuraminidase. An inoculum (2 ml) of a 48-h CMB culture
was added to 200 ml PPW5 broth and incubated anaerobically at 37°C
for 48 h. After centrifugation (2000 g for 1 h at 4°C) the packed
cell deposit was resuspended in 5 ml sterile normal saline and
disrupted by ultrasonic vibration for 30 min at 0-l°C; the
uncentrifuged cell extract was stored at -20°C.
Neuraminidase assays and related procedures
Substrate preparations. Cohn fractions IV^, IV-^4 and V were
obtained from approximately 1000 donations of plasma from out-dated
human blood by Cohn method 6 (Cohn et al.. 1946); the
fractionation procedures were done by Dr J.K. Smith, Scottish
National Blood Transfusion Service, Protein Fractionation Centre,
Ellen's Glen Road, Edinburgh EH17 7QT.
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The following method was used to prepare NANA-rich glyco¬
protein (fraction VII) from the supernate of Cohn fraction V. A
120-litre volume of supernate from Cohn fraction V was titrated to
pH 6.2 and cold (-25°C) ethanol was added until the final concen¬
tration of ethanol was 70% (v/v); the temperature of the solution
was lowered to -10°C during the addition, and maintained for 24 h.
The resulting white precipitate was removed by continuous-flow
centrifugation in a refrigerated Sharpies Super-centrifuge at
20,000 g and a flow rate of 40 litres/h. Approximately 700 g of
moist precipitate was recovered and dissolved rapidly in 5 litres
water. The solution was adjusted to pH 8.0 with 2M NaOH and
pasteurised in a stainless steel vessel at 60°C for 10 h. The
solution was cooled, titrated to pH 5.0 with dilute acetic acid and
held frozen at -20°C. After some weeks it was thawed at 5°C,
centrifuged at 4000 g for 1 h to remove insoluble protein, and
filtered rapidly through Green's 904V2 fluted paper to remove
floating lipoproteins. The solution was dispensed in vials, frozen
and freeze-dried to a final vapour pressure of 13.33 N/m^ (0.01
torr) at 20°C.
For information on the NANA content of different batches of
FVII substrate see table I/II.
Total protein determinations. Protein concentration in the
FVII substrate preparation was estimated by a biuret method
(Gornall, Bardawill & David, 1949); a copper-free control reagent
was used to correct extinction readings for the opalescence of the
glycoprotein preparations.
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Electrolytes. Hie concentrations of Na+ and K+ in substrate
FVII were determined by flame photometry, Cl~ by a titrimetric
method (Kit 830, Sigma London Chemical Co. Ltd) and Ca^+ by a
fluorimetric method (Fingerhut, Poock & Miller, 1969).
Electrophoresis. Cellulose-acetate electrophoresis of
substrate preparations was carried out on Sepraphore III medium
(Gelman Instrument Co., Ann Arbor, Michigan, USA) at pH 8.6.
Strips were stained for total protein (Ponceau S) and for glyco¬
protein (Kohn, 1968).
Gel filtration. Gel filtration of substrate preparations was
at 5°C on Sephadex G-200 in 0.01M tris-borate/O.lM NaCl buffer,
pH 8.6, in a glass column (2.5 x 80 cm) eluted at 20 ml/h. The
extinction of the eluate was measured continuously at 254 nm in a
flow-through analyser, and 5-ml fractions were collected for
extinction readings at 280 nm. Certain fractions were also pooled
and concentrated by ultrafiltration prior to electrophoresis on
cellulose-acetate strips, and immunoelectrophoresis in agar.
Assay for N-acetyl neuraminic acid (NANA). Aminoff's thio-
barbituric acid assay for free sialic acid as described by Cassidy
et al. (1966) was followed. The reagents were: Reagent 1, 0.025M
periodic acid (Koch Light Laboratories Ltd) in 0.25M H2SO4 (BDH
Chemicals Ltd, Analar) at pH 1.2; Reagent 2, NaAsC>2 (BDH Chemicals
Ltd) 2% (w/v) in 0.5M HC1 (BDH Chemicals Ltd, Analar); Reagent 3,
0.1M 2-thiobarbituric acid (Koch Light Laboratories Ltd) in 0.1M
NaOH (BDH Chemicals Ltd, Analar) adjusted to pH 9.0; and Reagent
136
4, butan-l-ol containing 12M HC1 5% (v/v). Pure synthetic NANA
(Koch Light Laboratories Ltd) was used as a standard.
In routine tests, 0.5-ml samples were assayed in glass tubes
(125 x 15 mm). Spectrophotometry readings of the organic phase at
a wavelength of 549 nm were made with 4-ml glass, or disposable
plastic, cuvettes (1-cm light path) in a spectrophotometer (Pye-
Unicam Ltd, York St, Cambridge CB1 2PX; SP 600). The reference
cell contained a "reagent blank" prepared by taking 0.5 ml
distilled water through the assay procedure. When it was desired
to analyse the absorbance curve for the assay product, the organic
phase was examined in a scanning spectrophotometer (Pye-Unicam Ltd;
SP 800OA), using the reagent blank in the reference cell.
Time-course studies of the release of NANA from substrate
FVTI bv acid hydrolysis. Equal volumes (0.7 ml) of a known concen¬
tration of H2SC>4 and of substrate dissolved in distilled water were
mixed in screw-capped "bijou" bottles and promptly put into a water
bath at 80°C Reference bottles contained equal volumes of H2S04
and of a solution of pure NANA in distilled water to demonstrate
the extent of breakdown of NANA under the conditions of the test.
The starting times were arranged so that the test periods of
incubation ended simultaneously. The bottles were then rapidly
cooled in two stages to 0-l°C, duplicate 0.5-ml samples were
transferred to tubes and the assay for NANA was immediately
performed. Time-zero (Tq) control tests were performed with
chilled reagents, the mixture being held for only a few min at
0-l°C before the assay for NANA. Test results were corrected by
subtraction of the appropriate Tq control readings.
137
Tests for effects of culture materials on the NANA assay.
Mixtures, prepared as for the standard neuraminidase assay but with
NANA in place of substrate EVII, contained: 0.1 ml test substance;
0.15 ml sodium acetate buffer, pH 5.1; and 0.25 ml pure NANA
(10 ^g) in distilled water. Time-zero (Tq) tests were prepared
with pre-cooled reagents. Each test value (E549) was corrected by
subtraction of the value obtained for control mixtures with buffer
in place of NANA. Reference tubes containing only NANA in buffer
were prepared by replacing the test substance with buffer, and each
test result was compared with the appropriate reference value to
show whether the test substance had interfered with the NANA assay.
When it was desired to demonstrate the extent of NANA break¬
down (NAN-lyase activity) that might occur during incubation under
the conditions of the neuraminidase assay, tests and controls were
also incubated at 37°C for the appropriate period before assaying
for NANA. Experiments were timed so that test periods of
incubation ended simultaneously and all tests, including Tq tests,
were assayed for NANA in a single batch. Any breakdown of NANA
during incubation of a test mixture can be detected by comparing
the corrected values for the incubated test and the Tq test. In
standard assays for NAN-lyase activity in culture products of
clostridial or Bacteroides strains, duplicate tests were incubated
with NANA for 24 h at 37°C; culture products that did not reduce
the assay value for 10 pg NANA (E549 c. 0.5) by 0.1 or more during
24 h incubation were regarded as having insignificant NAN-lyase
activity.
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Assay for neuraminidase activity. For the standard test,
0.5 ml of reaction mixture was prepared by adding the following
volumes to glass tubes (125 x 15 mm): 0.1 ml of test enzyme
preparation; 0.15 ml of 0.1M sodium acetate buffer, pH 5.1
(Cruickshank et ai., 1975, p.88); and 0.25 ml of substrate FVII.
See table I/III for concentrations of available NANA in standard
assays with different batches of FVII substrate. Unless stated
otherwise, dilutions of substrate or enzyme were made in acetate
buffer, pH 5.1. Throughout the text the stated dilution of an
enzyme preparation is that prepared for addition to the reaction
mixture, but the concentration of substrate is normally given as
the final concentration in the reaction mixture. Enzyme and
substrate control tubes contained the equivalent volume of acetate
buffer, pH 5.1, in place of the substrate and enzyme respectively.
Reagents were normally held at room temperature before making the
test mixtures, but were pre-warmed to 37°C when the period of
incubation was to be less than 10 min. After incubation for the
appropriate period at 37°C in a water bath, Reagent 1 was added to
the mixture and the standard NANA assay was performed.
In studies of the time-course of the reaction with different
concentrations of substrate and enzyme, standard tests were set up
and incubated for graded periods of time. The timing of
experiments was such that test periods of incubation ended simul¬
taneously and all tests, including time-zero (Tq) control tests,
were assayed for NANA in a single batch. For the T0 control tests,
the standard assay volumes of enzyme, substrate and buffer, pre-
cooled to 0-l°C, were mixed in a tube held in an ice bath at 0-1 °C;
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the assay for NANA was begun immediately by adding Reagent 1 and
transferring the mixture to a water bath at 37°C.
Each test and control assay was normally performed in
duplicate and an average value for the extinction at 549 nm was
calculated. The test reading was corrected to give a value
equivalent to the amount of NANA released from the substrate during
the incubation period by subtraction of either the sum of separate
enzyme and substrate control readings or the value for the TQ
control test; unless otherwise stated in the text, the results in
these studies have been corrected by subtraction of separate enzyme
and substrate control values. Reference assays of 10 ^g of pure
NANA in 0.5 ml distilled water were performed with each batch of
assays. The results of neuraminidase assays are expressed in terms
of spectrophotometric readings and are not routinely converted into
equivalent concentrations of NANA because the presence of
constituents of the culture medium may influence the reading
obtained in the assay for NANA (see Section Ila).
Reference neuraminidase preparations. Our preparations of
neuraminidase were standardised by comparison with a commercially
available preparation of chromatographically purified C. perfrin-
gens (C. welchi) neuraminidase (type VI, N3001; Sigma London
Chemical Co. Ltd); this batch had a declared activity of
1.1 unit/mg solid with NAN-lactose as substrate and 0.58 unit/mg
with bovine submaxillary mucin as substrate, 1 unit liberating
1.0 jjmole of NANA/min at pH 5.0 and 37°C from the test substrate
(see Section Ilf).
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Vibrio cholerae Receptor Destroying Enzyme (RDE; Wellcome
Reagents Ltd) was used as a source of V. cholerae neuraminidase.
Grading of clostridial neuraminidase activity. The relative
amounts of neuraminidase produced by various clostridial strains
and species in the supernates of the test cultures were graded
according to the results of standard neuraminidase assays incubated
for different periods of time at 37°C All tests were performed in
duplicate. The average value for the test assay (E54g) was
corrected by subtraction of the sum of the values for separate
substrate and enzyme control tests. Initial assays were incubated
for 1 h before assay for free NANA. When the 1-h assay clearly
showed neuraminidase activity, the assay was repeated with a 15-min
incubation period. When the 1-h assay showed little or no
activity, tests were incubated for 24 h in order to demonstrate the
presence or absence of detectable neuraminidase activity. Tests
that gave low values (E^g <0.5) in 24-h assays were further
examined with the SP 8000A spectrophotometer to confirm that the
absorption peak was at 549 nm, and at least one test from each
neuraminidase-positive species was also examined in this manner,
whether the assay values were high or low. In order to demonstrate
clearly whether a low assay value was or was not due to the
presence of NANA, it was occasionally necessary to read the
absorption curve of the test mixture against a time-zero (Tq)
control test, rather than the enzyme control, as reference sample.
The corrected results of neuraminidase assays were graded as
follows: ++++, very high spectrophotometric values in 15-min
assays (E^g >1.0); +++, NANA release clearly detectable in 15-min
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assays (>0.1); ++, low values in 15-min assays (<0.1) but NANA
release clearly detectable in 1-h assays (>0.1); +, not demon¬
strable in 1-h assays but high values (>0.5) in 24-h assays; -,
low values (<0.5 but >0.05) in 24-h assays and absorption peak
clearly shown at 549 nm; -, no peak at 549 nm demonstrable in
24-h assays.
Grading of Bacteroides neuraminidase activity. Tests for
neuraminidase activity in the cell extracts of Bacteroides strains
were performed in the same manner as for the tests for clostridial
neuraminidase and the results were graded on a similar scale.
Since none of the Bacteroides samples contained as much
neuraminidase as the clostridial samples graded I I I 1, 15-min assays
were not performed. The corrected results of neuraminidase assays
were graded as follows: +++, high values in the 1-h assays (E54g
>0.5); ++, moderate NANA release clearly demonstrable in 1-h
assays (>0.1); +, not demonstrable in 1-h assays but high values
(>0.5) in 24-h assays; -, low values (<0.5 but >0.05) in 24-h
assays and absorption peak clearly shown at 549 nm; -, no peak at
549 nm demonstrable in 24-h assays.
Tests that gave low values (E54g <0.5) in 24-h assays were
routinely examined to confirm that the absorption peak was at
549 nm; this was also done for at least one culture from each
species even if the assay value was high. Culture products that
gave very low or negative results (E54g <0.5) in 24-h neura¬
minidase assays were further examined to determine whether
destruction of NANA by NAN-lyase activity might be interfering with
the 24-h neuraminidase assay.
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Buffers for oH studies. Sodium acetate buffers were prepared
as described by Cruickshank £t al. (1975, p.88); the pH range was
extended to give buffers of higher pH by the use of progressively
smaller volumes of acetic acid and correspondingly higher volumes
of sodium acetate solution.
Tris-maleate buffer solutions were prepared as described by
Diem & Lentner (1970, p. 280); the pH range was extended to give
buffers of lower pH by the use of progressively smaller quantities
of NaOH.
Studies on the effect of pH on C. perfrinaens neuraminidase.
In order to ensure adequate buffering, tests were performed in a
greater volume than for standard neuraminidase assays. The total
reaction-mixture volume of 1.0 ml consisted of: 0.1 ml of enzyme
preparation P9D2 diluted 1 in 2 in distilled water; 0.65 ml of the
appropriate buffer; and 0.25 ml of substrate FVII(5) diluted in
distilled water to give a final concentration in the reaction
mixture of 143 /ag/ml. Separate enzyme and substrate controls were
prepared at each pH value by replacing the substrate and enzyme
respectively with the equivalent volume of the appropriate buffer.
Tests and controls were incubated for 30 min at 37°C and then
assayed for NANA by the standard method.
The starting pH values of this series of tests were measured
during a separate experiment. With pre-cooled reagents, test
mixtures were prepared in tubes held at 0-l°C in an ice bath and
the pH of each mixture was measured immediately. Small samples
were brought to 37°C in a Radiometer BMS2 system and the pH values
at 37°C were promptly read on a linked Radiometer PHM71 meter. The
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pH values plotted for fig. II/7 are these measured values for the
initial pH of the reaction mixture.
Studies on the effect of pH on the neuraminidase of B. fragi-
lis. Assays were performed in a range of sodium acetate buffers in
tests similar to those used with C. perfrinaens neuraminidase. The
total reaction-mixture volume of 1.0 ml consisted of: 0.1 ml of
the bulk cell extract (P15) of B. fraailis NCTC9344 diluted 1 in 40
in distilled water; 0.65 ml of the appropriate sodium acetate
buffer; and 0.25 ml of substrate FVII(8) diluted in distilled
water to give a final concentration in the reaction mixture of
160 pg NANA/ml. Separate enzyme and substrate controls were
prepared at each pH value. Tests and controls were incubated for
30 min at 37°C before the assay for NANA.
The pH values shown in fig. V/l are the initial values for
the buffers added to the tests. Separate measurements were made of
the initial pH values in sample reaction mixtures prepared with
equivalent proportions but in 3-ml total volumes.
Studies on the effect of pH on C. perfrinqens NAN-lyase. The
test mixtures contained: 0.1 ml of cell extract (P10) of C. per¬
frinqens strain L2Ab; 0.15 ml of the appropriate sodium acetate
buffer; and 0.25 ml of pure NANA (10 ^ig) dissolved in distilled
water. All assays were performed in duplicate and average values
were used for calculation of results. The tests were incubated for
1 h at 37°C and the result (E54g) of the test at each pH value was
corrected by subtraction of the assay value for the corresponding
Tq control test prepared with pre-cooled reagents.
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Effect of Ca2+ and EDTA on neuraminidase activity. CaCl2.
2H20 (BDH Chemicals Ltd, Analar) or EDTA (ethylenediaminetetra-
acetic acid disodium salt; BDH Chemicals Ltd, Analar) were added
to the sodium acetate buffer, pH 5.1, used in the neuraminidase
assay. The final concentrations of added Ca2+ or EDTA in the
reaction mixtures were 3mM Ca2+, ImM Ca2+, ImM EDTA or 5mM EDTA.
The test enzyme preparation (0.1 ml) and the acetate buffer
containing Ca2+ or EDTA (0.15 ml) were mixed and held at 37°C for
30 min before addition of the substrate FVII (0.25 ml) and the
start of incubation of the neuraminidase assay. Separate enzyme
and substrate control tubes contained the equivalent volumes of
acetate buffer in place of the substrate or enzyme respectively.
Enzyme and substrate control tests also contained the appropriate
amount of added Ca2+ or EDTA. All tests were performed in
duplicate and average values were used in calculation of results.
Each test result (E549) was corrected by subtraction of the sum of
the values for separate substrate and enzyme control tests.
Studies with antisera
Assay for serum anti-neuraminidase activity. Equal volumes
of the test antiserum, diluted appropriately in saline, and of the
C. perfrinaens neuraminidase preparation were mixed and held at
room temperature for 30 min to allow neutralisation of the enzyme
before the start of the standard assay for neuraminidase activity.
Throughout the text the stated dilution of an antiserum is the
initial dilution prepared for addition to the enzyme preparation;
standard assays were performed with sera diluted 1 in 100. The
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reaction mixtures contained: 0.05 ml neuraminidase preparation P9D3
or P9D4; 0.05 ml antiserum, diluted appropriately in saline;
0.15 ml acetate buffer, pH 5.1; and 0.25 ml substrate preparation
FVII(7) or FVII(8). Enzyme and substrate control tubes contained
the equivalent volume of acetate buffer, pH 5.1, in place of the
substrate and enzyme respectively. Test and control assays were
incubated for 30 min at 37°C before the start of the assay for
NANA. Average values for duplicate test and control assays were
used for calculation of the corrected assay value by subtraction of
the sum of the values for the enzyme and substrate control assays.
In a few experiments time-zero (Tq) tests were also performed; the
assay for NANA was started immediately after addition of the
substrate to the reaction mixture, with no period of incubation at
37°C. In general, however, Tq assays are not recommended for
correction of test results (see Section Via).
Reference assays to determine the activity of the standard
enzyme in the absence of antiserum were performed with enzyme that
had been mixed with saline in place of antiserum during the
neutralisation period. The degree of inhibition of the enzyme by
the test antiserum was expressed as the percentage reduction in the
test assay compared to the value given by the reference assay of
the enzyme with no added antiserum.
Preparation of standard C. perfrinaens phospholipase-C (PLC).
A 10-ml CMB culture of C. perfrinaens strain L2Ab was incubated
aerobically at 37°C for 6 h. This starter culture was shaken to
resuspend the organisms and the cooked-meat particles were allowed
to settle before the broth was decanted and added to 1050 ml of
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pre-reduced TGM broth. This bulk culture was incubated
anaerobically at 37°C for 20 h; its purity was checked by
microscopy and subculture to aerobic and anaerobic BA plates.
After centrifugation (1200 s for 1 h at 4°C) the supernate was
concentrated at 4°C in 7-cm Visking Cellophane tubing exposed to
polyethyleneglycol MW 6000 for 3 days, followed by dialysis against
running tap water for 2 days (final volume 30 ml). After centri¬
fugation (10,000 h for 90 min at 4°C) the supernate was lyophilised
in 4.5-ml volumes and stored at 4°C; this standard phospholipase-C
preparation is referred to as PLC.
Tube tests for titration of phospholipase-C activity. The
standard C. oerfrinaens phospholipase-C preparation (PLC) was
reconstituted and serial doubling dilutions were prepared with
Michaelis' barbital sodium-acetate buffer, pH 6.8 (Diem & Lentner,
1962, p. 314). Tests were performed in glass tubes (75 x 11 cm)
with 10% (v/v) lecithovitellin substrate as described by Holding &
Collee (1971). Equal volumes (0.5 ml) of the test dilution of
enzyme preparation and of lecithovitellin solution were mixed and
incubated in a waterbath at 37°C for 24 h. Results were recorded
as turbidity (+++), opalescence (++) or faint opalescence (+) by
visual comparison with a control tube in which the test material
was replaced by Michaelis' buffer, pH 6.8. The end-point was read
as the tube that contained the minimum dose (MOD) that gave ++
opalescence; the titre of the reconstituted PLC preparation was
found to be 64.
Assay for serum anti-phospholjpase-C activity. The activity
of the standard phospholipase-C preparation (PLC) was assayed in
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tube tests in order to determine the minimum dose (MOD) that gave
++ opalescence in the reaction mixture after incubation at 37°C for
24 h (see above). Equal volumes (0.25 ml) of the test antiserum,
serially diluted in Michaelis' buffer, pH 6.8, and of the PLC
preparation diluted in the same buffer to contain 2 MOD, were mixed
in the assay tubes and held for 30 min at room temperature to allow
neutralisation. The standard assay for phospholipase-C activity
was started by adding 0.5 ml of the lecithovitellin substrate and
the reaction mixture was incubated at 37°C for 24 h. Reference
samples contained saline in place of antiserum. The inhibitory
activity of the test antiserum was expressed as the reciprocal of
the highest dilution of serum that completely inhibited the
activity of the standard amount of enzyme; dilutions of antiserum
are expressed as the initial dilution prepared for addition to the
test.
Equine antisera. C. perfrinaens type A antitoxin (CPA) for
neuraminidase inhibition studies was obtained from Wellcome
Research Laboratories, Langley Court, Beckenham, Kent BR3 3BS
(C. welchi type A antitoxin, Wellcome Clostridial Diagnostic Anti¬
serum: two batches were used; CPA1 = lot K0697, CPA2 = lot
9159B). The other C. oerfrinaens sera (1863, 1881, 2748 and 5438)
were provided by Prof. Collee; these experimental sera, raised in
horses against C. perfrincens type A culture products, were
originally obtained from Wellcome Research Laboratories in 1963 and
had been stored at 4°C. C. tetani antitoxin (ATS) was also an
experimental equine antiserum originally obtained by Prof. Collee
from Wellcome Research Laboratories.
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Ammonium sulphate fractionation of PFW5 culture supernate of
C. perfrinaens strain L2Ab I£I2L More concentrated preparations
of neuraminidase for rabbit immunisation studies were obtained by
(NI^^SC^ fractionation of a further bulk PPW5 culture supernate
(P12) of C perfrincens strain L2Ab. The P12 preparation was made
by the same procedure as was used for the stock culture supernate
P9 (see above) and stored at -20°C. Two batches of P12 culture
supernate were subjected to (NI^^SC^ fractionation as described by
Cassidy et al. (1966) in order to obtain the precipitates produced
at 50% and 85% saturation. All procedures were carried out in the
cold (0-4°C). After centrifugation (20,000 g for 60 min) the
precipitates were redissolved in distilled water before
concentration in a stirred ultrafiltration cell (Model 52; Amicon
Ltd, Upper Mill, Stonehouse, Gloucestershire GL10 2BJ) at
45 lb/in^ with a PM10 membrane (10,000 MW cut-off). The samples
were assayed for protein (Lowry et al., 1951) and for neuraminidase
and were stored at -20°C until used for immunisation of rabbits.
Two batches of P12 culture supernate were fractionated in
this way. For batch A, 500 ml of the bulk P12 preparation was
thawed and fractionated directly. Before addition of (NI^^SC^ to
batch B, the P12 preparation (580 ml) was centrifuged (27,500 g for
60 min at 4°C) to remove a slight precipitate and then dialysed
against tap water at 4°C to remove peptone medium constituents that
interfered with the assay for protein in the starting material.
For the relative amounts of neuraminidase and protein in the
various fractions, see Section VIb.
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C. perfringens type A neuraminidase (Sigma) for rabbit immun¬
isation. For immunisation studies, further batches were obtained
of the chromatographically purified C. perfrinaens neuraminidase
used previously as a reference neuraminidase preparation (see
above: Sigma London Chemical Co. Ltd; type VI, N3001). Three
batches were used, with the following declared specific activities:
batch 1, 2.1 units neuraminidase activity/mg protein; batch 2, 5.4
units/mg; batch 3, 6.5 units/mg (1 unit liberates 1.0 pmole
NANA/min frcm NAN-lactose substrate at pH 5.0 and 37°C).
Procedure for immunisation of rabbits. Adult New Zealand
White rabbits (2-3 kg) of either sex were immunised with
C. oerfringens neuraminidase (see Section Vic for details of
antigen preparations and schedules of immunisation). Samples of
blood (usually 5 ml) were taken before the first injection (pre-
inoculation sample) and at intervals during the course of
immunisation; the serum was separated and held at -20°C. The
following adjuvant preparations were used: Freund's complete
adjuvant (Difco Laboratories, 0638-60-7); Freund's incomplete
adjuvant (Difco Laboratories, 0639-60-6); and aluminium hydroxide
(Alhydrogel; Miles Laboratories Ltd, PO Box 37, Stoke Poges,
Slough, Berkshire SL2 4LY). For each injection the antigen
preparation was emulsified with an equal volume of adjuvant in a
Sorvall Omni-mixer (Du Pont UK Ltd, Biomedical Products Division,
Wedgwood Way, Stevenage, Hertfordshire SGI 4QN). Hie total volume
given in a single injection was 2-4 ml; subcutaneous injections
were divided and given in four separate sites. Batches of sera,
diluted 1 in 100 in saline, were assayed in standard anti-
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neuraminidase assays in order to monitor the response of each
rabbit. A final collection of blood was made by cardiac puncture
when the animal was killed.
Gel-diffusion analysis of rabbit serum. Serum was examined
for the presence of antibody by gel diffusion in a Petri dish
(Cruickshank et al., 1975, p.241). The plates contained 1% (w/v)
ionagar (Ionagar No. 2; Oxoid Ltd) and were examined after being
held at room temperature for 48 h.
Guinea pia pathogenicity studies
Guinea oias. Normal guinea pigs of either sex and varied
markings were bred in the Animal House in this Department. Animals
weighed 350-500 g and were allowed free access to food and water
during the experiment.
Calcium chloride. A 15% (w/v) solution of CaC^.e^O (BDH
Chemicals Ltd, Analar) in distilled water was autoclaved at 121°C
for 15 min and used as sclerosing agent for promoting infection in
guinea pigs.
Adrenaline. Adrenaline tartrate 1 in 1000 (Evans Medical
Ltd, 891 Greenford Rd, Greenford, Middlesex UB6 0HE) was diluted 1
in 10 in sterile saline; this solution (100 pg adrenaline/ml) was
held in the dark until used in animal inoculation studies.
Preparation of bacterial inocula. The following procedure
was used to prepare washed cell suspensions containing known
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numbers of log-phase organisms of various clostridial species.
Each strain was freshly grown in CMB medium from freeze-dried stock
and its purity was tested by 24-h aerobic and anaerobic subculture
on BA plates. A second CMB culture (10 ml) from an inoculum of
0.1 ml of the initial culture was incubated anaerobically for 18 h
at 37°C. A further bottle of CMB medium (20 ml) was held
uninoculated with the cap loose in the same anaerobic jar, so that
it was pre-warmed and pre-reduced when the jar was opened next
morning. In order to produce an actively growing log-phase
culture, 0.2 ml of the 18-h culture was added with minimal delay to
the 20 ml of pre-reduced medium; the jar was promptly made
anaerobic and put in a waterbath at 37°C. After incubation for
2 h, the culture was shaken to resuspend the organisms and the
cooked-meat particles were allowed to settle before removal of the
broth. The packed cells (18,000 3. for 10 min at 4°C) were washed
once in 20 ml sterile saline and the cells were resuspended in 1 ml
sterile saline. In some experiments this washed cell suspension
was used undiluted to provide a high challenge dose for inoculation
into the animal; in others, the number of organisms was rapidly
estimated by a total count and the suspension was diluted
appropriately in sterile saline to give the desired number of cells
in the inoculum.
The purity and identity of the organism in the suspension
prepared for each inoculum was confirmed by subculture to BA plates
incubated aerobically and anaerobically at 37°C for 24 h. The
number of bacteria present in the inoculum was measured with
minimal delay by performing total and viable cell counts with
appropriate dilutions of the washed cell suspension. (For
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bacterial counting methods, see above.) Throughout the text, the
challenge dose cited is the number of organisms in the inoculum as
determined by total count (cfu). In general, when the results of
the viable counts became available next day they were very close to
the original total counts. Difficulties were experienced in some
early experiments when dilutions were prepared in saline and the
viable counts were delayed while the animals were inoculated;
these counts suggested a 100-fold or greater loss of viability in
the inoculum. However, this was shown to be an artefact when pre-
reduced NB medium was substituted for saline as diluent and the
viable counts were promptly performed during the time when the
animals were also being inoculated.
Inoculation of bacteria into guinea pigs. The washed bac¬
terial suspension was injected into the left hind leg of the test
animal. In experiments with CaCl2 as sclerosing agent, 0.2 ml of
15% CaCl2 was injected into the muscle mass of the left thigh 3 h
before the freshly prepared bacterial inoculum (0.2 ml of washed
cell suspension) was injected into the same site. Uninfected
control animals received an injection of 0.2 ml sterile saline 3 h
after the injection of CaO^.
When adrenaline was used for initiating infection, the
adrenaline and the challenge dose of bacteria were mixed in the
same syringe just before inoculation; the 0.2-ml inoculum
contained 0.1 ml of bacterial suspension mixed with 0.1 ml of
adrenaline solution (10 jug adrenaline). Control animals received
an inoculum containing 0.1 ml of adrenaline but with 0.1 ml sterile
saline in place of the bacterial suspension.
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Classification of outcome of bacterial challenge. The animals
were observed daily for up to 7 days and the course of infection
was noted. Some animals developed overwhelming infection and died
during the first or second day; the actual time of death was often
not more accurately known. Animals that were judged to be severely
ill or moribund (immobile, cold, with ruffled fur) were killed at
that stage by a blow on the head. Surviving animals usually had
only local signs in the inoculated leg (swelling, stiffness,
flexion) and were killed after 6-7 days. At post-mortem
examination the degree of infection in the thigh muscles was noted.
In general it was possible to classify the result of challenge for
each animal in one of the following broad categories: G = acute
gangrenous infection with extensive thigh muscle necrosis and
haemorrhagic oedema spreading to the anterior abdominal wall,
resulting in severe illness or death within 1-2 days; N = severe
local damage with extensive necrosis of thigh muscle but animal
survived for 3 days or more; LA = animal survived with signs
limited to the inoculated leg and a large abscess was found at
post-mortem examination; MA = similar but less severe infection
with a well-defined medium-sized abscess found in the inoculated
thigh muscles; SA = limited swelling and stiffness in the
inoculated leg and a small localised abscess found; NAD = minor,
sometimes transient, signs in the inoculated leg, but no
abnormality detected post mortem. These abbreviations are used in
the tables in Section VII; where significant differences from
these categories occurred they are described in the text.
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Sampling of guinea pia tissues and reisolation of challenge
strain. Tissue samples were taken from both legs at the post¬
mortem examination; samples of liver were also taken from some
animals. Where the thigh muscles were intact, as large a sample as
possible was taken. With animals that had developed gangrene, the
necrotic tissue and oedematous exudate were taken along with
remaining portions of muscle; a sterile syringe was used for
collection of liquid samples. In some animals there was a
localised abscess within the thigh muscle; these samples contained
varying amounts of abscess content, abscess wall and surrounding
intact muscle.
The samples were taken with sterile instruments and were
placed in sterile screw-capped glass bottles, but it was difficult
to avoid some degree of contamination from the overlying skin. A
few animals developed superficial lesions over the affected thigh;
samples from these were particularly liable to contamination or
superinfection. Samples were put at -20°C as soon as possible (and
always within 1 h) and were kept in the cold thereafter in order to
prevent further multiplication of infecting or contaminant
organisms. Gram films were made with impression smears or swabs
from the tissue samples of the inoculated limb to show the presence
of morphologically typical organisms. In order to reisolate and
confirm the identity of the infecting strain, cultures were made
from the inoculated thigh muscle samples on BA plates incubated
aerobically and anaerobically for 24 h; in some experiments, CMB
medium and EYA plates were also inoculated. Animals were excluded
from the study if the reisolated strain differed from that
inoculated, if more than one strain of Clostridium was recovered,
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or if another neuraminidase-producing contaminant was isolated;
these exclusions were few.
Homogenisation of tissue samples for neuraminidase assays.
The samples were promptly weighed; sodium acetate buffer, pH 5J.,
was added in the ratio of 3 ml buffer to 1 g tissue and the bottles
were put at -20°C. Thawed samples, held in an ice-water bath at
0-l°C, were later treated with a homogeniser (MSE Scientific
Instruments) for 2-10 min as required. The homogenised samples
were centrifuged (800 g. for 30 min at 4°C) and the supernates were
held at -20°C. Samples (OJL ml) were assayed for neuraminidase in
standard assay mixtures incubated for 1 h; repeat assays were
incubated for 24 h if clearly positive results were not obtained.
The results of assays for neuraminidase in the tissue extracts were
graded by the same scale (+++ to -) as was used for grading assays
with Bacteroides culture products (see above).
Tests for C. sordelli ft-toxin production. Freeze-dried stock
of each test strain was inoculated into 10 ml CMB medium and
incubated anaerobically at 37°C for 24 h; purity was checked by
aerobic and anaerobic subculture on BA plates. Aliquots (2 ml) of
the CMB cultures were centrifuged (5500 .g for 20 min at room
temperature) and 0.1 ml of each culture supernate was given by
intradermal injection to depilated albino guinea pigs. A sample of
supernate from uninoculated CMB was included as a control. Animals
were observed for 48 h. After 24 h p-toxin action was seen as a
large (1-2 cm diameter) oedematous zone with a central purple-brown
necrotic ulcer; this increased considerably in size by 48 h.
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There was no visible reaction to p-toxin-negative samples after 24
or 48 h.
Tests for protective effect of antisera in guinea pigs. Each
animal was given 1 ml of a 1 in 2 dilution of the test antiserum in
sterile saline by intraperitoneal (IP) injection 20 h before
challenge with a standard number of washed cells of G. oerfrinaens
strain L2Ab. Control animals were given 1 ml of saline in place of
the antiserum. The procedure for challenge of the guinea pigs was
as described above, with an inoculum containing a challenge dose
known to be the minimum lethal dose for the experimental conditions
employed, i.e. with either adrenaline or CaCl2 as initiating agent.
The outcome of infection was recorded as previously described.
157
RESULTS
I. EVALUATION OF A GLYCOPROTEIN FRACTION fFVII)
PREPARED FROM POOLED HUMAN PLASMA AS SUBSTRATE FOR THE
ASSAY OF CLOSTRIDIUM PERFRINGENS NEURAMINIDASE
la. Preparation and characterisation of
glycoprotein fractions
The oc^-acid glycoprotein (orosomucoid) of human plasma is
normally one of the waste products of large-scale plasma
fractionation. Various glycoprotein-containing fractions were
prepared from out-dated human plasma (see Materials and Methods)
and assessed for suitability for use as substrate in assays for
neuraminidase activity. In preliminary experiments, the
glycoproteins of Cohn fractions IV^ and IV1+4 were studied. When
these fractions were redissolved in water they were found to
contain material rich in N-acetyl neuraminic acid (NANA) that
withstood pasteurisation at pH 8. -However, the preparations were
very turbid and contained a material that acted as a chromogen in
the spectrophotometric assay for NANA before hydrolysis; the
absorption spectrum of the product had a peak at c. 530 nm that
overlapped to an unacceptable degree with that derived from pure
NANA (peak absorbance at 549 nm). Unsuccessful attempts were made
to remove the interfering material by absorptive filtration,
isoelectric precipitation, ultracentrifugation and fractionation
with polyethyleneglycol MW 4000.
Hie one-stage preparation, fraction VII (FVII), proved much
simpler and the product had none of the disadvantages of the
fraction TV derivatives. The procedure used for preparation of
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batch FVII(5) is detailed in Materials and Methods. Several other
such large-scale preparations were made and used in the course of
the present studies; the technique used for later batches was
essentially the same, differing only in minor details of scale, re¬
solution volume and the volume dispensed for freeze-drying. Each
batch was readily soluble in water, even in concentrations
exceeding 50 mg/ml. When a vial of batch FVII(5) containing
18.4 mg dry powder was dissolved in 1 ml water the solution
contained; 12.1 mg protein, 46 pnole Na+, <1 jimole K+, 8 jjmole
CI", and 0.42 jimole Ca^+.
Cellulose-acetate electrophoresis of FVII (fig. 1/1)
separated it into a minor zone with the mobility of serum albumin
and a major, rather broad, "inter-oc" zone with a mobility inter¬
mediate between theoc^ and^ serum globulins. The albumin zone
i
stained very poorly for glycoprotein, while the inter-oc zone
stained quite intensely. Because the relative dye-binding
characteristics of these proteins were unknown, it was not possible
to assess the proportion of the total protein migrating in each
zone.
The preparation was separated into two peaks by gel
filtration on Sephadex G-200 (fig. 1/2). The first peak was
excluded from the gel, and therefore consisted of proteins
with MW >200,000. Eluates from each peak were reconcentrated and
examined by cellulose-acetate electrophoresis and immunoelectro-
phoresis.
The high-MW peak contained approximately 65% of the applied
protein. It consisted of glycoprotein occupying the more slowly
migrating region of the broad inter-oc zone seen in the whole
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Fig. 1/1 - Separation of glycoprotein preparation FVII by
cellulose-acetate electrophoresis. Samples: (a) and (c), human
serum; (b) and (d), fraction FVII(6). Strips (a) and (b) stained
for total protein; strips (c) and (d) stained for glycoprotein.




Fig. 1/2 - Separation of glycoprotein FVII on Sephadex G-200.
Sample: 2 ml containing 70 mg FVII(6). Eluate monitored at 254 nm.
Horizontal scale represents time, which is linearly proportional to
eluate volume. After separate concentration of each peak, peak 1
was found to contain mainly aggregated glycoprotein and peak 2 to
contain mainly monomeric albumin and °<^-acid glycoprotein.
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preparation; there was also a trace of polymerised albumin,
detectable only by Immunoelectrophoresis.
The low-MW peak contained approximately 35% of the applied
protein. It consisted largely of monomeric albumin, but also
contained a little glycoprotein occupying the faster-migrating
region of the broad inter-oc zone. Both gel filtration peaks, i.e.
both the faster- and slower-migrating regions of the inter-oc zone,
were rich in orosomucoid detectable by Immunoelectrophoresis.
Ib. Release of NANA from substrate FVTI
Release of NANA from FVTI by acid hydrolysis. When samples
of NANA are heated at 80°C in 0.02M H2SO4 there is usually very
little breakdown of the NANA within 2 h. Fig. 1/3 shows the effect
of subjecting samples of FVTI to the same treatment. Separate test
mixtures were prepared and incubated at 80°C for graded periods of
time; the timing was such that test periods of incubation ended
simultaneously and all tests were assayed for NANA in a single
batch (see Materials and Methods). Test results (E^g) were
corrected by subtraction of the values for the appropriate time-
zero (Tq) control tests. There was progressive release of NANA
reaching a steady maximum between 1 and 2 h and there was excellent
correlation between the values obtained with the two test concen¬
trations of FVII. When a similar experiment was performed with
incubation in the same concentration of acid but at 100°C
(Yamashina, 1956) there was considerable breakdown of NANA
(fig. 1/4). Further tests showed that the use of stronger acid
(0.04M H2SO4) did not release more NANA from FVII but did also
produce some breakdown of NANA after 2 h at 80°C.
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Fia. 1/3 - Release of N-acetyl neuraminic acid (NANA) from FVII
substrate at two test concentrations by mild acid hydrolysis (final
concentration 0.02M H2SO4) at 80°C. The relative amount of NANA
released is plotted as the corrected extinction value of the assay
product at 549 nm. Concentrations in acid-hydrolysis mixtures:






Time of incubation at 100°C (min)
Fia. 1/4 - Release of NANA from FVII substrate by mild acid
hydrolysis (0.02M H2S04) at 100°C. The relative amount of NANA
released is plotted as the corrected extinction value of the assay
product at 549 nm. Concentrations in acid-hydrolysis mixtures:
• •, FVII(5) 0.92 mg/ml; x--x, NANA 20 pg/ml.
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The total amount of NANA that can be released from substrate
batches FVTI(5) and FVII(6) was estimated by incubating appropriate
concentrations in 0.02M H2S04 at 80°C for 2 h (table I/I). The
extinction value (E549) obtained on assay of NANA incubated in acid
under the same conditions was used for converting the test values
into equivalent concentrations of NANA. Substrate batch FVII(5)
contained 4.7% dry weight of NANA, and batch FVII (6) a little less.
Release of NANA from FVII by C. perfrinaens neuraminidase.
The total amount of NANA that can be released from substrate FVII
by C. perfringens (C. welchi) neuraminidase was determined by
incubation of appropriate concentrations of FVII(5) with undiluted
stock enzyme preparation P9D2 (see Materials and Methods).
Standard tests were prepared and incubated at 37°C in acetate
buffer, pH 5.1, for graded periods of time; the timing was such
I
that test periods of incubation ended simultaneously and all tests
were assayed for NANA in a single batch. Appropriate Tq control
tests were used for correction of test results. When reaction
mixtures were incubated for periods up to 2 h there was progressive
release of NANA to a steady maximum after 80 min (fig. 1/5); there
was excellent correlation between the amounts of NANA released from
the two test concentrations of substrate. Comparison of the
results given in figs 1/3 and 1/5 shows that a similar amount of
NANA was released from FVII by C. perfrinaens neuraminidase as was
released by the acid hydrolysis procedure.
Ic. Enzyme-substrate kinetic studies
Initial velocity of neuraminidase reaction with varying con¬
centrations of substrate FVII. Enzyme preparation P9D2 was used at
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i/I
Estimation of NANA content of two batches of human
glycoprotein substrate FVII by acid hvdrolvsis
Concentration Spectro¬ Concentration NANA as
Batch of of photometric of NANA percentage
substrate FVII in 0.02M reading after of
FVII H2S°4 incubation at test mixture dry weight80°C for 2 ha of FVII
(jjg/ml) (E549> (pg/ml)
FVII(5) 460 0.495 21.4 4.7
FVII(6) 890 0.865 37.4 4.2
a The spectrophotometric value (E549) is an average result obtained
from duplicate 2-h assay readings corrected by subtraction of the
value for the corresponding Tq test (see Materials and Methods).
k A sample of pure NANA at a final concentration of 20 pg/ml in the
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Fia. 1/5 - Release of NANA from FVII substrate at two test
concentrations by Clostridium perfrinaens neuraminidase. Substrate
incubated with enzyme preparation P9D2 at 37°C, pH 5.1. Concen¬
trations of FVII(5) in reaction mixtures: • •, 0.46 mg/ml; o—o,
0.23 mg/ml.
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a dilution of 1 in 2 in the acetate buffer, pH 5.1, and a range of
concentrations of substrate FVTI(5) was prepared in the same
buffer. Reaction mixtures were prepared for the standard neura¬
minidase assay and were incubated at 37°C for graded periods of
time before the NANA assay; TQ control tests were used for
correction of test readings. Fig. 1/6 shows the plots of values
for the amount of NANA released by the enzyme. These are linear
for the first 10 min for all test concentrations of substrate, and
a value for the initial reaction velocity (v) at each substrate
concentration (s) was derived from this portion of the graph. Fig.
1/7 shows the relationship of (v) to (s). Maximum velocity (Vmax)
occurred at substrate concentrations of c. 3 mg/ml; the standard
concentration of batch EVII(5) used in subsequent experiments was
3.07 mg/ml. The data given in fig. 1/7 allow calculation of the
values plotted in fig. 1/8. The slope of the line = Vvmax' from
this the value for Vmax was calculated to be 0.26 ,ug NANA released
from FVII/min. The s/v intercept (0.6) indicates the value for
Km/vmax; thus Km = 0.16 mg/ml for this substrate (formulae from
Dixon & Webb, 1964, chap. 4).
Initial velocity of neuraminidase reaction with varying con¬
centrations of enzyme preparation. The final concentration of
substrate FVII(5) was 3.07 mg/ml in the reaction mixture, and
enzyme preparation P9D2 was diluted in acetate buffer, pH 5.1, to
give test concentrations of 10, 25, 50, 75 and 100% (v/v). Stan¬
dard neuraminidase assays were carried out with the different
reaction mixtures incubated at 37°C for 10, 20, 30 or 40 min before
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Fia. 1/6 - Velocity of Clostridium perfrinaens neuraminidase
reaction when a standard amount of enzyme preparation P9D2 was
incubated with graded concentrations of substrate at pH 5.1.
Concentrations of substrate FVII(5) (mg/ml of reaction mixture):
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released/min)
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s: Concentration of substrate FVII(5)
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Fia. 1/7 - Relationship of initial reaction velocity (v) of neura¬
minidase reaction to concentration of substrate (s). The value for
v is calculated from the observed release of NANA during the first
10 min (fig. 1/6); a reference assay of 10 pg pure NANA gave a
spectrophotometric reading (E^g) of 0.536 and the data given in






Fia. 1/8 - The relationship of the substrate concentration (s) to
the value obtained for the quotient (data from fig. 1/7).
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correction of test results. Fig. 1/9 shows that the rate of
release of NANA was proportional to the concentration of the
neuraminidase preparation when the reaction mixtures were incubated
for periods up to 40 min. Thus, using a 15-min assay, we could
measure amounts of neuraminidase approximately 0.1-3 times that of
the test P9D2 preparation; this is equivalent to a range of
c. 2-50 milliunits/ml (see table II/V for activity of P9D2). More
concentrated neuraminidase preparations should be diluted before
the assay so that the results fall into the reliable range.
Experiments similar to that described above were used to
follow the release of NANA from the same amount of substrate by
lower concentrations of enzyme P9D2 during longer periods of
incubation at 37°C Fig. 1/10 shows that the plot of the release
of NANA from FVII remained linear for 4 h with test concentrations
of P9D2 from 1 to 10%. Fig. 1/11 extends the period of
observation and shows that the plot of the release of NANA from the
substrate is linear for 26 h with suitable dilutions of the
enzyme; as little as 0.5% of the enzymatic activity of P9D2 (i.e.
c. 0.1 milliunit/ml) can be reliably detected with a 24-h test.
Id. Comparative data on various batches of
substrate FVII
Data on the amount of NANA that can be released by mild acid
hydrolysis from substrate batches FVII (5) and FVII (6) were given in
table I/I. Similar experiments were performed to estimate the NANA
content of each subsequent batch of substrate prepared and
information on the various batches of FVII used in the course of





Percentage concentration (v/v) of enzyme
preparation P9D2 added to reaction
mixture
Fia. 1/9 - Amounts of NANA released at different times from a
standard amount of substrate FVII(5) by graded amounts of
Clostridium oerfringens neuraminidase. Period of incubation at
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Fig. 1/10 - Release of NANA from substrate FVII(5) by low
concentrations of Clostridium perfringens neuraminidase during
incubation at 37°C, pH 5.1, for 4 h. Percentage concentration
(v/v) of enzyme preparation P9D2 added to reaction mixture: •—«,
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Fig. 1/11 - Release of NANA from substrate FVII(5) by very low
concentrations of Clostridium perfrinaens neuraminidase during
prolonged incubation at 37°C, pH 5.1. Percentage concentration
(v/v) of enzyme preparation P9D2 added to reaction mixture: •—«,
2; o—o, 1; £*—0.5; x—x, 0.1.
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TABLE I/II
Comparative data on the NANA content of five batches
of substrate FVII estimated bv acid hydrolysis
Batch of Weight of Weight of NANA as
substrate FVII/vial NANA/viala percentage of
FVII (mg) (mg) dry weight of
FVII
FVII(5) 18.4 0.86 4.7
FVII(6) 178.0 7.49 4.2
FVII(7) 472.8 5.59 1.2
FVII(8) 135.1 5.12 3.8
FVII(11) 132.0 4.59 3.5
a See table I/I for method of NANA determination by acid hydro¬
lysis. The value obtained for the test concentration of substrate
was used to calculate the total amount of available NANA/vial for
each batch of substrate.
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of the different batches of substrate was in the range 3.5-4.7%,
with the exception of batch FVII (7) which contained only 1.2% NANA.
Initially, the concentration of substrate added to neura¬
minidase assays was expressed in terms of the total weight of the
FVII preparation (e.g. see fig. 1/6). However, since different
batches of substrate vary a little in their content of
glycoprotein, the substrate concentration is better expressed in
terms of the amount of available NANA present in the reaction
mixture. The standard concentration of substrate FVII (5) for use
in neuraminidase assays was determined from the experiment shown in
figs 1/6 and 1/7 and was fixed at 3.07 mg/ml; this is equivalent
to a concentration of 143 pg releasable NANA/ml. The concen¬
trations of subsequent batches of FVII used in neuraminidase assays
were standardised to give 140-170 ^g NANA/ml in the final reaction
mixture (table I/III). t
The performance of each batch of substrate was compared in
standard neuraminidase assays with 'undiluted enzyme P9D3. Assays
performed with the substrate concentrations shown in table I/III
were incubated for 10, 20 and 30 min; T0 control tests were used
for correction of the results. Separate substrate control tests
(see Materials and Methods) assayed at T0 and after incubation at
37°C for 30 min all gave low values (E549 <0.04) that did not rise
during incubation at 37°C; further tests confirmed that there was
no increase in value when incubation of samples of these batches of
substrate was continued for 24 h.
Fig. 1/12 shows the plot of the assay values obtained. Sub¬
strate batches 5,6,8 and 11 gave comparable results with assay
values (E549) in the range 0.25-0.30 after 10 min, 0.48-0.54 after
164
TABLE IZIII
Concentration of available NANA present in
standard neuraminidase assays with













a Concentration of available NANA in standard assay mixtures (see
Materials and Methods) calculated from values for NANA content (see















Time of incubation at 37 °C (min)
Fia. 1/12 - Rate of release of NANA from different batches of
substrate FVII by a standard amount of Clostridium perfringens
neuraminidase preparation P9D3 during incubation at 37°C, pH 5.1.
Batch of substrate tested: > •, FVII(5); o—o, FVII(6); x—x,
FVII(7); Jr-A, FVII(8); m-9, FVII(11).
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20 min and 0.69-0.75 after 30 min incubation. The values for the
20-min assays were not quite double those for the 10-min assays but
there is an approximately linear correlation up to values
of c. 0.5; readings above this level become progressively less
accurate and will tend to underestimate the enzyme activity.
Substrate batch FVII(7) gave comparable results in the 10-min
assay, but thereafter gave lower values than the other batches
tested. Assay values with batches 5, 6, 8 or 11 should thus be
comparable; assays with batch FVII(7) are liable to give rather
lower values, especially at higher readings.
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II. DEVELOPMENT OF STANDARD PROCEDURES FOR ASSAY
OF NEURAMINIDASE ACTIVITY
Ila. Studies on the assay for NANA
Reference assays with pure NANA. Fig. II/l shows the curve
obtained when the assay product for 10 ^g pure NANA dissolved in
distilled water is examined with the scanning spectrophotometer;
the peak absorbance (c. 0.52) is at 549 nm. Similar assays with
10 ,ug NANA dissolved in the standard assay buffer, pH 5.1,
confirmed that the assay values were unaffected by the presence of
the buffer.
The assay of graded amounts of pure NANA gives a linear plot
for spectrophotometric values (E549) up to c. 0.7 (e.g. see
fig. II/3); readings above this level are likely to be a little
high and give an overestimate of the amount of NANA present. When
values higher than 0.7 are obtained in an assay, an approximate
indication of the amount of NANA present can be obtained by
diluting the assay product before reading the spectrophotometric
value; however, the correlation between direct readings with the
undiluted product and readings after dilution in Reagent 4 (acid
butan-l-ol) follows a similar curve and may give rise to a similar
inaccuracy. When accuracy is important, samples should be diluted
before assay so that the results fall in the reliable range; for
neuraminidase assays it may be more convenient to shorten the
incubation period in order to achieve this.
Solutions of pure NANA in distilled water or in the standard
assay buffer, pH 5.1, are stable for many months at -20°C. Batches
of tubes containing 10 ^g pure NANA in 0.5 ml distilled water were
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Fig. II/l - Absorbance curve of the assay product for NANA. Sample
put through the assay: 10 ;jg pure NANA in 0.5 ml distilled water.
Absorbance curve read on the SP 8000A scanning spectrophotometer
with reagent blank in reference cell (see Materials and Methods).
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prepared at intervals and held at -20°C for use as reference
standards with subsequent neuraminidase assays. The results of the
NANA assays were reasonably consistent for series of assays
performed over a number of days or weeks (e.g. see Section lie);
however, over a longer period of time there may be greater
differences. Variation in assay values for the NANA standards may
be attributable to a number of factors, including different batches
of assay reagents, slight variations in volumes of reagents added
and minor inaccuracies in incubation times at various stages during
the assay. The commonest cause of low readings encountered
appeared to relate to differences in performance of the NaAsC^ in
Reagent 2.
In general, assay of the 10 jjg NANA standards gave a reading
(E54g) between 0.45 and 0.50. On occasion, the results might be as
high as 0.55; the assays were not accepted if the value fell below
0.40. Duplicate 10 jag NANA standards were included with each batch
of neuraminidase assays; the average value for these tests was
used when it was desired to express results of an experiment in
terms of rate of NANA release rather than as comparative spectro-
photometric values.
Effect of culture materials on the assay for NANA. Experi¬
ments were performed to study the effects of sterile proteose
peptone water (PFW5) medium on the assay for NANA. The total test
volume (0.5 ml) consisted of: 0.1 ml undiluted PPW5 broth; 0.25 ml
containing 10 ;ug NANA dissolved in distilled water; and 0.15 ml
acetate buffer, pH 5.1. Control samples contained PPW5 broth alone
or NANA alone, with the NANA or PPW5 respectively replaced by
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acetate buffer. A reagent blank, prepared by taking 0.5 ml
distilled water through the NANA assay, was used in the reference
cell for the absorbance curves shown in fig. II/2(a). The assay
product for the sample containing PPW5 broth alone contained a
chromogen with a peak absorption at c. 530 nm that gave rise to
significant absorption at 549 nm (c. 0.12). The absorption curve
for 10 pg NANA was distorted in the presence of PPW5 broth so that
the peak fell at c. 540 nm and there was a high shoulder at
c. 530 nm. Fig. II/2(b) shows the absorbance curve for the same
product when read with the assay product for the PPW5 broth alone
in the reference cell; this confirms that the true peak for NANA
occurs at 549 nm. However, it is also apparent that the height of
the NANA peak is rather lower (c. 10%) than for the reference
sample of 10 pq NANA in the absence of PPW5 broth.
Fig. II/3 shows the results of a similar experiment when
graded amounts of pure NANA were assayed in the presence and in the
absence of PPW5 broth. The test values (E^g) obtained when NANA
was assayed in the presence of PPW5 broth were corrected by
subtraction of the value for the control assay for PPW5 alone
(0.128); these corrected values were distinctly lower than the
values for equivalent amounts of pure NANA over the whole range
tested.
The extent of the depression of the assay value for the
standard test dose of NANA (10 ^ig) by constituents of PPW5 broth
may vary in different batches of the medium; in general, a
reduction of 5-10% was found. Constituents of other media, e.g.
Todd-Hewitt broth (THB), may produce a similar, though usually less




Fia. II/2 - Effect of PPW5 broth on the absorbance spectrum for
NANA. See text for details of samples taken through the assay for
NANA: , PPW5 + 10 jag NANA; ••••, PPW5 alone. Absorbance
curves read in SP 8000A scanning spectrophotometer with (a) reagent
blank and (b) assay product for PPW5 alone in reference cell. The
solid line indicates the curve obtained with assay of 10 jag NANA
read with reagent blank in the reference cell and is included in
both (a) and (b).
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Fig. II/3 - Effect of PPW5 broth on the assay for NANA. Absorbance
of assay product (E549) for graded amounts of NANA in acetate
buffer, pH 5.1: 0—0, NANA + PPW5; •, NANA alone (average of
duplicate spectrophotometer readings).
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with supernates of cultures in these media, e.g. the PPW5 culture
supernate (P9) used as stock neuraminidase preparation in these
studies; however, the interfering substance(s) can be removed by
dialysis (e.g. see table II/V). The effect is seen predominantly
in test materials that give high enzyme control values (E549) / and
there is a rough correlation between the level of the enzyme
control test and the extent of depression of the NANA assay value.
The effect may be avoided by working with dialysed culture
preparations; it is important to make allowance for it in
neuraminidase assays with crude culture products, and also in
assays for NAN-lyase activity (see Section lib). With occasional
cultures in PPW5 medium, the absorption curve for small amounts of
NANA was distorted when the standard enzyme control test was used
in the reference cell; this could be avoided by the use of a time-
zero (Tq) test as the reference preparation (see Section IVc).
lib. Tests for N-acetyl neuraminate pyruvate-lyase
(NAN-lyase) activity
Since the neuraminidase assay depends on the detection of
NANA released by the enzyme, results may be influenced by factors
that interfere with the assay for NANA; in particular, NANA might
be broken down by NAN-lyase present in the test material. An assay
procedure was developed to determine whether the presence of such
factors in culture products might be responsible for falsely low or
negative results in tests for neuraminidase.
Cell extract and culture supernate prepared from a bulk PPW5
culture of C. oerfrinaens strain L2Ab (P10; see Materials and
Methods) were tested for the ability to break down NANA under
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conditions equivalent to those of the standard neuraminidase assay.
Test mixtures, containing 0.1 ml test material, 0.15 ml acetate
buffer, pH 5.1, and 0.25 ml of a solution containing 10 jag pure
NANA dissolved in distilled water, were incubated at 37°C for
periods up to 4 h before the assay for NANA. Test results were
corrected by subtraction of the value for control tests containing
buffer in place of the NANA, and the results were expressed as the
percentage change from the corrected assay value for an unincubated
time-zero (Tq) test. The results plotted in fig. II/4 show that
the cell extract produced a progressive reduction in the assay
value for NANA, with c. 80% of the test dose of NANA destroyed
after incubation for 4 h. By contrast, the culture supernate
produced no NANA breakdown during this period of incubation, and
this suggests that NAN-lyase remained cell-associated in this
culture.
A further experiment was performed in order to assess the
effect of pH on the activity of C perfrincens NAN-lyase. Similar
test mixtures of P10 cell extract and NANA were prepared, but using
a range of sodium acetate buffers from pH 3.6 to pH 6.6 (see
Materials and Methods). The tests were incubated for 1 h at 37°C
and then put through the assay for NANA. Test results were
expressed as the percentage reduction from the assay value for a Tq
test with acetate buffer at pH 5.1 (E^g = 0.450); preliminary
studies confirmed that the assay value for pure NANA was constant
over this pH range. Fig. II/5 shows a plateau of enzyme activity
above pH 6.0; as the pH range tested did not extend above pH 6.6
the peak activity was not determined, but these results are







Time of incubation at 37 °C (h)
Fia. II/4 - Demonstration of NAN-lyase activity in Clostridium
perfingens cell extract. Test preparation (P10 cell extract)
incubated with 10 pg NANA in acetate buffer, pH 5.1, at 37°C for
periods up to 4 h before the assay for NANA. Test results
corrected by subtraction of enzyme control value (E^g = 0.010);







pH of acetate buffer
Fia. IT/5 - Effect of pH on the activity of Clostridium perfrinaens
NAN-lyase activity. Cell extract P10 incubated at 37°C with 10 pg
NANA in sodium acetate buffers for 1 h before assay for NANA.
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Brunetti et al. (1963). NAN-lyase activity was reduced by c. 20%
in the acetate buffer, pH 5.1, used in the standard neuraminidase
assay, and was completely inhibited below pH 4.2.
Similar tests were used to evaluate the extent by which
various preparations used in these studies might interfere with the
accurate determination of NANA under conditions equivalent to those
used in the standard assay for neuraminidase. Table II/I gives the
detailed results of tests with sterile PPW5 broth and with the
stock culture filtrates of C. perfringens in this medium, P9 and
P9D2. Tests were incubated at 37°C in acetate buffer, pH 5.1, for
periods up to 1 h before the start of the assay for NANA. The
corrected value for the Tq assay of each test mixture shows the
extent of the depression of the true value for NANA before the
start of incubation at 37°C Sterile PPW5 broth reduced the assay
reading by c. 10% and the undialysed P9 preparation reduced it by
c. 25%; the dialysed preparation P9D2 produced less than 5%
depression of the assay value. There was, however, no further
depression of the assay values when the mixtures were incuhated at
37°C for 1 h. Similar tests confirmed that there was no
significant breakdown of NANA even when incubation was prolonged to
24 h. It was also confirmed that the FVII substrate used in
neuraminidase assays did not affect the assay value for NANA in
24-h tests.
The absence of NAN-lyase activity in the supernates of
PPW5 broth cultures P9 and P10 confirms that the C. perfringens
enzyme is normally cell-associated. However, some enzyme may
occasionally be released into the culture supernate, e.g. the
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table ii/i
Effect of culture materials on NANA determination in
time-zero mixtures and in mixtures incubated at 37°C before assay
Time of Spectrophotometry reading'3
Test mixturea incubation (Ec4q)
at 37°C
(min) Test Control Corrected value0
nana alone 0 0.506 • • • 0.506
15 0.509 • • • 0.509
60 0.502 • • • 0.502
nana + PPW5 0 0.620 0.175 0.445
15 0.605 0.171 0.434
60 0.607 0.173 0.434
nana + P9 0 0.596 0.232 0.364
15 0.583 0.221 0.362
60 0.602 0.225 0.377
nana + P9D2 0 0.500 0.017 0.483
15 0.481 0.018 0.463
60 0.505 0.016 0.489
a Test mixtures contained 10 )iq NANA in 0.25 ml distilled water,
0.1 ml test substance and 0.15 ml acetate buffer, pH 5.1; NANA
alone = NANA + 0.25 ml buffer. PPW5 = sterile broth; P9 =
Clostridium oerfrinctens neuraminidase preparation; P9D2 = dialysed
P9 (see Materials and Methods).
k
Average of duplicate assay readings; ... = not applicable.
c Test readings corrected by subtraction of the control value
(0.1 ml test substance + 0.4 ml buffer).
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results presented in table III/XI show slow breakdown of NANA by
the supernate of a similar culture of the same strain. It is
important, therefore, to consider the possibility of NANA-
destroying activity in all assays for neuraminidase that give low-
positive or negative results.
lie. Standard procedures for assay of
C. oerfrinaens neuraminidase
Control assays for correction of test results. The standard
procedure for the neuraminidase assay is described in Materials and
Methods. Separate enzyme and substrate control tubes, containing
the acetate buffer in place of the substrate and enzyme respec¬
tively, were normally included for each assay and incubated for the
same period of time as the test assay tube. The test spectrophoto¬
metry reading (Ec^g) was corrected by subtraction of the sum of
the values for the separate enzyme and substrate control assays.
When it was desired to study the rate of release of NANA from
substrate in progress experiments (e.g. see figs 1/6 and 1/9), the
use of unincubated time-zero (Tq) control tests with pre-cooled
reagents (see Materials and Methods) proved more convenient and
more reliable than the use of separate enzyme and substrate control
assays for correction of test results. The data given in table
II/II show that the assay value for Tq tests with mixtures of
enzyme preparation P9 and substrate FVII (£549 = 0.246) was
equivalent to the calculated value for the sum of the separate Tq
enzyme and substrate control assays (0.252). This also held good
for the tests with P9D3 (Tq assay = 0.040; enzyme control +
substrate control = 0.036). There was no increase in value in
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TABLE II/II
Comparison of values for time-zero neuraminidase
assays with values for separate enzyme and substrate control
tests incubated at 37°C for periods up to 24 h
Spectrophotometric reading^ after





1 h 18 h 24 h
P9 alone 0.226 0.226 0.220 0.218
P9 + FVII(5) 0.246 • • • • • • • • •
P9D3 alone 0.010 0.013 0.009 0.009
P9D3 + FVII (5) 0.040 • • • • • • • • •
FVII(5) alone 0.026 0.031 0.031 0.033
a Test mixtures contained enzyme (0.1 ml) and/or FVII(5) substrate
(0.25 ml); the final reaction-mixture volume (0.5 ml) was reached
by addition of appropriate amounts of acetate buffer, pH 5.1 (see
Materials and Methods). P9 = Clostridium oerfrinaens enzyme
preparation; P9D3 = dialysed P9.
k The spectrophotometric reading is the average result for
duplicate assays incubated at 37°C for the appropriate period; Tq
tests were not incubated at 37°C before the assay for NANA (see
Materials and Methods): ... = not tested.
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enzyme or substrate control tests after incubation at 37°C in the
assay buffer for periods up to 24 h. Test results with these
reagents may therefore be corrected by subtraction of either the
sum of the values for separate enzyme and substrate control assays
or the value for T0 tests. However, when neuraminidase assays are
performed with less well characterised materials, the results of
separate enzyme and substrate control tests incubated for the same
period as the test reaction mixture should be used for correction
of assay results in case there is release of chromogenic material
from the test substance itself during incubation of the test (e.g.
see Section Via).
Procedures for progress experiments to study the rate of NANA,
release. It would be convenient to be able to perform progress
experiments in a bulk reaction mixture, taking samples at intervals
and holding them at some stage before completion of the assay for
NANA so that all results could be read in a single batch. In the
standard neuraminidase assay the reaction is stopped by addition of
Reagent 1 (periodic acid); the NANA assay proceeds immediately.
Various attempts to hold the assay tubes at each stage during the
NANA assay proved unsuccessful; consistent assay results were
obtained only when all assay tubes were put through the
uninterrupted assay for NANA in a single batch. The period between
extracting the chromophore into Reagent 4 (acid butan-l-ol) and
reading the assays was not critical; when assay tubes at this
stage are held in the refrigerator or at room temperature for a few
hours there may be a visible change in colour but the spectro-
photometric reading (E54g) is unchanged.
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Unsuccessful attempts were make to stop the neuraminidase
action at the end of the test period of incubation, before the
start of the assay for NANA. Assay tubes were put in a boiling
water bath for 1.5 min and then held in the refrigerator for
varying periods of time before assay for NANA; however, this did
not completely inactivate the enzyme and also produced an
unacceptable reduction in the final assay values. Other attempts
were made to hold assay samples at 0°C for varying periods before
the NANA assay. However, it proved impossible to prevent some
enzyme activity when a series of unincubated reaction mixtures,
prepared with pre-cooled reagents as for Tq tests, were held at 0°C
in an ice-water bath for graded periods up to 60 min before the
start of the NANA assay. The results presented in table II/III
show that even under these conditions there was a small amount of
activity, related to the amount of enzyme present.
In further progress experiments, assays were always performed
in separate tubes incubated for different periods of time; the
timing of the start of each assay was so arranged that the test
periods of incubation ended simultaneously and all tests were
assayed for NANA in a single batch at the end of the experiment.
lid. Determination of conditions for optimal activity of
C. oerfrinaens neuraminidase
The effect of temperature on C. perfrinaens neuraminidase
activity. Two experiments were performed in which standard assay
reaction mixtures prepared with enzyme P9D3, diluted 1 in 3, and
substrate FVII(6) were incubated for 60 min in a series of
waterbaths held at different temperatures between 33°C and 60°C;
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TABLE II/III
Effect of holding neuraminidase-assay reaction mixtures
at 0°C for graded periods before the start
of the assay for NANA
Time















a Standard neuraminidase-assay reaction mixtures containing
Clostridium perfrinaens enzyme preparation P9D2 and substrate
FVII(5) in acetate buffer, pH 5.1 (see Materials and Methods) were
prepared at intervals and held at 0°C in an ice-water bath before
the start of the NANA assay.
b Test spectrophotometric readings (Ec^q) corrected by subtraction
of the assay value for a control test (Tq test) taken through the
NANA assay immediately after addition of enzyme (average of
triplicate assays).
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one experiment covered the temperature range from 33°C to 50°C and
the other extended the observations to 60°C. The data plotted in
fig. II/6 show that similar curves were obtained where the two
experiments overlapped. There was a steady increase in enzyme
activity with increases in the temperature of incubation up to a
maximum at c. 45°C. There was little change in activity as the
temperature was further raised to 55°C, but a considerable decrease
in activity in assays incubated at 60°C. The assay value for
samples of NANA similarly treated over this range of temperatures
remained relatively unchanged; thus the low assay value for
neuraminidase at 60°C is not attributable to inactivation of NANA
These data show that the activity of C. oerfrinaens
neuraminidase at 37°C might be increased by c. 35% by raising the
temperature of the reaction mixture to 45°C. We have continued to
use an incubation temperature of 37°C in standard assays; however,
it should be appreciated that slight variations in the temperature
of the waterbath used for incubation of reaction mixtures may
contribute to differences in assay values in different batches of
tests.
The effect of pH and buffer system on C. oerfrinaens neura¬
minidase activity. Standard assay mixtures were prepared with
enzyme preparation P9D2 and substrate EVII(5) but with buffers at
different pH values (see Materials and Methods). An initial
experiment confirmed that the assay for 10 jjg pure NANA was
unchanged when performed in acetate buffers at different pH values
over the range 3.5-6.8. The results of neuraminidase assays in
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Fig. II/6 - Effect of temperature on activity of Clostridium
oerfringens neuraminidase. Activity plotted as the relative amount
of NANA released by a standard amount of enzyme P9D3 incubated with
substrate FVII(6) in acetate buffer, pH 5.1, for 60 min at
different temperatures. The spectrophotometric values (E549) for
duplicate tests at each test temperature were corrected by sub¬
traction of the sum of the values for separate enzyme and substrate
control tests: •—«, results of neuraminidase assays (two
experiments); x—x, results of assays of pure NANA (10 ^ig)
similarly incubated for 60 min at different temperatures.
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II/7(a). The plot of uncorrected test results shows a major peak
of activity at c. pH 4.6 and a subsidiary peak at c. pH 5.6; there
was close agreement between the results for duplicate assays at
each pH value tested. The results for single-tube substrate
control assays are also plotted and these suggest that the main
peak was actually at pH 4.7. The enzyme control readings were very
lew and are not plotted.
Fig. II/7(b) shows the results of a similar experiment when
tris-maleate buffers were used. There was a single peak of
activity at 01 5.7.
For these experiments, the initial pH of the reaction
mixtures was measured directly in a parallel experiment (see
Materials and Methods). Similar measurements were made after
incubation of the reaction mixtures in the acetate buffers for
30 min at 37°C; in no case was there a deviation of more than
0.05 pH unit during the assay period. Direct readings of the
initial and final pH of standard neuraminidase assays of dialysed
and undialysed samples of culture filtrate P9 in acetate buffer,
pH 5.1, showed that the initial pH of the standard reaction
mixtures might be pH 5J0-5.45, but did not vary during incubation
for 30 min at 37°C.
The effect of Ca2+ and EDTA on C. oerfringens neuraminidase
activity. Table II/IV compares the effect of varying the concen¬
tration of Ca^+ in assays of neuraminidase from C. perfringens and
from Vibrio cholerae. When V. cholerae RDE was incubated with
substrate FVII(7) for 15 min at 37°C in reaction mixtures
containing different concentrations of Ca^+ or EDTA, it was
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Fia. ll/l - Effect of pH and buffer system on the activity of
Clostridium perfrinaens neuraminidase: (a) in sodium acetate
buffers; (b) in tris-maleate buffers. Enzyme preparation P9D2
incubated with substrate FVII(5) at 37°C for 30 min. Activity
plotted as absorbance (Ec^g) of the assay product for the reaction




Effect of Ca2+and EDTA on the assay of neuraminidase
from Clostridium perfrinaens and Vibrio cholerae
Result of 15-min neuraminidase assay13
Concentration of on stated preparation
added Ca2+ or EDTA (E549^





3mM Ca2+ 0.348 0.576
ImM Ca2+ 0.315 0.436
None added 0.351 0.318
ImM EDTA 0.313 0.202
5mM EDTA 0.277 0.012
a See Materials and Methods.
b The spectrophotometric value (E549) is an average result obtained
from duplicate assay readings corrected by subtraction of the sum
of the values for separate substrate and enzyme control tests. See
Materials and Methods for tested enzyme preparations P9D3 and RDE.
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confirmed that it was very calcium-dependent. The activity in our
assay was almost doubled by the addition of 3mM Ca^+ and virtually
abolished by 5mM EDTA. By contrast, when C. oerfrinaens enzyme
preparation P9D3 was assayed under the same conditions it showed
little calcium dependence; the activity was not increased by
addition of 3mM Ca^+ and 5mM EDTA reduced the assay value by c. 20%
only. Ca^+ was not added to our assays as a routine.
lie. Reproducibility of the neuraminidase assay
A series of dilutions of enzyme preparation P9D2 was made in
acetate buffer, pH 5.1. Assay tubes containing 0.1 ml enzyme
dilution mixed with 0.15 ml of the acetate buffer were prepared and
stored at -20°C. On eight occasions over a period of ten weeks,
tubes were brought to room temperature and the contents were
assayed for neuraminidase activity by adding to each tube 0.25 ml
of substrate FVII(5) and incubating at 37°C for 15 min. Time-zero
(Tq) control tests were used for correcting the test results. All
assays were performed in duplicate and average values were used in
calculating the results plotted in fig. II/8. The means of the
results obtained with graded concentrations of the enzyme
preparation show the expected linear relationship. Reference tubes
containing 10 }iq pure NANA in 0.5 ml distilled water were also
assayed on each occasion as a check on the reagents; the results
fell in the range E549 0.551-0.563 (mean 0.554).
The ranges of the results in this experiment give an
indication of the reproducibility that was achieved with carefully
standardised assays performed over a period of ten weeks during
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enzyme preparation P9D2 added
to reaction mixture
Fia. 11/8 - Reproducibility of neuraminidase assay. Replicate 15-
min assays performed on 8 occasions over a period of 10 weeks (see
text for details). Test results (E549) corrected by subtraction of
the value for the corresponding TQ control test: •, individual
results; «, two or more results; o, mean of 8 results.
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However, over longer periods of time the value for assays of
reference NANA samples (10 pg) proved more variable (see Section
Ila) and assay values for standard neuraminidase preparations might
also vary considerably. For accurate comparisons of neuraminidase
activity in different preparations the tests should be performed
simultaneously in a single batch of assays.
Ilf. Neuraminidase activity of stock C. perfrinaens
culture preparations
Table II/V gives the results of an experiment that compared
the neuraminidase activities in the dialysed and undialysed
preparations of the bulk culture filtrate (P9) of C. perfrinaens
strain L2Ab used as stock enzyme preparations in these studies (see
Materials and Methods). Interfering substances in the PPW5 broth
gave rise to a high enzyme control value (E549 = 0.145) for the
undialysed preparation P9; the dialysed preparations gave
satisfactorily low control values. Hie value obtained on assay of
10 ,ug NANA in this experiment was used for conversion of the
corrected spectrophotometric value for each test enzyme preparation
into an estimate of the amount of NANA released during the 15-min
incubation period; the observed neuraminidase activity was
calculated from the rate of release of NANA (pmole/min) from the
FVII substrate at 37°C in acetate buffer, pH 5.1 (1 unit
neuraminidase releases 1 ^amole NANA/min). The final column in
table II/V shows these values adjusted for the slight increases in
volume that occurred during dialysis of different batches of P9;
it is apparent that there was little loss of activity during their
preparation. It should, however, be appreciated that assay values
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TABLE Il/V
Results of 15-min neuraminidase assays with stock























P9 0.702 0.145 0.505 23.2 23.2
P9D2 0.471 0.013 0.406 18.6 22.7
P9D3 0.432 0.008 0.372 17.1 18.6
P9D4 0.500 0.010 0.438 20.1 22.4
a See Materials and Methods.
k The corrected assay value is an average value obtained from duplicate
test readings corrected by subtraction of the sum of the values for the
FVII(8) substrate control (0.052) and the corresponding enzyme control.
° Observed neuraminidase activity calculated from rate of NANA release
from substrate Qjmole/min); reference sample of pure NANA (10 jag) gave a
reading (E549) of 0.470. (1 unit neuraminidase releases 1 jamole NANA/min
from substrate.)
Neuraminidase activity adjusted to allow for increase in volume during
dialysis of original P9 preparation (see Materials and Methods).
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for the undialysed preparation P9 are liable to give a slight
underestimate of neuraminidase activity because interfering
substances in the culture supernate must be assumed to have
depressed the assay slightly; the values for dialysed preparations
are more reliable (see Section Ila).
Purified C. oerfrincens neuraminidase was obtained
commercially and used in comparisons with our stock enzyme
preparations. Table II/VI gives the results of neuraminidase
assays with Sigma neuraminidase and our preparations P9 and P9D2
incubated for 15 min with substrate EVII at 37°C in acetate buffer,
pH 5.1. Hie Sigma neuraminidase does not interfere with the assay
for NANA; the test concentration gave an enzyme control value of
zero, and separate tests confirmed that it produced no depression
of the assay value for 10 jug NANA and no reduction in reading
during incubation with NANA at 37°C for 15 min.
The observed activities with the FVII substrate were
calculated as in the previous experiment; there was good agreement
between the values obtained for enzyme preparations P9 and P9D2 in
the two experiments. The Sigma neuraminidase was stated by the
manufacturers to have a potency of 1.1 unit/mg solid when tested
with NAN-lactose, or 0.58 unit/mg when tested with bovine
submaxillary mucin as substrate. The concentration of Sigma
neuraminidase in the test solution (25 jug/ml) would thus have an
activity of 27.5 milliunits/ml when tested with NAN-lactose, or
14.5 milliunits/ml with bovine submaxillary mucin. Comparison with
the value for the observed activity of this preparation with the
FVII substrate (24.8 milliunits/ml) suggests that the activities
calculated for our enzyme preparations in tables II/V and II/VI
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TABLE II/VI
Comparison of activity of stock neuraminidase preparations
with reference preparation of













Sigma 0.614 0.000 0.589 24.8
P9 0.729 0.174 0.530 22.3
P9D2 0.454 0.015 0.414 17.4
a Sigma = chromatographically purified neuraminidase (Sigma London
Chemical Co. Ltd) at an initial concentration of 25 ^ig/ml (0.1 ml
of this solution used in assay); P9 = undialysed supernate of
culture of C. perfringens strain L2Ab in PPW5 broth; P9D2 =
dialysed sample of P9.
k
Average of duplicate test readings after incubation of reaction
mixtures for 15 min.
c Test reading (E549) corrected by subtraction of the sum of the
values for the FVII(5) substrate control (0.025) and the
corresponding enzyme control assay.
^ See footnote to table II/V; reference sample of pure NANA
(10 ^pg) gave a reading (Ec^g) of 0.513.
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should be comparable to the values that would be obtained with NAN-
lactose as substrate, and considerably higher than those with
bovine submaxillary mucin.
Our stock enzyme preparations proved quite stable when stored
undiluted at -20°C for several years, e.g. the several dialysed
preparations of P9 were made at intervals over five years but
continued to give comparable assay values throughout the present
studies. The stability of dilutions of enzyme preparation P9D2
over a period of ten weeks at -20°C was demonstrated in fig. II/8.
Solutions of purified Sigma neuraminidase proved much less stable
at -20°C than our crude enzyme preparations. The Sigma
neuraminidase used in the previous experiment was assayed
immediately after the sample was dissolved and diluted for use in
the test. Table II/VII compares the assay results for Sigma
neuraminidase and enzyme preparation P9D3 in two experiments;
aliquots of the test enzyme preparations, diluted for use in the
assay as required, were held at -20°C for 11 days before performing
the second batch of assays. The values obtained on assay of P9D3,
and with reference samples of pure NANA, were very similar on the
two occasions, but the value for this concentration of Sigma
neuraminidase was reduced by c. 25% after storage for 11 days
at -20 °C.
180
Comparison of activity of two neuraminidase preparations




Assay 1 Assay 2
Sigma + FVII 0.589 0.445
P9D3 + FVII 0.385 0.375
NANA (10 jig) 0.513 0.535
a Test mixtures were standard assay mixtures (0.5 ml) containing
either 0.1 ml Sigma neuraminidase (25 jig/ml) or 0.1 ml undiluted
enzyme preparation P9D3, mixed with substrate FVII(5) in acetate
buffer, pH 5.1. Reference tubes contained 10 jig pure NANA in
distilled water.
k
Enzyme preparations held at -20°C for 11 days between Assay 1 and
Assay 2. The spectrophotometric value (E549) is an average result
obtained from duplicate assay readings corrected by subtraction of
the sum of the values for separate substrate and enzyme control
tests; NANA assay values are for unincubated reference samples of
NANA.
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III. IN-VITRO PRODUCTION OF NEURAMINIDASE BY
STRAINS OF CLOSTRIDIUM PERFRINGENS
Ilia. Production of neuraminidase by classical strains
of C. oerfrinaens type A
Time-course of neuraminidase production bv C. oerfrinaens
strain L2Ab in batch-culture suoernate. An apparatus was devised
that allowed samples to be taken at intervals from a stirred
anaerobic culture of G. oerfringens strain L2Ab without opening the
anaerobic jar or the incubator (see Materials and Methods). The
time-course of bacterial growth and neuraminidase production was
followed in 600 ml proteose peptone water (PPW5) broth culture
maintained at 37°C for 72 h. The counting techniques used for
constructing the growth curves shown in fig. III/l are described in
Materials and Methods. After a lag phase of c. 1 h, there was a
steady logarithmic (log) rise in viable count until c. 6 h; the
maximum count was reached at c. 8 h and the numbers remained
stationary until 24 h. The results of total cell counts were very
close to those of viable counts between 3 h (when the numbers
became detectable by microscopy) and 24 h. Most of the cells were
seen to occur as single cells and few formed clumps of more than
two organisms even during the log phase of growth; the values
plotted in fig. III/l are total cell counts. The total count
remained unchanged until 72 h, but the viable count began to fall
after 24 h.
Separate viable counts were performed with pasteurised sam¬
ples in order to detect spore formation. Up to 8 h there were no
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Fia. III/1 - Growth of Clostridium perfringens strain L2Ab in
600 ml PPW5 broth (see text for details): •—• , viable count;
o—o, total count; it—A, spore count.
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between 8 and 10 h but there was little further production by 24 h
and no increase thereafter. Thus, spores were formed in late log
phase, but represented only c. 0.1% of the total C. perfrinaen.q
present even after 72 h incubation.
Samples of culture supernate were assayed for neuraminidase
in standard tests incubated for 15 min at 37°C in acetate buffer,
pH 5.1. High levels of activity were found in this experiment;
samples were diluted appropriately in the assay buffer before the
tests and the results plotted in fig. III/2 have been corrected
accordingly. Further assays on the samples of culture supernate
confirmed that there was no significant NAN-lyase activity in 24-h
tests; thus the neuraminidase assay results are reliable even in
the 48- and 72-h samples when the number of viable organisms was
falling.
No neuraminidase was detected in 15-min assays of undiluted
samples taken during the first 5 h of growth, but this was followed
by a steady increase in enzyme activity in the culture supernate
during late log phase between 6 and 10 h. Although both spores and
neuraminidase were produced during late log phase, it is clear that
considerable amounts of neuraminidase had already been produced
before spores first became detectable at 9 h and that enzyme levels
continued to rise after spore production had stopped. Enzyme
production continued during early stationary phase but maximum
levels had been reached by 24 h; the amount of neuraminidase
activity in the culture supernate remained unchanged between 24 and
72 h. In general, cultures of clostridial species in later
experiments were tested for neuraminidase production after
incubation for 48 h.
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Relative
Time of incubation of culture at 37°C (h)
Fia. III/2 - Time-course of neuraminidase production by Clostridium
perfrinaens strain L2Ab in 600 ml PPW5 broth. Neuraminidase
activity (x—x) plotted as relative amount of NANA released (Ec^g)
by samples of culture supernate in standard 15-min neuraminidase
assays with substrate FVII(6). Samples diluted appropriately
before assay; test results corrected by subtraction of the sum of
the values for separate enzyme and substrate control tests and
corrected for dilution factor. Solid line (—) = viable count,
taken from fig. III/l.
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Effect of temperature of incubation on production of neura¬
minidase bv C. perfringens strain L2Ab. Twelve replicate 10-ml
cultures of C. perfrinaens strain L2Ab were prepared in screw-
capped bottles using a single batch of PPW5 medium and identical
inocula (0.1 ml) from a 48-h PFW5 culture incubated anaerobically
at 37°C. Triplicate cultures were incubated for 48 h in anaerobic
jars placed on their sides in covered waterbaths accurately
maintained at four different temperatures. Samples of the 12
culture supernates (800 g for 30 min at 4°C) were diluted 1 in 8 in
acetate buffer, pH 5.1, before assay for neuraminidase; the
results shown in fig. III/3 have been corrected accordingly. There
was some variation in the assay values obtained for the triplicate
cultures incubated at each temperature, but it is apparent that the
incubation temperature was responsible for quite marked variations
in the amount of neuraminidase produced. The maximum yield was
obtained at 39°C and was approximately double that obtained at
35°C. It may be that minor differences in the temperature of
incubation may contribute to variations in the amount of
neuraminidase produced in apparently similar cultures on different
occasions.
Variation in production of neuraminidase in replicate cul¬
tures of C. perfringens strain L2Ab. The amount of neuraminidase
produced by a particular strain of C. perfrinoens under apparently
similar cultural conditions was found to vary considerably on
different occasions, although the factors responsible for this were
not easily identified or controlled. An experiment was designed to
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Fia. III/3 - Influence of incubation temperature on neuraminidase
production by Clostridium perfrinaens strain L2Ab in PPW5 culture
supernates. Triplicate cultures incubated at different tempera¬
tures (see text). Neuraminidase activity plotted as relative
amount of NANA released (E549) by samples of culture supernate in
standard 15-min neuraminidase assays with substrate FVII(6).
Samples diluted 1 in 8 before assay; test results corrected by
subtraction of the sum of the values for separate enzyme and sub¬
strate control tests and corrected for dilution: x, individual
assay results; • , mean of results for assays with triplicate
cultures at each incubation temperature.
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replicate cultures incubated simultaneously in the same anaerobic
jar. Ten replicate 10-ml cultures of C. oerfrinaens strain L2Ab
were prepared, using a single batch of PPW5 medium and identical
inocula (0.1 ml) from a 48-h PPW5 culture incubated anaerobically
at 37°C. Ten replicate cultures of the same organism were
similarly prepared in Todd-Hewitt broth (TUB), with inocula from a
48-h THB culture. The 20 tubes were incubated together in an
anaerobic jar at 37°C for 48 h. The centrifuged culture supernates
(800 g. for 1 h at 4°C) were tested in standard 15-min neuraminidase
assays. Table III/I shows that there was a moderate degree of
variation in neuraminidase production in each medium; it appears
that the assay value may vary by c. 10% from the mean in such
replicate cultures. In this experiment, about four times more
neuraminidase was produced in PPW5 than in THB medium, but this
pattern was not consistently found on other occasions (e.g. see
table III/II).
Production of neuraminidase by C. perfringens strain L2Ab in
serial cultures. The experiment shown in fig. III/4 was designed
to demonstrate the variation in neuraminidase production that
occurred when C. oerfrinaens strain L2Ab was grown in serial 48-h
cultures in two different media, and to compare enzyme production
in the two media. After five serial cultures in PPW5 medium, five
further serial cultures were made in nutrient broth (NB) medium,
and these were followed by a further five serial cultures in the
original medium. At the same time, a parallel series of 15
cultures was made, starting with five in NB, followed by five in
PIW5, and reverting to NB medium for the final five cultures.
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TABLE III/I
Neuraminidase production by Clostridium perfrinaens strain
L2Ab in ten replicate cultures in each of two broth media
Results of 15-min neuraminidase assays on















a Results of standard 15-min assays with substrate FVII(6) for each
replicate culture are the means of duplicate test readings (E549) r
with no correction for enzyme or substrate control tests. Super-
nates of proteose peptone water (PPW5) cultures were diluted 1 in
8, and of Todd-Hewitt broth (THB) cultures 1 in 3, before assay;
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Fia. Ill/4 - Production of neuraminidase by Clostridium perfrinaens
strain L2Ab in serial 48-h cultures in two broth media. Two
experiments were performed, each with 15 serial cultures (see
text); x = culture in nutrient broth (NB), o = culture in
proteose peptone water (PPW5). Neuraminidase activity in the
culture supernates is expressed as the result of standard 15-min
neuraminidase assays (E549) corrected by subtraction of the sum of
the values for separate enzyme and substrate control tests.
184B
A stock of tubes containing 10-ml amounts of culture medium
was prepared from a single batch of each medium before the
experiment; they were held at 4°C until pre-steamed just before
inoculation. Initially, 0.1 ml of a 24-h anaerobic culture in
cooked-meat broth (CMB) was used to inoculate the first tube in
each series. Thereafter, each serial culture was incubated
anaerobically at 37°C for 48 h and 0.1 ml of the 48-h culture was
used as inoculum for the next culture in the series. Each serial
culture was carefully checked for purity by subculture on blood
agar (BA) plates incubated aerobically and anaerobically for 18 h
at 37°C. Samples of each culture supernate (800 g. for 1 h at 4°C)
were held at -20°C until they were assayed for neuraminidase at the
end of the experiment.
Fig. III/4 shows the results of 15-min assays for
neuraminidase activity in the culture supernates of the two series
of cultures; the assays were performed in two batches, one for
each series of 15 cultures. There was considerable variation in
the yield of neuraminidase on different occasions but it is
apparent that there was usually a higher yield in PPW5 than in NB
medium. Although there was some overlap between the range of assay
values (E549) found with PPW5 (0.39-1.02) and NB (0.11-0.55), the
values in PPW5 broth were always higher than in the equivalent NB
culture made at the same time, and there was a distinct step up or
down in enzyme yield after each change of medium in both series of
cultures. The degree of variation seen in these serial cultures is
greater than that found in replicate cultures incubated in a single
batch (table III/I). It seems probable that these variations are
185
partly attributable to minor differences in cultural conditions,
e.g. temperature of incubation (see fig. III/3).
There might appear to be a tendency for serial cultures in NB
medium to show a progressive increase in activity, but this is not
borne out with the PPW5 cultures where the variation appears more
random. In other similar series of cultures, with a variety of
strains of C. oerfrinaens grown in various culture media, no
consistent pattern was found that would confirm sequential
enhancement of enzyme production during serial culture; the
initial cultures often produced high amounts of the enzyme and
subsequent serial cultures might contain high or low levels,
apparently at random (e.g. see fig. III/5 and table III/VII).
However, as a routine, tests for clostridial neuraminidase were
performed with the supernates of the second serial culture in the
test medium.
Production of neuraminidase by classical strains of C. oer-
frinaens type A in various broth media. It proved difficult to
choose a single culture medium that would consistently give maximum
neuraminidase production with any strain of C. oerfrinaens. Enzyme
production in cultures of a single strain grown under apparently
similar conditions but in different batches of medium and on
different occasions over a period of months or years showed
considerably greater variability than was seen with serial cultures
using a single batch of medium over a period of 30 days (see
fig. III/4). Thus, values for 15-min neuraminidase assays (E549)
with supernates of second serial cultures of C. perfringens strain
L2Ab incubated at 37°C for 48 h in 10-ml volumes of PPW5 broth
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varied from c. 0.5-3.5 on different occasions in these studies
(c.f. values in figs III/3-5, tables III/I-III and VI).
It was not possible to identify differences between different
batches of medium that might contribute to this. Preliminary
experiments showed greater neuraminidase production in broth
containing 5% proteose peptone than with lower concentrations. A
number of unsuccessful attempts were made to identify inducing
substances, e.g. by addition of FVII glycoprotein, NANA or proteose
peptone to media in which little enzyme was produced. Although all
these substances appeared on occasion to increase neuraminidase
production in 48-h cultures, consistent results were not obtained.
This was partly because the variability of neuraminidase production
in the basic medium was too great to allow detection of small
increases in enzyme production; however, in some repeat
experiments the addition of these substances might actually
correlate with decreased enzyme production.
Production of neuraminidase by four classical (haemolytic,
heat-sensitive) strains of C. oerfrinaens type A was compared in a
range of broth media. Each strain was cultured for 48 h in each
medium, and a second serial 48-h culture was made from each in the
same medium. The results of neuraminidase assays on the supernates
of the second serial cultures (table III/II) indicate that enzyme
production is relatively poor in NB and generally good in PPW5 and
THB media. These results reflect our general experience with many
strains of C. perfrinaens and these two media were used in further
studies of neuraminidase production by various clostridial species.
Most Clostridia grow well in either medium. Occasional cultures in
THB medium were found to be unduly mucoid; this occurred rather
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TABLE ITT/II
Production of neuraminidase by four classical strains of
Clostridium perfrinaens type A grown in four broth media
Result of 15-min neuraminidase assay*3 on supernate





NB 0.315 0.056 0.280 0.346
CMB 0.732 0.190 0.441 0.649
THB 1.320 0.656 0.692 0.900
PFW5 0.640 1.052 0.920 0.492
a NB = nutrient broth; CMB = cooked-meat broth; THB = Todd-Hewitt
broth; PEW5 = proteose peptone water.
b The spectrophotometric value (E549) is an average result obtained
from duplicate assay readings corrected by subtraction of the sum
of the values for separate substrate and enzyme control tests.
Samples giving high assay values were diluted in acetate buffer, pH
5.1, before assay; the results have been corrected accordingly.
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less frequently with PPW5 cultures. Although mucoid cultures were
more difficult to handle, e.g. for centrifugation, there was no
apparent effect on neuraminidase levels in the culture supernate.
CMB cultures usually contained moderate amounts of enzyme but the
presence of meat particles and debris makes these cultures
relatively inconvenient and this medium was not used routinely in
tests for neuraminidase production.
The results given in table III/III give an indication of the
amount of growth that occurs in the different media in such
cultures. Two serial 48-h cultures of strain L2Ab were prepared in
each medium, using 10-ml volumes of medium and the same conditions
for inoculation and incubation as for the previous experiment.
Total and viable counts of organisms were made with the second
serial culture in each medium (see Materials and Methods). The
organism grew well in each culture medium; total counts did not
differ markedly (1.1-6.7 x 10®/ml) but there was a greater loss of
viability in NB medium (c. 20-fold) than in the others (c. 2- to 3-
fold).
The degree to which variations in neuraminidase production
might correlate with variations in total or viable counts of
organisms in 48-h broth cultures was not explored further, but
attempts were made to ensure that all organisms tested for
neuraminidase production were cultured in media that ensured good
growth of the test strain. In later experiments, with other
clostridial species (see Section IV), the amount of growth in
cultures tested for neuraminidase production was recorded; all
G. perfrinaens strains gave ++ or +++ growth in 48-h PPW5 cultures
by this scale (see Materials and Methods).
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TABLE III/III
Production of neuraminidase and amount of growth in 48-h cultures
of Clostridium perfrinaens strain L2Ab in four broth media
Number of organisms in second Result of 15-min
serial 48-h culture neuraminidase assay on
Culture (orgs/ml) supernate from second
medium3 *. x serial 48-h culture0
Total count Viable count (E549)
NB 1.1 X 108 7.4 X 01—1 0.427
CMB 1.1 X 0001—1 7.0 X 107 0.391
THB 6.7 X 0001—1 2.1 X 108 1.352
PFW5 2.7 X 0001—1 9.3 X r~-0iH 0.722
a NB = nutrient broth; CMB = cooked-meat broth; THB = Todd-Hewitt
broth; PFW5 = proteose peptone water.
k See Materials and Methods for counting techniques.
0 See footnote to table III/II.
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Illb. Production of neuraminidase bv food-poisonina
strains of C. oerfrinoens type A
Production of neuraminidase by food-poisonina C. oerfrinaens
of serotypes 1-24 and i-xviii. Reference food-poisoning strains of
C. perfrinoens type A were obtained from Dr Betty Hobbs, Central
Public Health Laboratory, Colindale (see Materials and Methods).
Serotypes 1-24 are "typical food-poisoning strains" that are non-
haemolytic and produce very heat-resistant spores. Serotypes
i-xviii include both haemolytic and non-haemolytic strains; all
produce relatively heat-sensitive spores. These strains were
originally collected and classified by Dr Hobbs; more recently the
two series of organisms have been amalgamated into a single series
(serotypes 1-75) and revised serotype numbers have been allocated
to strains i-xviii (see Discussion). For clarity, the original
Hobbs' serotype numbers have been retained in this study.
All of the 41 reference strains grew well in PPW5 broth and
the supernate of the second serial 48-h culture in this medium was
tested for neuraminidase activity. The culture supernates were
first tested in a screening assay incubated with substrate FVII(6)
for 1 h; thereafter, positive supernates were assayed (at
appropriate dilutions) by the standard 15-min assay procedure. The
assay product of all positive tests was further examined with the
scanning spectrophotometer to confirm that the absorption peak was
at 549 nm. Table III/IV shows the relative amounts of enzyme
produced by neuraminidase-positive strains (see Materials and
Methods for grading of neuraminidase activity). Most of these
strains produced large amounts of enzyme that gave high readings
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tapie ni/iv
Enzvme production bv neuraminidase-oositive food-poisonina
strains of Clostridium perfrinaens type A
in suoernates of PEW5 broth cultures
Serotype of Relative amount of



















a Reference strains of different serotypes obtained from Dr Hobbs
(see Materials and Methods).
k
Supernate of second serial 48-h culture in PPW5 broth tested in
assays with substrate FVII(6). Samples diluted in acetate buffer,
pH 5.1, before assay where necessary. Test results corrected by
subtraction of the sum of the values for separate enzyme and sub¬
strate control tests. See Materials and Methods for grading of
neuraminidase activity.
c Positive results confirmed in repeat culture.
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(E549 >0.1: +++ score) or very high readings (E549 >1.0: ++++
score) in 15-min assays; these are comparable to the amounts
produced by the classical C. oerfrinaens strain L2Ab in similar
cultures. Two strains, Hobbs' types 24 and i, gave very low
results in the 1-h screening assay (E549 <0.1). These supernates
were reassayed in tests incubated for 4 and 24 h in order to
demonstrate a progressive release of NANA during prolonged
incubation; assays with both supernates were clearly positive
in the 24-h tests (Ej49 >0.5: + score). A number of strains were
retested in repeat cultures in order to check the consistency of
our results; all were again clearly neuraminidase-positive. The
Hobbs' type-13 and type-ix strains again produced high levels of
enzyme and the type-24 strain again produced a rather small amount.
The type-i strain, however, produced much larger amounts than
before (+++ score); this suggested that it may be more variable
than the type-24 strain.
Culture supernates that were negative in the 1-h screening
assay were retested with 24-h incubation; all remained negative.
It was confirmed that cultures of several strains (Hobbs1 types
1-4, 11 and viii) remained negative in repeat cultures.
Table III/V summarises the results of the neuraminidase
assays with both series of reference food-poisoning strains. Most
of the typical non-haemolytic, heat-resistant C. perfrinaens
strains were neuraminidase-negative, but there was good production
of the enzyme by the reference strains of Hobbs' types 13, 18 and
21, and the strain of Hobbs' type 24 produced a small amount of
activity. Thirteen of the 17 heat-sensitive food-poisoning strains
produced neuraminidase but the remaining four strains were
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TABJLE UIZY
Production of neuraminidase by heat-resistant and heat-sensitive
reference food-poisonina strains of Clostridium perfrinaens
type A in supernates of PFW5 broth cultures
Reference Haemolytic Serotype numbers Serotype numbers
strains effect on of neuraminidase- of neuraminidase-
blood agara positive strains'3 negative strains0
Hobbs' NH 13, 18, 21, 24 1, 2, 3, 4, 5, 6,
types 1-24 7, 8, 9, 10, 11,
(heat-resistant) 12,14, 15, 16, 17,
19, 20, 22, 23
Hobbs1 NH i, ix xiii, xiv, xv
types i-xviii
(heat-sensitive)
H ii, iii, v, vi, viii
vii, x, xi, xii,
xvi, xvii, xviii
a See Materials and Methods: H = haemolytic; NH = non-haemolytic.
k See table III/IV for relative amounts of neuraminidase produced.
0 Tests incubated with substrate FVII(6) at 37°C for 24 h gave
negative results.
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completely negative. It appears that in general non-haemolytic
strains do not produce neuraminidase whereas haemolytic strains do,
though there are clear exceptions to this general correlation.
The same procedures were used to investigate neuraminidase
production by a further four strains of Hobbs' serotype 13.
Strains 029 and 153 were isolated from food-poisoning outbreaks in
Edinburgh and strains 611 and 4621 were supplied by Dr Hobbs. The
results presented in table III/VI show production of a moderate
amount of neuraminidase by strain 611 and rather smaller amounts by
the reference type-13 strain (NCTC10240) and by strains 029 and
153; nevertheless, activity was clearly demonstrable in tests
incubated for 15 min (E549 >0.1). By contrast, there was no
activity in the supernate of strain 4621 even when the tests were
incubated for 24 h. When a sample of this supernate was incubated
with NANA for 24 h under conditions equivalent to those of the
neuraminidase assay, there was no significant reduction in the
assay value for NANA; thus, the negative result in the 24-h
neuraminidase assay was not due to destruction of NANA by NAN-lyase
activity. It therefore appears that there may be variation in the
ability to produce neuraminidase among strains of a single Hobbs'
serotype of C. oerfrinaens.
Tests for production of neuraminidase during serial cultures
of food-poisoning strains of C. perfringens type A in PPW5 broth.
Five serial 48-h cultures of the classical strain L2Ab and the
neuraminidase-positive type-13 food-poisoning strains 029 and 153
were made in 10-ml volumes of PPW5 broth prepared from a single
batch of medium at the start of the experiment. Fig. III/5 shows
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TABLE III/VI
Production of neuraminidase bv five strains of
Clostridium oerfrinaens of Hobbs1 type 13 in supernates of
PEW5 broth cultures
Result of 15-min neuraminidase assay
Strain on supernate from second serial 48-h








a See footnote to table III/II.
b Hobbs' type-13 reference strain.
c The negative result for the culture supernate of strain 4621 was








Number of serial culture in
PEWS broth
Fia. III/5 - Production of neuraminidase by Clostridium perfrinaens
strains in serial 48-h cultures in PPW5 broth; x—x, strain Li2Ab;
A-A, strain 153; •—•, strain 029. Neuraminidase activity in the
culture supernates is expressed as the result of standard 15-min
assays (E54g) corrected by subtraction of the sum of the values for
separate enzyme and substrate control tests. Strain L2Ab
supernates were assayed at a dilution of 1 in 4 in acetate buffer,
pH 5.1, and the values corrected accordingly; supernates of
strains 153 and 029 were assayed undiluted.
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the results of standard 15-min assays for neuraminidase activity in
the culture supernates. Strain L2Ab produced moderate but variable
yields of neuraminidase in all cultures. Initially, the two
Edinburgh food-poisoning strains produced rather small amounts of
enzyme but this increased during the serial cultures until by the
fifth culture the activity was comparable with that produced by
strain L2Ab. The presence of small amounts of activity in the
first cultures in this series was confirmed by demonstrating that
more NANA was released when the period of incubation of the assays
was extended. In tests in which samples of supernate were
incubated with a standard amount of NANA there was no significant
breakdown of NANA. The values plotted in fig. III/5 therefore give
a valid indication of the relative amounts of neuraminidase
produced by the three strains in this experiment.
These results might suggest that sequential culture in PFW5
broth of strains 029 and 153 produced a gradually increased yield
of neuraminidase. However, further experiments with organisms
derived from the same freeze-dried stocks and grown under
apparently identical conditions did not confirm this pattern; the
initial cultures often produced high amounts of the enzyme and
variations in yield could not be attributed to any particular
variable in experimental conditions. The results of one such
experiment, with strain 029, are given in table III/VII. Fifteen
serial 48-h cultures were made in the same way as for the
experiment with strain L2Ab shown in fig. III/4. After five serial
cultures in PPW5 broth, five further cultures were made in NB
medium and then another five in PPW5 broth; the supernates of the
15 serial cultures were tested in standard 15-min neuraminidase
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TABLE HIZYU
Production of neuraminidase bv Clostridium perfrinaens





Result of 15-min neuraminidase

















a PIW5 = proteose peptone water; NB = nutrient broth,
k See footnote to table III/II.
c
Presence of small amounts of neuraminidase confirmed in assays
incubated for 4 h.
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assays. There were high enzyme yields in all cultures in PPW5
broth; the levels were again rather variable but there was good
production in the initial cultures on both occasions. Small, but
clearly demonstrable, amounts of activity were found in the 15-min
assays with all the NB culture supernates.
Because of the apparent variation that may occur during
serial cultures of neuraminidase-positive strains, four neuramini-
dase-negative C. oerfrinoens strains were also tested in serial
cultures. Five serial 48-h cultures of the reference strains of
Hobbs1 types 1-4 were made in PPW5 broth; these cultures were made
as part of the experiment shown in fig. III/5, using the same batch
of medium and incubating each serial culture of all strains in the
same anaerobic jar. Hie results presented in table III/VIII show
that there was no evidence of neuraminidase activity in any of the
culture supernates of Hobbs' serotypes 1-4 when tested in 24-h
assays. This was not due to destruction of NANA during the assay,
as the results given in table III/IX show that there was no
reduction in assay value when NANA was incubated with samples of
the fifth serial culture supernates for 24 h under conditions
equivalent to those of the neuraminidase assay. Thus, these
typical food-poisoning strains remained neuraminidase-negative even
when grown under conditions that simultaneously gave very good
production of neuraminidase by the Edinburgh type-13 strains.
Assays for cell-associated neuraminidase. Five serial 48-h
cultures of the neuraminidase-positive classical strain L2Ab and
the neuraminidase-negative food-poisoning strain Hobbs' 2 were made
successively at 39°C in 10-, 10-, 10-, 100- and 500-ml volumes of
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TABLE III/VIII
Results of 24-h assays for neuraminidase in supernates of
serial 48-h cultures of typical food-poisonina strains of










Hobbs1 1 1 0.193 0.169 -0.014
2 0.192 0.171 -0.017
3 0.196 0.172 -0.014
4 0.194 0.165 -0.009
5 0.191 0.162 -0.009
Hobbs1 2 1 0.182 0.159 -0.015
2 0.181 0.158 -0.015
3 0.179 0.159 -0.018
4 0.180 0.156 -0.014
5 0.179 0.163 -0.022
Hobbs1 3 1 0.188 0.155 +0.005
2 0.183 0.162 -0.007
3 0.177 0.158 -0.009
4 0.165 0.148 -0.011
5 0.167 0.147 -0.008
Hobbs1 4 1 0.169 0.151 -0.010
2 0.168 0.146 -0.006
3 0.172 0.156 -0.012
4 0.164 0.147 -0.011
5 0.166 0.147 -0.009
a The corrected assay value is an average value obtained from
duplicate test readings corrected by subtraction of the sum of the
values for the substrate and enzyme control tests. The tests were
performed in two batches; the average of duplicate FVII(6)
substrate control values was 0.038 for the assay of supernates of
Hobbs' 1 and 2 serotypes and 0.028 for the assay of supernates of
Hobbs1 3 and 4 serotypes.
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TABLE III/IX
Effect of sterile PEW5 broth and of PFW5 culture supernates of
typical food-poisoning strains of Clostridium perfrinaens
on NANA determination in time-zero mixtures and in mixtures













NANA + Hobbs' 1
NANA + Hobbs1 2
NANA + Hobbs' 3





































3 Test mixtures contained 10 jug NANA in 0.25 ml distilled water,
0.1 ml test substance and 0.15 ml acetate buffer, pH 5.1. NANA
alone = NANA + 0.25 ml buffer; PPW5 = sterile broth; Hobbs' 1-4 =
supernate of fifth serial 48-h culture of respective strain in PPW5
broth (see table III/VIII).
b
Average of duplicate assay readings; ... = not applicable.
c Test readings corrected by subtraction of the control value
(0.1 ml test substance + 0.4 ml buffer).
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PPW5 broth. Samples (100 ml) of culture supernates from the fifth
serial cultures were concentrated c. 5-fold; the L2Ab culture was
concentrated to 22.1% of its original volume, and the Hobbs' type-2
culture to 17.8%, after dialysis (see Materials and Methods). The
washed cells from the 500 ml of the fifth serial cultures were
resuspended in 20 ml saline and disrupted ultrasonically; the
resultant suspension was then centrifuged free of cell debris and
is referred to as cell extract. Table III/X presents the results
of 15-min neuraminidase assays with substrate FVII(6) on the
culture products of the strain L2Ab cultures. In this experiment
the first culture in the series contained the greatest amount of
enzyme but there were very high yields in the supernates of all
five serial cultures; concentration of a sample of the fifth
culture supernate produced a proportional increase in activity.
The amount of neuraminidase in the successive washings fell rapidly
to trace amounts, but there was release of a little further
neuraminidase after ultrasonic treatment of the suspension of L2Ab
cells; it should be appreciated that the enzyme in the cells from
500 ml culture was extracted into 20 ml saline and this concen¬
tration factor is reflected in the assay value of E54g = 1.428. By
contrast, neuraminidase activity was not detected in any of the
equivalent samples from the cultures of strain Hobbs1 2 even though
the tests were incubated for 24 h.
Table III/XI shows the amount of NANA that was destroyed
during incubation with samples of the fifth culture supernates for
periods up to 24 h under conditions equivalent to those of the
neuraminidase assay. Hie supernate of the fifth culture of strain
L2Ab produced slight destruction of NANA after incubation for 24 h;
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TABLE TTT/X
Neuraminidase activity in various culture
products of Clostridium perfrinaens strain L2Ab
grown in PTO5 broth










Supernate 5 concentrate0 13.640
1st washing from bacillary deposit 5 0.433
2nd washing 0.032
3rd washing 0.021
Extract of sonicated washed deposit 5 1.428
a See Materials and Methods,
k See footnote to table III/II.
c Concentrated to 22.1% of the original volume.
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2&BLE UlZXI
Effect of incubating NAM with culture suoernates of
Clostridium perfrinaens strains L2Ab and
Hobbs' 2 for up to 24 h at 37°C
Result of assay for NANA (E549)1"5 after
Reaction mixture3 incubation of mixture for stated time
30 min 2 h " 3 h 22 h 24 h "
NANA alone 0.514 0.514 0.506 0.530 0.531 0.537
NANA+supernate of 0.516 0.502 0.474 0.474 0.299 ...
5th serial culture
of strain L2Ab
NANA+supernate of 0.503 0.500 0.494 0.511 0.511 0.500
5th serial culture
of strain H2




a Test mixtures contained 0.1 ml test substance and 10/ig NANA in
0.5 ml final volume (see footnote to table III/IX). For culture
products, see text; H2 = Hobbs1 type-2 strain.
k Spectrophotometric reading (E549)
by subtraction of the control value
acetate buffer, pH 5.1); ... = not
of single-tube assays corrected
(0.1 ml test substance + 0.4 ml
done.
1 9AB
this suggests that there is slight NAN-lyase activity in this
culture supernate (although not enough to interfere appreciably
with the 15-min neuraminidase assay). There was, however, no
destruction of NANA by the supernate of the fifth culture of the
strain of Hobbs' type 2 and even with this product concentrated 5-
fold there was only a very slight reduction in the assay value for
NANA after incubation for 24 h. This confirms that the results of
the neuraminidase assays on culture supernates of the strain of
Hobbs' type 2 are valid, i.e. that this strain produced no
demonstrable extracellular neuraminidase.
Disruption of the washed cells of strain L2Ab and the strain
of Hobbs1 type 2 liberated NAN-lyase into the supernate. The
results presented in table III/XII show that in each case the
supernate from the third washing of the cells in saline produced no
desctruction of NANA but that the supernate after disruption of the
cells was able to destroy the test dose of NANA during incubation
for 24 h. The amount of NAN-lyase activity in the cell extracts of
the two strains appears to be comparable, as judged by the similar
rate of NANA destruction during the first 3 h of the test.
Fig. III/6 shows the effect of the NAN-lyase in the L2Ab cell
extract with neuraminidase assays incubated for periods up to 8 h.
The amount of NANA released increased rapidly to reach a peak at 1
h and thereafter there was a progressive fall in assay value; thus
the result of the 15-min neuraminidase assay on the L2Ab cell
extract given in table III/X is liable to be an underestimate.
Because the cell extract prepared from the Hobbs' type-2 strain
contains a similar amount of NAN-lyase activity, the negative
result in the 24-h neuraminidase assay on this sample might have
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TABLE III/XII
Effect of incubating NANA with cell extracts of Clostridium
perfrinaens strains r,9Ah and Hobbs' 2
for up to 24 h at 37°C
Result of assay for NANA (E549)a after
incubation of mixture for stated time
Reaction mixture3 , ^
Tq 30 min lh 2 h 3 h 24 h
NANA+3rd washing 0.477 0.467 0.481 0.474 0.470 0.461
of strain L2Ab
NANA+cell extract 0.460 0.334 0.250 0.125 0.086 0.020
of strain L2Ab
NANA+3rd washing 0.485 0.502 0.494 0.487 0.489 0.492
of strain H2
NANA+cell extract 0.480 0.372 0.300 0.163 0.113 0.008
of strain H2





2 3 4 5 6 7
Time of incubation of assay
mixture at 37°C (h)
Fia. III/6 - Release and destruction of NANA during neuraminidase
assays with undiluted cell extract from Clostridium perfrinaens
strain L2Ab incubated with substrate FVII(6) for up to 8 h at 37°C.
The relative amount of free NANA is plotted as the spectrophoto¬
metry reading ^549) of single-tube assays corrected by
subtraction of the value for the Tq test. The assay product for
each test was diluted 1 in 5 in reagent 4 (acid butan-l-ol) before
reading and the results were corrected accordingly.
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been due to subsequent destruction of the NANA released; however,
further studies showed no detectable release of NANA even during
the first 3 h of incubation of assay mixtures containing cell
extract of this strain.
To give an indication of the amount of neuraminidase that we
could expect to detect in the Hobbs' type-2 cell extract despite
its NANA-destroying activity, dilutions of L2Ab cell extract were
assayed in the presence and absence of the undiluted cell extract.
The results are presented in fig. III/7. The assay values for
neuraminidase were reduced by the Hobbs' type-2 cell extract in
tests incubated for 2-3 h, but even 1% of the amount of
neuraminidase released by ultrasonic treatment of strain L2Ab cells
could clearly be detected in the presence of the cell extract
prepared from the Hobbs' type-2 strain.
IIIc. Production of neuraminidase by various other
strains of C. oerfringens types A-E
Table III/XIII shows the results of standard tests for
production of neuraminidase by various other strains of
C. oerfringens. All grew well (+++ growth) in PPW5 broth and the
supernate of the second serial 48-h culture in PPW5 broth was
tested for neuraminidase in screening assays incubated at 37°C for
60 min. The supernates were retested in 15-min assays and the
assay product was examined in the scanning spectrophotometer to
confirm that the absorption peak was at 549 nm.
The reference classical strain of C. oerfrinaens type A,












Time of incubation of reaction mixture
at 37°C (h)
Fio. III/7 - Results of neuraminidase assays incubated for periods
up to 3 h in the presence of cell extract of the Hobbs' type-2
strain of Clostridium perfringens. The test mixtures (final volume
0.6 ml) contained: 0.25 ml FVII(6) substrate; 0.15 ml acetate
buffer, pH 5.1; 0.1 ml L2Ab cell extract diluted in buffer; and
either 0.1 ml buffer or 0.1 ml undiluted cell extract of the Hobbs"
type-2 strain. Test readings (E549) corrected by subtraction of
the value for the corresponding Tq test: x—x, 2% (v/v) L2Ab cell
extract + buffer; •—•, 2% L2Ab cell extract + Hobbs'-2 cell
extract; £r-£>, 1% L2Ab cell extract + buffer; V—17, 1% L2Ab cell
extract + Hobbs'-2 cell extract.
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TABLE III/XTTI
Production of neuraminidase bv various strains
of Clostridium oerfrinaens of types A-E in
supernates of PEW5 broth cultures
Relative amount of neuraminidase2
produced in stated medium



















produced good yields of neuraminidase. Three other type-A strains,
NCTC11144, CW6 and CW7, were also shown to produce neuraminidase
well in both PPW5 and THB media; these strains do not produce
phospholipase-C (oc-toxin) and are of interest in our later studies
(see Section VII).
Mutant strains. A collection of mutant strains derived from
the wild-type C. perfringens type A strain CN3870 (Rood &
Wilkinson, 1975) was obtained from Drs Rood and Wilkinson and
recharacterised in this laboratory. Hie phenotypic characters that
these workers reported for these strains are summarised in table
III/XIV. They selected mutant strains with reduced haemagglutinin
production and noted that neuraminidase production was also
reduced; in several cases this was linked with a marked reduction
in sporulation frequency. Production of phospholipase-C was
unchanged, apart from one strain (CM165) that showed an increase in
activity. We were able to obtain three strains (CM156, 165 and
173) that showed a marked reduction in neuraminidase activity in
their hands, but unfortunately their only neuraminidase-negative
strain (CM171) was no longer available. They also selected
revertant strains from a nalidixic-acid-resistant variant (CM198)
of strain CM165; these strains (CM206, 209 and 218) all had
increased sporulation frequency and were reported to have regained
neuraminidase production to different degrees.
These strains were received by us as freeze-dried stock, with
the caution that "the mutants revert very easily and must be cloned
prior to each experiment" (J.I. Rood, personal communication,
1976). The results of our observations with these strains after
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TABLE TTT/XTV
Properties of mutant strains of
Clostridium perfrinaens strain CN3870
Strain number3
Stated phenotypic Characters in
characters" this laboratory0
_\ / * \


















































a See text for description of mutant strains; strain CM171 no
longer available.
k Data from Rood & Wilkinson (1975), table 2. HA = haemag-
glutinin; SP = sporulation frequency; NM = neuraminidase; PC =
phospholipase-C: in each case + = activity of wild-type strain, ++
= increased activity, - = reduced activity, - = no activity. NA =
sensitivity to nalidixic acid (50 pg/ml); S = sensitive, R =
resistant.
c Properties of strains determined in this laboratory (see text).
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minimal subculture (but without any attempt to clone them) are also
given in table III/XIV. Hie freeze-dried material was inoculated
directly to CMB medium and to plates of BA and half-antitoxin EYA
media for anaerobic incubation at 37°C for 24 h; a further BA
plate was incubated aerobically. All cultures were confirmed to be
anaerobic Gram-positive bacilli in pure culture. Nalidixic acid
sensitivity was tested with a disk containing 35 /ig of the
drug added to the anaerobic BA plate; all strains produced the
expected results. Strain CM198, however, proved not to be
C. perfrinaens: the cells were smaller and of diphtheroid
morphology, growth was slow and no phospholipase activity was
detected even after incubation of EYA plates for 3 days. Further
investigation showed it to be catalase-positive and it was
tentatively identified as a Propionibacterium species. All of the
other strains, including the nalidixic-acid-resistant derivatives
of strain CM198, were C. oerfringens. producing opalescence on EYA
medium that was inhibited by the C. perfrinaens antitoxin.
Hie primary 24-h CMB culture of each strain was used to seed
tubes of CMB, PPW5 and THB media, which were incubated
anaerobically for 48 h at 37°C and assayed for neuraminidase. Hie
organisms grew well in the test media and the supernates of all
these cultures contained large amounts of enzyme activity (+++ or
I I I I score, see Materials and Methods) in assays incubated for 1 h
or 15 min; only the culture of the Propionibacterium strain was
neuraminidase-negative. There was no detectable reduction in
neuraminidase activity with any of the mutant strains. These
strains were not further investigated in these studies; it was
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felt that such unstable strains would be unlikely to be of value in
tests for pathogenicity in animals.
Hid. Further characterisation of strains of
C. perfringens type A
The strains of C. perfrinaens type A examined for
neuraminidase production were further characterised for phospho-
lipase-C (oc— toxin) and haemolysin (0-toxin) production. Phospho-
lipase-C production was tested by culture on EYA plates (see
Materials and Methods). The classical type-A strains L2Ab, L3Af
Clr 032 and NCTC8237 were all phospholipase-positive, while strains
NCTC11144, CW6 and CW7 were confirmed to be phospholipase-negative.
All of the food-poisoning strains tested for neuraminidase
production in tables III/V and VI were clearly shown to produce
phospholipase well, apart from the strains of Hobbs' serotypes 14,
viii and xvii, which produced much smaller zones of opacification
in the medium and were classified as producing only low levels of
phospholipase, and the type-18 strain, which was phospholipase-
negative.
The strains were also tested for 0-toxin production by
observing haemolysis on horse-blood agar (HBA) plates (see
Materials and Methods). Horse red-blood cells are relatively
resistant to the haemolytic action of phospholipase-C, which
produces a fairly broad zone of partial haemolysis around the
colonies of classical strains of C. perfrinaens type A on HBA
plates; 0-toxin activity is seen as a smaller zone of complete
("beta") haemolysis around the colony. Thus non-haemolytic strains
199
(those that do not produce 0-toxin) may either show no haemolysis
or only a zone of faint incomplete haemolysis attributable to
phospholipase-C production (Willis, 1977, p. 131). The haemolytic
reactions of the reference food-poisoning strains of G. oerfrinaens
type A recorded in table III/V indicate their production of
0-toxin; the other Hobbs' type-13 strains in table III/VI were
also tested and found to be non-8-toxin producing. The classical
type-A strains L2Ab, L3A, CI, 032 and NCTC8237 were all haemolytic,
as were the phospholipase-negative strains NCTC11144, CW6 and CW7.
The properties of a number of C. perfrinaens type A strains that
produced different combinations of these bacterial products and
were selected for pathogenicity studies are tabulated later (see
table VII/IX).
200
IV. TN-VITRO PRODUCTION OF NEURAMINIDASE BY OTHER
SPECIES OF CLOSTRIDIUM
IVa. Examination of clostridial strains for
neuraminidase production
Strains from a range of clostridial species were tested by
standardised procedures developed from those used in studying
neuraminidase production by strains of C. perfringens. The purity
and identity of all strains were carefully checked as detailed in
Materials and Methods. The supernate of the second serial 48-h
culture was tested for neuraminidase as a routine. All strains
were initially tested in PFW5 broth; most Clostridia grew well in
this medium- Most strains were also grown in THB medium, which
occasionally gave better growth. When growth was poor in either
medium (<+ score, see Materials and Methods), the cultures were
repeated using a larger inoculum (1.0 ml) and prolonged incubation
(96 h) for each serial culture. All strains that produced very
little or no neuraminidase were tested in at least two media that
supported adequate growth.
Culture supernates were initially tested in neuraminidase
assays incubated for 60 min with substrate FVII(6) or FVII(7).
When these were positive, the tests were repeated with 15-min
incubation in order to give a more accurate indication of the
amount of enzyme present. When the 60-min assay results were low
or negative, the culture supernates were re-examined in tests
incubated for 24 h. The relative amounts of neuraminidase produced
by different strains were indicated on the same scoring system as
was used for food-poisoning C. oerfrinaens (see Materials and
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Methods). The assay product from at least one test with each
strain that gave a positive result was further examined in the
scanning spectrophotometer to confirm that the peak absorbance was
at 549 nm. Culture supernates that gave low-positive or negative
results (score + or less) in 24-h neuraminidase assays were further
tested to show that these results were not falsely low because of
NAN-lyase production. Ca2+ was not added to the assays as a
routine but a few neuraminidase-negative culture supernates were
retested in the presence of Ca2+ in order to confirm that our
inability to demonstrate enzyme activity was not due to lack of
Ca2+ in the assay.
IVb. Production of neuraminidase by C. seoticum.
C. chauvoei. C. tertium and C. absonum
Table IV/I gives the data for production of neuraminidase by
various strains and species of Clostridia examined in this study;
the results of tests with C. perfrinqens strain L2Ab are included
for comparison. Strain L2Ab grew well in both PPW5 and THB media,
producing large amounts of enzyme (++++ score) in the culture
supernates. Cell-associated neuraminidase was also demonstrable in
the cell extract of the PPW5 culture, although the enzyme is pre¬
dominantly extracellular (see table III/X). The procedure used for
making cell extracts in these experiments did not involve washing
the packed cells to remove surface enzyme; it should also be
appreciated that the cell extract was somewhat more concentrated
than the original culture as the cells from 10 ml culture were used
to produce 2 ml cell extract (see Materials and Methods).
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TfiBBg IV/I
Production of neuraminidase by Clostridium septicum.
C. chauvoei. C. tertium and C. absonum
Relative amount of neuraminidase
























a See Materials and Methods for assessment of growth; ... not
tested. PPW5 = proteose peptone water; THB = Todd-Hewitt broth.
b Culture supernate or cell extract from second serial culture in
stated medium was tested. See Materials and Methods for grading of
neuraminidase activity; ... = not tested.









The strains of C. septicum grew adequately in PPW5 broth and
all produced large amounts of enzyme in the culture supernate.
Cell-associated neuraminidase was easily demonstrated in the PPW5
culture of strain NCTC547, and it was confirmed that the enzyme was
also well produced in THB medium. Three strains of C. absonum also
grew well in both test media and produced large amounts of enzyme
in each.
The two strains of C. chauvoei tested did not grow well in
PPW5 broth and they failed to grow in THB medium. Nevertheless,
strain CC2 produced moderate amounts of neuraminidase in the PPW5
culture supernate, and neuraminidase production by strain NCTC8070
was clearly demonstrated when the incubation time of the assay was
prolonged to 24 h; the enzyme was predominantly extracellular.
The low values for neuraminidase activity in the culture supernate
and the cell extract were not attributable to NAN-lyase activity.
Both strains of C. tertium produced small amounts of neuraminidase;
more enzyme was produced in PPW5 culture supernates although the
organisms grew better in THB medium. The PPW5 culture supernates
of C. chauvoei and C. tertium were further tested to confirm that
their low neuraminidase activity was not increased by the addition
of Ca2+ to the assay mixtures (see below, table IV/III).
IVc. Studies with C. sordelli and
C. bifermentans
Table IV/II gives the data for neuraminidase production by 17
strains of these closely related species. Most of the C. sordelli
strains grew well in PPW5 broth and all the culture supernates
contained neuraminidase. The enzyme was predominantly extra-
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TABLE IV/II
Production of neuraminidase bv Clostridium sordelli
and C. bifermentans
Growth in Relative amount of neuraminidase
Test stated mediuma activity*3 in culture product
organism anu / *■ V t * x
strain PFW5 THB PEW5 THB




NCTC1340 4+ + 4+ 444
NCTC2914 + + 4 ... ++
NCTC6800 + ++ 4 ... 4
NCTC6801 +++ + 44 ... 44
NCTC6927 ++ ++ 4 ... 44-
NCTC6929 4+ ++ 44 ... 4-4
NCTC8780 44+ + 4444C 444
1734 +++ + 444C 444
P3 44+ + 444C 444
CB2 +++ + 444° ... 44
CB3 4+ ++ 44° ± 4
CB4 ++ ++ 4C ± 44+
C. bifermentans
NCTC506 444 ++ _C -
NCTC1341 ++ ++ - • • •
NCTC6928 +4 +++ - • • •
B4 +++ +++ _c — -
1617 44+ +++ _c — —
a Cultures incubated for 48 h: see Materials and Methods for
assessment of growth; ... = not tested. PPW5 = proteose peptone
water; THB = Todd-Hewitt broth,
k See footnote to table IV/I.
c Result confirmed in repeat culture.
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cellular in two strains whose cell extracts were also examined.
Although several strains grew rather poorly in THB medium, enzyme
activity was also clearly demonstrated in these supernates. By
contrast, the five strains of C. bifermentans could not be shown to
produce the enzyme in culture supernates of either medium and no
cell-associated activity was demonstrated in 24-h assays with the
cell extracts of three strains grown in PPW5 broth. These negative
results were shown not to be due to NAN-lyase activity.
Enzyme control values used for correcting neuraminidase
assays with THB culture supernates were low (E54g c. 0.06) and
there was no difficulty in demonstrating the absorption peak at 549
nm of the chromophore formed in these assays. However, the PPW5
culture supernates often gave high enzyme control values (E54g =
0.2-0.3) due to the formation of a chromophore with peak absorption
at c. 530 nm (see Section Ila) and this tended to obscure the
presence of small peaks attributable to neuraminidase action. In
this situation it was sometimes necessary to use a time-zero (TQ)
control test as reference sample for spectrophotometry in order to
confirm that a low corrected assay value was indeed due to
formation of a product with peak absorption at 549 nm.
For example, detailed investigations were made with the PFW5
culture supernate of C. sordelli strain CB4 which contained rather
small amounts of neuraminidase (score +). Standard assay mixtures
were incubated at 37°C for 2 h. When the assay products were
examined in the scanning spectrophotometer with reagent blank in
the reference cell, both the test and the enzyme control contained
a chromogen that gave a very high absorption peak at c. 530 nm.
The shoulder of this curve gave a reading at 549 nm; the test
204
value (E549) was 0.40 and the enzyme control value was 0.24; the
substrate control value was very low (0.02). The corrected assay
value (0.14) should indicate the release of a small amount of NANA,
but fig. IV/1 shows that the absorption peak appeared to be at
c. 530 nm when these products were compared. The explanation for
this artefact is not clear but when the assay product of the Tq
test was used in the reference cell the presence of a small peak at
549 nm (c. 0.1) was clearly shown. It was confirmed that this was
attributable to NANA release by extending the period of incubation
and demonstrating a progressive rise in the peak at 549 nm, to
c. 0.9 after 24 h. The distortion of the NANA peak was seen only
with samples that contained very small amounts of NANA and that had
rather high enzyme control values (E^^g); the problem was avoided
by using Tq controls in confirmatory tests. Thus although
equivocal results were initially obtained in standard 24-h assays
with a few PPW5 culture supernates of C. bifermentans strains,
comparison with Tq control tests confirmed that there was no NANA
release during incubation of assay mixtures for 24 h.
In order to confirm that low-positive or negative
neuraminidase assay results were not due to lack of Ca2+ in the
assay mixtures, the culture supernates of various clostridial
strains were retested in the presence of added Ca2+ (table IV/III).
The tests were performed with and without added 3mM Ca2+ in the
assay mixtures, as was done previously with C. perfringens strain
L2Ab (see table II/IV); in this case enzyme control tests were not
included and uncorrected assay results were compared. Culture
supernates with strong neuraminidase activity were diluted before
testing in 15-min assays and the time of incubation of assays of
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Wavelength (nm)
Fia. IV/1 - Comparison of Tq control test and enzyme control test
as reference preparation in determining the absorption peak of the
neuraminidase-assay product with a PPW5 culture of Clostridium
sordelli strain CB4. The PPW5 culture supernate (see table IV/II)
was incubated in the assay mixture for 2 h at 37°C with substrate
FVII(7). Absorbance curves read in the scanning spectrophotometer
with the control assay product as reference preparation:
enzyme control test incubated for 2 h with no substrate; ...,
unincubated Tq control test (see Materials and Methods). The solid
line indicates the curve obtained with assay of 10 pg of pure NANA
read with reagent blank in the reference cell.
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TABLE TV/III
Effect of Ca2+ on neuraminidase assays with culture
supernates of various Clostridia
Test Time of Result of
organism and incubation neuraminidase



































KDE 15 min 0.370 0.755
a Supernate of second serial culture in PPW5 broth tested (see
tables IV/1 and IV/II). For Vibrio cholerae FDE see Materials and
Methods.
k Tests incubated at 37°C for the stated period before assay for
NANA. Test material assayed undilute except C. perfrinaens.
diluted 1 in 16, and C. septicum, diluted 1 in 8, in the acetate
buffer, pH 5.1, before addition to the test mixture.
0 The spectrophotometric value (E^g) is the uncorrected value for
standard neuraminidase-assay mixtures with or without added Ca2+
(see Materials and Methods). Average of values for duplicate
tests.
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supernates with weak activity was prolonged in order to give assay-
results (E^^g) in the range 0.2-0.8. The calcium dependence of
Vibrio cholerae neuraminidase was clearly demonstrated but none of
the clostridial enzymes showed any increase in activity. Further
detailed tests were performed with the PPW5 and THB culture
supernates of C. bifermentans strains NCTC506, NCTC1341, NCTC6928
and B4 that could not be shown to contain neuraminidase in standard
assays (see table IV/II). The 24-h assays remained negative in the
presence of added 3mM Ca2+.
The identity of each of the strains of C. sordelli and
C. bifermentans was carefully rechecked by the biochemical criteria
shown in table IV/IV. All strains classified as C. sordelli were
positive in tests for urease production and growth inhibition by
mannose while the strains classified as C. bifermentans were all
negative; this correlated exactly with our findings for
neuraminidase production. All strains of C. sordelli failed to
ferment mannose and sorbitol; most strains of C. bifermentans did
ferment these substances but two gave inconsistent results in these
tests. It appears that these fermentation tests may be less
reliable in discriminating between the two species.
IVd. Studies with C. nowi and other
neuraminidase-neaative Clostridia
No neuraminidase production was demonstrable in cultures of
10 strains of C. novyi types A-D. Table IV/V shows that some
strains grew poorly in the test media, although the PPW5 broth was
supplemented with cysteine and dithiothreitol (PPW5S) and a large
inoculum and prolonged incubation time were used. No neuraminidase
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TABLE IV/IV
Biochemical characterisation of strains of













NCTC1340 - + + +
NCTC2914 - - + + +
NCTC6800 - - + + +
NCTC6801 - - + + +
NCTC6927 - - + + +
NCTC6929 - - + + +
NCTC87 80 - + + +
1734 - - + + +
P3 - + + +
CB2 - + + +
CB3 - + + +
CB4 - + + +
C bifermentans
NCTC506 + + - -
NCTC1341 - - -
NCTC6928 + - -
B4 + + - -
1617 + + — —
a See Materials and Methods for tests and methods of reading results.
b Results from table IV/II.
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TABLE IV/V



























a See Materials and Methods for assessment of growth; ... = not
tested. PPW5S = proteose peptone water supplemented with cysteine
and dithiothreitol; THB = Todd-Hewitt broth; CMB = cooked-meat
broth.
k 96-h culture, 1-ml inoculum; other cultures incubated 48 h.
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activity could be shown in culture supernates in PPW5S or TUB media
even in assays incubated for 24 h. Culture supernates and cell
extracts of four strains grown in CMB medium were also
neuraminidase-negative. No significant NANA destruction was found
with the majority of these culture products; a few produced a
small reduction in the assay value (E549) for 10 pg NANA after
incubation for 24 h, but in no instance was this greater than 0.15
and this would not have obscured significant neuraminidase
activity. Tests similar to those with C. bifermentans (see Section
IVc) were done to confirm that the addition of Ca did not affect
these negative results. The CMB culture supernates and cell
extracts shown in table IV/V were reassayed in 24-h neuraminidase
assays with and without 3mM Ca^+ but all remained negative.
Tables IV/VI and IV/VII show the other strains of Clostridia
that did not produce neuraminidase; no activity was demonstrable
in 24-h assays in any of the culture supernates. A few strains
that grew poorly in one of the test media showed better growth in




Growth of Clostridium tetani. C. botulinum and
C. difficile strains obtained in two broth media
Growth in stated medium3
Test organism and y ^









Type A, NCTC7272 +++ ++
Type B, NCTC7273 +++ ++
Type C, NCTC3732 -b +++








a See Materials and Methods for assessment of growth. PPW5 =
proteose peptone water; THB = Todd-Hewitt broth.
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TABLE IV/VII
Growth of other neuraminidase-neaative Clostridia
obtained in two broth media
Growth in stated medium3
Test organism and , &



























a See footnote to table IV/VI.
b 96-h culture, 1-ml inoculum; other cultures incubated 48 h.
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V. TN-VITRO PRODUCTION OF NEURAMINIDASE
BY BACTEROTDACEAE
Va. Production of neuraminidase by
Bacteroides fraailis strain NCTC9344
The methods developed for investigation of neuraminidase
production by Clostridium perfrinoens were adapted for studies with
Bacteroides fragilis (B. fraailis ss. f raoilis) strain NCTC9344.
Table V/I gives the results when culture supernates and cell
extracts from 48-h cultures in a range of broth media were tested
by the standard neuraminidase assay procedure. The culture
supernates contained small amounts of enzyme that could be detected
when the incubation time of the assays was prolonged to 24 h. Cell
extracts prepared from the same cultures contained larger amounts
of neuraminidase that gave high values (E54g) in 60-min assays.
Neither the culture supernates nor the cell extracts had
significant NAN-lyase activity that might interfere with the assay
for neuraminidase. Enzyme control values were satis¬
factorily low with the Bacteroides cell extracts and there were no
problems in demonstrating that the assay product had a typical
absorption curve for NANA with a peak at 549 nm. Cell extracts
were examined as a routine in further studies with Bacteroides
species.
The organism grew adequately in all of the media tested.
Growth was least good in thioglycollate broth (TCB) and there were
difficulties in centrifuging this medium because it contains a low
concentration of agar. DB, PPW5 and BM broth media were chosen for
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TABLE V/I
Production of neuraminidase bv Bacteroides fraailis





Result of neuraminidase assay"




Culture supernate Cell Extract
DB +++ 0.112 0.457
PPW5 ++ 0.076 0.547
BM ++ 0.164 0.713
CMB +++ 0.231 0.936
PPY ++ 0.175 0.711
TGB + 0.893 0.737
THB +++ 0.053 0.546
a DB = digest broth; PPW5 = proteose peptone water; BM = BM medium;
CMB = cooked-meat broth; PPY = PPY medium; TGB = thioglycollate
broth; THB = Todd-Hewitt broth.
13 See Materials and Methods for assessment of growth.
c Supernates of 48-h cultures tested in 24-h assays with substrate
FVII(8); cell extracts from the same cultures tested in 60-min
assays. The spectrophotometric value (E549) is an average result
obtained from duplicate assay readings corrected by subtraction of
the sum of the values for separate substrate and enzyme control
tests.
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further studies as media likely to support growth and give good
neuraminidase production with a range of Bacteroides species.
A more concentrated bulk cell extract (P15) was prepared from
a 200-ml PPW5 culture of B. fragilis NCTC9344 (see Materials and
Methods) for studies of the effect of pH and Ca2+ on the enzyme.
Fig. V/l shows the results of 30-min neuraminidase assays in
acetate buffers at different pH values. The assay values were
corrected by subtraction of the values obtained in separate
substrate and enzyme control tests at each pH value; the enzyme
controls were constant (E549 c. 0.02) but the substrate controls
were slightly higher at lower pH values (range 0.06-0.11). Fig.
V/l shows the pH optimum for B, fraoilis neuraminidase with
substrate FVII to be at c. 4.2. Our standard assay uses acetate
buffer at pH 5.1; this allows good neuraminidase activity and was
therefore used when testing for neuraminidase production by other
Bacteroidaceae. The pH values shown in fig. V/l are the values for
the initial pH of the buffers prepared for use in the tests.
Direct measurement of pH in equivalent test mixtures showed that
the actual pH values might be 0.2-0.3 units higher, but they did
not vary during incubation of the tests; thus the pH optimum for
B. fraailis neuraminidase in sodium acetate buffers is likely to be
c. 4.5.
The influence of Ca2+ on the activity of the B. fraailis
neuraminidase preparation P15 was tested by the procedures used for
the enzymes of C. oerfrinoens and Vibrio cholerae (see table
II/IV). Table V/II shows that the addition of Ca2+ did not
stimulate B. fraqilis enzyme activity; the addition of ImM EDTA did
not inhibit the enzyme and even 5mM EDTA reduced the assay value by
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Fig. V/l - Effect of pH on the assay for the neuraminidase of
Bacteroides fraailis. Cell extract of B. fraailis NCTC9344 (P15)




Effect of Ca2+ and EDTA on the assay of
neuraminidase from Bacteroides fraailis NCTC9344
Concentration of added











See Materials and Methods.
b B. fraailis NCTC9344 cell extract (P15) diluted 1 in 40 in
acetate buffer, pH 5.1, was used as test enzyme in standard assay
mixtures with substrate FVII(8). The spectrophotometric value
(E54Q) is an average result obtained from duplicate 15-min assay
readings corrected by subtraction of the values for the corres¬
ponding substrate and enzyme control tests.
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c. one third only. Ca^+ was not added as a routine to assays for
neuraminidase production by species of Bacteroidaceae.
Vb. Production of neuraminidase bv species
of the B. fraailis group
Table V/III gives the results when a range of strains
belonging to the group of species known collectively as the
B. fraailis group were tested for neuraminidase production by
procedures similar to those developed for testing clostridial
species. The purity and identity of each organism was carefully
checked as described in Materials and Methods. The strains were
cultured at 37°C for 48 h in DB and PPW5 media and the amount of
growth was noted. Cell extracts were prepared and tested in
standard neuraminidase assays incubated at 37°C for 60 min; samples
giving low-positive or negative results were retested in 24-h
assays. The detailed procedures and the system used for grading
the amount of neuraminidase present are described in Materials and
Methods.
In general, these organisms grew better in DB than in PPW5
broth, but neuraminidase-positive strains usually produced greater
activity in PPW5. All the strains of B. fraailis (B. fraailis ss.
fragilis) and B. vulaatus produced large amounts of the enzyme in
both media, and the strains of B. distasonis and B. ovatus were
also clearly positive.
All strains of B. thetaiotaomicron produced neuraminidase
well in PPW5 but production in IB medium sometimes varied. Strain
NCTC10582 was cultured in DB medium on four occasions;
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TABLE V/III
Production of neuraminidase by organisms of the Bacteroides
fraailis group grown in two broth media
Test organism and Growth in Relative amount of neuraminidase
strain number stated medium3 activity in culture product^
' ■ 'V / * -V















































R. eaaerthi/... /see next page
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TABLE V/III/contd.
Test organism and Growth in Relative amount of neuraminidase
strain number stated medium3 activity in culture product*3
r * v / * v











a Cultures incubated for 48 h at 37°C; see Materials and Methods for
assessment of growth. DB = digest broth; PIW5 = proteose peptone water.
" Cell extract from culture in stated medium was tested. See Materials
and Methods for grading of neuraminidase activity; V = variable results
in different experiments (see text).
c Result confirmed in repeat culture.
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neuraminidase assays were twice positive (+ and ++) and twice
negative even with assays incubated for 24 h. Variable results
were also obtained with strain GNAB16, which was once positive (+)
but twice negative. By contrast, three separate cultures of each
organism in PEW5 broth were consistently positive.
Results with B. variabilis also varied. Strain GNAB18
consistently produced neuraminidase. Strain VPI11368 twice
produced moderate amounts (++) in PPW5 medium but failed, however,
to produce detectable activity in one other PPW5 culture and in
three cultures in DB medium.
All strains of B. uniformis. B. eagerthi and B. splanchnicus
grew adequately but none produced detectable neuraminidase activity
in either medium, even when tested in 24-h assays. As a routine in
all these studies it was confirmed that negative results were not
attributable to NAN-lyase activity in the cell extract
preparations. Similarly, the position of the absorption peak at
549 nm was confirmed for all positive neuraminidase assays.
Vc. Production of neuraminidase by other
Bacteroides species
The results of similar tests with other Bacteroides species
are shown in table V/IV; the current classification of these
strains is described in Materials and Methods. Most strains grew
adequately in DB and BM media in 48 h; a few cultures required
96-h incubation for adequate growth. Since many of the strains
grew very poorly or not at all in PPW5 broth even when incubated
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TABLE V/IV
Production of neuraminidase by strains of various Bacteroides
species grown in broth media
Test organism and Growth in Relative amount of neuraminidase
strain number stated medium3 activity in culture product
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TABLE V/lV/contd.
Test organism and Growth in Relative amount of neuraminidase
strain number stated medium3 activity in culture product'3









WPH57 ++ + -C
B. gingivalis
WPH15 +c ++ -c
B. corrodens
143A
151RV +c ±c +c
+c ±c
a See Materials and Methods for assessment of growth; ... = not tested.
DB = digest broth; BM = BM broth; PIW5 = proteose peptone water.
k See footnote to table V/III; ... = not tested.
c Culture incubated 96 h; other cultures incubated 48 h.
^ Result confirmed in repeat culture.
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for 96 h, the cultures in this medium were not tested for
neuraminidase as a routine.
The three strains of B. melaninogenicus ss. melaninogenicus
and the single strain of B. melaninogenicus ss. levi produced
neuraminidase. All were consistently positive except strain WPH67
which proved variable; it twice gave ++ production in DB medium,
but was negative on one other occasion and was twice negative in BM
medium. By contrast, the five strains of B. melaninoaenicus ss.
intermedius were negative in both media.
The strains of B. oralis and B. bivius were all
neuraminidase-positive as was strain VPI5906D, now allocated to the
new species B, buccalis. The strains of B. pentosaceus.
B. ruminicola, B. disiens, B. asaccharolyticus, B. aingivalis and
B. corrodens (B. ureolvticus) were all neuraminidase-negative. The
B. corrodens strains did not grow well in BM broth; they were also
tested and found to be negative in PPW5 medium.
Vd. Studies with Caonocvtophaga, Fusobacterium
and Leototrichia species
Strains of other genera of Gram-negative anaerobic non-
sporing bacilli were examined for neuraminidase production by the
same procedures as were used for Bacteroides species. Table V/V
shows that all the strains of Capnocytophaga (previously classified
as B. ochraceus; see Materials and Methods) could produce
neuraminidase. The strains grew best in DB medium and this medium
gave the best production of neuraminidase. Four strains produced
the enzyme well in DB medium; however, their enzyme production in
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TABLE V/V
Production of neuraminidase bv strains of








DB BM PPW5 DB BM PEW5
10 t + I o ++ ± • • •
73 ++ ++ + ++ i+ i+
1956C +++ + + +++d _d
2467B +++ ++ ++c ++ -
VPI2845 -H- + +c V _d
79B +++ + -c ±d V
a See Materials and Methods for assessment of growth. DB = digest
broth; BM = BM medium; PEW5 = proteose peptone water.
k Cell extract from culture in stated medium was tested. See
Materials and Methods for grading of neuraminidase activity; ... =
not tested. V = variable results in different experiments (see
text).
c Culture incubated 96 h; other cultures incubated 48 h.
d Result confirmed in repeat culture.
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BM and PFW5 media was very unreliable. Strain 79B produced trace
amounts (- score) on three occasions in DB medium and on one
further occasion in BM broth. Strain VPI2845 produced a trace of
activity in only one of three cultures in DB medium and was
consistently negative in BM and PFW5 cultures. The difficulty in
demonstrating neuraminidase activity in these cultures may be
partly explained by the presence of small amounts of NANA-
destroying activity in the cell extract of several of the
Capnocvtophaga cultures.
Table V/VI shows the results when eight strains of Fuso-
bacterium species and one of Leototrichia buccalis were grown in DB
and PFW5 medium; in general, they grew well in I® and less well in
PPW5. The two strains that grew poorly in PPW5 were also grown and




Growth of neuraminidase-neaative Fusobacterium and
Leptotrichia species obtained in three broth media























a See Materials and Methods for assessment of growth; ... = not
tested. DB = digest broth; PPW5 = proteose peptone water; BM =
BM broth.
b Culture incubated 96 h; other cultures incubated 48 h.
213A
VI. STUDIES WTTH ANTISERA
Via. Assay for anti-neuraminidase activity
in serum
The standard neuraminidase assay was adapted to allow
measurement of the degree of enzyme inhibition by various antisera
(see Materials and Methods). Test sera were allowed to react with
a standard C. perfrinaens type A neuraminidase preparation for
30 min at room temperature in order to allow neutralisation of the
enzyme before the start of the neuraminidase assay. Table VI/I
gives the results of an experiment to determine the degree of
inhibition of neuraminidase preparation P9D4 by C. perfrinaens
diagnostic antiserum (CPAl), a commercially available equine
antiserum prepared by injecting C. oerfringens type A culture
products in order to produce high-titre anti-phospholipase-C
activity (see Materials and Methods). Assays were incubated for 15
and 30 min; time-zero (Tq) assays were also performed. The assay
values for P9D4 in the absence of antiserum show the expected
doubling in value when incubation was prolonged from 15 to 30 min.
The C. perfrinaens CPAl serum produced a marked reduction in assay
value after each of these periods of incubation, the degree of
inhibition remaining approximately constant at c. 85%. It is
apparent that this antiserum, although prepared primarily for its
anti-phospholipase activity, also has considerable anti-
neuraminidase activity.
The Tq enzyme control value was higher for the reaction
mixture that contained antiserum than for the reference assay with
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TABLE Vl/I
Inhibition of Clostridium oerfrinaens type A neuraminidase
























saline 0 0.025 0.003 0.002 • • •
15 0.218 0.006 0.192 • • •
30 0.427 0.007 0.400 • • •
P9D4 +
CPA1 0 0.047 0.028 0.000 • • •
15 0.101 0.048 0.033 83
30 0.144 0.066 0.058 86
a Enzyme preparation P9D4 allowed to react with undiluted CPA1 serum or
with saline for 30 min at room temperature before the assay for neura¬
minidase. For assay mixtures, see Materials and Methods.
13
Average of duplicate assay readings.
c Test readings corrected by subtraction of the sum of the values for
the FVII(7) substrate control (E^g = 0.020) and the appropriate enzyme
control assays.
^ Inhibition of enzyme activity by serum expressed as a percentage of
the value for the equivalent test with no added antiserum; ... = not
applicable.
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the serum replaced by saline, and these enzyme control values
increased progressively during incubation of the tests; it was
confirmed that the 30-min enzyme control value (£543 = 0.066) was
due to the production of a chromogen with the typical absorption
spectrum of NANA (peak absorption 549 nm). Thus, test sera may
contain glycoprotein that can itself act as substrate for the
enzyme during these assays. It is possible that this experiment
underestimates the extent of this, since the good anti-neuramini-
dase activity of serum CPA1 might be expected to inhibit the
enzyme's action; however, similar assays with other equine
antisera that contain very low inhibitory activity for C. perfrin-
aens neuraminidase (e.g. C. tetani ATS serum, see below) gave only
marginally higher 30-min enzyme control values. It is important to
correct test results for undiluted sera by subtraction of the
values for separate 30-min enzyme and substrate control assays;
the use of the Tq control assay for correcting the test values in
table VI/I would give misleadingly high assay values (and hence an
underestimate of the inhibitory action of the antiserum). This
effect is not seen in our standard anti-neuraminidase assays with
sera diluted 1 in 100, when enzyme control levels are very low and
do not rise during incubation at 37°C for 30 min.
Fig. VT/1 shows the effect of two equine antisera on the
release of NANA from the FVII substrate by the enzyme preparation
P9D4 in assays incubated for periods up to 1 h (see Materials and
Methods for details of sera). The ATS serum, an experimental
antiserum raised against C. tetani toxin, was included as a control
serum that should not contain specific antibody against C. oerfrin-
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SO
Fia. VT/1 - Release of NANA from substrate FVII(7) by Clostridium
perfrinaens neuraminidase preparation P9D4 after neutralisation by
two antisera. Sera, diluted 1 in 100 in saline, allowed to react
with enzyme for 30 min at room temperature before the assay for
neuraminidase. Test results corrected by subtraction of the value
for the appropriate TQ assay. Test sample: •—«, P9D4 + C.
perfrinaens 1863 serum; o—-o, P9D4 + C. tetani ATS serum; x—x,
P9D4 + saline.
21 5 A
raised against C. perfrinaens type A culture products that was
found to have a good level of anti-neuraminidase activity. Both
antisera were tested at a dilution of 1 in 100 in saline. The
reference assays of enzyme activity with no added antiserum show
the expected linear release of NANA up to values (Eg4g) of c. 0.5.
The C. tetani ATS serum had very little effect on the activity of
the enzyme but the C. oerfrinaens 1863 serum gave marked inhibition
(c. 85%) and this remained constant regardless of the period of
incubation of the assays. The incubation time for further tests of
neuraminidase inhibition was standardised at 30 min; this gave
reliable reference enzyme assay values (E549) of c. 0.4 with enzyme
preparations P9D3 or P9D4.
Fig. VI/2 shows the titration curves obtained when serial
dilutions of these equine sera were assayed for anti-neuraminidase
activity in standard 30-min tests. Undiluted C. perfrinaens 1863
serum gave complete inhibition of the neuraminidase preparation but
there was a steep fall in the amount of inhibitory activity when
dilutions greater than 1 in 4 were tested; on this occasion the
value for a dilution of 1 in 100 (c. 55%) would appear to be
somewhat lower than was found in the previous experiment. The
C. perfrinaens CPA1 serum was also active against the test enzyme
but it did not give complete inhibition even when tested undilute;
the value here (84%) is similar to that obtained in the experiment
detailed in table VI/I. It produced rather less inhibition than
serum 1863 over most of the range of dilutions tested, though the
slope of the curve appears a little less steep. By contrast, the
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Dilution of serum added to test mixture
Fig. VI/2 - Inhibition of Clostridium perfrinaens neuraminidase by
serial dilutions of three equine antisera. Neutralisation period
30 min at room temperature. Test sera; •—«, C. perfrinaens CPA1;
o—o, C. perfrinaens 1863; Jr-A, C. tetani ATS (see Materials and
Methods).
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fell rapidly to insignificant levels on dilution. It seems
probable that undiluted horse serum contains glycoproteins that may
act as non-specific inhibitors of neuraminidase; all sera should
be diluted at least 1 in 10 before assay to avoid this problem.
It is conventional to express the antibody content of serum
as a titre - the reciprocal of the greatest dilution that will
produce a particular observable effect, e.g. 100% or 50% inhibition
of the observed activity. It is apparent from fig. VI/2, and from
similar curves prepared for other serum samples (e.g. see figs
VI/8, 10 and 13), that it would be difficult to express the
inhibitory effect of these sera as a simple titre even when these
full titration curves are prepared. It is not uncommon for the
slopes of such curves to vary so that the lines intersect (e.g. see
figs VI/10 and 13); in such cases the relative efficiencies of the
two sera are reversed at high and low dilutions. A further problem
is that the preparation of such titration curves requires so many
neuraminidase assays that only two or three sera can be assessed in
a single batch of tests and this makes it very difficult to include
control tests to confirm the comparability of results obtained on
different occasions. In practice it proved much simpler to compare
sera by assessing the degree of inhibition produced at the standard
dilution of 1 in 100; thereafter only a limited number of sera
were examined in greater detail in assays performed with serial
serum dilutions.
Fig. VI/3 gives the results of an experiment performed to
determine whether our standard assay procedure allows adequate
neutralisation of the enzyme by antiserum. Serial dilutions of the
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Fig. VI/3 - Comparison of two procedures for neutralisation of
Clostridium perfringens neuraminidase by serial dilutions of
C. perfringens 1863 antiserum. Conditions for neutralisation:
•—•, 30 min at room temperature; o—o, 20 h at 4°C.
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preparation P9D4 either for 20 h at 4°C, or for 30 rain at room
temperature, before standard assays for neuraminidase activity with
FVII(7) substrate. It is apparent that there is very little
difference between the results obtained with the two procedures;
our standard neutralisation procedure (30 min at room temperature)
was adopted because of its greater convenience.
On this occasion the value for the inhibitory activity of
serum 1863 at a dilution of 1 in 100 was c. 80%; this agrees well
with the value obtained in fig. VI/1. In general, assays for anti-
neuraminidase activity performed on different occasions with either
P9D3 or P9D4 as standard enzyme preparation proved reasonably
consistent (e.g. see similar titration curves for serum 1863 in
figs VI/8, 10 and 13). However, occasional batches of assays gave
results that were generally higher or lower; for this reason it is
advisable to include a standard serum of known inhibitory activity
with each batch of assays.
VIb. Production of concentrated neuraminidase preparations
from PPW5 culture suoernate of C. oerfrinaens
strain L2Ab for rabbit immunisation
In order to produce concentrated preparations of neura¬
minidase from C. oerfrinaens strain L2Ab, a further bulk PPW5
culture was prepared by the same procedure as was used for the
stock P9 neuraminidase preparation. The supernate from this
culture (P12) was fractionated with ammonium sulphate in two
batches as described in Materials and Methods. Table VI/II
summarises the results of assays for protein and neuraminidase in
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TABLE VI/II
Neuraminidase content of samples prepared from the bulk
PPW5 culture supernate (P12) of Clostridium perfrinaens strain























A 500 25.8 • • • 40 20.0 • • •
A50 88 4.8 0.4 34 3.0 7.5
^5 9.0 148.2 1.3 1795 16.2 12.5
B 580 21.5 • • • 42 24.4 • • •
B(dial) 685 6.4 4.4 30 20.6 4.7
b50 4.7 21.8 0.1 1329 6.2 62.0
b85 8.0 146.0 1.2 1241 9.9 8.3
Precipitates obtained at 50% and 85% (NH^SC^ saturation with two
batches (A and B) of the P12 culture supernate; batch B was
centrifuged and dialysed before fractionation (see Materials and
Methods).
k Protein estimations in undialysed samples A and B were falsely
high and not used for further calculations (see text).
° Values for neuraminidase activity calculated from the results
(E549) of 60-min assays for appropriate dilutions of each sample
with FVII(ll) substrate by comparison with the value obtained on
assay of the reference sample of 10 ;ig NANA (see footnote to table
II/V).
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the dialysed fractions prepared from the precipitates obtained at
50% and 85% saturation. The assay used for estimation of the
protein content of the undialysed P12 samples also detects smaller
peptone molecules present in the PPW5 culture medium; the lower
value obtained for the dialysed sample of batch B is likely to give
a more accurate estimate of the protein present in the starting
material. The neuraminidase activity in the various samples was
expressed as the observed rate of release of NANA (pnoles/min) from
substrate FVII under the conditions of our standard assay. The
sample containing the precipitate from batch A at 50% (NH4)2S04
saturation (A^g) contained only c. 15% of the total neuraminidase
in the starting material; it was not further concentrated and was
discarded because the specific activity of the enzyme in this
fraction had not been significantly increased. The bulk of the
enzyme (c. 80%) was present in the precipitate obtained on
increasing the (NH4)2S04 concentration from 50% to 85% saturation;
the concentrated preparation from this fraction had high
neuraminidase activity and a specific activity of 12.5 units/g
protein.
The pattern of neuraminidase precipitation was slightly
different when the dialysed preparation of the second batch of P12
was similarly fractionated. In this case a higher proportion
(c. 30%) of the enzyme was present in the 50% precipitate (Bgg);
the concentrated preparation from this fraction contained
relatively little protein and the specific activity was much higher
(62 units/g). When the (NH4)2S04 concentration in batch B was
increased to 85% saturation the precipitate (Bg5) contained c. 50%
of the total enzyme; the concentrated preparation from this
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fraction had high enzyme activity but its specific activity was
rather low (8.3 units/g). It seems probable that greater
purification of neuraminidase might be obtained with fractions
produced by increasing the concentrations of (NH^SC^ in smaller
steps around the 50% saturation level. As the present
fractionation procedure produced several preparations that
contained moderate amounts of partially purified enzyme in
relatively high concentration, these were used for rabbit immun¬
isation studies (see below).
Vic. Immunisation of rabbits with C. oerfrinaens
neuraminidase
Attempts were made to produce high-titre anti-neuraminidase
sera by immunising rabbits with various preparations of neuramin¬
idase. The results for each of five rabbits immunised by different
procedures are presented below. In each case samples of blood were
taken at intervals and the anti-neuraminidase activity was
monitored in standard assays with serum diluted 1 in 100. The
values obtained for an individual serum sample might vary a little
in different batches of assays on different occasions; a selection
of serum samples was assayed on each occasion in order to obtain an
accurate picture of the trend of the current response as a guide to
decisions about the immunisation procedure. The graphs showing the
overall picture of antibody response for each rabbit (see below)
are constructed with values taken from batches of tests performed
on a number of separate occasions that gave values that were
consistent with each other; the results of many other batches of
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assays that also included many intermediate serum samples confirmed
the accuracy of the general patterns shown in these graphs.
Rabbits 1 and 2. Two rabbits were given injections of the
concentrated preparations of C. perfrinaens strain L2Ab
neuraminidase described in Section VIb. Each rabbit was given a
series of three injections of antigen mixed with an equal volume of
adjuvant; the details of each injection are shown in table VI/III.
It should be appreciated that the values given for neuraminidase
content of these injections are calculated from the observed
activity with FVII substrate under our standard assay conditions
but that they may not be directly comparable with those given below
for the Sigma enzyme used in later immunisation studies (see
Section Ilf for comparison of these assay systems). The initial
injection to each rabbit contained the Agg fraction (see table
VI/II) with incomplete Freund's adjuvant and a second injection of
the same mixture was given three weeks later. Fig. VI/4 shows that
there was very little response to these injections; the anti-
neuraminidase activity remained below 20% and much of the apparent
fluctuation in level is likely to be due to variability of the
assay at these low levels. A third injection, with complete
Freund's adjuvant, was given to each animal after 10 weeks. For
this injection, Rabbit 1 was given the more purified B^q fraction
whereas Rabbit 2 was given the rather weaker Bg5 fraction; neither
animal showed more than a transient low-level response. Titration
curves prepared for the serum samples at week 14 (fig. VI/5)




Schedule of immunisation of Rabbits 1 and 2 with















1 FI a85 1.6 130
2 FI A85 1.4 111
3 FC B50 2.3 39
Rabbit 2
1 FI a85 1.5 120
2 FI ^5 1.8 148
3 FC B85 0.9 110
a All injections subcutaneously; for timing of injections see fig.
Vl/4.
k FI and FC = incomplete and complete Freund's adjuvant
respectively.
c For neuraminidase preparations see table VI/II.
^ The amounts of neuraminidase and protein given in each injection












Fia. VI/4 - Immunisation of Rabbits 1 and 2 with Clostridium per-
frinoens strain L2Ab neuraminidase (see text); the arrows indicate
antigen injections. Anti-neuraminidase response measured as
inhibition of C. oerfrinaens neuraminidase preparation P9D4 by test




Dilution of serum added
to test mixture
Fia. VI/5 - Inhibition of Clostridium perfrinaens neuraminidase by
serial dilutions of two rabbit antisera: •—«, Rabbit-1 week-14
serum; o—o, Rabbit-2 week-14 serum.
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Fig. VI/6 shows the precipitation lines obtained when the
Rabbit-1 week-14 serum was tested against serial dilutions of the
antigen preparation in a gel-diffusion plate. A major band of
precipitation was seen with each of the antigen concentrations
tested and at least three other precipitation lines could be
distinguished with the antigen diluted 1 in 4, where the best
resolution occurred. Similar tests were performed with two other
sera known to have much greater anti-neuraminidase activity (serum
1863 and the pooled Rabbit-4 weeks 23-32 antiserum; see Section Via
and fig. VI/10); there was no line of precipitation with either
serum. Thus, although the Rabbit-1 serum contained antibodies to
at least four components in our crude antigen preparation, it is
likely that none of the precipitation lines seen in the gel-
diffusion plate was due to antibody with neuraminidase-inhibitory
activity. It is probable that our crude neuraminidase preparations
contained other proteins that acted as better antigens in these
animals. Since the rabbits were already primed to respond to these
antigens they would be unlikely to give a good anti-neuraminidase
response even if further challenged with purer preparations. The
rabbits were killed and the sera discarded; no further attempts
were made to produce anti-neuraminidase with these crude enzyme
preparations.
Rabbit 3 was immunised with three identical subcutaneous
injections containing Freund's incomplete adjuvant and batch 1 of
the commercially purified Sigma G. perfringens neuraminidase (see
Materials and Methods). Hie calculated enzyme and protein content
of each injection is given in table VI/IV and the course of
222
Fia Vl/6 - Gel-diffusion analysis of serum from Rabbit 1 (see
Materials and Methods). Centre well; Rabbit-1 week-14 serum.
Peripheral wells; serial dilutions of Clostridium perfrinaens
strain L2Ab neuraminidase preparation Agg in distilled water. At
least 4 lines of precipitate were formed with the antigen dilution
1 in 4.




Schedule of immunisatiop of Rabbits 3. 4 and 5 with
Clostridium perfrinaens Sienna neuraminidase
No. of Route of Adjuvant Batch of Dose of Dose of




1, 2, 3 SC FI 1 2.1 1.0
Rabbit 4
1 SC FC 1 2.1 1.0
2 SC FC 2 2.1 0.4
3 SC FC 2 3.2 0.6
4 IV A 2 5.4 1.0
Rabbit 5
1 SC FC 3 5.0 0.8
2 IP A 3 5.0 0.8
3 IV A 3 4.2 0.7
a SC = subcutaneous; IV = intravenous; IP = intraperitoneal. For
timing of injections see figs VI/7, 9 and 11.
b See footnote to table VI/III; A = aluminium hydroxide.
c See Materials and Methods for enzyme and protein content of the
three batches of Sigma neuraminidase.
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immunisation is shown in fig. VI/7. The first injection produced a
slow rise in antibody to a level of c. 50% inhibition after 6 or 7
weeks but there was no further increase in response to the second
and third injections; thereafter there was a slow decline until
the inhibitory level was only c. 40% when the animal was killed
after 26 weeks. The samples taken between weeks 8 and 11 were
pooled in order to give a larger sample representative of the most
active serum produced by this animal. The titration curves in fig.
VI/8 show that this serum had less inhibitory activity than the
experimental C. perfringens 1863 serum over the whole range of
concentrations tested; the shape of the early part of the rabbit-
serum curve suggests that the activity of the undiluted sample may
be partly attributable to the non-specific inhibition noted
previously (Section Via).
Immunisation with the purified Sigma enzyme preparation
clearly gave a better response than was obtained with the cruder
preparations given to the first two animals although the inhibitory
activity produced was still distinctly less than that found in the
1863 serum. The doses of neuraminidase given to this animal (2.1
units/injection) were a little greater than those given to the
previous animals but because of the considerably greater purity
they contained much less protein (1 mg; see tables VI/III and IV).
It seems that the enzyme is a poor antigen since it produced a very
slow primary response and no enhancement occurred with further
antigen administration. The lack of a secondary response could
have been due to the presence of circulating antibody at the time
of the repeat injections; this might prevent the effective
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Fia. VI/7 - Immunisation of Rabbit 3 with Clostridium perfrinaens
Sigma neuraminidase (see text); the arrows indicate antigen
injections. Anti-neuraminidase response measured as inhibition of
C. perfrinaens neuraminidase preparation P9D4 by test serum
samples diluted 1 in 100 before assay.
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Dilution of serum added to
test mixture
Fia. VI/8 - Inhibition of Clostridium perfringens neuraminidase
by serial dilutions of two antisera: •—•, Rabbit-3 weeks 8-11
pooled serum; A-A, C. oerfringens 1863 serum (see text).
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Rabbit 4 was also immunised by giving subcutaneous
injections of the purified Sigma neuraminidase preparation;
details are given in table VI/IV and fig. VI/9. The first
injection was similar to that given to Rabbit 3 but with the
complete Freund's adjuvant; however, the primary response was less
good than on the previous occasion. There was no secondary
response to a further injection which contained the same amount
(2.1 units) of neuraminidase (but less protein because of the
greater specific activity of this batch of enzyme). The antibody
level was allowed to decline slowly until the inhibitory level was
<10% before the third injection (3.2 units enzyme) was given. The
inhibitory level rose steadily again over the next 6 weeks but
reached a plateau at c. 60%. A final attempt was made to boost the
antibody response by giving a large dose of enzyme (5.4 units)
intravenously with aluminium hydroxide as adjuvant. Unfortunately
the animal became unwell and died 36 h later, perhaps because of a
hypersensitivity reaction provoked by the circulating antibody.
No final serum was obtained but the samples taken between
weeks 23 and 32 were pooled. The titration curves in fig. VI/10
confirm that the pooled Rabbit-4 serum had less anti-neuraminidase
activity than the C. oerfrinaens equine serum 1863 over most of the
range of concentrations tested, though it appears that there was
little difference in activity between the two sera in high
dilutions. The curve for the pre-inoculation serum again suggests
non-specific inhibition with the undiluted normal serum. This
further attempt to immunise with higher doses of Sigma
neuraminidase and complete Freund's adjuvant was only a little more
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Fia. VI/9 - Immunisation of Rabbit 4 with Clostridium perfringens
Sigma neuraminidase (see text); the arrows indicate antigen
injections. Anti-neuraminidase response measured as inhibition of
C. perfringens neuraminidase preparation P9D4 by test serum samples
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Dilution of serum added to test mixture
Fia. VI/10 - Inhibition of Clostridium perfringens neuraminidase by-
serial dilutions of three antisera: •—«r Rabbit-4 weeks 23-32
pooled serum; o—o, Rabbit-4 pre-inoculation serum; Jk—
C. perfringens 1863 serum (see text).
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a better secondary response may occur if the primary response is
allowed to decline before further antigen administration.
The titration curves shown in fig. VI/11 were performed with
a similar amount of Sigma neuraminidase as test enzyme in place of
the standard C. oerfrinaens strain L2Ab preparation. Comparison of
figs VI/10 and 11 shows that, although the values obtained for the
equine serum 1863 were very similar, the Rabbit-4 serum did appear
rather more active in assays with the Sigma preparation as test
enzyme. It seems that our standard assays with P9D4 enzyme give
reliable results with the equine antisera but may slightly under¬
estimate the anti-neuraminidase content in sera from rabbits
immunised with the Sigma enzyme. This possibility was not further
investigated since the discrepancy was not great and our estimates
are on the conservative side. Furthermore, assays with the
C. oerfringens strain L2Ab enzyme may be more valid for the
assessment of the protective potency of antisera for animals
challenged with the L2Ab strain (see Section Vile).
Rabbit 5 was immunised with larger doses of the Sigma
neuraminidase preparation (see table VI/IV and fig. VI/12). The
initial subcutaneous injection contained 5.0 units of
neuraminidase; its protein content was low (0.8 mg) because this
batch of enzyme had a slightly higher specific activity than the
previous batches (see Materials and Methods). There was again a
prolonged primary response; the inhibitory level rose steadily to
c. 50% during the first five weeks and thereafter remained around
this level although no further injections were given during the
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Fia. VI/11 - Inhibition of Clostridium perfrinaens Sigma neuramin¬
idase by serial dilutions of two antisera: •—•, Rabbit-4 week-32
serum; A—A, C. perfringens 1863 serum (see text). The reference
assay with the test dose of Sigma neuraminidase in the absence of
serum gave a value (E549) of 0.681 after incubation with substrate
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Fig. VI/12 ~ Immunisation of Rabbit 5 with Clostridium oerfrinaens
Sigma neuraminidase (see text); the arrows indicate antigen
injections. Anti-neuraminidase response measured as inhibition of
C. perfrinaens neuraminidase preparation P9D3 by test serum samples
diluted 1 in 100 before assay.
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hydroxide as adjuvant, was given by intraperitoneal injection after
38 weeks and this boosted the inhibitory level to c. 70%. A
further injection given two weeks later by the intravenous route
did not further enhance the response. Since it was difficult to be
certain whether each of these injections produced a short-lived
rise in antibody that would rapidly fall again, the animal was
killed at week 42 while the serum still had a high level of
activity.
The titration curve obtained with the Rabbit-5 week-41 serum
(fig. VI/13) shows that the inhibitory activity in this serum is
very similar to that in the experimental equine 1863 serum;
although it may give marginally less inhibition in high
concentrations it appears to give better inhibition when diluted
beyond c. 1 in 100. Comparison with the pre-inoculation serum
confirms the production of specific anti-neuraminidase activity
during the immunisation procedure.
Our experience in attempting to produce high-titre antisera
by injecting C. oerfringens neuraminidase into rabbits suggests
that it is not a good antigen and that it is difficult to produce
antibody that will completely inhibit the activity of the en2yme.
Hie Rabbit-5 serum is the best that was obtained; its activity is
very similar to that found in the experimental equine serum 1863.
Further comparisons of these sera are included below.
VId. Evaluation of anti-neuraminidase and
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Fio. vi/13 - Inhibition of Clostridium oerfrinaens neuraminidase by
serial dilutions of three antisera: •—•, Rabbit-5 week-41 serum;
o—o, Fabbit-5 pre-inoculation serum; A—Ar C. perfringens 1863
serum (see text).
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Table VI/V gives details of the antibody content of a number
of sera that were tested for their ability to protect guinea pigs
from experimental C. perfringens infection in later studies (see
Section Vile). The equine antisera are described in Materials and
Methods. The rabbit sera tested were the pre-inoculation sera from
Rabbits 3, 4 and 5 (R3P, R4P and R5P), the pooled weeks 8-11 sample
from Rabbit 3, the pooled weeks 23-32 sample from Rabbit 4 and the
week-41 sample from Rabbit 5 (see Section Vic). Anti-neuraminidase
assays were performed at the standard dilution of 1 in 100 as
previously. The anti-phospholipase-C (anti-oc-toxin) content was
titrated as described in Materials and Methods with a test enzyme
preparation (PLC) prepared from the supernate of a culture of
C. perfringens strain L2Ab in trypticase glycogen medium (T3M).
Serum CPA2, a second batch of the commercially available
C. perfringens type A diagnostic antiserum, contained moderate
anti-neuraminidase activity (comparable to that of the first batch,
CPA1; see fig. VI/2) as well as the anticipated potent anti-
phospholipase activity. The experimental equine antisera prepared
against C. perfringens culture products contained varying amounts
of the two antibodies. The 1863 serum had the highest anti-
neuraminidase activity and also had a high anti-phospholipase
content. Sera 2748 and 1881 had lower levels of anti-neuraminidase
but both had strong anti-phospholipase activity. The 543 8 serum
had very low levels of antibodies, as did the C. tetani ATS serum.
The values for anti-neuraminidase activity in the rabbit antisera
were similar to those obtained previously (figs VI/7, 9 and 12);
none had detectable anti-phospholipase activity. Although each of
these assays gives an indication of the relative amounts of
227
TABLE VI/V
The relative anti-neuraminidase and anti-ohospholip*sp-r


















b Anti-neuraminidase activity measured as inhibition of test enzyme
preparation P9D4 with sera diluted 1 in 100.
c Anti-phospholipase titre is the reciprocal of the highest dilution
of serum that inhibited the activity of the test enzyme preparation
PLC.
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inhibitory activity for that enzyme in different sera, it should be
appreciated that the relative sensitivity of the two assays for
inhibition of the different enzymes is unknown. Thus, although
serum 1863 had high activity against each enzyme, it seems probable
that the amount of anti-phospholipase antibody (sufficient to
inhibit the test enzyme with the serum diluted 1 in 20,000) is
considerably greater than the amount of anti-neuraminidase
(sufficient to give 85% inhibition of the test enzyme with the
serum diluted 1 in 100).
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VII. PATHOGENICITY AND NEURAMINIDASE PRODUCTION
OF CLOSTRIDIA IN GUINEA PIGS
Vila. Virulence of C. oerfringens strain L2Ab in
experimental guinea-pig infection
Ihe virulence of the classical C. perfrinaens strain L2Ab was
tested by injecting graded numbers of washed log-phase cells into
the muscle mass of the left hind leg in a series of guinea pigs
(see Materials and Methods). Table VII/I gives the results of one
such experiment; the sclerosing agent CaCl^ was injected into the
same site 3 h previously in order to promote infection. After
microscopic estimation of the total count of organisms in the
suspension of washed cells, a sample was diluted in sterile saline
so that it contained 2 x 105 cells/ml (i.e. 4 x 104 cells in the
0.2-ml inoculum given to the first animal); further 10-fold
dilutions were made for the other inocula. Viable counts made with
this series of dilutions gave results very close to those for total
cell counts (see Materials and Methods).
Animals given challenge doses of 4 x 10^ or more cells
developed acute overwhelming infection and died or were killed
within 24 h; the animal given c. 40 organisms was also severely
ill after 24 h and died during the second day. All these animals
showed the classical appearances of experimental gangrene (G in
table VII/I, see Materials and Methods for classification system);
the inoculated limb was markedly swollen and post-mortem
examination revealed extensive necrosis and dissolution of the
muscle mass with haemorrhagic oedematous exudate spreading up over
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TEPHE VLl/l
Virulence of Clostridium oerfrinaens strain L2Ab for
guinea pias. tested with CaCl2 as initiating aaent
Challenge dosea Outcome of challenge'3
(no. of organisms)
4 X 104 G; dead by day 1
4 X 103 G; killed on day lc
4 X 102 G; dead by day 1
4 X 101 G; dead by day 2
4 MA; killed on day 7
4 MA; killed on day 7
Nil Slight local swelling;
NAD when killed on day 7
a Total count of organisms in inoculum (0.2 ml) to left hind thigh;
the control animal received sterile saline with no bacteria. CaCI^
was injected to the same site 3 h previously in all animals.
k See Materials and Methods for classification of outcome of
challenge; further details in text.
c Animal killed because of severe infection.
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the anterior abdominal wall. C. perfrinoens with culture
characteristics typical of strain L2Ab was reisolated from the
infected tissue. All samples were shown to contain many charac¬
teristic large Gram-positive bacilli in direct Gram films of
impression smears; there were very few polymorphonuclear
leucocytes present.
Two animals given an inoculum containing only c. 4 cells
survived and did not develop gangrene. In these animals infection
was established but it was contained locally; they developed
stiffness and swelling in the inoculated leg during the first 2-3
days but this did not increase further and the animals remained
lively. At post-mortem examination there was a medium-sized
abscess (MA) localised in the muscle of the inoculated thigh. Gram
films showed many polymorphonuclear cells and smaller numbers of
Gram-positive bacilli, some of which were degenerate in appearance
(beaded or becoming Gram-negative); some intracellular Gram-
positive material was also seen. Typical C. oerfrinaens were
reisolated.
Control animals, given CaCl2 but no bacterial inoculum, were
included with each batch of test animals during these studies. In
some cases, as in this experiment, the animal developed a limited
degree of stiffness and swelling in the inoculated limb over the
first two days but this tended to improve thereafter and no abnor¬
mality was seen at post-mortem inspection of the inoculated muscle.
On other occasions, however, the injection of CaCl2 produced a
moderate degree of swelling and a small localised abscess (SA) was
found when the animal was killed (e.g. tables VII/III, VI and VII).
Microscopy and culture failed to reveal the presence of organisms
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in these sterile necrotic foci, which contained only small numbers
of inflammatory cells. There was no obvious explanation for the
different response to CaCl2 in different animals; it did not
appear to be related to the weight of the test animal, but it might
be attributable to inevitable minor variation in the exact site of
inoculation.
A similar experiment was performed but with adrenaline as
initiating agent instead of CaC^; this produces an area of
transient vasoconstriction and ischaemia that may permit establish¬
ment of infection. Table VII/II gives the results when the inocula
contained graded challenge doses of the same strain of
C. perfringens mixed with adrenaline (see Materials and Methods).
In this experiment two animals were inoculated at each challenge
dose; they were observed for only four days and no tissue samples
were taken. The animals given 10^ cells developed classical
gangrene and died within 24 h; those given 10® cells also developed
gangrene and were killed at 24 h. Animals that received 10® or 10^
cells developed only slight transient signs in the left leg but had
apparently recovered fully by the second or third day, while those
given less than 10^ cells showed no obvious ill effects.
It is apparent that C. perfrinaens strain L2Ab is a virulent
strain capable of producing experimental gangrene in guinea pigs.
A considerably higher challenge dose was required to establish
infection with adrenaline, which produces a transient ischaemic
focus, than with CaCl^r a sclerosing agent that may produce a small
necrotic focus even in control animals. No attempt was made to
determine accurately the lethal dose (LD50) of the organism in
these models of infection but the results of these experiments with
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TABLE VTI/II
Virulence of Clostridium perfrinaens strain L2Ab for




107 G; dead by day 1
106 G; killed on day lc
105 Transient swelling days 1-2





a See footnote to table VII/I; animals given adrenaline (10 jjg)
instead of CaCl^ as initiating agent (see Materials and Methods).
k See footnote to table VII/I. Two animals were injected at each
challenge dose, with similar outcome; animals were observed for 4
days.
c Animals killed because of severe infection.
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very small numbers of animals proved reasonably reproducible. Hie
observed minimum lethal doses in these experiments (between 4 and
40 cells with CaCl2, between 10® and 10® cells with adrenaline)
were consistent with those found in repeat experiments (see
Sections Vllb and e), and similar experiments with graded doses of
other strains of C. perfringens also usually gave a clear-cut
endpoint (see Section VIIc).
VTIb. Production of neuraminidase during infection
with C. oerfrinaens strain L2Ab
Tissue samples taken at post-mortem examination of various
animals challenged with C. perfringens strain L2Ab were homo¬
genised and tested for neuraminidase activity (see Materials and
Methods). Table VII/III gives the results of an experiment similar
to that recorded in table VII/I, with graded doses of the organism
inoculated into guinea pigs after CaCl2 injection. The animals
receiving inocula of 10® or 10® cells developed classical gangrene
and died between 24 and 48 h after challenge; the animal given
c. 10 cells survived but developed a localised infection with a
small abscess in the inoculated muscle. The minimum lethal dose in
this experiment (between 10 and 100 cells) was comparable to that
found in the previous experiment ( between 4 and 40 cells; table
VII/I).
Neuraminidase was present in large amounts in the tissue
samples taken from the inoculated limbs of the two animals that
developed classical gangrene and died within 48 h; it was
confirmed that the assay product had the typical absorption
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TAPhL vif/fif
Production of neuraminidase during infection of guinea










in tissue sample from
—— 1 " 1 ■ ———
L. leg R. leg Liver
103 G; dead by day 2 ++-I- +++ +
102 G; dead by day 2 ++-i- ++ ±
101 SA; killed on day 6 +■1- ± -
Nil SA; killed on day 6
3 See footnotes to table VII/I; the results for a control animal
that developed a sterile abscess after CaCl2 injection in a
separate experiment are included for comparison.
13 See Materials and Methods for grading of neuraminidase activity
in homogenised tissue samples.
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spectrum for NANA, with peak absorption at 549 nm. Moderate
amounts of enzyme were found in the samples from the uninoculated
leg in these animals and there was also some activity in the liver
samples. This enzyme might have been blood-borne or due to
septicaemic spread of the organism, but it might also have been due
to direct extension of the original lesion from the left thigh to
involve the lower abdominal wall and the opposite limb; some
spread might have occurred post mortem, as these animals died
during the night and had been dead for some time before dissection
next morning. It is also possible that there was some superficial
contamination of the samples with the enzyme-containing oedema
fluid that tended to overflow from the infected areas during the
sampling procedure.
Enzyme activity (score ++) was also clearly shown in the
sample of muscle containing a small localised abscess following the
administration of a very low challenge dose. By contrast, even
with assays incubated for 24 h, no neuraminidase activity could be
demonstrated in the sterile localised abscess of comparable size
produced in a control animal by injection of CaCl2 but no bacteria.
Both of these samples were taken from freshly killed animals 6 days
after inoculation. Assays for neuraminidase in the right leg and
liver of the control animal were also completely negative.
Table VII/IV gives the results of an equivalent experiment
when the same strain of C. perfrinaens was inoculated into guinea
pigs with 10 pg adrenaline as initiating agent. On this occasion
the animal given 10^ cells developed gangrene and died within
24 h; the animals given 10® or 10® cells developed very extensive
necrotic infection of the inoculated limb although neither died
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TAPJ.E VJl/XV
Production of neuraminidase during infection of
guinea pigs bv Clostridium perfringens strain L2Ab.









in tissue sample from
r— * \




G; dead by day 1
N; killed on day 3
N; killed on day 3
+
+
a See footnote to table VII/II.
k See footnote to table VII/I.
c See footnote to table VII/III; ... = not tested.
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within 3 days. Neuraminidase was present in large amounts in the
infected limbs, and smaller amounts were again detected in some of
the other tissue samples.
These results are characteristic of those found in a number
of similar experiments. It is apparent that neuraminidase is
produced in the tissues during infection by C. oerfringens strain
L2Ab, whether in animals developing a full-blown gangrenous
infection or in those in which a low challenge dose produces only a
small abscess that is localised to the area where CaCl2 was
injected. Our test procedures, however, do not detect any
neuraminidase activity in normal guinea-pig muscle or liver, nor in
muscle containing a sterile abscess produced by injection of CaCl2
alone.
VIIc. Pathogenicity and neuraminidase production of other
strains of C. perfrinqens type A in guinea pigs
A range of strains of C. perfrinqens type A that produce
different amounts of neuraminidase and of phospholipase-C (oc-toxin)
in vitro were assessed for their ability to produce infection in
guinea pigs by a procedure similar to that used with strain L2Ab.
Large challenge doses (c. 10^ cells) were inoculated into the left
hind leg 3 h after an injection of CaCl2 into the same site. The
results of several batches of tests have been amalgamated in table
VIl/V, where the strains are subdivided according to their ability
to produce neuraminidase in vitro; within each group they are
roughly ranked according to their pathogenicity in these tests.
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TABLE VJl/V
Pathogenicity and production of neuraminidase with large
inocula of strains of Clostridium perfringens type A injected
into guinea pigs with CaC^ as initiating agent
Strain Challenge Outcome of Relative amount
numbera dose challenge13 of neuraminidase
(no. of in L. leg tissue
organisms) sample







Hobbs1 xvi 1.9 X G
Hobbs' xviii 1.1 X G
Hobbs' xvii 2.5 X G
Hobbs' i 1.3 X G
CW6 1.9 X N








Hobbs' x 2.0 X LA
NCTC11144 1.2 X MA
Hobbs1 vi 2.4 X MA
Hobbs1 ix 1.4 X MA
NCTC10240c 1.0 X MA
Hobbs' 18 3.8 X MA
Hobbs' 24 3.8 X MA
dead by day 1
dead by day 1
killed on day 1
killed on day 1
killed on day 2
killed on day 3
killed on day 7
killed on day 7
killed on day 6
killed on day 7
killed on day 7
killed on day 6
killed on day 7
killed on day 7
Hobbs' viii 1.1 X 108
108
G killed on day 2 —
Hobbs' 21 1.1 X LA killed on day 7 ...




MA killed on day 7 —
Hobbs1 XV 8.0 X MA killed on day 6 -
Hobbs1 14 2.5 X MA killed on day 7 -
Hobbs1 2 1.8 X SA killed on day 7 -
4621° 2.3 X SA killed on day 7 -
a Strains that produce neuraminidase iji vitro in upper part of
table; neuraminidase-negative strains below (see tables III/II, V
and XIII).
k See footnotes to table VII/III; ... = not tested.
c Both strains of Hobbs' serotype 13.
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The classical strain CI and the food-poisoning Hobbs' type-
xviii strain both caused gangrene in the test animals and it was
confirmed that large amounts of neuraminidase were present in the
infected tissues. The strains of Hobbs' serotypes xvi and xvii
also caused gangrenous infection. The Hobbs' type-i strain
produced only slightly less dramatic illness and when the animal
was killed at 48 h there was extensive muscle necrosis (but see
below for further tests; table VII/VII). These food-poisoning
strains are all similar to classical strains in that they are
haemolytic and produce relatively heat-sensitive spores; none of
the "typical food-poisoning" strains (non-haemolytic, heat-
resistant) produced gangrenous infection in these studies.
Strain CW6, a strain that does not produce phospholipase-C,
did not cause the full picture of gangrene but produced extensive
destruction of the inoculated muscle; the animal became unwell and
was killed on day 3. Strain CW7, also phospholipase-negative, was
less virulent but produced a large localised abscess in the
inoculated muscle. Strain NCTC11144 is also neuraminidase-positive
and phospholipase-negative; it produced a smaller localised
abscess. Large amounts of neuraminidase were demonstrated in the
tissues from these three animals. A number of other neuraminidase-
positive strains were tested and found to produce only localised
infection.
Of the neuraminidase-negative organisms, only the Hobbs'
type-viii strain produced acute gangrenous infection; the other
strains tested produced localised abscesses. No neuraminidase was
demonstrable in the tissue samples from these animals, regardless
of the severity of infection produced.
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Further tests were performed in order to amplify and confirm
these findings with a number of the strains that produced
gangrenous infection at high challenge doses in the initial series
of tests. Table VII/VI gives the results when graded doses of the
strain of Hobbs' serotype xviii were injected into guinea pigs with
CaC^ as initiating agent. It was confirmed that this strain could
produce classical gangrenous infection; it proved less virulent
than strain L2Ab (see table VII/I), having a minimum lethal dose
between 4 x 10® and 4 x 10^ organisms. When similar tests were
performed with the Hobbs' type-i strain, it proved less virulent.
In the initial test (table VII/V) an inoculum of 1.3 x 10® cells
produced gangrenous infection; the animal was judged to be
severely ill and was killed at 48 h. However, in the repeat tests
with graded challenge doses of this strain (table VII/VII) only
localised infections were produced; even at the highest challenge
dose tested (6 x 10^ cells) the animal survived, although the limb
was very swollen and the muscle mass was found to have been almost
entirely destroyed. It appears that high challenge doses of this
strain can cause very severe localised infection of the muscle but
that the organism may not be able to produce the full classical
picture of generalised "toxaemia" and rapid death.
Further tests were performed with the Hobbs' type-viii
strain, the only neuraminidase-negative strain that was found to be
virulent in the initial tests shown in table VII/V. An experiment
was performed with graded challenge doses of this strain, following
the same procedures as were used for assessing the virulence of
strains L2Ab, Hobbs' xviii and Hobbs' i above. On this occasion,
however, challenge doses of 1.3 x 10® - 1.3 x 10® organisms
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TABLE VII/VI
Virulence of Clostridium perfrinoens strain Hobbs' xviii
for guinea pigs, tested with CaC^ as initiating agent
Challenge dosea Outcome of challenge3
(no. of organisms)
4 x 10' G; killed on day 2
4 x 106 G; killed on day 2
4 x 105 • • •
4 x 104 G; dead by day 2
4 x 103 MA; killed on day 6
4 x 102 MA; killed on day 6
4 x 101 SA; killed on day 6
Nil SA; killed on day 6
3 See footnotes to table VII/I; ... = animal omitted from
experiment because of error in inoculation.
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XAPLE VII/VII
Virulence of Clostridium perfrinaens strain Hobbs' i for
guinea pigs, tested with CaC^ as initiating aaent
Challenge dosea Outcome of challenge3
(no. of organisms)
6 X 107 N
6 X 106 LA
6 X moi—i MA
6 X 104 SA
6 X 103 MA
6 X 102 SA
6 X 101 MA
6 SA
Nil SA
a See footnotes to table VII/I; all animals killed on day 6.
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produced only small or medium-sized localised abscesses (SA or MA)
with no generalised illness; lower doses produced slight swelling
and stiffness of the inoculated limb but no infection was
demonstrated when the animals were killed after 6 days. It is not
clear why the organisms proved less virulent in these tests than in
the initial test. There was no unusual delay in preparing or
inoculating the bacteria, and viable counts with the diluted
inocula were very close to the total counts. On each occasion the
organism had been freshly grown from a vial of the same freeze-
dried stock, and on each occasion the organism reisolated from the
infected limb was shown to have the typical properties of the
Hobbs' type-viii strain, i.e. weak phospholipase activity inhibited
by C. oerfringens antitoxin on EYA plates, production of haemolysis
on BA plates, no neuraminidase produced in THB cultures. The
tissue sample from the infected limb of the animal given the
highest challenge dose in this experiment was also tested and
confirmed to be neuraminidase-negative.
Further tests were performed, inoculating guinea pigs with
high challenge doses of the organisms that had been reisolated from
the infected limbs in the first two experiments with the Hobbs'
type-viii strain. Table VII/VIII summarises these experiments.
Although the conflicting results of the first two experiments
raised some doubts about the virulence of this strain, the results
of challenge with the same strain reisolated from the original
infections were quite convincing - all the animals developed
classical gangrenous infection; three died within 24-48 h and the
fourth became severely ill and was killed at 24 h. Typical
organisms were again reisolated from the infected leg samples and
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TAPhF VJJ/VIII
Pathogenicity for guinea pigs of Clostridium perfrinaens
strain Hobbs' viii before and after animal passage
Experiment Challenge dose Outcome of
number3 (no. of organisms)b challenge13
1 1.1 x 108 G; killed on day 2
2 1.3 x 108 MA; killed on day 6
3 3.8 x 107 G; dead by day 2
3.8 x 107 G; killed on day 1
4 8.5 x 107 G; dead by day 1
8.5 x 107 G; dead by day 1
a The challenge organisms for Expts 1 and 2 were freshly grown from
freeze-dried stock; the organisms for Expt 3 were reisolated from
the animal infected in Expt 1; the organisms for Expt 4 were
reisolated from Expt 2 (see text). All animals were given CaCl2
3 h before bacterial challenge.
b See footnotes to table VII/I; the results for Expt 1 are from
table VII/V.
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no neuraminidase was demonstrable in the tissue samples from the
infected leg in any of these four animals, even in assays incubated
for 24 h. It is possible that the virulence of the original stock
was increased during animal passage; however, it is clear that
this was not accompanied by any change in its neur am ini da se¬
negative status.
These tests revealed a broad spectrum of pathogenicity for
strains of C. oerfrinoens type A in this animal model, where the
injection of CaCl2 provides a necrotic focus in which infection can
be easily established. Very virulent strains, e.g. L2Ab, can
produce the full classical picture of gangrene and rapid death even
at very low challenge doses (101-102 cells); slightly less
virulent strains, e.g. Hobbs' type xviii, produce the same picture
but only at higher doses (104-105); some strains, e.g. Hobbs' type
i, can produce severe local necrosis when large numbers (c. 10^)
are injected, but may not kill the animal; even large numbers of
other strains of lower virulence produce only an abscess of greater
or lesser size localised in the muscle around the site of injection
of CaCl2. Small numbers of virulent strains, or large numbers of
low-virulence strains, are often able to establish a local
infection and multiply to some extent; neuraminidase-positive
strains can be shown to have produced the enzyme _in vivo in this
situation also.
Microscopic examination of Gram films of impression smears
taken from the infected tissues of these animals gave results
similar to those found with C. perfringens strain L2Ab. When
animals developed acute gangrenous infection and died in 24-48 h
the films contained tissue debris and many large Gram-positive
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bacilli but only occasional polymorphonuclear leucocytes. When
animals survived for 6 or 7 days with infection localised to the
site of CaCl2 inoculation the films contained many pus cells and
smaller numbers of degenerate bacilli.
No clear correlation appears between virulence and production
of either phospholipase-C (oc-toxin) or neuraminidase in these
studies (table VII/IX). Although the most virulent strains all
produced phospholipase-C, many other phospholipase-producing
strains were of low virulence and at least one phospholipase-
negative strain (CW6) could produce an extensive necrotic infection
in response to a large challenge dose. Similarly, although most of
the virulent strains produced neuraminidase well in vitro, the
neuraminidase-negative Hobbs' type-viii strain was undoubtedly
fully pathogenic in this model of infection.
Vlld. Pathogenicity and neuraminidase production of strains
of other clostridial species in guinea pigs
The pathogenicity of a number of other species of Clostridium
was investigated by the same procedures that were used for testing
C. perfringens strains; high challenge doses of various
neuraminidase-positive and neuraminidase-negative species were
inoculated into the thigh muscles of guinea pigs that had already
received an injection of CaCl2 in the same site. In all cases, the
challenge organism was recultured from the infected tissue after
the death of the animal and the identity of the reisolate was




Correlation of pathogenicity and production of extracellular
products for various strains of Clostridium oerfrinaens type A
Strain Patho- In-vitro production of
number genicitya r — * —\
Phospholipase-C3 Neuraminidase0 Haemolysin
(of-toxin) (6-toxin)
L2Ab G + + +
CI G + + +
xvi G + + +
xviii G + + +
viii G + - +
xvii G + + +
i G/N + + -
CW6 N - + +
X LA + + +
21 LA + + -
CW7 LA - + +
vi MA + + +
13(10240) MA + + -




xiii MA + - -
XV MA + - -




18 MA + -
2 SA + - -
13(4621) SA + — —
a Test strains ranked in approximate descending order of virulence;
for fuller details of outcome of inoculation with high challenge doses
for each organism, see tables VLI/I, V, VII and VIII.
k For phospholipase-C production, see Section Hid.
c For neuraminidase production, see tables III/II, IV, V, VI and
XIII. The consistently small amounts of enzyme produced by the
Hobbs' type-24 strain is recorded here as -.
For haemolysin production, see table III/V and Section Hid.
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In table VII/X, both total and viable counts of the number of
organisms in the challenge dose are given. There was very little
loss of viability in the washed cell suspensions of C absonum and
C. bifermentans, and this was also true for a number of strains of
C. perfringens that were included in the same batches of
experiments. There was, however, a reduction in count by a factor
"I O
of 10 -10 with C. septicum, C. paraoerf rinaens and many of the
C. sordelli strains; the fall was of the order of 102 with
C. nowi and C. sordelli strain P3. It is likely that these
strains are more delicate (sensitive to Eh changes, cooling,
suspension in saline, etc.) than C. perfringens and that the total
count gives an overestimate of the effective challenge dose with
these organisms. Viable spore counts were also performed with
pasteurised samples of the washed cell suspensions (see Materials
and Methods). Very few resistant spores were present in these log-
phase preparations with C. perfringens. C absonum.
C. paraperfrinaens and most of the C. sordelli strains. However,
counts of the order of 102-102 spores were obtained in the inoculum
(0.2 ml) of the strains of C. novvi and C. bifermentans and even
higher counts (104-105) with C. septicum and C. sordelli strain
1734. Thus, although the challenge dose was predominantly in the
form of vegetative cells for most strains tested, spores may have
formed a substantial proportion of the inoculum with C. noyvi,
C. seoticum and C. sordelli strain 1734.
The strains of C. septicum and C. novyi type A each killed
the test animal within 24 h, producing overwhelming gangrenous
infection similar to that seen with C. perfringens strain L2Ab,
with marked swelling, extensive haemorrhagic oedema and necrosis
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TflBLg Vfl/X
Pathogenicity and production of neuraminidase with large
inocula of various clostridial species injected into



















NCTC547 1.2 x 10° 1.2 x 10- G; dead by day 1
1734 7.5 X 107 1.2 X 108 S; dead by day 21734 (repeat) 9.8 X 107 6.6 X 108 S; dead by day 1CB2 2.0 X 107 1.2 X 108 LA; dead by day 3
P3 5.8 X 108108
4.0 X 10i LA; killed on day 5
CB3 1.4 X 6.0 X 108 MA; killed on day 6






4.5 x 107 2.7 x lOj
1.4 x 108 7.6 x 10'
MA; killed on day 6
SA; killed on day 6
C. novyi type A
NCTC538 3.1 x 10° 2.0 x 10- G; dead by day 1
C. bifermentans





1.4 x 107 8.8 x 10^
7.9 x 10' 3.0 x 105
SA; killed on day 6
SA; killed on day 6
a Strains that produce neuraminidase in. vitro in upper part of table;
neuraminidase-negative strains below (see tables IV/I, II, V and VII).
k See Materials and Methods for counting methods.
c See footnote to table VII/I; S = muscle very swollen but no abscess
or oedema.
d See footnote to table VII/III.
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of the inoculated muscle. In each case microscopy showed many
Gram-positive bacilli but very few pus cells. Neuraminidase was
clearly shown to have been produced during the C. seoticum
infection, but no enzyme was detectable during the equally severe
infection produced by the neuraminidase-negative species, C. novyi.
C. absonum and C. paraoerfrinaens are non-pathogenic species that
are similar to C. perfrinoens but with differences in their
phospholipase-C (see Materials and Methods); they proved to be of
very low virulence in these tests, producing only small localised
abscesses around the site of CaCl2 inoculation. However, here too,
the neuraminidase-positive C. absonum strains were shown to produce
the enzyme in vivo while the non-neuraminidase-producing
C. paraperfrinaens did not.
The strains of C. sordelli proved to be of varied virulence.
On two occasions the inoculation of strain 1734 killed the test
animal within 48 h. The appearances at post-mortem examination
differed from those with the other gas-gangrene species; there was
extensive gelatinous exudate spreading over the surface of the
inoculated thigh muscles but no necrosis of the muscle itself,
which was swollen, firm and pink. Microscopy showed many Gram-
positive bacilli, some containing spores, but few pus cells.
C. sordelli strain CB2 also killed the test animal, but after
3 days; there was a large localised necrotic abscess in the
inoculated thigh, similar to that seen with a number of strains of
C. oerfrinaens (see table VII/V). Strain P3 was a little less
virulent; the animal also developed a large localised abscess but
survived for 5 days. The two other C. sordelli strains produced
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localised abscesses but did not kill the test animals; these
reactions were little more marked than that found with the non¬
pathogenic C bifermentans strain.
These strains were further tested in order to determine which
of them produced the C. sordelli p-toxin that is held to be
responsible for the pathogenicity of this species (Willis, 1969, p.
226). When samples of CMB culture supernate were tested in guinea-
pig skin tests (see Materials and Methods), only strain 1734
produced the purple-brown necrotic response typical for C. sordelli
p-toxin; there was no response after injection of sterile CMB
supernate or the supernates of cultures of C. sordelli strains CB2,
CB3, CB4, P3 or C. bifermentans strain B4. This correlates with
our finding that only strain 1734 produced the appearances typical
of pathogenic C. sordelli on intramuscular injection.
There may be a rough correlation between virulence and the
ability to produce neuraminidase in vitro for these strains (see
table IV/II); C. sordelli strains 1734, CB2 and P3 produced larger
amounts of the enzyme in PFW5 cultures (score +++) than strains CB3
(++) or CB4 (+), while C. bifermentans strains produced none.
However, it should be borne in mind that this quantitation is
rather imprecise in view of the marked variations found on
different occasions in the amounts of enzyme produced by various
species in repeat cultures in the same medium, or in other media
(c.f. scores in THB medium, table IV/II). No enzyme activity could
be detected in the tissues of the animal inoculated with
C. bifermentans but the enzyme was clearly shown to be produced
in vivo in moderate amounts by strain 1734 and in lesser amounts by
the other strains of C. sordelli (table VII/X). There may again
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appear to be a rough correlation with the virulence of these
strains, but this should not be overstated because of the
unstandard nature of the tissue samples in different types of
infection and after different periods of time (see Materials and
Methods).
These experiments bear out the conclusions from the previous
tests with a range of C. perfrinaens strains. In this model, high
challenge doses of many clostridial species can produce at least a
limited degree of local infection in the necrotic focus produced by
CaO-2. During such infection, neuraminidase is produced in vivo by
strains that have been found to produce it .in vitro: no strain
previously classified as neuraminidase-negative was induced to
produce the enzyme in vivo. Although a number of pathogenic
species produce the enzyme well, there is not a clear-cut
correlation between enzyme production and virulence; in
particular, the classical picture of overwhelming gangrenous
infection is produced not only by neuraminidase-positive species,
but also by the completely neuraminidase-negative C novyi type A.
Vile. Protective effect of various antisera for
guinea pigs challenged with C. perfrinaens strain L2Ab
Table VII/XI summarises the results obtained when a selection
of antisera were tested for their ability to protect guinea pigs
challenged with C. perfringens strain L2Ab with adrenaline used as
initiating agent. The antibody content of the sera tested was
included in table VI/V above. Each animal was given antiserum by
intraperitoneal injection 20 h before challenge with 10^ cells (see
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TAPER VII/XI
Protective effect of various antisera for caiinea pias
challenged with Clostridium oerfrinaens strain L2Ab with
adrenaline as initiating agent
Antiserum Relative amount of
given to Outcome of challenge" neuraminidase
animal3 in L. leg tissue
sample0
Eouine
CPA2 NAD; killed on day 6 -
1863 SA; killed on day 6 ...
1881 NAD; killed on day 6 -
2748 NAD; killed on day 6 -
5438 G; killed on day 1 +++
ATS N; killed on day 3 +++
Rabbit
R3P G; dead by day 2 +++
R3(8-ll) G; dead by day 2 +++
Nil N; killed on day 3 +++
a For antisera, see text. 1 ml of a 1 in 2 dilution of antiserum
in sterile saline given by IP injection 20 h before challenge with
10 cells and 10 jug adrenaline as initiating agent; control animal
given 1 ml saline in place of antiserum.
13 See Materials and Methods for outcome of challenge; further
details in text.
0 See Materials and Methods for grading of neuraminidase activity
in homogenised tissue samples; ... = specimen lost.
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Materials and Methods); the challenge dose was the minimum lethal
dose determined in previous experiments with this model of
infection (see tables VII/II and IV). The control animal, given
saline in place of antiserum, became seriously ill with extensive
necrosis of the inoculated muscle and was killed on day 3. Animals
given the equine sera CPA2, 1863, 1881 or 2748 were protected from
infection; they developed only minor transient signs in the
inoculated limb and little or no abnormality was seen when the
animals were killed after 6 days. By contrast, animals that
received the Rabbit-3 sera or the equine sera ATS or 5438 developed
acute gangrenous infection similar to (or more severe than) that in
the control animal. Assays for neuraminidase in tissue samples
from the inoculated limbs showed that there was little or no enzyme
present in the animals that were protected from infection whereas
there were large amounts in the unprotected animals.
Similar results were obtained when the same antisera were
tested in animals challenged with 10^ cells with CaCl2 used for
initiation of infection (table VII/XII). The challenge dose,
determined from previous experiments (see tables VII/I and III),
produced an acute fatal infection in the control animal. Hie four
equine antisera that gave protection when adrenaline was used for
initiation of infection also gave protection in this experiment;
infection was established in the necrotic focus produced by the
injection of CaCl2 but the animals survived with the infection
localised in the inoculated leg. Hie equine ATS and 5438 sera gave
no protection, the animals developing acute overwhelming infection.
The results with the Rabbit-3 antisera were a little anomalous.
Hie immune rabbit serum gave no protection but the animal given the
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TABLE VII/XII
Protective effect of various antisera for guinea pigs
challenged with Clostridium perfringens strain L2Ab with
CaCl2 as initiating agent
Antiserum Relative amount of
given to Outcome of challenge3 neuraminidase in
animal3 L. leg tissue
sample3
Equine
CPA2 MA; killed on day 6 +++
1863 SA; killed on day 6 +++
1881 MA; killed on day 6 +++
2748 MA; killed on day 6 +++
5438 G; dead by day 2 +++
ATS G; killed on day 2 +++
Rabbit
R3P LA; killed on day 2 +++
R3(8-ll) G; dead by day 2 +++
Nil G; dead by day 2 +++
3 See footnotes to table VTI/XI; animals challenged with 10^ cells
and given CaC^ in place of adrenaline as initiating agent.
2 AAA
pre-inoculation serum was less severely infected; when it was
killed on day 2 the infection was localised to a large abscess at
the site of inoculation. It is unlikely that this normal rabbit
serum gave significant protection against infection in this
experiment and this result was ascribed to the variation in
response that should be expected with tests performed with single
animals as in these studies. Although the result with the normal
serum was anomalous there was no suggestion that the immune
Rabbit-3 serum gave any protection with this model of infection.
Large amounts of neuraminidase were present in all the samples of
infected tissue; this confirmed our previous finding that the
enzyme is produced when even minor degrees of infection are
established (see Section Vllb).
The protective effect of this selection of sera was the same
in both of the experimental models, i.e. with adrenaline and with
CaCl2, and appears to correlate with the content of anti-
phospholipase-C (anti-sc-toxin) rather than anti-neuraminidase (see
table VI/V). The four protective equine sera all had high-titre
anti-phospholipase activity whereas the two equine sera with very
low levels were non-protective. In general the sera with high
anti-phospholipase activity also had high anti-neuraminidase
activity, but the 1881 serum had considerably lower anti-
neuraminidase activity and was still clearly protective for the
animals. The Rabbit-3 sera contained no anti-phospholipase
activity and were non-protective; the anti-neuraminidase present
in the immune serum had no apparent effect. Thus, although two
models were established in which selected antisera could be shown
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to give passive protection against challenge with C. perfrinaens
type A, there was no evidence that the anti-neuraminidase activity
in these sera might contribute to the protective effect.
A similar experiment was performed in order to assess the
protective effect of the anti-neuraminidase sera raised in
Rabbits 4 and 5 (table VTI/XIII). Adrenaline was used to initiate
infection and each serum was assessed at two challenge-dose
levels - 10® and 10^ cells of C. oerfringens strain L2Ab. Previous
experiments (tables VII/II, IV and XI) suggested that the minimum
lethal dose for this strain injected with adrenaline was c. 10®
cells; on this occasion even 10® cells produced typical acute
gangrenous infection that killed the control animal within 24 h.
Equine serum 1863 again proved to have a strong protective effect;
at each challenge-dose level the animal developed slight local
swelling but survived with only a small abscess localised at the
site of inoculation. By contrast, none of the sera from Rabbits 4
and 5 gave protection against infection with strain L2Ab in these
challenge doses; all the animals died with typical gangrenous
infection in 1-2 days. Although the immune rabbit sera contained
levels of anti-neuraminidase similar to that in the equine 1863
serum (see table VI/V and figs VI/10 and 13) they did not give
protection and there is thus no evidence that the anti-
neuraminidase content of serum 1863 contributes to its protective
effect.
Figs VII/1 and 2 show the microscopic appearances in Gram
films of material sampled from the lesions in two of the animals in
this experiment. These appearances are also typical of those seen
in the previous experiments with C. perfrinaens strains (Sections
246
tapee Yu/xm
Protective effect of sera from Rahhit.q 4 and 5 for guinea
pics challenged with Clostridium perfrinaens strain
L2Ab with adrenaline as initiating agent
Antiserum Challenge
given to doseb Outcome of challenge3
animal3 (no. of organisms)
Rabbit
R4P 10® G; dead by day 2
107 G; dead by day 1
R4 (23-32) 10® G; dead by day 1
107 G; dead by day 1
R5P 10® G; dead by day 1
107 G; dead by day 1
R5 (41) 10® G; dead by day 1
107 G; dead by day 1
Equine
1863 10® SA; killed on day 6
107 SA; killed on day 6
Nil 10® G; dead by day 1
10® G; dead by day 1
107 G; dead by day 1
3 See footnotes to table VII/XI.
b See footnotes to table VII/I.
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Fig. VII/1 - Microscopic appearances of acute gangrenous infection
with Clostridium perfrinaens strain L2Ab (x 1250). Gram stain of
material from infected thigh muscle of a guinea pig that died
c
within 24 h after inoculation of 10 cells with adrenaline as
initiating agent (control animal in table VII/XIII).
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Fia. VII/2 - Microscopic appearances of localised infection with
Clostridium oerfrinqens strain L2Ab (x 1250). Gram stain of
material from small abscess in thigh muscle of a guinea pig killed
six days after inoculation with 107 cells with adrenaline as
initiating agent but protected by equine serum 1863 (see table
VII/XIII).
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Vlla-c). In animals that developed acute gangrenous infection and
died within 24-48 h, the films contained many Gram-positive bacilli
with tissue debris but very few polymorphonuclear leucocytes (e.g.
fig. VII/1); the same picture was seen whether CaC^ or adrenaline
was used for initiation of infection. By contrast, in animals that
survived challenge and contained the infection in an abscess
localised at the site of inoculation, the films showed many pus
cells with smaller numbers of extracellular bacilli, often
degenerate, and evidence of intracellular bacterial debris (e.g.
fig. VII/2). This picture was seen in animals given sublethal
challenge doses of virulent strains and where antisera gave
protection against an otherwise lethal challenge; it was also seen
with large doses of less virulent strains where the injection of
CaCl2 provided a focus for the establishment of low-grade
infection. It seems probable that the first few hours are critical
in determining the outcome of challenge in these models of
infection. Animals that survive have been able to mount an
effective phagocytic response and eliminate or contain the
challenge organisms; those that die have not. Antisera may tip
the balance and protect the animal in the early stages so that
effective defences can be mobilised and infection can be contained;
our results do not suggest that anti-neuraminidase plays an
important part in conferring this protection.
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DISCUSSION
DEVELOPMENT OF HUMAN GLYCOPROTEIN SUBSTRATE
AND NEURAMINIDASE ASSAY PROCEDURES
The results presented in Sections I and II describe the
development of a sensitive assay procedure that was suitable for
detection of neuraminidase activity in bacterial products or
extracts of infected tissue, and that could be adapted to
demonstrate inhibition of enzyme activity by antibody. Neuramini¬
dases are unusual in the very wide range of substrates and assay
procedures that can be used for detection of the enzyme (see
reviews by Rafelson et al., 1966; Gottschalk & Bhargava, 1971;
Drzeniek, 1972, 1973; Gottschalk & Drzeniek, 1972; Schauer, 1982).
The early assays, using indirect systems such as destruction of
virus receptors on red cells, were replaced by assays that measure
directly the release of sialic acid from an appropriate sialic-
acid-containing substrate. The assay system developed for the
present work used a preparation of human oc-j-acid glycoprotein that
is cheap and can be made available in large amounts; it proved to
be an excellent substrate in our assays.
Assay for NANA
Methods for assay of sialic acids have been reviewed by Tuppy
& Gottschalk (1972), Ledeen & Yu (1976) and Schauer (1978). Most
of the available procedures detect both free and bound molecules;
assays for neuraminidase require a procedure that detects only the
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free sialic acid released from an excess of substrate by action of
the enzyme. Hie most frequently used assay system is the periodic
acid/thiobarbituric acid reaction described by Aminoff (1959, 1961)
and Warren (1959, 1963); various modifications have been suggested
to increase the sensitivity and it has been adapted for automated
assay systems and micro-techniques (Kendal & Madeley, 1969; Fidgen,
1973; Schauer, 1978). Other methods of estimating free sialic
acid include the use of the enzyme N-acylneuraminate pyruvate-lyase
(NAN-lyase); the amount of free NANA is reflected in the amount of
pyruvate produced, which is determined by DPNH oxidation in the
presence of lactate dehydrogenase (Brunetti et al., 1963; Ledeen &
Yu, 1976). An alternative approach with sialyl-lactose as
substrate is to assay for the release of lactose rather than of
sialic acid (Holmquist, 1969). Synthetic chromogenic substrates,
e.g. p-methoxyphenyl and 4 -methylumbelliferyl compounds (Tuppy &
Palese, 1969; Potier et al.. 1979), and various radioactive-
labelled substrates (Bernacki & Bosmann, 1973; Bhavanandan, Yeh &
Carubelli, 1975; Schauer et al.. 1976; Frisch & Neufeld, 1979)
have also been developed, allowing detection of enzyme action by
other techniques. Hiese procedures may be more sensitive and more
specific in particular circumstances, e.g. in detecting with
confidence very low amounts of neuraminidase activity in mammalian
tissue fractions. However, they also pose their own problems and
many require expensive substrates that are not commercially
available, or involve separation procedures that make them no less
time-consuming than the original thiobarbituric acid assay.
The present studies used Aminoff^s thiobarbituric acid assay
for free NANA as described by Cassidy et al (1966; see Materials
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and Methods). A number of factors are known that may interfere
with this assay. The colour yield (Ec^g) is reduced in the
presence of L-fucose, DNA, ferrous ions and a variety of other
chemicals, and false positive results may occur with 2-keto-3-
deoxyaldulonic acids, which give rise to the same chromophore
(Warren, 1959; Hartree & Brown, 1970; Ledeen & Yu, 1976;
Cabezas, 1978). False chromogens may give rise to other reddish
products that give significant absorption at 549 nm; these include
sucrose, 2-deoxyribose, malonaldehyde and unsaturated fatty acids
(Warren, 1959; Horvat & Touster, 1968; Schauer, 1982). Warren
(1959) recommended the use of a correction factor based on the
absorption value at 532 nm to compensate for this but it is
accurate only with lew concentrations of interfering substances.
Factors such as the above are presumably responsible for the
depression in assay value for NANA in the presence of various
culture media and bacterial products that was observed in the
present studies (Section Ila). Different batches of PPW5 broth
vary in the extent to which they depress the NANA assay and the
effect of the P9 culture filtrate shown in table II/I is the most
marked that was observed; the effect is minimal with dialysed
preparations or with purified Sigma neuraminidase. The mechanism
of depression of the NANA assay in our studies was not investigated
further but the possibility of this effect should be taken into
account when neuraminidase assays are performed with unpurified
enzyme preparations. In the present studies with crude culture
materials and tissue extracts, care was taken to include control
tests in order to determine the basal value (E54g) before enzyme
action (Section lie); high initial readings might have been
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attributable either to free sialic acid or, more commonly, to the
presence of other interfering substances in the test material. It
was important to demonstrate clearly that an increase in assay
reading during incubation of the tests was due to release of a
product with peak absorption at 549 nm, and this was done in all
cases where crude materials or products of previously
uncharacterised bacterial species were examined.
A further source of error with the thiobarbituric acid assay
occurs if there is NAN-lyase activity in the test material (Section
lib), since the NANA released by neuraminidase action might be
destroyed during incubation of the reaction mixture (e.g. see fig.
III/6). Nees et al. (1976) found that NAN-lyase activity was
inhibited by pyruvate and recommended the addition of lOmM pyruvate
in order to allow assay of neuraminidase when both enzymes might be
present. Contaminating NAN-lyase may be one of the major
indications for using a different type of assay procedure, e.g.
with a chromogenic or radioactive substrate; however, the present
studies included careful tests to assess this possibility and no
insuperable problems were encountered.
Development of human glycoprotein substrate
No single neuraminidase assay procedure is ideal for all
purposes. As outlined in the Introductory Review, neuraminidases
from different sources vary quite markedly in substrate
specificity, with their activity dependent on the particular N- and
O-acyl substituents in the sialic acid, the specific oc-glycosidic
linkage to the neighbouring sugar, and the nature of the
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glycoconjugate involved (protein or lipid). Most naturally
occurring sialoglycoconjugates have some degree of heterogeneity,
with a variety of linkages and sialic acids; in some cases these
occur even within the same molecule. For detailed characterisation
of enzymes from different sources it is desirable to use a battery
of purified oligosaccharides, glycopeptides and gangliosides with
defined N-acetyl and N-glycolyl sialic acids, and defined (2—>3),
(2 —*■ 6) or (2 —> 8) linkages (e.g. Corfield & Schauer, 1982b;
Schauer, 1982). However, this is obviously impractical in
screening assays for detection of neuraminidase in bacterial
culture products when a broad-spectrum, general-purpose assay is
required.
One of the simplest substrates is the oligosaccharide sialyl-
lactose prepared from bovine colostrum; c. 80% of the sialic acid
is (2 —>3) linked and 20% in the (2 6) isomer (Schneir &
Rafelson, 1966). Most, but not all, neuraminidases have greatest
activity against the (2 —>3) linkage; bacterial neuraminidases are
generally of broad specificity though viral enzymes are markedly
less active with the (2—=>6) linkage (see Introductory Review).
Drzeniek (1973) recommended the use of purified N-acetylneura-
minyl(2 —*-3) lactose as standard substrate for neuraminidase assays,
though many have continued to use the cruder mixture of both
isomers. Glycoprotein substrates of animal origin in various
degrees of purification have also been widely used, e.g. oc^-acid
glycoprotein (orosomucoid), fetuin, submandibular gland
glycoprotein or glycopeptides from edible-bird^ s-nest substance
(Collocalia mucoid; see Kathan & Weeks, 1969). It may be argued
that glycoprotein substrates provide a closer parallel to the
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natural action of microbial neuraminidases than does NAN-lactose, a
unique compound found only in colostrum (and the neonatal gut) of
mammalian species. In some cases higher Km and Vmax values have
been found with glycoproteins than with NAN-lactose as substrate
(Drzeniek, 1972; Rosenberg & Schengrund, 1976b). For studies of
enzymes with predominantly glycolipid activity, ganglioside
preparations are more appropriate (Drzeniek, 1973; Schauer, 1982).
Colominic acid has been used in screening for enzymes with good
activity against (2 —> 8) linkages (Uchida et al., 1974).
It is desirable to use a substrate that contains only N-
acetyl neuraminic acid, since N-glycolyl and some O-acyl sialic
acids give lower readings in thiobarbituric acid assays (Warren,
1959; Aminoff, 1961; Drzeniek, 1972; Schauer, 1982). For this
reason substrates derived from human materials may be preferable to
those from many other convenient animal sources, e.g. cattle, pigs
and horses, which also contain a proportion of N-glycolyl
derivatives. Walkowiak, Kedzierska & Starzinski (1968) claimed to
have detected trace amounts of N-glycolyl neuraminic acid in human
serum, but this has not been confirmed and it is generally agreed
that N-glycolyl sialic acids do not occur in man (Ledeen & Yu,
1976; Corfield & Schauer, 1982a).
For the present studies a human oc^-acid glycoprotein
substrate that could be easily prepared from a waste product of
large-scale plasma fractionation was developed. Popenoe & Drew
(1957) used <X]_-acid glycoprotein prepared from the urine of
nephrotic patients as substrate for C. oerfrincens neuraminidase,
and Hughes & Jeanloz (1964) prepared it from human plasma for
studies with pneumococcal neuraminidase. Cassidy, Jourdian &
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Roseman (1965) purified and characterised the neuraminidase of
C. perfrinaens: they recommended NAN-lactose as substrate for
assays but also studied the release of NANA from oc-^-acid glyco¬
protein. In early work on C. perfrinaens neuraminidase in this
laboratory (Collee, 1962, 1965b), hen egg-white was used as
substrate. This was later replaced by human plasma (Gadalla &
Collee, 1968), and Collee & Barr (1968) then described a simple
method of preparing an unrefined glycoprotein fraction from 200-400
ml of plasma from outdated human blood by trichloracetic acid
precipitation. This human glycoprotein preparation gave more
reliable results than were obtained with whole plasma, but the
problems of scaling up certain stages, e.g. dialysis, would make it
difficult to ensure a supply of closely standardised substrate
during a prolonged investigation.
Preparation of the FVII glycoprotein substrate was undertaken
in collaboration with Dr J.K. Smith, Protein Fractionation Centre,
Scottish National Blood Transfusion Service (see Fraser & Smith,
1975, included in the Appendix). The fractionation procedures
described in Section la were done by Dr Smith in the Protein
Fractionation Centre; sialic acid analyses and evaluation as
substrate for neuraminidase assays were done in this laboratory.
Preliminary attempts to recover glycoproteins from Cohn fraction IV
were unsuccessful but the one-stage FVII preparation from the
supernate of fraction V proved much simpler. It was found to
contain predominantly oc^-acid glycoprotein and also some albumin.
A method for purification of o^-acid glycoprotein from the same
starting material, involving DEAE-cellulose adsorption and
chromatography on CM-cellulose, has also been reported (Hao &
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Wickerhauser, 1973). An alternative method of recovering pure
acj-acid glycoprotein from Cohn fraction VI involves the use of zinc
salts, the residues of which might be undesirable in enzyme
reaction mixtures (Bezkorovainy & Winzler, 1961; Schmid, 1975).
The gel filtration and electrophoretic data indicate that the
glycoprotein in our preparation was largely excluded from Sephadex
G-200; native oc^-acid glycoprotein (MW 44,000) would not be. It
is assumed that much of the glycoprotein in the FVII preparation is
polymerised as a result of the pasteurisation procedure (Spragg et
al.. 1969); this partial denaturation might facilitate hydrolysis
by neuraminidase. Although the probability of transmission of
serum hepatitis by this fraction is relatively small (Berg et al.,
1972) there is a risk that any product from pooled human serum may
contain hepatitis or other viruses; all such products should have
been pasteurised (60°C for 10 h) at some stage before use in normal
laboratory conditions.
Human oc^-acid glycoprotein contains c. 40% of carbohydrate;
NANA constitutes 11-12% of the total weight of the protein. Rather
more than 50% of the NANA is in the (2—*3) linkage and the rest
predominantly in the (2 -» 6) linkage; variation in linkage of NANA
is responsible for electrophoretic microheterogeneity (Jeanloz,
1972; Schmid, 1975). Although the presence of (26) linkages
might be a disadvantage in studies with viral neuraminidase, it
might be an advantage in screening for bacterial enzymes with their
broader substrate range. Popenoe & Drew (1957) and Cassidy et al.
(1965) found that all of the NANA could be released from ocj-acid
glycoprotein by C. perfringens neuraminidase. The results
presented in Section lb show that C. perfringens neuraminidase can
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also release all the NANA from our FVII preparation. Mild acid
hydrolysis is recommended for complete removal of sialic acid from
sialoglycoconjugates but many such procedures also give significant
degradation of the released NANA, and allowance has to be made for
this in calculating the results (Schauer, 1982). Our procedure,
using 0.02M H2SO4 at 80°C gave complete hydrolysis from the FVII
substrate within 1-2 h without significant destruction of the
released NANA (fig. 1/3); with stronger acid or higher temperature
there was no increase in the total released but there was
significant NANA degradation (e.g. see fig. 1/4). Comparison of
the results in figs 1/3 and 1/5 confirms that our stock preparation
of C, oerfrincens neuraminidase could release the same amount of
NANA from the FVII substrate as was released by acid hydrolysis.
Hie enzyme-substrate kinetic studies described in Section Ic
showed that the FVII preparation is a good substrate for the
C. oerfrinaens enzyme. Calculations based on the observed activity
of the commercially available purified enzyme (Sigma) with our
substrate suggest that the initial velocity with FVII substrate is
comparable to that with bovine NAN-lactose (Section Ilf). Cassidy
et al. (1965) found the initial rate of release of NANA from ox¬
acid glycoprotein to be slightly faster than from NAN-lactose;
Schauer .et al. (1976) also found a radioactive-labelled o^-acid
glycoprotein preparation to be a good substrate for C. perfringens
neuraminidase. Fig. 1/9 shows that there was linear release of
NANA from an excess of substrate when concentrations of enzyme in
the range of c. 2-20 milliunits/ml were tested in assays incubated
at 37°C for periods between 10 and 40 min. The thiobarbituric acid
assay becomes less accurate at readings (E549) above c. 0.5 (see
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fig. II/3) but with a 15-min assay it was possible to measure up to
c. 50 milliunits/ml quite accurately; more concentrated samples
should be diluted before assay so that the results fall in the
reliable range. Even very small amounts of neuraminidase activity
(c. 0.1 milliunit/ml) can be detected with confidence by prolonging
the period of incubation for up to 24 h (figs 1/10 and 11); this
is of great value when it is important to demonstrate the absence
of the enzyme in defining neuraminidase-negative strains of
bacteria.
A number of batches of FVII substrate were prepared,
differing only in minor details of scale. With substrate batch
FVII(5), Vmax occurred at concentrations of c. 3 mg FVII/ml
(Section Ic), equivalent to c. 140 fig releasable NANA/ml. Further
batches of substrate were used at concentrations containing 140-170
pg NANA/ml (see table I/III). Comparison of different batches of
substrate (Section Id) showed them to be very similar; the concen¬
tration of NANA in batch FVII (7) was rather low, and assays with
this batch of substrate might also be a little lower. Never¬
theless, with meticulous assay technique and appropriate control
tests used to correct the assay values, it was possible to produce
results that gave a linear correlation with enzyme activity up to
values (E549) of c. 0.4-0.5 (fig. 1/12).
Hie pasteurised FVII preparation is not an ideal substrate in
that it does not consist of a pure well characterised substance,
but it possesses certain compensating advantages. It is produced
from a waste fraction and can therefore be made available compara¬
tively cheaply. (In the United Kingdom, with its important
tradition of volunteer blood donors, blood products cannot be sold
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commercially; special permission was obtained to allow a nominal
charge for the EVII substrate to defray the cost of recovering this
product from otherwise waste material.) It is free from the risk
of hepatitis virus transmission, is easy to prepare in standard
form in very large quantities and is very stable as a freeze-dried
powder and even in solution at 4°C. It has a low ionic content,
the only residual buffer being a small amount of acetate, and the
pH and ionic strength of the reaction mixture can therefore be
easily adjusted. The content of readily hydrolysable NANA is high
enough to avoid problems of viscosity or turbidity, and the level
of free chromogen before hydrolysis is conveniently low. It should
be borne in mind that the EVII preparation may contain a mixture of
glycoproteins and of glycosidic linkages that may be hydrolysed at
different rates by the same or by different enzymes. Nevertheless,
it has proved to be a good substrate for the neuraminidase of
Clostridia, Bacteroides species and Vibrio cholerae in the studies
reported here, and also for myxovirus and Corynebacterium
diohtheriae neuraminidase in other hands (Fidgen, 1975).
Assay procedure for C. perfringens neuraminidase
The development of standardised procedures for assay of
C. perfringens neuraminidase with the EVII substrate is described
in Section II. Studies with the commercially available purified
enzyme preparation (Sigma) suggested that the EVII substrate gives
assay values comparable to those obtained with NAN-lactose, and
considerably higher than with bovine submaxillary mucin (Section
Ilf). However, the purified Sigma enzyme is expensive, and
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unstable when held in solution; further studies to determine
optimal conditions for the neuraminidase assay were performed with
unpurified enzyme preparations derived from the filtered supernate
of a PPW5 broth culture of C. oerfrinoens type A strain L2Ab (see
Materials and Methods). Samples of the original bulk preparation
(P9) were dialysed in order to remove substances that interfere
with the thiobarbituric acid assay (Section Ila). These
preparations had good neuraminidase activity (c. 20 milliunits/ml;
table II/V) and did not contain detectable phospholipase-C; they
proved stable for long periods at -20°C (Section Ilf) and were used
as stock enzyme preparations throughout these studies.
The control tests used for correcting neuraminidase assay
results are discussed in Section lie. Separate enzyme and
substrate control tests incubated at 37°C for the same period of
time as the reaction mixture give the most accurate results for
correction of standard assays. This is impractical for progress
experiments because of the inaccuracies in timing of addition of
assay reagents that would result from inclusion of too many tubes
in a single batch of assays; conditions under which time-zero (Tq)
control tests give accurate results were carefully defined. In
general, test and control assays were performed in duplicate and
average values were used in calculation of results; this minimised
the chances of error arising from an occasional anomalous test or
control assay.
The results given in table II/IV confirm that C. oerfrinaens
neuraminidase, in contrast to the Vibrio cholerae enzyme, does not
require added Ca^+ (Cassidy et al., 1965; Drzeniek, 1972); even
the addition of 5mM EDTA (Boschman & Jacobs, 1965) reduced the
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assay value only by c. 20%. Ca^+ was not added to our assays as a
routine; however, occasional tests were repeated with added Ca^+
to confirm that apparently negative results might not conceal a
calcium-sensitive enzyme.
Varying the pH of our assay in tris-maleate buffer produced a
plot of activity that showed a simple curve with a clear-cut
optimum at c. pH 5.7; when sodium acetate buffer was used the
curve was more complex with the main peak at c. pH 4.7 and a
subsidiary peak at c. pH 5.6 (fig. II/7). The pH optimum for the
activity of a particular neuraminidase may vary considerably when
tested with different substrates (Rafelson et al.. 1963; Uchida et
al., 1979) or in the presence of different buffer ions (Cassidy et
al.. 1965; Drzeniek, 1972). Burton (1963) found a sharp optimum at
pH 5.0-5.1 for C. perfringens neuraminidase tested with a
ganglioside substrate in acetate buffer. Nees et al. (1975), with
Collocalia mucoid and acetate buffer, reported optimum activity
between pH 43 and 5.2. Popenoe & Drew (1957) found the optimum to
be pH 5.0-5.5 in acetate buffer with o^-acid glycoprotein. Cassidy
et al. (1965) reported the optimum for C. perfringens neuraminidase
acting on bovine NAN-lactose to be at c. pH 5.6 in tris-maleate or
in citrate-phosphate buffers, but pH 4.0-4.8 in acetate buffer.
Our finding of a subsidiary peak around pH 5.6 in acetate buffer
with the FVII substrate may reflect a heterogeneity of NANA
linkages in the preparation, perhaps due to the presence of a
mixture of glycoproteins or to alterations in glycoproteins
produced by pasteurisation; it might also be due to different pH
optima for the hydrolysis of (2—>3) and (2—^-6) linkages, as was
found for myxovirus neuraminidase by Schneir & Rafelson (1966).
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When the assay is done with FVII substrate and sodium acetate
buffer at pH 5.1 the results fall on the high plateau between the
two peaks of activity and would not be markedly influenced by
slight divergence from this value in reaction mixtures. A very
much lower pH (below pH 4.2) would be required if it was desired to
prevent possible interference with the assay for neuraminidase by
contaminating NAN-lyase (see fig. II/5).
Neuraminidase activity is commonly expressed in terms of
units; 1 unit liberates 1 |imole of NANA/min from the substrate at
37°C in a suitable buffer at the optimum pH (Drzeniek, 1972).
Maximum activity of the stock enzyme preparation P9D3 occurred at
temperatures of 45-55°C (fig. II/6) but our standard assays were
performed at 37°C. It seems desirable that enzyme activities
should be stated in standard units measured with NAN(2—>3) lactose
as substrate and we have refrained from expressing our results
routinely in terms of units measured with our substrate; the
presence of interfering substances or NAN-lyase activity further
complicate the accurate calculation of neuraminidase activity in
unpurified bacterial culture products or tissue extracts. However,
reference assays of 10 ^ig pure NANA were used for calculation of
the observed activity of our stock enzyme preparations so that they
could be related to that of the reference Sigma preparation (tables
II/V and VI).
For reliable results, only tests performed in a single batch
should be regarded as strictly comparable; careful attention to
detail was necessary in order to produce accurate and consistent
results such as are presented in Sections I and II. The results
presented in fig. II/8 show the reproducibility that could be
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achieved with carefully standardised neuraminidase assays on
different occasions over a period of some weeks; however in series
of tests performed over longer periods of time results were found
to be much more variable. Reference assays with standard tubes
containing 10 ^g pure NANA were included with all batches of
neuraminidase assays (Section Ila). Variations in the values
obtained with these reference assays for NANA, and with our stock
neuraminidase preparations, might be attributable to different
batches of assay reagents, minor inaccuracies in timing,
temperature or volumes of reagent added at different stages of the
assay for NANA, or differences in pH or temperature of incubation
of the enzyme reaction mixture. For most purposes such variation
in values for reference assays was not important, since
inaccuracies due to the presence of interfering substances or NAN-
lyase in the test material, or variations in production of the
enzyme in different culture media by the test organism, were likely
to be greater. The standardised assay procedures adopted for use
with the FVII substrate proved very satisfactory when applied, with
a semi-quantitative scale (see Materials and Methods), to studies
of neuraminidase production by a wide range of clostridial and
bacteroides strains in the next part of this investigation.
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PRODUCTION OF NEURAMINIDASE BY ANAEROBIC BACTERIA
Production of neuraminidase by C. perfringens
The results of experiments investigating production of the
enzyme by strain L2Ab, a classical gas-gangrene-producing strain of
C. perfringens type A, are reported in Section Ilia. It was
confirmed that C. perfrinaens neuraminidase is an exoenzyme
produced in large amounts in the supernate of cultures in
appropriate media (Cassidy et al., 1965; Nees & Schauer, 1974b).
Exoenzymes and exotoxins are classically produced by intact cells
during log-phase growth and this was demonstrated in the growth-
curve experiment shown in figs III/l and 2; the level reached a
maximum during early stationary phase and did not increase further
after 24 h although the numbers of viable cells began to decline.
The enzyme is predominantly in the culture supernate; other
experiments (e.g. table III/X) showed that only a little neura¬
minidase remains cell-associated after thorough washing of the
cells. A few clostridial products, notably the enterotoxin
associated with food-poisoning strains of C. perfrinaens type A,
are not produced during log-phase growth but are directly related
to sporulation (Duncan, Strong & Sebald, 1972). Most strains of
C. perfrinaens produce few spores during culture in ordinary
laboratory media; in this experiment they formed only c. 0.1% of
the total L2Ab cells present even after incubation for 72 h (fig.
III/l). Although production of spores started in late log phase it
is clear that considerable amounts of the enzyme had already
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appeared before spores became detectable and there was no
indication that neuraminidase production is related to sporulation.
The assay procedures developed for detection of NAN-lyase in
these studies were intended primarily to assess inaccuracies in the
neuraminidase assay attributable to contaminating NAN-lyase rather
than to give a sensitive assay for the enzyme; however, the
results presented in Section lib confirm that NAN-lyase remains
predominantly cell-associated in C. perfringens cultures (Comb &
Roseman, 1960; Nees & Schauer, 1974a). There was no evidence of
NAN-lyase activity in the stock P9 enzyme preparations (table II/I)
and none was detected in the experiment shown in fig. III/l even at
72 h when the viable count was falling and cell lysis might be
expected. However, Popenoe & Drew (1957) found a little NAN-lyase
in culture filtrates of C. oerfringens. and some NANA-destroying
activity was occasionally detected in culture supernates of strain
L2Ab and other clostridial strains in the present studies (e.g. see
table III/XI); this possibility was carefully checked when low-
positive or negative results were obtained in assays of bacterial
pro-iucts for neuraminidase.
Neuraminidase was generally well produced by C. perfringens
strains in several broth media but considerable variations in yield
were found even under apparently identical culture conditions. The
results given in table III/I showed that the assay values in
replicate cultures in the same batch of medium incubated in the
same anaerobic jar might vary by c. 10% from the mean; in serial
cultures much greater variation was seen (e.g. fig. III/4). It
proved difficult to identify or control factors responsible for
such variation and this made it difficult to define conditions that
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would consistently give maximum yields of the enzyme. Cultures
were incubated for 48 h as a routine; the results of the growth-
curve experiment (fig. III/2), with a larger volume of culture than
in the standard tests, suggest that maximum enzyme activity is
achieved well before 48 h and that it remains very stable in the
culture supernate thereafter. Fig. III/3 shows that the
temperature of incubation of the culture markedly influences
neuraminidase production; some inaccuracy in temperature control
may be hard to avoid when using anaerobic jars in conventional
incubators in a busy laboratory and this was probably responsible
for some of the variation encountered in the present studies.
Neuraminidase has been shown to be an inducible enzyme in
several bacterial species (see Introductory Review). Nees &
Schauer (1974a), using a synthetic basal medium in which their test
strain of C. perfrinoens produced very low levels of neuraminidase
and NAFF-lyase, showed co-ordinated induction of both enzymes when
free NANA or Collocalia sialopeptides were added in a chemostat
system. The glycopeptide-bound NANA gave more rapid induction and
higher enzyme levels than free NANA; N-acetyl manriosamine had a
very low inductive effect with this organism, in contrast to the
situation with Vibrio cholerae (Ada & French, 1959), pneumococci
(Kelly etal., 1966) and Pasteurella multocida (Drzeniek et al.,
1972). Schauer (1982) postulated that free NANA inside the cell is
the inducer for the enzymes in C. oerfringens; the delay in
induction by free NANA added to the external medium reflects the
time taken to induce a hypothetical permease for efficient uptake
of NANA. The rapid inductive effect of sialopeptides suggests that
these can be taken up directly by the cell, and do not depend on
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extracellular hydrolysis and subsequent uptake of the released
NANA. He further suggested that protease production by Clostridia
would act in co-operation with this system, releasing sialopeptides
from glycoproteins in the environment and thus triggering induction
of the full system for NANA release, uptake and breakdown by the
cells; it should be appreciated that C. perfrinoens type A is
usually regarded as a non-proteolytic species, although it does
have collagenase and gelatinase activity (see Willis, 1977, chap.
4). In the present studies it was not possible to identify
inducing substances that would consistently produce higher yields
of neuraminidase in the supernate of 48-h broth cultures (Section
Ilia). Although on occasion the addition of free NANA, FVII
glycoprotein or proteose peptone appeared to give increased final
enzyme yields, this did not occur consistently and varied yields
were obtained on different occasions with any particular medium.
Fig. III/4 shows that strain L2Ab produced more neuraminidase
during serial cultures in PPW5 medium than in NB medium; there was
a clear-cut step up or down in enzyme production after each change
of medium. Neuraminidase production by classical C. oerfrinaens
strains was found to be generally good in PPW5 and THB media (table
III/II) and these were used for further studies with clostridial
species. Although it appeared that neuraminidase production might
be enhanced by serial culture in some experiments (e.g. figs III/4
and 5), this was not found to be generally true (Section Ilia);
however, the supernate of the second serial 48-h culture in PPW5 or
THB medium was assayed as a routine in testing for production of
the enzyme by clostridial species.
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A number of other C. oerfrinaens strains were also examined
for neuraminidase production (Section IIIc). Collee (1965a)
reported that the enzyme was produced by strains of types B, C, D
and E as well as by type-A strains and this was confirmed in the
present studies (table III/XIII). Strains of C. perfringens type A
from various sources were characterised in order to select a range
of organisms with different properties for later studies of
virulence in experimental guinea pig infections. Strains
NCTC11144, CW6 and CW7, three non-phospholipase-producing
C. oerfringens strains, all produced good levels of neuraminidase
in vitro (table III/XIII). Rood & Wilkinson (1975) described
mutant strains of C. oerfrinaens that were neuraminidase-negative
or were very weak producers of neuraminidase. A number of their
strains were obtained and recharacterised in this laboratory (table
III/XIV). Unfortunately, they all produced high yields of enzyme
with our test procedures, perhaps because of genetic instability;
they were not further investigated in the present studies.
However, a number of naturally-occurring neuraminidase-negative
strains were identified during studies with food-poisoning strains
of C. perfrinqens (discussed below) and these were used in later
studies of the correlation of virulence and neuraminidase
production.
Production of neuraminidase by food-poisoning
strains of C. perfrinaens type A
When the present investigation was undertaken there was
confusion in the literature regarding the production of neura-
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minidase by food-poisoning strains; this partly reflected the
changing definition of such strains. C. oerfrinoens type A occurs
regularly as a commensal in the gut of man and animals, and this
for long delayed recognition of its role as a pathogen in the human
gut (for reviews of C. perfringens food poisoning see Hauschild,
1974; Willis, 1977, chap. 7; Hobbs, 1979; McDonel, 1980: see
also Fraser & Collee, 1979, included in the Appendix). The work of
Hobbs et al. (1953) in Britain finally established the organism as
a cause of food poisoning; the "typical food-poisoning strains"
that were implicated could be distinguished because they grew as
non-haemolytic colonies on horse-blood agar and produced unusually
heat-resistant spores. Such organisms have been classified as
type-A2, to distinguish them from classical strains of type-A^
(Sterne & Warrack, 1964). Although type-A2 strains are the more
likely to survive cooking and cause food poisoning, later studies
in Britain and America established that food poisoning can also be
produced by classical type-Aj strains that produce relatively heat-
sensitive spores (Hall et al., 1963; Hauschild & Thatcher, 1967;
Sutton & Hobbs, 1968). It is now clear that the potential to cause
food poisoning depends upon the ability to produce enterotoxin
during sporulation in the gut, and that both haemolytic and non-
haemolytic strains may do this (Hauschild, Niilo & Dorward, 1967,
1971; Duncan & Strong, 1969a and b).
The sensitive assay procedures developed with C. oerfringens
strain L2Ab were used for investigation of neuraminidase production
by reference British food-poisoning strains of C. perfringens sero¬
types 1-24 (heat-resistant) and i-xviii (heat-sensitive); this
work was reported by Fraser & Collee (1975, included in the
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Appendix). Various attempts have been made to develop serotyping
methods for C. oerfrinoens strains (see Willis, 1969, chap. 2;
Chakrabarty & Narayan, 1979). Two sets of antisera were developed
in the Central Public Health Laboratory, Colindale, for epidemio¬
logical studies on type-A2 or type-A^ food-poisoning strains (Hobbs
et al., 1953, 1973) but there was some overlap between the two
groups and more recent efforts have been aimed at producing a
unified set of antisera for all C. oerfringens type A strains
(Hughes, Turnbull & Stringer, 1976; Stringer, Turnbull & Gilbert,
1980). Table Disc/I shows the revised numbers allocated to the
strains previously given Roman serotype numbers; for clarity the
original designations have been retained in the present report.
Collee (1965b) found that four British type-A2 food-poisoning
strains were neuraminidase-negative but, because culture supernates
of two strains produced a myxovirus-receptor-inactivating effect on
red cells (Collee, 1965a), he concluded that "more extensive
investigation is required before it can be claimed that
neuraminidase is never produced by typical food-poisoning strains".
Moss, Schekter & Cherry (1967) confirmed that 12 British food-
poisoning strains (the reference strains of Hobbs^ types 1-3 and
5-13) were neuraminidase-negative; however they went on to
demonstrate that one of five American food-poisoning isolates that
were otherwise indistinguishable from the British type-A2 strains
did produce the enzyme. American food-poisoning isolates generally
include many that are haemolytic or heat-sensitive or both; the
majority of the American food-poisoning strains examined by Moss et
al. (1967) were neuraminidase-positive.
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Table III/V contains the results of tests with the British
reference food-poisoning strains cultured in PPW5 broth; the
relative amounts of enzyme produced by neuraminidase-positive
strains are shown in table III/IV. Twenty of 24 heat-resistant
strains were neuraminidase-negative, whereas 12 of 17 so-called
heat-sensitive strains produced the enzyme; thus, in British as in
American strains, the ability to cause food poisoning is not
strictly correlated with lack of neuraminidase production, although
the majority of non-haemolytic, heat-resistant isolates are
neuraminidase-negative.
The four heat-resistant strains that were found to be clearly
neuraminidase-positive include the reference strain of Hobbs% type
13, which was reported not to produce the enzyme by Moss et al.
(1967). Three other type-13 strains also produced neuraminidase
(table III/VI), including strains 029 and 153 which were amongst
the strains reported as negative by Collee (1965b). It is possible
that these strains might have altered as a result of prolonged
storage and subculture, although their characteristics were
carefully rechecked to confirm that they were still non-haemolytic
and produced heat-resistant spores. PPW5 broth is generally much
better for the production of neuraminidase than the media used by
Collee in 1965 and it is unlikely that the less sensitive assay
procedure then in use, with egg-white as substrate, would have
detected the small amounts of neuraminidase produced in some
cultures of these strains even in PPW5 broth, e.g. in the
experiment shown in fig. III/5. Although the results in this
experiment suggested that sequential subculture in PPW5 broth might
result in a gradually increased yield of the enzyme, this could not
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be confirmed in further studies (e.g. see table III/VII); there
was considerable variation in the amount of enzyme produced by
strains 029 and 153 on different occasions but all cultures
examined could be clearly shown to be neuraminidase-positive. It
is probable that the difference between the present findings and
those of Collee (1965b) are attributable to developments in culture
and assay procedures. However, it appears that there may be
variation in the ability to produce neuraminidase even among
strains of a single C. perfringens serotype as tests with strain
4621 (also Hobbs^ serotype 13) showed no evidence of neuraminidase
production even after incubation of assays for 24 h (table III/VI).
A further example emerges from the amalgamation of the former sets
of serotype strains shown in table Disc/I. Strains i and xii, both
neuraminidase-positive, have now been reallocated to serotype 23;
however, the original type-23 reference strain was neuraminidase-
negative in the present survey (table III/V).
The strains of C. perfringens listed in table III/IV are
clearly neuraminidase-positive; it is more difficult to be certain
that an organism is truly neuraminidase-negative and can never
produce the enzyme. Because of the variations in enzyme production
seen in cultures of neuraminidase-positive strains, four apparently
negative strains (HobbsN serotypes 1-4) were also examined in five
serial cultures in PFW5 broth undertaken as part of the experiment
shown in fig. III/5; no enzyme could be demonstrated even with
assays incubated for 24 h (table III/VIII). The absence of
detectable enzyme was confirmed in further serial cultures of the
Hobbsv type-2 strain grown at 39°C under conditions that gave very
271
high enzyme levels with strain L2Ab (table III/X). Even with the
culture supernate concentrated 5-fold no extracellular enzyme was
detected, and no neuraminidase was released from the cells by
ultrasonic disintegration. Further studies showed no NAN-lyase
activity in the culture supernates (table III/XI); this
demonstrates the validity of the 24-h assays and confirms that the
HobbsN type-2 strain produces no extracellular neuraminidase (i.e.
<0.001% of the neuraminidase produced by strain L2Ab). When the
L2Ab cells were disrupted, the NAN-lyase that was released produced
some interference with the neuraminidase assay (table III/XII;
fig. III/6). A similar amount of NAN-lyase was released from the
neuraminidase-negative Hobbs^ type-2 strain, but further
experiments showed that this would not prevent the demonstration of
quite small amounts of neuraminidase - as little as 1% of that
associated with strain L2Ab cells (fig. III/7).
These studies demonstrated that British food-poisoning
strains of C. perfrinoens type A include some that are
neuraminidase-positive and others that still cannot be shown to
produce the enzyme in vitro. Satterlee & Walker (1969) suggested
that C. oerfrinaens neuraminidase might be the factor producing
increased intestinal passage time in mice fed on a diet to which
the organism had been added. However, since many food-poisoning
strains do not produce the enzyme, and since the role of the
enterotoxin has since been clearly attested, it is unlikely that
neuraminidase is involved in the mechanism of pathogenicity of
C. perfrinaens type A in the gut.
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Production of neuraminidase by other species of Clostridia
The procedures developed for definition of neuraminidase-
negative strains of C. perfringens were used in a study of a range
of well characterised strains of other clostridial species (see
Section IV, and Fraser, 1978, included in the Appendix).
Neuraminidase-positive strains were shown to produce the enzyme in
culture supernates in both PPW5 and THB media although there were
often considerable differences in the relative amounts produced and
these did not correlate clearly with differences in the relative
amounts of growth in the two media. Neuraminidase-negative strains
grew adequately in the test media but could not be shown to produce
the enzyme in either, even when assays were incubated for 24 h;
none of the culture products of these strains contained sufficient
NAN-lyase activity to interfere significantly with the assays for
neuraminidase. Assays were performed in acetate buffer at pH 5.1
by the standard procedure used for the C. perfringens enzyme and
this proved satisfactory for detection of neuraminidase produced by
other clostridial species. The enzyme produced by various
Clostridia was shown not to be calcium-dependent (table IV/III);
Ca^+ was not added to the assays as a routine but culture products
of a few neuraminidase-negative Clostridia were retested with added
Ca^+ as a precaution. Clostridial neuraminidase is essentially
extracellular (tables IV/I and II) but several neuraminidase-
negative strains were further tested to confirm that no cell-
associated enzyme could be detected after disruption of the cells.
The results of these studies are summarised in table Disc/II.
The strains and species of Clostridium tested are described in
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TABLE Disc/TT



























a Extracted from tables IV/1, II, V, VI and VII; number of strains
tested indicated in brackets.
k Both neuraminidase-positive and -negative strains of G. perfrin-
aens type A occur (see table III/V) .
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Materials and Methods, where the procedures used for their identi¬
fication are also detailed. The clostridial species that produced
neuraminidase in the present study were G seoticum. G chauvoei.
C. tertium. C. sordelli and C. absonum; all strains of each
species tested were neuraminidase-positive. Although these results
were clear-cut and consistent it should be appreciated that
relatively small numbers of strains of each species were
investigated; it remains possible that a more exhaustive search
might reveal neuraminidase-negative variants such as occur among
food-poisoning strains of C. perfrinaens type A.
G seoticum and G chauvoei are usually regarded as separate
species although the differences between them are very small;
Willis (1969, chap. 4) discussed the arguments for regarding them
as two types of a single species. Warren & Spearing (1963) noted
the presence of neuraminidase activity in a lyophilised preparation
of C. seoticum toxin. Gadalla & Collee (1968) found that the
enzyme was produced by all of 15 strains studied, and Muller
(1970b) demonstrated neuraminidase production by a strain of
G seoticum isolated from a patient with a wound infection. Muller
& Schallehn (1972) detected the enzyme in two strains of
C. chauvoei by demonstrating characteristic electrophoretic changes
in serum proteins included in the culture medium. The present
study confirmed that strains of G seoticum generally produce large
amounts of neuraminidase, whereas the two strains of C. chauvoei
produced rather smaller amounts under the same test conditions
(table IV/I).
Howe .et al. (1957) reported that G tertium produced an
enzyme that destroyed myxovirus receptor substances. Muller &
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Werner (1974) demonstrated neuraminidase production by a strain of
C. tertium and the present study confirmed that small amounts of
the enzyme were produced by two other strains (table IV/I).
C. sordelli and C. bifermentans are very closely related and
there has been considerable debate as to whether or not they should
be regarded as separate species (see Willis, 1969, chap. 5).
Pathogenic strains of C. sordelli produce the p-toxin whereas
C. bifermentans is non-toxigenic, but this is not an adequate
criterion for classification as non-toxigenic strains of
C. sordelli also occur; in the present studies only one of the
five C. sordelli strains tested was found to produce the toxin
(Section Vlld). Nakamura et al. (1975) used numerical taxonomy and
DNA homology in a reinvestigation of this problem. They scored for
162 features (not including neuraminidase activity) and concluded
that the two species could be reliably differentiated by only a few
biochemical tests - fermentation of mannose and sorbitol, urease
activity, arginine deamination and growth inhibition by mannose.
The identity of our strains was carefully rechecked in the present
studies; minor inconsistencies were obtained with the fermentation
tests for two C. bifermentans strains (see table IV/IV). Warren &
Spearing (1963) noted neuraminidase activity in a preparation of
C. sordelli toxin; White & Mellanby (1969) separated the
neuraminidase from the toxic activity in the culture supernate of a
strain of C. sordelli. The present finding that all of 12 strains
of C. sordelli produced neuraminidase but that none of five strains
of C. bifermentans did so (Section IVc), suggests that this may be
another character that distinguishes the two species. C. difficile
produces a cytotoxin that is antigenically related to the
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C. sordelli toxin and neutralised by C. sordelli antitoxin
(Bartlett et al.. 1978; Bartlett, 1979; Burdon, 1981), and the two
species have serologically related surface antigens (Poxton &
Byrne, 1981); however, none of the C. difficile strains examined
was found to produce neuraminidase.
C. absonum and C. paraperfringens are non-pathogenic species
that are related to C. perfrinoens but can be distinguished by
differences in their phospholipase reactions (Nakamura et al.,
1973; Hayase et al., 1974). When grown on EYA medium, C. absonum
strains produce a broad zone of opalescence that is only partially
inhibited by C. perfringens antitoxin; C. paraperfrinaens strains
produce a narrow zone of opalescence that is completely inhibited
by the antiserum (see Materials and Methods). Nakamura et al.
(1973) found that these species differed from each other and from
C. oerfringens in only a few other biochemical tests. It now
appears that neuraminidase production may be a further
distinguishing feature; C. absonum strains resembled
C. perfringens in producing the enzyme whereas C. oaraoerfringens
strains were neuraminidase-negative (tables TV/I and VII). Solovev
et al. (1972) have suggested that tests for neuraminidase
production may be of interest in studies of Vibrio taxonomy and it
now appears that they may also be of value in certain aspects of
clostridial taxonomy (see also Collee et al., 1982, included in the
Appendix).
The other species of Clostridium found to be neuraminidase-
negative in these studies are also shown in table Disc/II. Werner
& Muller (1974) described a neuraminidase-positive strain of
Clostridium pseudotetanicum: however, this is presumably different
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from the C. tetanomorohum strain NCTC2909 included in table IV/VII,
which is now reclassified as C. cochlearium (see Materials and
Methods). The possible relationship of neuraminidase production to
pathogenicity in Clostridia is discussed later. However, it is
clear that several important pathogenic species do not produce
neuraminidase, e.g. the strains of C. novyi. C. tetani.
C. botulinum and C. difficile were all neuraminidase-negative.
Production of neuraminidase by Bacteroidaceae
The importance of the Bacteroides-Fusobacterium group of
Gram-negative anaerobic bacilli as significant pathogens in a
variety of infections has become increasingly apparent with recent
improvements in methods for their isolation and identification
(Finegold, 1977). Little is known of their mechanisms of patho¬
genicity, and the biochemical attributes of the different species
are still being defined. The studies of neuraminidase production
by Clostridia were extended to a range of well characterised
strains representing the major species of Gram-negative non-sporing
anaerobic bacilli (see Section V, and Fraser & Brown, 1981,
included in the Appendix); the current classification of the test
strains is detailed in Materials and Methods.
Section Va describes the results of experiments undertaken to
characterise production of the enzyme by Bacteroides fraailis
(B. fraailis ss. fraqilis) strain NCTC9344. The enzyme was found
to be predominantly cell-associated, with very little activity
detectable in the supernates of 48-h cultures (table V/I); cell
extracts contained strong activity and were tested in all further
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studies with bacteroides strains. Hammann, Von Nicolai & Werner
(1981) reviewed their group^s studies with neuraminidase from
several bacteroides strains; they found generally greater activity
against NAN-lactose than glycoprotein substrates and reported pH
optima of 5.6-6.5 with NAN-lactose in barbital-acetate buffers (Von
Nicolai, Werner & Zilliken, 1977, 1978). Fig. V/l shows that the
optimum for B. fragilis neuraminidase in our assays with the FVII
substrate and acetate buffer was c. pH 4.2; the standard assay
procedures at pH 5.1 gave good results and were used throughout
these studies. The enzyme was shown not to be calcium-dependent
(table V/II) and Ca^+ was not added to the assays. Berg et al.
(1983) have recently reported the properties of purified
B. fraailis neuraminidase with NAN-lactose as substrate; they were
able to demonstrate some stimulation of enzyme activity (by 20%)
when CaCl^+ was added and the pH optimum was found to be at pH 65.
The discrepancies between their findings and the results in the
present study may be attributable to differences in the substrate
and buffer system employed.
Many of the Bacteroidaceae are nutritionally fastidious and
do not grow well in fluid media even with the addition of growth
supplements and meticulous anaerobic technique. The three media
used in the present study were chosen for their ability to give
good enzyme production by neuraminidase-positive species and also
good growth of a wide range of Gram-negative anaerobes (Sections Vb
and c). DB medium allowed adequate growth of all species tested
but did not always give the best production of neuraminidase. Some
of the B. fraailis group of organisms produced more enzyme in PPW5
broth; however, this medium did not support adequate growth of
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several other species, even when incubation of the cultures was
extended to 96 h. A few of these strains produced more enzyme in
BM broth than in DB medium, but there were also clear exceptions.
Growth was assessed by observation of turbidity in test cultures;
a number of species, e.g. B. corrodens and Fusobacterium strains,
do not give strong turbidity even when many cells are present, and
this was allowed for in the scoring system for recording growth
(see Materials and Methods). Neuraminidase-positive strains
generally produced the enzyme in each of the two media in which
they were grown, but a few proved variable or negative in one or
the other (see tables V/III and IV). The purity of all cultures
was carefully checked in subcultures from the test culture. Since
no single medium consistently gave optimum production by
neuraminidase-positive strains, other strains were tested in at
least two media that supported adequate growth. All cell extracts
were tested in assays incubated for 24 h before being classed as
neuraminidase-negative.
Muller & Werner (1970b), using a paper chromatographic
method, reported the presence of NAN-lyase in several species of
Bacteroides. including B. fragilis, and Muller (1973b) also found
activity with a strain of Fusobacterium polymorohum (F. nucleatum).
In the present study there was no significant NANA-destroying
activity in the cell extracts of the neuraminidase-positive
B. fraailis NCTC9344 or in the cell extracts of the various
cultures that gave low-positive or negative results in
neuraminidase assays. Very few of these cell extracts reduced the
assay value for added NANA by as much as 10-20% during incubation
for 24 h under conditions equivalent to those of the neuraminidase
279
assay. This amount of NANA destruction would not appreciably
reduce the ability to detect small amounts of neuraminidase
activity. Several of the Caonocvtophaga cell extracts produced a
reduction of c. 40% in 24 h and this could have contributed to our
difficulty in demonstrating neuraminidase production consistently
in this group (Section Vd).
The results for neuraminidase production by Bacteroides
species in the present studies are summarised in table Disc/Ill;
they are consistent within each species and thus tend to confirm
the present classification. Within the B. fraailis group,
B. fraailis. B, vulaatus. B. distasonis and B. ovatus were all
neuraminidase-positive. Seven strains of B. thetaiotaomicron were
positive while six strains of the closely related B. eggerthi were
negative. The B. variabilis strains were distinguished from the
B. uniformis strains by their production of the enzyme, though it
proved difficult to define conditions under which the enzyme was
consistently produced by strain VPI11368 (table V/III).
Within the B. melaninogenicus - B. oralis group, B. oralis
and B. melaninogenicus ss. me.ianinogenicus were neuraminidase-
positive while ss. intermedius and B. ruminicola were negative;
the single strain of B. melaninogenicus ss. levi that was available
proved to be neuraminidase-positive. It has recently been
suggested that the subspecies of B. melaninogenicus should now be
regarded as separate species, and that strain ATCC15930 should
become the type strain of a new species, B. loeschei (Holdeman &
Johnson, 1982; Johnson & Holdeman, 1983). Strain VPI8906D, pre¬
viously B. oralis but reclassified as the new species B. buccalis.
produced the enzyme; strain NP333, previously B. ruminicola but
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now reclassified as B. pentosaceus, was neuraminidase-negative.
The B. bivius strains produced the enzyme, while the closely
related B. disiens did not. The strains of the asaccharolytic
species B. asaccharolyticus. B. gingivalis and B. corrodens
(B. ureolyticus) were -all neuraminidase-negative.
Production of neuraminidase by Bacteroides species was
studied by Muller & Werner (1970b; Werner & Muller, 1971) and
reviewed by Hammann et al. (1981). These studies depended
primarily on observing the electrophoretic changes in serum
proteins in the culture medium after incubation of cultures for 2-
19 days, but were also supported by paper chromatography of NAN-
lactose and its split products. They found that all of 24 strains
of B. fraailis produced the enzyme, but only six of 11 B. vulgatus,
three of five B. distasonis and six of eight B. thetaiotaomicron
could be shown to be positive. With our more direct assay
procedures, using cell extracts of the cultures, all of the strains
of these species examined were clearly shown to be neuraminidase-
positive. At least one of their negative B. thetaiotaomicron
strains (ATCC8492) is now reallocated to B. uniformis: this strain
was negative in our assays also. Their findings with other
Bacteroides species are in broad agreement with our present
results: B. ovatus ATCC8483 and three strains of B. oralis
(including ATCC15930, here classified as B. melaninogenicus ss.
melaninoaenicus) were positive, and single strains of
B. asaccharolvticus (NCTC9337) and of B. putredinis were negative.
In a later study (Marx et al., 1980) the same group of workers have
also reported that a strain of B. bivius produces the enzyme.
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The results of our tests in Bacteroides species are
consistent and conform with the latest classifications (Holdeman et
al., 1977; Duerden et al.. 1980). They help to discriminate
between several closely related species that are otherwise
distinguished only by a small number of sugar fermentation
reactions, e.g. between the species previously included in
B, thetaiotaomicron. and between various species of the
B, melaninoaenicus - B. oralis group. It is possible that tests
for neuraminidase production would be a valuable addition to the
range of biochemical tests currently used in classification of
Bacteroides organisms (see Collee et al., 1982, included in the
Appendix).
The production of neuraminidase by other species of Gram-
negative anaerobic bacilli was studied in Section Vd. Strains of
Caonocvtoohaaa ochracea were formerly considered as Bacteroides
species but have been reclassified because they are CO2-dependent
rather than strict anaerobes (see Materials and Methods); the six
strains tested could all produce the enzyme although it was
difficult to define conditions that would give reliable production.
Werner & Muller (1971) described neuraminidase production by one
strain of Leptotrichia innominata var. ochracea. which would
probably now be reclassified as Capnocvtoohaga ochracea (Hammann et
al., 1981) .
None of the Fusobacterium and Leptotrichia strains listed in
table V/VI could be shown to produce the enzyme. Fukui et al.
(1971) failed to detect neuraminidase in four strains of
Fusobacterium species and two of Leptotrichia buccalis isolated
from the mouth. However, Werner & Muller (1971) reported weak
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neuraminidase activity against plasma proteins in two of ten
strains of Sphaeroohorus necrophorum (F. necrophoruml. two of three
S. varium (F. varium) including NCTC10560, and one of seven other
Fusobacterium strains. Muller (1973b) isolated a strain of
F, nucleatum from the throat of a patient with actinomycosis;
there was strong neuraminidase activity on first isolation but this
declined to a low level during subsequent laboratory passage. The
Fusobacterium strains that we found to be neuraminidase-negative
have been maintained in laboratory culture for some years and it
remains possible that they might have lost the ability to produce
the enzyme during storage. The taxonomy of the fusobacteria
remains debatable (see Duerden et al., 1980) and little is known
about their pathogenic potential or possible virulence factors.
B. fragilis is now well recognised as one of the most
important Bacteroides species in clinical infections although the
mechanism of pathogenicity remains poorly understood (see Ingham,
Sisson & Selkon, 1980; Bartlett, 1982). The organism occurs as a
minor component of the commensal anaerobic flora of the colon and
vagina (Duerden, 1980a and b; Hammann, 1982) and causes infections
predominantly when injury or damage to these mucosal surfaces
allows access to otherwise sterile tissues. At one stage the
B. fragilis group of organisms were regarded as subspecies of a
single species, but they have now been reinstated as separate
species on biochemical and genetic grounds (Cato & Johnson, 1976).
Polk & Kasper (1977) confirmed the clinical importance of this
distinction when they demonstrated that clinical isolates of these
organisms from blood, wound and abscess cultures over a two-year
period were predominantly B. fraailis (i.e. the former subspecies
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fraailis); B. thetaiotaomicron, B. distasonis and B. vulgatus were
much less commonly incriminated and B. ovatus was not encountered.
Polk & Kasper (1977) also noted that most B. fragilis strains
were capsulate when freshly isolated from clinical material. Since
only a small proportion of commensal strains are capsulate,
interest has focused on the role of the capsule as a virulence
factor promoting the selection and pathogenicity of these strains.
In an experimental model of infection, implantation of faecal
material leads to the development of peritonitis in rats;
Escherichia coli may produce septicaemia and death during the first
few days but the survivors develop chronic abscesses due to
B. fragilis infection thereafter (see Bartlett, 1982). The
relative roles of the two organisms were confirmed when gentamicin
or clindamycin were used to inhibit either species selectively, and
when pure cultures of the organisms were used in place of faecal
contents. Only capsulate strains of B. fraailis cause infection in
this model, and indeed injection of the purified capsular material
itself may also lead to abscess formation (Onderdonk et al., 1977).
It appears probable that surface components of B. fraailis impede
phagocytosis and intracellular killing, ^though the precise
mechanisms involved are debated (Ingham et aJL., 1981; Bartlett,
1982).
The roles of other factors in B. fraoilis pathogenesis are
still poorly understood. Intravenous injection of B. fraailis to
experimental animals does not produce infection or toxic effects,
perhaps because the endotoxin of the organism differs chemically
from that of Escherichia coli and is not nearly so toxic (see
284
Bartlett, 1982). Werner and colleagues (Muller & Werner, 1970a;
Hammann et al., 1981) suggested that neuraminidase might play a
role in the pathogenicity of B. fraailis. arguing that it is
produced in greater amounts and has a broader spectrum of activity
against a range of serum glycoproteins than the enzymes produced by
other bacteroides species. Muller & Werner (1970a) studied pus
from a B. fragilis abscess and showed that the enzyme was produced
in vivo by demonstrating appropriate electrophoretic changes in the
exudate glycoproteins; at present, however, there is no other
evidence to support a significant role in pathogenesis. The enzyme
is produced by all strains of B. fracilis examined, but it is also
produced by the numerically dominant faecal species B. thetaiotao-
micron and B. vulgatus. The pathogenic potential of these and
other Bacteroides species is much less clearly understood at
present; it will be interesting to note whether there is any
correlation between their ability to produce neuraminidase and
their occasional occurrence as pathogens.
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STUDIES ON EXPERIMENTAL CLOSTRIDIAL MYONECROSIS
Experimental C. perfrinaens type A myonecrosis
The results presented in Section Vila confirm the classical
observations on experimental C. perfringens myonecrosis in the
guinea pig that were described in the Introductory Review.
C. perfringens strain L2Ab proved to be a virulent strain that
could produce dramatic overwhelming infection with collapse and
death within 28-48 h. There was marked local swelling with
extensive necrosis and dissolution of the inoculated thigh muscles
and accumulation of a large amount of haemorrhagic oedema fluid,
often spreading up over the anterior abdominal wall. Microscopic
examination showed many bacilli and few polymorphonuclear cells.
The virulence of strain L2Ab was assessed in experiments with
graded challenge doses of washed log-phase cells. The minimum
lethal dose was low (<10^ cells) when initial muscle damage was
produced by previous injection of CaC^ (table VII/I). In some
control animals the injection of CaCO^ itself produced a necrotic
area that was demonstrable as a small sterile abscess when the
animal was killed 6-7 days later; in others there was minimal
transient swelling and stiffness but no abnormality was found post
mortem. Larger doses (c. 10^ organisms) were required for
production of infection when adrenaline was used as initiating
agent (table VII/II); there was no detectable abnormality in
control animals given adrenaline without bacteria. Although these
experiments were in general performed with a single animal for each
challenge dose the results proved reasonably reproducible in later
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experiments. It appears that the challenge dose required for
establishment of infection is dependent on the degree and duration
of hypoxia produced by the initiating procedure. Hie course of the
disease in the two models was indistinguishable thereafter.
When sublethal challenge doses were given, infection might be
established but it was usually contained locally and did not
progress to produce the full picture of clostridial myonecrosis.
The response to bacterial challenge was graded on the scale
described in Materials and Methods so that the results could be
presented succinctly in the tables in Section VII. It proved
fairly easy to allocate each result to a particular grade although
judgement of the precise distinction between, for example, small,
medium and large abscesses, was subjective and might occasionally
be debatable; the recorded results are certainly accurate to
within one grade on this scale. Sublethal doses of strain L2Ab or
other virulent strains usually produced a localised abscess in
experiments with CaCl2 as sclerosing agent. On occasion (e.g.
table VII/III), the resultant abscess was little bigger than might
be produced in some control animals given CaCl^ alone, although it
was clear from microscopic examination that the bacteria had
multiplied considerably after inoculation. More frequently,
however (e.g. tables VII/I, VI and VII), there was a medium or
large abscess that was clearly due to bacterial infection. It
appears that in this situation the host defences were adequate to
limit extension of infection and prevent development of systemic
illness; microscopic examination showed many polymorphonuclear
cells and relatively few bacilli. When adrenaline was used as
initiating agent, sublethal challenge doses occasionally produced
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severe localised infection in the inoculated limb (e.g. table
VII/IV) but more often there was little or no local reaction and no
evidence of infection was found at post-mortem examination 6-7 days
later (e.g. table VII/II). It seems that in these animals the
challenge dose of organisms was insufficient to allow infection to
be established before the vasoconstrictor effects of the adrenaline
had worn off; thereafter the normal host defences were able to
prevent damage and remove the organisms.
Various strains of C. perfrinaens type A were compared for
virulence in guinea pigs with CaCl2 as sclerosing agent (Section
VIIc). After initial tests with a high challenge dose (c. 10®
cells), a number of virulent strains were more fully assessed in
tests with lower challenge doses. The types of infection produced
in these experiments were similar to those seen with different
challenge doses of strain L2Ab. A number of strains were clearly
pathogenic, able to produce the full picture of clostridial
myonecrosis and death within 24-48 h. Some variation was seen in
different experiments but in general the results were reasonably
consistent. Thus with the Hobbs^ type-xviii strain, inoculation of
challenge doses above c. 10^ cells produced severe infection with
collapse or death before 48 h (table VII/VI). The results with the
Hobbs^ type-i strain suggested that the minimum lethal dose was
c. 10® cells (tables VII/V and VII). An inoculum of c. 107 cells
gave extensive local necrosis but the animal survived; it appeared
that this strain might not prove lethal even when infection was
rapidly established and progressed to give almost complete
dissolution of the thigh muscles. The Hobbs^ type-viii strain was
investigated in a series of tests because a second experiment did
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not confirm the initial finding that it could produce severe
myonecrotic infection; however the final results, presented in
table VII/VTII, demonstrated that high challenge doses of this
strain could undoubtedly be fully pathogenic in this model.
Other strains proved unable to kill the animals even at high
challenge doses although some could produce extensive local
infection (table VII/V). Thus the animal inoculated with 10^ cells
of strain CW6 survived for 3 days even though only fragments of
muscle remained in a huge accumulation of haemorrhagic fluid in the
grossly swollen limb. With several other strains the animals
survived for 6-7 days despite the production of large abscesses,
which, however, remained localised in the inoculated muscle. Many
other strains were clearly less virulent and even high challenge
doses produced only small or medium-sized local abscesses, similar
to those produced by sublethal doses of more virulent strains.
Although the full picture of lethal myonecrosis following
administration of virulent G. perfringens has been well documented
(e.g. see Willis, 1969, chap. 2), the range of effects produced by
less virulent strains has not been so fully described. Evans
(1943a), using an experimental protocol very similar to that in the
present studies, reported results with four strains of the
organism. Two strains produced lethal infection with challenge
doses of 5-50 organisms; it appears that strain L2Ab is of
comparable virulence. A third strain had a minimum lethal dose of
5 x 10^ cells, but smaller doses produced "severe infection with
survival". The fourth strain was not lethal with challenge doses
of 5 x 10? cells, "although the animal become infected and
exhibited well marked and typical lesions"; the grading system
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used to record these lesions in his tables was not explained in
detail but appears consistent with that used in the present study.
There is no absolute criterion of pathogenicity for C. per-
fringens strains. It is apparent that most strains are capable of
multiplying and producing some degree of local infection when
inoculated into an area of tissue damaged by prior injection of
CaO^, but this can often be contained so that infection does not
spread locally and there is no systemic illness. Strains that
produce only this pattern of infection may be regarded as
relatively avirulent and are presumably unlikely to produce serious
clinical problems. A second group consists of strains that are
able to cause severe local infection in damaged tissue, with
extension of the local lesion to produce considerable muscle
necrosis but without systemic collapse and death. In some cases
the host defences can contain this within the muscle mass and a
large localised abscess is formed; in others virtually the whole
muscle mass is destroyed but the animal may survive for several
days. A third group of strains contains clearly virulent organisms
able to produce rapid and extensive local tissue necrosis and kill
the animal in the acute phase of the illness. It is difficult to
determine which is the critical level of virulence in this animal
model that would be of significance in human infection; clinical
experience during World Wars I and II might suggest that it is not
unusual for environmental strains to prove virulent if introduced
into a suitable wound. The apparent distinction between strains
that do and do not produce death in experimental animals may
reflect differences in degree rather than in kind, as the results
of inoculation of high challenge doses of less virulent strains are
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very similar to those obtained with sublethal doses of more
virulent strains. Hie outcome of infection probably depends on a
balance of factors, including the degree of tissue injury and the
number of organisms achieved at an early stage of the disease as
well as the virulence of the infecting strain as measured in this
animal model.
The strains of C. oerfringens type A tested for virulence in
the present studies included classical and food-poisoning strains
that were selected because of differences in various biological
properties. Hauschild & Thatcher (1968) used a similar guinea-pig
model to assess a selection of classical and food-poisoning
strains. They found that the virulence of food-poisoning strains
that were heat-sensitive and haemolytic was comparable to that of
classical strains that were unrelated to food poisoning. In each
group a number of strains were very virulent and able to produce
myonecrotic infection with a low challenge dose, whereas other
strains were less virulent, and some did not produce fatal
infection even when 10® cells were injected. A few heat-sensitive
but non-haemolytic food-poisoning strains were pathogenic when
fairly high challenge doses were given, but none of the heat-
resistant strains that they tested could produce gas gangrene. The
results of the present studies with food-poisoning strains are
included in table VII/IX, where the strains are ranked in
approximate order of virulence; these findings are in general
agreement with those of Hauschild & Thatcher (1968). A number of
the heat-sensitive, haemolytic strains were fully virulent, able to
produce the classical picture of clostridial myonecrosis (Hobbs%
types viii, xvi, xvii and xviii); one heat-sensitive but
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non-haemolytic strain (HobbsN type i) was also pathogenic. The
most virulent of the heat-resistant strains (Hobbsv type 21)
produced a large localised abscess but did not kill the animal, and
various other food-poisoning strains, both heat-sensitive and heat-
resistant, also proved to be of lower virulence. It is clear that
while heat-resistant food-poisoning strains may generally be of low
virulence in the guinea pig model, the heat-sensitive strains may
be able to produce either experimental gas gangrene or food-
poisoning or both.
Table VII/IX shows the correlation between virulence and in-
vitro production of a-toxin and ©-toxin for various strains of
C. oerfringens type A. Although oc-toxin is also a haemolysin it is
the ©-toxin that is responsible for the broad zone of complete
haemolysis obtained on blood-agar media (see Materials and
Methods); the terms haemolytic and non-haemolytic are used here to
denote the presence or absence of ©-toxin activity. Production of
oc-toxin was judged by production of opacification around colonies
on egg-yolk agar; this does not give an accurate measure of the
maximum amount that a strain can produce in vitro but it allows
strains to be divided into three groups - normal, low or negative
(for discussion of assays for phospholipase-C, see Rigby, 1981).
It should in any case be appreciated that the amounts of various
toxins produced _in vitro may vary considerably in different media
(see Willis, 1969, chap. 2; Nord et al., 1974; Mollby et al.,
1976). It is generally accepted that there is a reasonable
correlation between oc-toxin production and virulence for
experimental animals, although Bullen (1970) has emphasised that
discrepancies also occur (see Introductory Review). Willis (1969,
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p. 122) has observed that "just as ten times the lethal dose of
potassium cyanide is no more lethal than a single dose, so too a
highly toxigenic strain ... is unlikely to cause effects more
serious than those produced by a strain of minimum effective
toxigenicity". Hauschild & Thatcher (1968) concluded that, for the
classical and food-poisoning strains examined by them, their
results "did not show a strict proportionality between virulence
and (production of oc-toxin)"; however a statistical correlation
between the two factors was shewn.
In the present studies, two virulent strains (Hobbsv viii and
xvii) were consistently weak oc-toxin producers, and two phospho-
lipase-negative strains (CW6 and CW7) were able to produce severe
local infection. Although these phospholipase-negative strains did
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not kill the animals during the acute infection they were
originally isolated from human wound infections (see Materials and
Methods); a further phospholipase-negative strain (NCTC11144) was
a food-poisoning isolate (Pinegar & Stringer, 1977) and was found
to be of low virulence in the guinea pig model. All three strains
were confirmed to have remained phospholipase-negative when they
were reisolated from the infected animal. Thus the present studies
tend to confirm that there is not a strict correlation between
oc-toxin production and virulence; although the most virulent
strains were phospholipase-positive, some moderately virulent
strains might produce low levels or be phospholipase-negative, and
many phospholipase-positive strains were of very low virulence.
Most of the virulent strains were haemolytic, and most of the non-
haemolytic strains were non-virulent (see table VII/IX). This
probably reflects the generally low virulence of these unusual
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food-poisoning strains rather than a direct link between 0-toxin
production and virulence; it is unlikely that this oxygen-labile
cytolysin will be active outside the area of established necrosis
and there is little evidence to suggest that it plays a primary
role in gas gangrene (see Introductory Review).
Food-poisoning strains of C. perfringens are generally
regarded as "feebly toxigenic" because heat-resistant strains of
the type initially incriminated in enteropathogenicity fail to
produce the 0-haemolysin, and levels of oc-toxin and other toxins
are also usually low (Hobbs et al., 1953). Hauschild & Thatcher
(1968) confirmed that non-haemolytic food-poisoning strains
generally produce low levels of oc-toxin, but found that heat-
sensitive, haemolytic food-poisoning strains might produce quite
high levels. Skjelkvale, Stringer & Smart (1979) re-examined the
relationship between production of oc-toxin and of enterotoxin with
239 strains of C. oerfrincens from a variety of sources. They
showed that 86% of 65 strains that were associated with separate
food-poisoning outbreaks produced enterotoxin in conditions that
induced sporulation in vitro, whereas only two of 174 strains from
environmental sources did so. Enterotoxin production was not
confined to particular serotypes, and both positive and negative
strains were found in the same serotype. In general, strains that
were haemolytic produced higher levels of enterotoxin than those
that did not produce 0-toxin, but there was no apparent correlation
between the levels of enterotoxin and ac-toxin produced; some high
enterotoxin producers were low oc-toxin producers and vice versa.
Furthermore, they confirmed that five phospholipase-negative
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strains that had been associated with food-poisoning outbreaks did
produce enterotoxin.
Nakamura et al. (1976) examined strains of the non-haemo-
lytic, phospholipase-negative species C. plaaarum and demonstrated
that on biochemical and genetic grounds they should be regarded as
non-toxigenic variants of C. perfrinaens. Skjelkvale et al. (1979)
confirmed that former C. plagarum strains were closely related
biochemically and serologically to their phospholipase-negative
food-poisoning strains, except that they were also enterotoxin-
negative. Thus it appears that the species C. oerfrinoens includes
variants that do not produce one or more of these toxins (ot-toxin,
0-toxin, enterotoxin). Strains that do not produce 0-toxin usually
produce low levels of oc-toxin but not infrequently produce high
enough levels of enterotoxin to be involved in food-poisoning
outbreaks. The common haemolytic strains may produce higher levels
of cx-toxin and of enterotoxin and may be implicated in gas gangrene
or food poisoning. Strains that do not produce a-toxin are seldom
isolated, perhaps partly because of the difficulties in recognising
and identifying these organisms; however such strains may
occasionally be associated with either wound infection or food
poisoning.
The results presented in Section Vllb show that
C. oerfrinoens strain L2Ab produces neuraminidase in vivo during
experimental myonecrotic infection in the guinea pig. With the
present experimental procedure no enzyme activity was detected in
normal guinea-pig liver or muscle. Tissue samples were disrupted
by ultrasonic vibration for a few minutes and a tissue extract was
prepared as described in Materials and Methods; this procedure was
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presumably not sufficiently refined for extraction and detection of
the relatively small amounts of neuraminidase that might be
expected in lysosomal fractions of normal guinea-pig tissues (see
Introductory Review). It was possible that muscle infection might
by itself lead to the release of neuraminidase from host tissues;
however no enzyme activity was demonstrable in abscesses produced
by sterile CaCl2 or by neuraminidase-negative organisms even when
severe tissue damage was produced (see tables VII/III, V and X).
The enzyme was shown to be present in large amounts in severe
infections produced by strain L2Ab, whether CaCl2 or adrenaline was
used as initiating agent (tables VII/III and IV); variable amounts
were also found in tissue samples from other sites, perhaps due to
blood-borne spread of the enzyme but perhaps merely reflecting
direct extension of infection. The enzyme was also present in the
localised abscesses produced in response to injection of sublethal
challenge doses (e.g. table VII/III).
Muller (1973b, 1974a) has suggested that strains of a number
of bacterial species may lose the ability to produce the enzyme
during laboratory subculture, and that it may be regained in vivo.
However, no evidence was found that any of our neuraminidase-
negative strains was induced to produce the enzyme during
experimental guinea-pig infections (tables VTI/V and VIII); this
tends further to confirm the validity of our test procedures for
defining neuraminidase-negative clostridial strains. The quanti¬
tation of neuraminidase present in infected tissues is not very
accurate because the samples may vary from a portion of tissue
containing a small localised abscess, but complete with surrounding
fibrotic material and healthy muscle, to a sample of the
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haemorrhagic oedema fluid formed when almost the entire muscle mass
is destroyed. Nevertheless, neuraminidase was easily demonstrated
in infections produced by neuraminidase-positive strains whereas
none could be shown with neuraminidase-negative strains. In a
number of cases, e.g. with the Hobbsx type-viii strain, it was
confirmed that the organism remained neuraminidase-negative when it
was reisolated from infected tissue. Thus, it is clear that the
enzyme is produced in vivo by neuraminidase-positive strains and
that strains defined as neuraminidase-negative in vitro remain so
in vivo.
Muller (1970a) demonstrated electrophoretic changes
indicative of neuraminidase action in exudate proteins from two
patients with C. perfrinaens wound infections. Preliminary results
(not reported here) have confirmed that the enzyme is produced in
vivo during human infection. Neuraminidase was present in a sample
of muscle tissue removed during surgical treatment of a diabetic
patient who developed clostridial myonecrosis following a compound
fracture of the leg. In this case two neuraminidase-positive
Clostridia (C. perfringens and a non-toxigenic C. sordelli strain)
were isolated from the specimen as well as three neuraminidase-
negative organisms (C. sporoaenes. another phospholipase-negative
Clostridium and Bacillus coaaulans).
The results presented in table VII/IX indicate a general but
imperfect correlation between neuraminidase production and
virulence in the guinea pig model. Most virulent strains do
produce the enzyme well but the virulent HobbsN type-viii strain
was neuraminidase-negative. Most of the other food-poisoning
strains that did not produce the enzyme were of low virulence. The
297
pathogenicity of C. perfrinaens strains in producing experimental
myonecrosis is likely to be multifactorial, as no single factor has
been detected that is clearly correlated with virulence. In
general, virulent strains produce a number of different products
that might play a part in local tissue damage, e.g. a-toxin,
0-toxin, neuraminidase, but a few strains that appear to be at
least moderately virulent and able to produce extensive local
damage fail to produce one or other of these factors, and this
makes it difficult to claim that production of any particular
bacterial product is a prerequisite for the pathogenicity of
C. perfrinoens type A.
Experimental myonecrosis with other clostridial species
"Cable VII/X contains the results of tests for pathogenicity
in the guinea pig model with a variety of strains of other
clostridial species. Although the total count of organisms was
high (c. 10^-10® cells), it is likely that with a number of the
more oxygen-sensitive species there had been appreciable loss in
viability in the challenge dose before injection into the animal;
in a few cases a significant proportion of the inoculum consisted
of spores (see Section Vlld). Thus the results in table VII/X may
tend to underestimate the virulence of some species by comparison
with the results for C. perfringens strains in earlier tests.
The infection produced by C. septicum NCTC547 was very
similar to that produced by C. perfrinaens strain L2Ab, with
extensive local myonecrosis and death within 24 h. Aikat & Dible
(1960) reported that the histological appearances of C. septicum
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muscle damage were almost indistinguishable from those produced by
C. perfrinoens. Tissue damage is attributed to the toxins produced
by this organism (see Willis, 1969, chap. 4). The oc-toxin is the
major lethal toxin; it has haemolytic and dermonecrotic activity
but is unrelated to C. oerfringens oc-toxin and its biochemical mode
of action is unknown. C. septicum also produces a DNA-ase which
may act as a leucocidin (p-toxin), a hyaluronidase Of-toxin), an
oxygen-labile haemolysin (S-toxin) and a gelatinase. The
haemagglutinin of C. septicum was studied by Gadalla & Collee
(1967, 1968) and may be related to the neuraminidase, as discussed
in the Introductory Review. The present studies confirm that
C. seoticum neuraminidase is produced in vivo (Gadalla & Collee,
1968; Muller, 1970b). The pathogenesis of C. septicum infections
in man and animals has not been as intensively investigated as that
of C. perfrinoens. Antiserum with high C. septicum anti-oc-toxin
gives passive protection against infection. It seems probable that
the oc-toxin plays the main role here, but that the other factors
might also play a part in the local infection. There is some
similarity in the disease pathology and in the potentially toxic
factors produced by C. perfringens and C. septicum. and it is
interesting to note that this extends to the production of large
amounts of neuraminidase in muscle infected by either organism.
C. sordelli strain 1734 produced the typical picture
associated with experimental infection by this organism, with
swollen pink muscle, a gelatinous exudate and death within 48 h
(Willis, 1969, chap. 5; Smith, 1975, chap. 15). Table VII/X shows
that the other strains of this species produced abscesses of
varying size, of the type seen with sublethal doses of
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C. perfringens. rather than the typical C. sordelli reaction.
Strain CB2 was quite virulent, however, with production of a large
local abscess and death during the third day; strain P3 also
produced extensive local infection with death on the fifth day, but
the other strains, and the strain of C. bifermentans. produced
smaller local lesions and did not kill the animals. The typical
pathogenic effects of C. sordelli are attributed to its lethal and
necrotising pr-toxin, and it was confirmed that strain 1734 produced
the toxin whereas the others did not. Toxigenic strains of
C. sordelli are occasionally implicated in human and animal
infections; non-toxigenic strains, and strains of C. bifermentans,
are generally regarded as non-pathogenic contaminants (although
many accounts refer simply to C. bifermentans. regarding
C. sordelli as the same species and not reporting tests for toxin
production or animal pathogenicity).
C. sordelli and C. bifermentans produce a number of other
products that might be thought to be involved in pathogenesis;
however, they evidently do not confer pathogenicity on C. bifer¬
mentans. Both species produce a phospholipase-C that has
serological cross-reactions with the C. perf ringens g-toxin but
which has some differences in substrate specificity and is very
much less toxic (Miles & Miles,1947,1950; Mollby,1978); they
have also been reported to produce an oxygen-labile haemolysin and
some poorly characterised proteases (Willis, 1969, chap. 5).
Arseculeratne, Panabokke & Wijesundera (1969) also reported the
presence of DNA-ase and phospholipase-A activity and described a
haemorrhagic toxin in cell extracts of a strain of C. sordelli.
Mellanby & White (1968; White & Mellanby, 1969) separated these
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components and confirmed that p-toxin, phospholipase-C, phospho-
lipase-A, haemorrhagic toxin and neuraminidase were all distinct
products in the cell extract; the neuraminidase was non-toxic in
rabbit skin tests and did not enhance the toxic effect of p-toxin.
The present results confirm that neuraminidase is produced in vivo
during infection by C. sordelli but that none is produced by
C. bifermentans (table VII/X). The finding that neuraminidase
production is one of the few features that distinguish the two
species raises the possibility that the enzyme may play a part in
the pathogenicity of C. sordelli. It seems probable that the
p-toxin is the critical factor that distinguishes very virulent
strains of C. sordelli. but it may be that neuraminidase production
contributes to the more limited pathogenicity of some non-toxigenic
strains of C. sordelli. such as that found in these studies with
the guinea pig model.
The infection produced by C. novyi NCTC538 was very similar
to that produced by virulent C. perfrinaens and C. seoticum strains
(see table VII/X). A moderate challenge dose rapidly killed the
animal, with extensive necrotic destruction of the inoculated thigh
muscles; no neuraminidase was present in the infected tissues.
Ihe pathogenicity of C. novyi type A (see Willis, 1969, chap. 3) is
attributed to its oc-toxin, a lethal and necrotising toxin that has
not been characterised biochemically. It also produces an oxygen-
labile haemolysin (S-toxin), a lipase (€-toxin) and a
phospholipase-C (tf-toxin) that is not related serologically to
C. oerfrinaens oc-toxin and that differs in its substrate
specificity and haemolytic reactions (see Oakley, Warrack & Clarke,
1947; Rutter & Collee, 1969; Taguchi & Ikezawa, 1975, 1977).
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Boyd et al. (1972a and b) demonstrated that active or passive
immunisation of sheep could prevent the development of gas gangrene
with C. novyi spores implanted in gunshot wounds; as with
C. oerfrinaens infections, antitoxin was of little value in
treatment of established infection. The sera used in these
experiments were polyvalent, produced with toxoids prepared from
products of C. perfrinaens and C. septicum as well as C. novyi;
although the level of C. novyi anti-ec-toxin was high, it is
possible that antibody active against other C. novyi products might
also have been present.
The present studies did not investigate the mechanisms of
pathogenicity of the various clostridial species that may be
associated with wound infection, but it is apparent that species
that produce different toxins in vitro can produce similar
myonecrotic infection in this guinea pig model and in clinical gas
gangrene. As with C. perfringens. the injection of culture
filtrates can reproduce most of the features of the local muscle
damage (Aikat & Dible, 1956, 1960) and it is probable that
combinations of the various toxic products and enzymes that have
been identified are reponsible at least for initiation of the
muscle damage and for many of the features of the local gangrenous
infection. There is good evidence that toxins are important in a
number of veterinary infections caused by related types of
Clostridia, e.g. enterotoxaemias and necrotic infections of muscle
or liver. In these diseases infection may prove rapidly fatal;
there may be a terminal septicaemia but death is often attributable
to toxaemia with the major lethal toxin produced by the infecting
organism. Stephen & Pietrowski (1981, pp. 74-5) emphasised the
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dramatic success of active vaccination with clostridial toxoids in
preventing a range of infections in sheep and cattle and conclude
that "it is inconceivable not to ascribe an important role to
C. oerfrinaens P- and S-toxins, C. novvi oc-toxin (and) C. septicum
oi-toxin in the pathogenesis of (these diseases); however, one
cannot absolutely rule out the possibility that other factors might
also play a vital or ancillary role". Although consideration of
these diseases may be thought to strengthen the general case for
the importance of toxins in clostridial pathogenicity, Bullen
(1970) was at pains to emphasise that the evidence was much less
convincing for gas gangrene than for enterotoxaemic infections.
It is apparent that neuraminidase is produced both In vitro
and in vivo by a number of important pathogenic Clostridia and it
may be generally true that virulent strains produce high levels of
the enzyme, but it is clear that the correlation is not absolute.
C. perfringens type A is the species most commonly incriminated in
clinical gas gangrene, whether in war injuries or in civilian
practice. The commoner involvement of C. perfringens might reflect
a greater prevalence in soil, dust, etc., or its relative
aerotolerance, allowing initiation of infection at higher Eh
values, in less severely compromised tissue. C. septicum and
C. nowi type A appear equally pathogenic and produce very similar
experimental infection in guinea pigs, though C. nowi may have a
longer incubation period in human infection (see MacLennan, 1962).
Although it is tempting to postulate that the neuraminidase
produced by C. perfringens and C. septicum might be a virulence
factor for these organisms, it is striking that C. novyi. which can
produce equally dramatic infection, does not produce the enzyme.
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C. absonum and C. paraperfrinaens are regarded as non¬
pathogenic clostridial species that are related to C. perfringens
in that they produce phospholipase-C enzymes that show serological
cross-reactions with C. perfrinaens cc-toxin. They proved to be of
low virulence in the guinea pig tests (table VII/X). However some
multiplication of bacteria occurred in the necrotic focus produced
by CaCl2 injection; neuraminidase was detected in the tissues of
animals challenged with C. absonum but none was present with
C. oaraperfringens. and this conforms with the results of tests for
production of the enzyme in vitro. Of the other neuraminidase-
positive species, C. chauvoei is pathogenic for animals
(blackquarter) but not for man, whereas C. tertium is regarded as
non-pathogenic. C. tetani, C. botulinum and C. difficile, all
neuraminidase-negative, are important non-invasive and essentially
toxic human pathogens. C. sporogenes, which is closely related to
C. botulinum. is neuraminidase-negative and essentially non¬
pathogenic, but C. histolyticum and C. fallax are neuraminidase-
negative Clostridia with invasive potential in experimental
infections. The other Clostridia found not to produce the enzyme
in this study are regarded as non-pathogenic (see Willis, 1969,
1977). It is clear that there is no strict correlation between
neuraminidase production and the ability of various clostridial
species to cause wound infection; however, several pathogenic
species produce neuraminidase in addition to recognised toxins and
it is possible that this might contribute to muscle damage during
infection by these organisms.
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Protective effects of antisera in
C. perfringens myonecrosis
A collection of antisera were characterised in preparation
for studies to determine their protective effects in guinea pigs
challenged with C. perfringens strain L2Ab. The standard assay for
neuraminidase activity was adapted in order to demonstrate
inhibition of the enzyme by antibody (Section Via). The full
picture of the inhibitory activity of an antiserum can be shown by
measuring the effect produced by serial dilutions of the serum
(e.g. fig. VI/2). For routine tests the titre of anti-
neuraminidase activity was expressed as the percentage inhibition
of the standard enzyme when tested at a dilution of 1 in 100; this
avoided problems of non-specific enzyme inhibition due to
glycoproteins in the undiluted sera. Although the slope of the
curve might vary a little for different sera, perhaps reflecting
variations in avidity of antibody, the degree of enzyme inhibition
produced by the serum at a dilution of 1 in 100 gave a reasonable
comparison of the anti-neuraminidase activity in the sera used in
this study.
For the present studies it was judged to be more appropriate
to measure antibody against neuraminidase by a direct assay that
indicates inhibition of enzyme action than to use immunoassays that
may be more convenient (e.g. in antigenic analysis of influenza
viruses; see Introductory Review) but may measure antibody
directed against other parts of the molecule. Few antisera were
able to produce complete inhibition of enzyme activity even when
tested undiluted. This problem may also arise with viral
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neuraminidase, where it is attributed to the existence of separate
antigenic and enzymic sites on the surface of the molecule, with
enzyme inhibition occurring by steric hindrance rather than
complete blocking of the active site (see Introductory Review).
Published references to antibody against C. perfringens
neuraminidase (e.g. Warren & Spearing, 1963; Nees & Schauer,
1974b) do not indicate the degree of inhibition achieved; in
discussion at the conference at which the latter paper was
presented Warren stated that "with Clostridium neuraminidase you
only get 50% inhibition; it doesn^t matter how much antibody is
added" (Behring Institute Mitteilungen, 1974, 55, p. 149), although
later in the discussion Nees (ibid., p. 154) said that their rabbit
antiserum did give complete inhibition in vitro.
It is possible that there is antigenic variation between
neuraminidases produced by different C. perfrinaens type A strains
and that greater inhibition might be demonstrable in tests using
the same neuraminidase preparation as was used for production of
the antiserum. An indication that this might occur was obtained
with the Rabbit-4 serum assays shown in figs VI/10 and 11; these
suggested that antibody produced in response to the Sigma
neuraminidase might appear more active when tested with that enzyme
than with the standard strain L2Ab preparation (though the 1863
serum appeared to have similar activity against either enzyme).
This was not explored further, since it appeared that assays for
activity against the strain L2Ab enzyme would in any case be more
relevant for studies designed to assess the protective effect of
various antisera for animals that were to be challenged with that
strain.
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The specificity of anti-neuraminidase antibody in inhibition
of enzymes from different sources has not been systematically
investigated but the occurrence of antigenic shift and drift in
influenza A viruses suggests that serological differences in the
enzyme might occur even within closely related groups of micro¬
organisms. Weak cross-reactions have been observed between neura¬
minidases produced by different species within a single genus, e.g.
with Streptococcus (Hayano et al., 1969), Pasteurella (Scharmann,
1974) and Arthrobacter (Huchzermeier, Tanenbaum & Flashner, 1980).
Most studies have found no cross-reactions or cross-inhibition in
comparative studies with antisera against enzymes produced by
different genera of bacteria or by viruses or mammalian cells (e.g.
Madoff, Eylar & Weinstein, 1960; Muller, 1974a; Scharmann, 1974;
Huchzermeier et al., 1980). The exception to this was the early
report by Warren & Spearing (1963) of serological cross-reactions
involving the neuraminidases that they detected in semi-purified
preparations of toxins produced by Corvnebacterium diphtheriae and
Clostridium perfrinaens. They showed that commercially available
antitoxins prepared for use in clinical treatment of infections
with either organism not only had anti-neuraminidase activity
against the homologous enzyme but also could neutralise the enzyme
produced by the other species. Studies in this laboratory (not
reported here) suggested that one available sample of equine
diphtheria antitoxin did inhibit C. oerfrinaens neuraminidase, but
it also had activity against C. perfrinqens phospholipase-C; a
second diphtheria antitoxin preparation from a different source had
no activity against either enzyme. It appears possible that equine
antisera may contain antibody against a variety of bacterial
307
products that have been previously encountered by the animal as
well as against the antigens currently being administered. The
investigation was not taken further since it appeared unlikely that
the reported cross-reaction between the enzymes of the two species
would offer a means of obtaining an antiserum that would
specifically inhibit neuraminidase action during experimental
C. perfrinaens infections.
A variety of equine antisera against C. perfringens culture
products were available in Prof. Collee"s collection in this
laboratory and were tested in order to assess their content of
anti-neuraminidase (section VId). The results presented in fig.
VI/2 show that the commercially available C. oerfringens antitoxin
used for demonstration of anti-phospholipase activity in diagnostic
tests also had activity against neuraminidase, whereas the
C. tetani antitoxin preparation could be used as a control equine
serum with no anti-neuraminidase activity. The most potent of the
equine antisera tested was an experimental serum (serum 1863) that
had been prepared primarily for its anti-oc-toxin activity and had
been held in this laboratory for many years; it produced c. 80%
inhibition when tested at 1 in 100 dilution in the standard
anti-neuraminidase assay, and was used as reference serum in assays
for titration of inhibitory activity in other sera (e.g. figs VI/2,
8, 10 and 12).
It appears from the results presented in Section Vic that
C. perfringens neuraminidase is rather a poor antigen.
Concentrated preparations of neuraminidase-containing culture
supernate of strain L2Ab gave rise to very low levels of anti-
neuraminidase activity in Rabbits 1 and 2 (fig. VI/4), although
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analysis by gel diffusion showed that antibody had been produced to
at least four other components in the crude antigen preparation
(fig. VT/6). Three other rabbits were immunised with the purified
Sigma enzyme preparation, with varied doses, adjuvants, routes of
injection and immunisation schedules (table VI/IV). In each case
there was a very slow rise in antibody titre that did not reach a
maximum until 5-10 weeks after the initial injection and might
remain at much the same level for many months thereafter (figs
VI/7, 9 and 12). Further injections of antigen generally produced
little booster effect, perhaps because the presence of circulating
antibody impeded presentation of antigen to the immune system. The
neuraminidase was initially given by the subcutaneous route with
incomplete Freund"s adjuvant; however substitution of the complete
FreundNs adjuvant, or the administration of larger doses of antigen
by intraperitoneal or intravenous injection with aluminium
hydroxide as adjuvant, still did not produce a satisfactory booster
effect. The best effects were obtained in Rabbits 4 and 5, but the
antibody levels achieved gave only 60-70% inhibition of the test
enzyme in standard tests at a dilution of 1 in 100. Titration
curves prepared with serial dilutions of these sera showed that the
final serum from Rabbit 5 was the more potent of the two, with
anti-neuraminidase activity equivalent to that in the reference
equine serum 1863 (figs VI/10 and 13).
It is not clear why it is difficult to produce more potent
anti-neuraminidase sera. The techniques used appear comparable to
those employed in the other studies mentioned above in which
antisera were raised against bacterial neuraminidases. It may be
that our tests with antiserum diluted 1 in 100 are more demanding
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than those used in other studies, but amounts of antibody are
conventionally expressed in terms of serial dilutions of serum, and
titres of antibody raised against other products are frequently
very much higher than this. It seems unlikely that the poor
response is attributable to the activity of the injected enzyme,
e.g. on cells of the immune system, since the enzyme from
myxoviruses appears to be a good antigen; some of the difference
in response may be attributable to the particulate nature of the
virus enzyme in contrast to the low MW of C. oerfrinuens
neuraminidase.
The anti-neuraminidase and anti-phospholipase titres of a
range of equine and rabbit antisera were compared in standard
assays (see table VI/V). Four equine antisera had high levels of
anti-phospholipase but one other experimental serum and the
C. tetani antitoxin had negligible activity; none of the rabbit
antisera had activity against C. perfringens phospholipase. Serum
1863 and two other equine sera had fairly high levels of anti-
neuraminidase activity, of the same order as that in the immune
rabbit sera; the tetanus antitoxin and the pre-inoculation normal
rabbit sera had insignificant activity. This collection of sera
with different combinations of anti-neuraminidase and anti-
phospholipase activity were used in animal studies in order to
determine the correlation of protective effect and antibody content
(Section Vile).
Animals were challenged with C. perfrinaens strain L2Ab in
doses close to the minimum lethal dose with either adrenaline or
CaCl2 as initiating agent (tables VII/XI and XII). The adrenaline
model gave more clear-cut results; with some sera infection was
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established and proceeded to produce myonecrosis, whereas with
others there was complete protection or, at most, formation of a
small localised abscess. With CaCl2 as initiating agent, surviving
animals developed more pronounced local infection in the damaged
muscle; however, protection from lethal myonecrosis was clearly
demonstrable in this model too. Bullen & Cushnie (1962) studied
protection of guinea pigs challenged with a strain of
C. perfringens that was described as feebly toxigenic but invasive
and lethal; in their studies, protection was much more effective
with adrenaline than with CaCl2 as initiating agent. They used
similar challenge doses in each model (27-65 x 10^ cells with
CaCl2, 56-65 x 10° with adrenaline); an earlier report suggested
that the minimum lethal dose for this strain with CaCl2 was 50-100
cells (Bullen et al., 1961) and the use of a high challenge dose
may have contributed to their difficulty in demonstrating
protection with the CaCl2 model.
In the present studies four equine sera (CPA2, 1863, 1881 and
2748) were clearly protective, whereas two others (5438 and ATS)
were not; none of the sera from Rabbits 3, 4 or 5 were protective
(tables VII/XI, XII and XIII). It is interesting that the same
pattern of results was produced in each experimental model, as it
is possible that the mechanisms involved might differ. Since
adrenaline produces a transient ischaemic focus it is likely that
the protective effect of serum in this model is related primarily
to initial events important for establishment of infection during
the first few hours. By contrast, CaCl2 produces a long-lasting
necrotic focus in which infection is easily established. The
effect of antiserum in this model is not to prevent establishment
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of infection but to control its progress so that the animal
survives with infection localised in an abscess at the site of
inoculation.
It is evident that the protective effect of the sera
correlates with the level of anti-oc-toxin, but not with the level
of anti-neuraminidase (see table VI/V). The four protective equine
antisera all had high anti-phospholipase activity whereas the two
equine sera with low levels were non-protective; the rabbit sera
contained no anti-phospholipase and were not protective (tables
VII/XI, XII and XIII). Most of the equine sera with high anti-
phospholipase activity also had high levels of anti-neuraminidase
activity; however, serum 1881 was also protective despite its
considerably lower anti-neuraminidase content. None of the immune
rabbit sera were protective although they contained levels of anti-
neuraminidase equivalent to those in the protective equine sera
CPA2, 1863 and 2748. The effect of these sera appears to be
comparable to that of the antisera studied by Evans and by Bullen
in similar experimental models (see Introductory Review), though
the present studies did not explore the fuller picture that would
be obtained with graded doses of antisera, different challenge
doses or alternative challenge strains of C. perfringens. Our
results, therefore, tend to confirm those of Evans (1943a and b,
1945a, 1947), who concluded that the protection afforded by
antisera in the early stages of experimental myonecrosis in guinea
pigs is attributable to their anti-ec-toxin content.
It is possible that the amounts of anti-neuraminidase present
were inadequate to neutralise the enzyme in vivo despite their
activity in vitro. Neuraminidase was produced in the infected
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tissues and could be demonstrated in the animals challenged in the
CaCl2 model despite the presence of protective antisera; it was
absent only in some animals given adrenaline where antiserum proved
able to prevent infection completely (tables VII/XI and XII). The
significance of this is not clear. The critical time for antibody
action appears to be during the first few hours after challenge
when small numbers of bacteria and small amounts of enzymes and
toxins are present; the neuraminidase-positive samples from
protected animals were taken 6 days later when a localised abscess
had been produced by bacteria multiplying in the area of necrosis
produced by injection of CaO^. The levels of anti-neuraminidase
in the protective equine sera were as high as those that could be
produced by immunisation of rabbits with purified enzyme, and it
is difficult to suggest procedures that would be likely to produce
higher levels. It might be possible to purify and concentrate
anti-neuraminidase from these sera, e.g. by adsorption to
immobilised neuraminidase, and it would be interesting to
demonstrate whether increased amounts of anti-neuraminidase might
have any protective effect. However, it is clear that the amounts
of anti-neuraminidase present in protective antisera did not
contribute to their protective effect.
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CONCLUSION
The general case for considering that neuraminidase might
have a role in bacterial pathogenicity is presented in the
Introductory Review. Neuraminidase is produced In vitro by a
number of important pathogenic bacteria. The enzyme is thought to
have a nutritional role in nature and it is likely that it will
also function in this way if it is produced in vivo during
infection. Sialic acids are important constituents of circulating
glycoproteins and of the surface membranes of a wide variety of
fixed and circulating cells in man and animals. Mammalian
neuraminidase is predominantly intracellular, and its activity is
carefully controlled in the normal animal; decreased host enzyme
levels are associated with disease, and it appears probable that
the production of increased levels of neuraminidase during
infection by bacteria that produce the enzyme in vivo will also
upset delicate regulatory mechanisms in the host. The effects of
treatment with bacterial neuraminidase have been studied with many
different glycoconjugates and cell types; it is not directly toxic
but can profoundly affect the normal distribution and lifespan of
various glycoproteins and cells, and neuraminidase-induced
antigenic changes in various cell types can lead to adsorption of
naturally occurring antibody and cell damage. Neuraminidase might
act as an aggressin, reducing surface charge and removing
protective sialic acid from cells and molecules and facilitating
further breakdown by other toxins and enzymes; it might have a
particular role in attacking protective mucins overlying various
epithelial surfaces in the body.
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These possibilities were appreciated in outline by 1970.
Intensive research on sialic acids in the last 10 years has
sustained the general proposition that sialic acids are important
molecules and hence that bacterial neuraminidase produced during
infection might well contribute to host damage. It must be
conceded, however, that little positive evidence for a pathogenic
role for bacterial neuraminidase has been produced in this period.
It has been suggested that there is a general correlation between
virulence and production of the enzyme for a variety of pathogenic
species, but there are many exceptions and it seems likely that the
enzyme is also of value for various commensal organisms. The case
for neuraminidase as a virulence factor for a variety of aerobic
bacterial species was examined in the Introductory Review, but
remains unsubstantiated.
The present studies have examined neuraminidase production by
a variety of well characterised anaerobic bacteria in the genera
Bacteroides and Clostridium. The taxonomy of the Bacteroidaceae
has been much refined in recent years, with continuing alterations
and subdivisions as the biochemical attributes of different species
are defined. The present results are consistent within the species
studied and it is suggested that tests for neuraminidase production
might be of value in some aspects of classification of these
organisms. Little is known of the pathogenic mechanisms of the
Gram-negative anaerobes but it is clear that strains of
B. fragilis. the species most commonly incriminated in infection,
are strongly neuraminidase-positive in vitro and it is possible
that the ability to produce the enzyme is a factor in the patho¬
genicity of this organism.
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A number of pathogenic clostridial species are neuraminidase-
positive, notably C. oerfrinoens and C. septicum. two important
organisms causing gas gangrene. Some C. oerfrinoens strains do not
produce the enzyme but most gangrene-producing strains do.
Although there may be a general correlation between virulence and
neuraminidase production in these gas gangrene species, the link is
not absolute as C. novyi is equally virulent but neuraminidase-
negative. Neuraminidase production is one of the few biochemical
characters that distinguish the pathogenic species C. sordelli from
the non-pathogenic C. bifermentans and this may be of value in
taxonomic studies with these organisms. A variety of other
clostridial species that produce different types of infections,
e.g. C. botulinum. C. tetani and C. difficile, are neuraminidase-
negative, as are many, but not all, of the saprophytic and
commensal Clostridia examined.
The pathogenesis of clostridial myonecrosis is discussed in
the Introductory Review; attention has focused primarily on
C. perfrinaens although the disease may also be produced by
C. seoticum and C. novyi. alone or in various combinations of the
three species. Many of the features of the local muscle necrosis
can be reproduced, in vitro and in vivo, by exposure of muscle to
culture filtrates, and this supports the hypothesis that
clostridial myonecrosis is attributable to the action of toxins
and/or enzymes produced by these species. Experimental infection
in the guinea pig reproduces many of the features of the human
disease and has been used for elucidation of the role played by
various toxic products. There may be a general correlation between
virulence and oc-toxin production by C. perfrinoens strains, and the
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protective effects of antisera broadly reflect their content of
anti-oc-toxin. Several features of the disease, however, and
notably the terminal toxaemic phase, do not appear to be adequately
explained by theories that attribute the major role in C. oerfrin-
gens pathogenicity to the K-toxin.
The present studies were designed to assess the hypothesis
that neuraminidase might be an important factor in pathogenesis of
clostridial myonecrosis. It was confirmed that the enzyme is
produced in vivo during experimental infections by clostridial
strains that produce the enzyme in vitro, and that no enzyme was
detectable in infections produced by neuraminidase-negative
strains. The enzyme was present in large amounts in the tissues of
animals that died during fatal myonecrotic infection with
C. perfringens or C. septicum but was absent from animals with
comparable fatal myonecrosis produced by C. novyi. The enzyme was
also demonstrable in samples taken from animals where the injection
of non-pathogenic strains, or of sublethal doses of virulent
strains, produced only a small localised infection.
Strains of C. oerfringens that varied in their production of
oc-toxin, 0-toxin, enterotoxin and neuraminidase were selected and
assessed for virulence in guinea pigs. These strains were
naturally occurring strains isolated originally from a variety of
sources including outbreaks of food poisoning, though they may not
be representative of environmental strains liable to contaminate
and infect wounds and injuries. It is difficult to determine
criteria of virulence in experimental guinea-pig infection that
will accurately reflect pathogenic potential in human wounds.
Nevertheless, a number of strains were clearly virulent, able to
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produce lethal experimental infection, while others produced severe
local infection without causing death, and most strains could
multiply to some extent in an area of damaged tissue, producing a
degree of localised infection and abscess formation. There was no
clear correlation between virulence and any of the bacterial
products studied. The most virulent strains did produce of-toxin,
although some apparently pathogenic strains produced rather small
amounts, and at least one phospholipase-negative strain could
produce severe local necrotic damage; however, the correlation
between virulence and neuraminidase production was similarly
incomplete, as at least one neuraminidase-negative strain was able
to produce fatal myonecrotic infection.
A selection of antisera were characterised for their content
of anti-ec-toxin and anti-neuraminidase activity. A number of
experimental equine sera had high anti-ot-toxin titres and were able
to protect animals challenged with a lethal dose of the virulent
C. perfringens strain L2Ab. Several of these sera also had
moderate anti-neuraminidase activity but rabbit antisera with
equivalent amounts of anti-neuraminidase gave no protection. These
studies tend to confirm the classical view that the protective
effects of antisera in clostridial myonecrosis are attributable to
their anti-oc-toxin content. It appears that neuraminidase is
rather a poor antigen and that it is difficult to produce antisera
that will give good neutralisation of the enzyme when tested at
high dilution; however, there is no evidence that anti-
neuraminidase contributes to protection against experimental
C. perfringens infection. The results of studies in guinea pigs
can be related to human infection only with great caution, but the
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limited protection given by antitoxic sera in the guinea pig
appears to parallel clinical experience with antitoxin therapy in
gas gangrene; there is no reason to suppose that improved
protection in man could be achieved by increasing the anti-
neuraminidase content of therapeutic antisera.
The present studies, designed to assess the relative
importance of neuraminidase and oc-toxin in experimental clostridial
myonecrosis, have not explored other factors in pathogenesis, and
little can be added to the general discussion in the Introductory
Review. Infection is a dynamic process; the minimum lethal dose
of a challenge strain is that which enables the organisms to
multiply rapidly enough to outstrip the host's response and proceed
to kill the animal. With sublethal doses the host is normally able
to remove the bacteria and prevent infection. In experimental
clostridial myonecrosis there is a delicate balance between host
and bacterial factors and it appears that the initial few hours are
critical in determining the eventual outcome of bacterial
challenge. The degree and duration of tissue hypoxia is an
important variable in the host's ability to respond. Infection is
more easily established, with lower challenge doses, when a nidus
of necrotic tissue is produced by injection of CaCl2 than when
transient ischaemia and reduction of Eh are produced with
adrenaline. In either case, however, sublethal doses of the same
virulent strain may produce infection that is contained locally and
does not proceed to give the full picture of fatal myonecrosis. In
this situation the outcome of infection does not depend on the
biological properties of the strain but on the rate at which some
critical point is reached; it appears that, after this point,
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either the organism will proceed unchecked and overwhelm the host,
or it will be contained and the host will survive. The fatal
outcome is not dependent on the extent of local infection
ultimately produced but rather on the initial rate at which
infection is established.
The critical importance of the size of challenge dose might
reflect the effectiveness of the host's phagocytic cell response.
The difference in minimum lethal dose of C. perfrinaens with CaO^
or adrenaline used as initiating agent is attributable to different
degrees of tissue compromise; ischaemia and Eh reduction may be
important in impairing early phagocytic function in addition to
their role in providing conditions suitable for clostridial growth.
The strikingly low numbers of polymorphonuclear cells seen during
acute infection suggests that bacterial products also interfere
with the normal leucocyte response or have leucocidal activity.
Differences in virulence of different challenge strains might
reflect factors that confer protection against phagocytosis, e.g.
the production of capsules (see Introductory Review). However, a
correlation between virulence and capsule production has not been
generally observed, and the absence of pus cells in acute infection
suggests that the leucocidal effects of bacterial toxins may be
more important in virulence. The present studies showed that many
polymorphonuclear leucocytes were present when infection had been
contained in a local abscess some days later; it might be
instructive to compare the dynamics of the polymorphonuclear cell
response in the initial stages of challenge with sublethal and
lethal doses of various strains of C. perfrinaens. It may be that
Bullen's studies, which emphasised the importance of non-specific
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host defences involving serum factors, e.g. transferrin, have
diverted attention frcm the role of the cellular response.
The protective effects of anti-c<-toxin in the early stages of
experimental infection with C. perfrinaens. though limited to
situations where the degree of tissue damage is not too great,
indicates that K.-toxin plays a critical part in initiation of
infection. This is particularly evident when infection follows an
injection of washed cells mixed with adrenaline; early production
of K-toxin is presumably required in order to damage cells and
perpetuate low Eh values after the vasoconstrictor effects of the
adrenaline wear off. The role of K-toxin in extending the local
lesion is not so well attested, but it is not easy to ignore the
evidence that oc-toxin can by itself produce many of the features of
muscle damage. The local infection is often rapidly progressive
and no doubt there are two parallel processes, necrosis of tissues
due to lack of oxygen and falling Eh and pH values, and active
destruction of tissue by bacterial toxins and enzymes. The
efficacy of hyperbaric oxygen and the lack of efficacy of antitoxic
sera in preventing expansion of the lesion into neighbouring
healthy tissue suggest that hypoxia is more important than oc-toxin
or other bacterial products at the edge of the infected area.
Although C. oerfringens may contribute to the extension of hypoxia
by active removal of oxygen as suggested by Bullen, it appears
unlikely that C. seoticum or C. novyi. much stricter anaerobes,
will play a comparable role; with infection by these organisms
other factors, e.g. vascular damage, oedema, increased tissue
pressure and shock, appear to be sufficient to produce rapidly
extending muscle necrosis.
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The present studies give little information about the
mechanisms involved in the toxaemic phase beyond recording the fact
of death following challenge with adequate doses of virulent
organisms. There may well be differences between the processes
leading to systemic collapse and death in man and in the guinea
pig. Although death of a guinea pig during clostridial muscle
infection is usually taken to indicate toxaemia, there might also
be terminal septicaemic spread. Some guinea pigs survive despite
massive muscle destruction and the accumulation of a large volume
of haemorrhagic exudate around the hind limb; it is improbable
that untreated patients would survive comparable damage and fluid
loss, and it may be that guinea pigs are more resistant to shock
than man. The speed of fluid loss from the circulation may be
important in this model; perhaps a slower process of muscle
destruction allows greater compensation. Modern techniques for
investigation of mechanisms of shock and circulatory collapse could
now give a much more detailed picture of the terminal stages of
human gas gangrene than could be obtained in World War II.
Fortunately, the disease remains rare in areas where such expertise
is available, but such studies should be valuable in redefining the
role of toxaemia in gas gangrene. It seems unlikely that a single
toxin is the final lethal factor in clostridial myonecrosis, if
only because there is no common bacterial product formed by
C. perfringens. C. septicum and C. novvi that might be held
responsible for systemic collapse and death; this, and the failure
of antitoxic sera to prevent death, tend to suggest that more
general mechanisms are involved.
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The evidence against a major role for circulating
C. perfrincens oc-toxin in the toxaemic phase of clinical gas
gangrene is discussed in the Introductory Review. It is also
unlikely that neuraminidase plays a role in the terminal stages of
clostridial myonecrosis, but the possibility should be borne in
mind. Haemolysis is a rare feature of the disease, and it might be
attributed to a variety of mechanisms. However, T-activation of
red cells has been detected on occasion during clostridial
infections and it is possible that it is more frequently
overlooked. It is not clear whether exposure of T antigen _in vivo
leads to significant red-cell damage by interaction with the
patient's own natural anti-T, but haemolysis has on occasion been
demonstrated in this situation following transfusion of whole blood
containing anti-T; it may be safer to use packed cells where this
risk may occur (see Introductory Review).
The results of the present studies leave C. oerfrinaens
neuraminidase in the same category as various other potential
virulence factors, e.g. 0-toxin, hyaluronidase and collagenase of
C. perfringens and equivalent products of C. seoticum and C. novyi.
Ihe biological activities of these bacterial products suggest that
they contribute to tissue damage and digestion in vivo. However,
no strict correlation can be shown between ability to produce these
factors and the virulence of different organisms, and antibody
against them cannot be shown to contribute to protection against
infection. It seems probable that these products do contribute to
tissue digestion in the established lesion, and that the oc-toxin
also plays a critical role in initiation of infection. When
anaerobic conditions are established the condition becomes
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irreversible and none of the specific toxins plays an essential
role in the progress of infection. Each pathogenic species
produces a battery of cytolytic toxins and degradative enzymes that
are of value to the organism in its commensal or saprophytic roles
and it would be surprising if they did not also contribute to
digestion of the tissues in an area where anaerobic conditions
prevail, cells are dying and host defences are impaired; however,
they do not appear to be essential for extension of the local
lesion or the subsequent toxaemia, collapse and death. The
detailed pathogenesis of gas gangrene is still not understood, but
there is no evidence that neuraminidase plays a major role.
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Plate XV
Neuraminidases (EC 3.2.1.18) are widely distributed in nature, being found
in viruses, bacteria, protozoa and vertebrate tissues. In mammalian cells,
neuraminidase appears to be a lysosomal enzyme (Taha and Carubelli, 1967).
The role of neuraminidase in the replication and pathogenicity of myxo-
viruses has been much studied but remains unclear (Drzeniek, 1972). Neuram¬
inidase is produced by a number of important bacterial pathogens, e.g., Clos¬
tridium welchii (C. perfringens), Corynebacterium diphtheriae, Vibrio cholerae
and Streptococcus pneumoniae, as well as by many harmless commensal organ¬
isms (Gottschalk and Bhargava, 1971). It has been suggested that neuramini¬
dase production may be related to bacterial pathogenicity (Dewitt and Rowe,
1961; Collee, 1962 and 1965; Gadalla and Collee, 1968; Pardoe, 1970),
but no positive correlation has so far been demonstrated (White and Mellanby,
1969; Drzeniek, Scharmann and Balke, 1972). In the course of investigations
into the possible role of neuraminidase in infections caused by C. welchii, we
found it necessary to develop a substrate for neuraminidase that is cheap and
readily available in quantity.
Neuraminidases are usually assayed by measuring the release of N-acetyl neuraminic acid
(NANA) from a suitable glycoprotein, glycolipid or oligosaccharide substrate. The free
NANA can be measured in the presence of excess substrate by the thiobarbituric-acid assays
of Aminoff (1959 and 1961) or Warren (1959 and 1963). Cassidy, Jourdian and Roseman
(1965 and 1966) recommend the use of N-acetyl neuramin-lactose (NAN-lactose) prepared
from bovine colostrum as substrate for the assay of C. welchii neuraminidase; this is widely
used in neuraminidase assays, but commercially available preparations are very expensive,
and it may be that the cost of NAN-iactose has been inhibiting further work on bacterial
neuraminidases.
Popenoe and Drew (1957) prepared a!-acid glycoprotein (orosomucoid) from the urine
of nephrotic patients and showed it to be a suitable substrate for C. welchii neuraminidase
assays, and Hughes and Jeanloz (1964) used cq-acid glycoprotein prepared from human
plasma as substrate in studies on pneumococcal neuraminidase. In early work on C. welchii
neuraminidase in this laboratory (Collee, 1962 and 1965) hen egg-white was used as substrate.
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This was later replaced by human plasma (Gadalla and Collee, 1968), and Collee and Barr
(1968) then described a simple method of preparing an unrefined glycoprotein fraction from
200-400 ml of plasma from out-dated human blood by trichloracetic-acid precipitation.
This human glycoprotein gave more reliable results than were obtainable by the use of whole
plasma, and it has proved a very satisfactory substrate in this laboratory. However, the
limited supply of starting material and the problems of scaling up certain stages such as
dialysis would make it difficult to ensure a supply of closely standardised substrate during a
prolonged investigation.
In this paper we describe a method of preparing large amounts of a glyco¬
protein fraction from pooled human plasma. The oq-acid glycoprotein is
normally a waste product of large-scale plasma fractionation and a simple
method of recovering it from the supernate from Cohn fraction V has been
developed. It is considerably cheaper than commercially available NAN-
lactose or pure aracid glycoprotein, does not carry the risk of transmitting
serum hepatitis (hepatitis B) and is recommended as a substrate for routine
use in neuraminidase assays.
Materials and methods
Substrate preparations. The following method was used to prepare NANA-rich glyco¬
protein (fraction VII) from the supernate of Cohn fraction V, obtained from approximately
1000 donations of plasma from out-dated blood, by Cohn method 6 (Cohn et al., 1946). A
120-litre volume of supernate from Cohn fraction V was titrated to pH 6-2 and cold (—25°C)
ethanol added until the final concentration of ethanol was 70% (v/v); the temperature of the
solution was lowered to — 10°C during the addition, and maintained for 24 h. The resulting
white precipitate was removed by continuous-flow centrifugation in a refrigerated Sharpies
Super-centrifuge at 20,000 g and a flow rate of 40 litres per h. Approximately 700 g of
moist precipitate was recovered and dissolved rapidly in 5 litres water. The solution was
adjusted to pa 8-0 with 2m NaOH and pasteurised in a stainless steel vessel at 60°C for 10 h.
The solution was cooled, titrated to pH 5 0 with dilute acetic acid and held frozen at — 20°C.
After some weeks it was thawed at 5°C, centrifuged for 1 h at 4000 g to remove insoluble
protein, and filtered rapidly through Green's 904)- fluted paper to remove floating lipoproteins.
The solution was dispensed in vials, frozen and freeze-dried to a final vapour pressure of
13-33 n/m2 (0 01 torr) at 20°C.
Two such large-scale preparations were made, differing in minor details of scale, re¬
solution volume and the volume dispensed for freeze-drying; there was no detectable
difference between the batches. The results given in this paper were all obtained with the
original batch, FVII(5). Each batch was very readily soluble in water, even in concentrations
exceeding 50 mg per ml.
Electrophoresis. Cellulose-acetate electrophoresis was carried out on Sepraphore III
medium (Gelman Instrument Co., Ann Arbor, Mich., USA) at pH 8-6. Strips were stained
for total protein (Ponceau S) and for glycoprotein (Kohn, 1968).
Totalprotein. Protein was estimated by a biuret method (Gornall, Bardawill and David,
1949); a copper-free control reagent was used to correct extinction readings for the opales¬
cence of the glycoprotein preparations.
Electrolytes. Na+ and K+ were determined by flame photometry, chloride by a titrimetric
method (Kit 830: Sigma Chemical Co. Ltd, Kingston upon Thames, Surrey) and Ca2+ by a
fluorimetric method (Fingerhut, Poock and Miller, 1969).
Strain of C. welchii. This was a laboratory sub-strain (L2Ab) derived from a classical
type-A strain originally obtained from Professor C. L. Oakley, School of Medicine, University
of Leeds.
Culture media. Cultures, periodically prepared from lyophilised stock, were maintained
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Fig. 1.—Separation of glycoprotein preparation FVII by cellulose-acetate electrophoresis. Samples
(a) and (c), human serum; samples (b) and (d), fraction FVII. Strips (a) and (6) stained for total
protein; strips (c) and (d) stained for glycoprotein.
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in tubes (10 ml) of cooked-meat broth prepared as described by Cruickshank (1968, p. 757),
but with Nutrient Broth (Oxoid, no. 2) replacing the peptone infusion broth.
The broth used for the production of neuraminidase contained (g per litre): Proteose
Peptone (Difco, code 0120) 50 g and NaCl 5 g and was adjusted to pH 7 0. It was autoclaved
at 121°C for 15 min. and is referred to as 5% proteose peptone water (PPW5).
Anaerobic culture. Broth media were held in a steamer at 100°C for 30min. (pre-steamed)
and promptly cooled to 37°C just before inoculation. BTL jars (Baird and Tatlock Ltd,
Chadwell Heath, Essex) were used with room-temperature-active catalyst sachets supplied by
BTL. The caps of bottles were loosened when they were put into anaerobic jars. Jars were
filled with hydrogen and 10% (v/v) CO2 according to the standardised procedure described
by Collee, Rutter and Watt (1971).
Preparation of C. welchii neuraminidase. The test strain was inoculated into a tube of
cooked-meat broth and incubated anaerobically at 37°C for 18 h; 1 ml of this culture was
inoculated into 100 ml of pre-steamed PPW5 broth and incubated anaerobically at 37°C for
48 h; 20 ml of this starter culture was used as inoculum for each of three 600-ml (20-oz)
narrow-mouthed Winchester bottles containing 500 ml of pre-steamed PPW5 broth which
were then incubated anaerobically at 37°C for 48 h. The cultures were centrifuged at 1700 g
for 1 h at 4°C and the culture supernates were pooled and stored at 4°C. The pooled super-
nate was passed through a Seitz filter and the filtered supernate (P9) was stored at — 20°C
for some months.
A 100-ml sample of P9 material was thawed and, after centrifugation (2400 g for 30 min.
at 4°C) to remove a slight precipitate, the supernate was dialysed at 4°C in 25 mm (1 in)
Visking Cellophane tubing for 72 h against running tap water, and finally against a large
excess of distilled water for 24 h. This dialysed preparation (P9D2) had strong neuraminidase
activity and was stored in 5-ml volumes in " bijou " bottles at — 20°C. No phospholipase-C
(a-toxin) activity was demonstrable in tube tests with egg yolk and calcium-gelatin-saline
(Holding and Collee, 1971).
Neuraminidase standard. Our preparations of neuraminidase were standardised by
comparison with a commercially available preparation of chromatographically purified
C. perfringens (C. welchii) neuraminidase (Sigma London Chemical Co. Ltd; neuraminidase,
type VI, N3001); the batch had a declared activity of 1-1 unit per mg of solid with NAN-
lactose as substrate and 0-58 unit per mg with bovine submaxillary mucin as substrate, 1 unit
liberating 10 /zmole NANA per min. at pH 5 0 and 37°C from the test substrate.
Assay for N-acetyl neuraminic acid. Aminoff's thiobarbituric-acid assay for free sialic
acid as described by Cassidy et al. (1966) was followed. The reagents were: Reagent 1—
0 025m periodic acid (Koch Light) in 0-25m H2SO4 (BDH, Analar) at pH 1-2; Reagent 2—
NaAs02 (BDH) 2% (w/v) in 0-5m HC1 (BDH, Analar); Reagent 3—01m 2-thiobarbituric
acid (Koch Light) in 0-1 m NaOH (BDH, Analar) adjusted to pH 9 0; and Reagent 4—
n-butanol containing 12m HC1 5 % (v/v). Pure synthetic NANA (Koch Light) was used as a
standard. In routine tests, 0-5-ml samples were assayed in glass tubes (125x15 mm).
Spectrophotometric readings of the organic phase at a wavelength of 549 nm were made with
4-ml glass cuvettes (1-cm light path) in a Pye-Unicam SP 600 spectrophotometer. The
reference cell contained a " reagent blank " prepared by taking 0-5 ml distilled water through
the assay procedure.
Assay for neuraminidase activity. For the standard test, 0-5 ml of reaction mixture was
prepared by adding the following volumes to glass tubes (125x 15 mm): 01 ml of enzyme
preparation; 015 ml of 0-Im sodium acetate buffer, pH 5-1, (Cruickshank, 1968, p. 853);
and 0-25 ml of substrate FVII. Unless stated otherwise, dilutions of substrate or enzyme were
made in acetate buffer, pH 5-1. Throughout the text the stated dilution of an enzyme pre¬
paration is that prepared for addition to the reaction mixture, but the concentration of sub¬
strate is normally given as the final concentration in the reaction mixture. Enzyme and
substrate control tubes contained the equivalent volume of acetate buffer, pH 5-1, in place of
the substrate and enzyme respectively. Reagents were normally held at room temperature
before making the test mixtures, but were pre-warmed to 37°C when the period of incuba¬
tion was to be less than 10 min. After incubation for the appropriate period at 37°C in
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a water bath, reagent 1 was added to the mixture and the standard NANA assay was
performed.
In studies of the time-course of the reaction with different concentrations of substrate
and enzyme, standard tests were set up and incubated for graded periods of time. The timing
of experiments was such that test periods of incubation ended simultaneously and all tests,
including time-zero (To) control tests, were assayed for NANA in a single batch. The To
controls were set up as follows: the standard assay volumes of enzyme, substrate and buffer,
pre-cooled to 0°-l°C, weremixed in a tube held in an ice bath at 0°-l°C. The assay for NANA
was begun immediately by adding reagent 1 and transferring the mixture to a water bath at
37°C. As preliminary tests showed that the value for the To control was equal to the sum of
separate enzyme and substrate controls performed at To, and that the values for enzyme and
substrate controls did not increase significantly during incubation for periods up to 24 h, a
To control was used in place of separate enzyme and substrate controls for each test period.
Each test and control assay was performed in duplicate and an average value for the
extinction at 549 nm was calculated. The test reading was corrected to give a value equivalent
to the amount of NANA released from the substrate during the incubation period by sub¬
traction of either the sum of separate enzyme- and substrate-control readings or the value for
the To control test. Reference assays of 10 pg of pure NANA in 0-5 ml of distilled water were
performed with each batch of assays. The results of neuraminidase assays are expressed in
terms of spectrophotometric readings and are not routinely converted into equivalent
concentrations of NANA because the presence of constituents of the culture medium may
influence the reading obtained in the assay for NANA (see Results).
Studies of the effect of pH on the neuraminidase assay. Sodium-acetate buffer solutions
were prepared as described by Cruickshank (1958, p. 853); the pH range was extended to
give buffers of higher pH by the use of progressively smaller volumes of acetic acid and corres¬
pondingly larger volumes of sodium-acetate solution. In order to ensure adequate buffering,
tests were performed in a greater volume than for standard neuraminidase assays. The total
reaction-mixture volume of 1 0 ml consisted of: 0-1 ml of enzyme preparation P9D2 diluted
1 in 2 in distilled water; 0-65 ml of the appropriate buffer; and 0-25 ml of substrate FVII
that had been diluted to 6-13 mg per ml in distilled water. Separate enzyme and substrate
controls were prepared at each pH value by replacing the substrate and enzyme respectively
with the equivalent volume of the appropriate buffer. Tests and controls were incubated for
30 min. at 37°C and then assayed for NANA by the standard method.
The starting pH values of this series of tests were measured during a separate experiment.
With pre-cooled reagents, test mixtures were prepared in tubes held at 0°-l°C in an ice bath
and the pH of each mixture was measured immediately. Small samples were brought to
37°C in a Radiometer BMS2 system and the pH values at 37°C were promptly read on a
linked Radiometer PHM 71 meter. ThepH values plotted for fig. 5 are these measured values
for the initial pH of the reaction mixture. The tests were then incubated at 37°C for 30 min.
and the final pH again measured. In no case was there a deviation of more than 0 05 pH
unit during the assay period.
Tris-maleate buffer solutions were prepared as described by Diem and Lentner (1970);
the pH range was extended to give buffers of lower pH by the use of progressively smaller
quantities of NaOH. Tests were performed by the same method as for the tests in acetate
buffer and initial pH values were similarly determined.
Tests for effects ofculture materials on the NANA assay. The effects of various prepara¬
tions on the NANA assay were investigated by preparing test mixtures of 01 ml of test
substance, 0-15 ml of sodium acetate buffer, pH 5-1, and 0-25 ml of pure NANA in distilled
water. Time-zero (To) tests were prepared with pre-cooled reagents. Each test value was
corrected by subtraction of the value obtained for control mixtures with buffer in place of
NANA. Reference tubes containing only NANA in buffer were prepared by replacing the
test substance with buffer, and each test result was compared with the appropriate reference
value to show whether the test substance had interfered with the NANA assay.
When it was desired to demonstrate the extent of NANA breakdown that might occur
during incubation under the conditions of the neuraminidase assay, tests and controls were
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also incubated at 37°C for the appropriate period before assaying for NANA. Experiments
were timed so that test periods of incubation ended simultaneously and all tests, including
To tests, were assayed for NANA in a single batch. Any breakdown of NANA during
incubation of a test mixture can be detected by comparing the corrected values for the in¬
cubated test and the To test.
Time-course studies of the release of NANA from substrate by acid hydrolysis. Equal
volumes (0-7 ml) of a known concentration of H2SO4 and of substrate dissolved in distilled
water were mixed in screw-capped " bijou " bottles and promptly put into a water bath at
80°C. Reference bottles contained equal volumes of H2SO4 and of a solution of pure NANA
in distilled water to demonstrate the extent of breakdown of NANA under the conditions of
the test. The starting times were arranged so that the test periods of incubation ended
simultaneously. The bottles were then rapidly cooled in two stages to 0°-l°C, duplicate
0-5-ml samples were transferred to tubes and the assay forNANA was immediately performed.
Time-zero (To) control tests were performed with chilled reagents, the mixture being held for
only a few min. at 0°-l°C before the assay for NANA. Test results were corrected by sub¬
traction of the appropriate To control readings.
Results
Characterisation of the glycoprotein fraction FVII
A vial of the glycoprotein fraction FVII prepared as described in the
Methods section contained 18-4 mg of dry powder. When this was dissolved
in 1 ml of water, the solution contained protein 12-1 mg, Na+ 46 /xmole,
K+<1 /amole, Cl~ 8 ^.mole and Ca2+0-42 ^mole.
Cellulose-acetate electrophoresis of fraction FVII (fig. 1) separated it into
a minor zone with the mobility of serum albumin and a major, rather broad,
" inter-a " zone with a mobility intermediate between the oq and a2 serum
globulins. The albumin zone stained very poorly for glycoprotein while the
" inter-a" zone stained quite intensely. Because the relative dye-binding
characteristics of these proteins were unknown it was not possible to assess
the proportion of the total protein migrating in each zone.
Electrophoretic and immunoelectrophoretic examination of fractions of
FVII separated on Sephadex G-200 confirmed that the " inter-a " zone consisted
of aj-acid glycoprotein, most of which had been polymerised during pasteurisa¬
tion.
Release ofNANA from the substrate FVII by hydrolysis
Release by acid hydrolysis. The total sialic acid present in fraction FVII
was estimated by mild acid hydrolysis. When samples of it were heated at
80°C in 0-02m H2S04 (final concentration) for periods up to 2 h there was
progressive release of NANA, reaching a steady maximum between 1 and 2 h.
When samples ofNANA were similarly treated there was usually no significant
breakdown and the extinction value obtained on assay of NANA incubated
in acid for 2 h was used to convert the test value into the equivalent concentra¬
tion of NANA. It was calculated that NANA constituted 4-7% of the dry
weight of substrate FVII.
Release by C. welchii neuraminidase. The total amount of sialic acid that
can be released from fraction FVII by C. welchii neuraminidase was determined
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by incubation of dilutions of it with undiluted enzyme preparation P9D2
under the conditions of the standard test for periods up to 2 h. When reaction
mixtures were incubated at 37°C in acetate buffer, p\ \ 5-1, there was progressive
release of NANA to a steady maximum after 80 min.; the same amount of
NANA was released from our substrate by C. welchii neuraminidase as by
the acid-hydrolysis procedure.
Enzyme-substrate kinetic studies
Initial velocity of neuraminidase reaction with varying concentrations of
substrate. Enzyme preparation P9D2 was used at a dilution of 1 in 2 in
the acetate buffer, pH 5-1, and a range of concentrations of substrate was pre¬
pared in the same buffer. Reaction mixtures were prepared for the standard
neuraminidase assay and were incubated at 37°C for different periods of time
before the NANA assay. Fig. 2 shows the plots of values for the amount
of NANA released by the enzyme; these are linear for the first 10 min. for all
test concentrations of substrate, and a value for the initial reaction-velocity
at each substrate concentration was derived from this portion of the graph.
Time of incubation at 37°C (min.)
Fig. 2.—Velocity of neuraminidase reaction when a standard amount of enzyme P9D2 was incubated
with graded concentrations of substrate at pH 5-1. Concentrations of substrate FVII (mg per ml
of reaction mixture): ©— ®, 9-2; O O, 3-07; A A. 0-92; E——H, 0-23;
□——□, 0-12. NANA = N-acetyl neuraminic acid.
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Maximum velocity (Vmax) occurred at substrate concentrations of c. 3 mg
per ml; the standard concentration of the original batch of substrate, FVII(5),
used in subsequent experiments was 3-07 mg per ml. Vmax for this substrate
was calculated tQ be 0-26 pg NANA per min. and the Km value was 0-16 mg
per ml.
Initial velocity of neuraminidase reaction with varying concentrations of
enzyme preparation. The final concentration of substrate FVII was 3-07 mg
per ml in the reaction mixture, and enzyme preparation P9D2 was diluted
in acetate buffer, pH 5-1, to give test concentrations of 10, 25, 50, 75 and 100%
(v/v). Standard neuraminidase assays were carried out with the different
Percentage concentration (v/v)
of enzyme preparation P9D2
Fig. 3.—Amounts of NANA released at different times from a standard amount of substrate FVII by
graded amounts of C. welchii neuraminidase. Period of incubation at 37°C (min.): ® ©, 40;
O 0,30; A A, 20; x x,10.
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Fig. 4.—Release of NANA from substrate FVII by very low concentrations of neuraminidase duringprolonged incubation at 37°C andpH 51. Percentage concentration (v/v) of enzyme preparationP9D2 added to reaction mixture: • •. 2; O O, 1; A A. 0-5; x x, 01.
reaction mixtures incubated at 37°C for 10, 20, 30 or 40 min. before the NANA
assay. In fig. 3 the rate of release of NANA is shown to be proportional to
the concentration of the neuraminidase preparation when the reaction mixtures
were incubated for periods of up to 40 min. Thus, using a 15-min. assay,
we could measure amounts of neuraminidase approximately 0T-3 times that
of the test P9D2 preparation. More concentrated neuraminidase preparations
should be diluted before the assay so that the results fall into the reliable range.
Detection of release of NANA by small amounts of neuraminidase after
prolonged incubation with substrate FVII. Experiments similar to that described
above were used to follow the release of NANA from the same amount of
substrate by lower concentrations of enzyme P9D2 during longer periods of
incubation at 37°C. Fig. 4 shows that the plot of the release of NANA from
the substrate is linear for 26 h with suitable dilutions of enzyme P9D2 and that
as little as 0-5 % of the enzymatic activity can be reliably detected with a 24-h
test.
The effect ofpH on the neuraminidase assay. The results of the neuraminidase
assay at different pH values in acetate buffer are shown in fig. 5(a). The plot
of uncorrected results of duplicate tests shows a major peak of activity around
pH 4-6 and a subsidiary peak around pH 5-6. The results of single-tube
substrate-control assays are also plotted and these suggest that the main peak
is actually at pH 4-7. Fig. 5(b) shows the results of a similar experiment when
tris-maleate buffers were used. There is a single peak of activity at pH 5-7.
Direct readings of the initial and final pH of standard neuraminidase assays
of dialysed and undialysed preparations of culture filtrate P9 in acetate buffer,
pH 5-1, showed that the initial pH of the reaction mixtures might be as high
as pH 5-45, but did not vary during incubation.
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/?H of reaction mixture
Fig. 5.—Effect of pH and buffer system on the neuraminidase assay. Enzyme preparation P9D2
incubated with substrate FVII, (a) in sodium-acetate buffers, (b) in Tris-maleate buffers. Un¬
corrected test readings, • •; substrate-contro! readings, A A- The enzyme control
readings were very low and are not plotted.
Effects of culture materials on the NANA assay
When a sample of sterile PPW5 broth is taken through the NANA assay
the formation of a chromogen with a peak absorption at 530 nm gives rise to
significant absorption at 549 nm. This gives rather high enzyme control
values in assays of supernates of cultures in this medium, e.g. P9; the effect
is very much reduced after dialysis.
When a standard amount of NANA is assayed with PPW5 culture super-
nate in the assay mixture, the corrected value (after subtraction of the enzyme-
control value) is sometimes markedly less than the value obtained in an equiva¬
lent assay devoid of culture supernate. The effect may also be seen with sterile
PPW5 broth or other culture media; it is most marked with test mixtures
that have high enzyme control readings (see below).
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Tests for destruction ofNANA under the conditions of the neuraminidase assay
Samples of pure NANA (10p.g) were incubated for periods up to 60 min.
with sterile PPW5 broth or with enzyme preparations P9 or P9D2 under
conditions equivalent to those of the neuraminidase assay. The corrected
value for the time-zero (T0) assay of each test mixture showed the extent of
depression of the true value for NANA before the start of incubation at 37°C.
Sterile PPW5 broth reduced the assay reading by about 10% and the undialysed
P9 preparation reduced it by about 25%, whereas the dialysed preparation
P9D2 produced less than 5% depression of the assay reading. There was no
significant further depression of the assay values when the mixtures were
incubated at 37°C for 60 min., and there is therefore no evidence of significant
N-acyl neuraminic acid-aldolase (NAN-aldolase: N-acyl neuraminate lyase,
EC4.1.3.3) activity in either of the test enzyme preparations under the neura-
< minidase assay conditions. However, in view of the marked depression of the
true NANA level by undialysed culture fluids, it is recommended that dialysed
preparations be used where possible.
Comparative studies on neuraminidase preparations
Samples of Sigma neuraminidase in distilled water were compared in our
assay with undiluted samples of undialysed enzyme preparation P9 and the
dialysed preparation P9D2. The 0.1-ml enzyme samples were incubated for
15 min. at 37°C, pH 5-1, with substrate FVII at a final concentration of 3-07
mg per ml in standard 0-5-ml reaction mixtures. Separate enzyme and substrate
controls were included and the results are shown in the table. The corrected
spectrophotometric reading for undialysed enzyme P9, which has a high enzyme-
control reading, is a minimum value because interfering substances in the
culture supernate must be assumed to have depressed the assay; the dialysed
preparation has a satisfactorily low control value. The Sigma neuraminidase
Table
Results of 15-min. neuraminidase assay of Clostridium welchii enzyme preparations
Spectrophotometric reading (£549^
Test enzyme , A , Neuraminidase
preparation* Enzyme Corrected activity§
Test control valuej (milliunits per ml)
Sigma 0-614 0-000 0-589 27-5
P9 0-729 0-174 0-530 24-7
P9D2 0-454 0-015 0-414 19-3
* Sigma = chromatographically purified neuraminidase (Sigma Chemical Co., Ltd) at an initial
concentration of 25 jug per ml (0-1 ml of this solution used in assay); P9 = undialysed supernate of
culture of C. welchii strain L2Ab in PPW5 broth; P9D2 = dialysed sample of P9.
t Average of duplicate readings.
t Test reading corrected by subtraction of the sum of the values for the substrate control (0-025)
and the corresponding enzyme control.
§ See text for method of calculation.
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was stated by the manufacturers to have a potency of 1-1 unit per mg of solid
when tested with NAN-lactose as substrate; the concentration of Sigma
neuraminidase in the test solution would thus have an activity of 27-5 milliunits
per ml. Separate tests similar to those described in the preceding section
showed that this concentration of Sigma neuraminidase produced no depression
of the assay value for NANA and no reduction in reading during incubation
at 37°C for 15 min. The corrected test value of £,549=0-589 for Sigma neura¬
minidase can thus be used to calculate the approximate potency of our neura¬
minidase preparations in terms of the standard unit based on the release of
NANA from NAN-lactose.
The reference sample of 10 /xg of pure NANA gave a reading of 0-513 in
this experiment. This allows calculation of the rate of NANA release from
substrate FVII by the test amount (2-5 /xg) of Sigma neuraminidase; thus
the potency of this batch of Sigma neuraminidase when acting on our substrate
is approximately 1-0 unit per mg of solid, as compared with the stated 1-1
unit per mg with NAN-lactose or 0-58 unit per mg with bovine submaxillary
mucin as substrate.
Discussion
Most of the glycoprotein in our preparation was polymerised, probably
as a result of the pasteurisation procedure (Spragg et al., 1969). This partial
denaturation may facilitate hydrolysis of the substrate by neuraminidase.
Although the risk of transmission of serum hepatitis by the fraction that we
use is relatively small (Berg et al., 1972), it would be unwise to use the un-
pasteurised product in normal laboratory conditions. The glycoprotein
fraction described by Gadalla and Collee (1968) is also liable to contain the
agent of serum hepatitis, although the risks are low because plasma from only
a few donors is used. If that preparation is being used, great care should
be taken in handling the plasma and it should be pasteurised (60°C for 10 h)
at some stage during preparation.
The pasteurised FVII preparation is not an ideal substrate in that it does
not consist of a pure, well-characterised substance, but it possesses certain
compensating advantages. It is produced from a " waste " fraction with
few manipulations and can therefore be made available comparatively cheaply.
It is easy to prepare in standard form in large quantities and is very stable as
a freeze-dried powder and even in solution at 4°C. Its preparation does not
involve the use of zinc salts (Bezkorovainy and Winzler, 1961), the residues
of which might inhibit the action of enzymes on the substrate. The prepar¬
ation has a low ionic content, the only residual buffer being a small amount
of acetate, and its y>H and ionic strength can therefore be easily adjusted in
any incubation mixture. The content of readily hydrolysable NANA is high
enough to avoid problems of viscosity or turbidity in the incubation mixture,
and the level of free chromogen before hydrolysis is conveniently low. It
must be borne in mind, however, that the preparation may contain a mixture
of glycoproteins that might be hydrolysed at different rates by the same or
by different enzymes.
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Cassidy et al. (1965) found that the NANA in oq-acid glycoprotein could be completely
released by C. welchii neuraminidase and that the initial rate of release was slightly faster than
the initial rate of release from bovine NAN-lactose. About 80% of the NAN-lactose in
bovine colostrum is N-acetyl neuramin-(2->3)-lactose but the (2—>6) isomer is also present
(Schneir and Rafelson, 1966; Drzeniek, 1973). Viral neuraminidases may show a marked
difference in ability to hydrolyse (2->3) and (2—»6) linkages; both linkages are completely
liydrolysed by C. welchii or V. cholerae neuraminidase although the rate of the reaction is
rather slower with the (2-»6) isomer (Cassidy et al., 1965; Drzeniek, 1967). In cq-acid glyco¬
protein, NANA is linked to the carbohydrate side chains by both (2^3) and (2—>6) linkages
(Drzeniek, 1973).
A variety of acyl groups are found on the neuraminic acid of naturally occurring com¬
pounds. Since the Warren and Aminoff assays give lower readings for N-glycolyl than for
N-acetyl derivatives (Warren, 1959; Aminoff, 1961; Drzeniek, 1972), it is desirable that a
substrate should contain only the N-acetyl derivatives. Human cq-acid glycoprotein, unlike
that from many other species, does not contain N-glycolyl neuraminic acid (see Jeanloz,
1972). It has generally been considered that human tissues contain only the N-acetyl
derivatives (Gottschalk, 1960), but Walkowiak, Kedzierska and Starzynski (1968) have re¬
ported a trace of N-glycolyl neuraminic acid in human serum.
The cq-acid glycoprotein prepared from nephrotic urine was shown to be a good substrate
for assays of C. welchii neuraminidase by Popenoe and Drew (1957) and we have now shown
that our FVII preparation from human plasma is also a good substrate. The calculations
based on the activity of purified C. welchii (Sigma) neuraminidase in our assay sugggest that
the initial velocity of release of NANA from our substrate is comparable to that from bovine
NAN-lactose. The assay procedure that we describe allows accurate measurement of a wide
range of concentrations of the enzyme. Even very small amounts of neuraminidase activity
can be detected with confidence by prolonging the period of incubation to 24 h, and this is of
value when it is important to demonstrate the absence of neuraminidase, e.g. in comparative
studies of neuraminidase production by different strains of C. welchii (Fraser and Collee,
1975).
Varying thepH of our assay in tris-maleate buffer produced a plot of activity that showed
a simple curve with a clear-cut optimum at about pH 5-7. When sodium-acetate buffer was
used, the curve was more complex with the main peak at about pH 4-7 and a subsidiary peak
at about pH 5-6. The pH optimum for the activity of a particular neuraminidase may vary
considerably when tested with different substrates (Rafelson, Schneir and Wilson, 1963) or
in the presence of different buffer ions (Cassidy et al., 1965). Burton (1963) found a sharp
pH optimum at pH 5-0-5-1 for C. welchii neuraminidase tested with a ganglioside substrate
in acetate buffer. Popenoe and Drew (1957) found the optimum to be pH 5-0-5-5 in acetate
buffer with oq-acid glycoprotein as substrate. Cassidy et al. (1965) found the optimum for
C. welchii neuraminidase acting on bovine NAN-lactose to be approximately pH 5-6 in
tris-maleate or in citrate-phosphate buffers but between pH 4-0 and 4-8 in acetate buffer.
Our finding of a subsidiary peak around pH 5-6 in acetate buffer with fraction FVII as
substrate may reflect a heterogeneity of NANA linkages in the preparation, perhaps due to
the presence of a mixture of glycoproteins or to alterations in glycoproteins produced by
pasteurisation; it might also be due to different pH optima for the hydrolysis of (2->-3) and
(2^-6) linkages, as was found for influenza-virus neuraminidase by Schneir and Rafelson
(1966). Cassidy et al. (1966) recommend that the assay of C. welchii neuraminidase with
NAN-lactose as substrate should be performed in potassium-acetate buffer atpH 4-5. When
the assay is performed with FVII substrate and sodium acetate buffer at pH 5-1, the results
fall on the high plateau between the two peaks of activity; for assays performed in tris-
maleate buffer the pH should be pH 5-7 with this substrate. C. welchii neuraminidase does
not require added Ca2+ (Cassidy et al., 1965); optimum buffer and ion conditions may differ
when fraction FVII is used as substrate for enzymes derived from other organisms or from
viruses.
C. welchii produces neuraminidase well when grown in PPW5 broth,
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and the culture filtrate is a good source of neuraminidase. When undialysed
culture filtrate is assayed, there is a rather high control value in the neuramini¬
dase assay, and we have found that there may be a significant depression of
the assay value for pure NANA. Different batches of PPW5 broth vary in
the extent to which they depress the NANA assay and the 25% depression
produced by our culture filtrate P9 is the most marked that we have observed.
The effect is minimal with dialysed preparations, e.g. P9D2, or with purified
(Sigma) neuraminidase. We have not investigated the mechanism of the
depression of the NANA assay by dialysable components of the PPW5 broth;
a number of substances are known to interfere with the thiobarbituric acid
assay for NANA (see Tuppy and Gottschalk, 1972) and this should be taken
into account when neuraminidase assays are performed on unpurified enzyme
preparations.
C. welchii also produces N-acyl neuraminic acid-aldolase (NAN-aldolase),
an enzyme that hydrolyses NANA to N-acetyl mannosamine and pyruvate
(Comb and Roseman, 1960). This enzyme is normally intracellular, but
Popenoe and Drew (1957) found a little activity in culture filtrates of C. welchii;
however, our enzyme preparations did not reduce the assay value for NANA
during incubation under conditions equivalent to those of the neuraminidase
assay.
Neuraminidase activity is commonly expressed in terms of units; 1 unit
liberates 1 /xmole of NANA per min. from the substrate at 37°C in a suitable
buffer at the optimum pH (Drzeniek, 1972). It seems desirable that neura¬
minidase activities should be stated in standard units measured with NAN-
(2->3)-lactose as substrate and we have refrained from expressing our results
in terms of units measured with our substrate, though we have related the poten¬
cies of our test enzyme preparations to a commercially available reference
preparation (Sigma neuraminidase). We have shown that our product is a
good substrate for routine use in assays of neuraminidase from C. welchii,
and preliminary experiments suggest that it should also prove valuable in
studies of neuraminidase from other sources, e.g. Corynebacterium diphtheriae
(personal communication, Dr D. C. Edwards and Mrs Karen Fidgen, Wellcome
Research Laboratories, Beckenham, 1972), V. cholerae, influenza virus and
Newcastle disease virus. It is hoped that the availability of this substrate
at reasonable cost will encourage further studies on bacterial neuraminidases.
Summary
A glycoprotein fraction (fraction VII) suitable for use as a substrate in
assays of microbial neuraminidase was prepared from pooled human plasma.
It is pasteurised during preparation to eliminate the risk of transmission of
serum hepatitis. This results in polymerisation of some of the oq-acid glyco¬
protein, but fraction VII is shown to be an excellent substrate for the neura¬
minidase of Clostridium welchii (C. perfringens). A sensitive assay procedure
is described. A number of factors may interfere with the measurement of
NANA released by the action of microbial neuraminidase and procedures
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are described for evaluation of this problem. Fraction VII is easy to prepare,
cheap and available in standard form in large amounts (inquiries should be
addressed to J. K. S.); it is recommended for routine use as a convenient
substrate for neuraminidase assays.
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THE PRODUCTION OF NEURAMINIDASE BY FOOD-
POISONING STRAINS OF CLOSTRIDIUM WELCHII
(C. PERFRINGENS)
A. G. Fraser and J. G. Collee
Department of Bacteriology, Medical School, University of Edinburgh, Teviot Place,
Edinburgh EH8 9AG
There is confusion in the literature regarding the production of neuraminidase
(EC 3.2.1.18) by food-poisoning strains of Clostridium welchii (C. perfringens)
type A; this partly reflects the changing definition of these food-poisoning
strains. Many episodes of food poisoning caused by C. welchii result from
ingestion of strains that produce very heat-resistant spores, i.e., spores that
survive boiling in faecal suspension for 1 h or more (Hobbs et al., 1953).
These strains, which are also non-haemolytic, have been considered as " typical
food-poisoning " strains. Although such strains are most likely to survive
cooking procedures, it is now well recognised that food poisoning can also
be caused by strains that produce relatively heat-sensitive spores, and these
strains may be haemolytic or non-haemolytic (Hauschild and Thatcher, 1967;
Sutton and Hobbs, 1968; Hobbs, 1969). Food-poisoning strains of C. welchii
are serotyped with two sets of antisera, one for the typical heat-resistant
strains—Hobbs' types 1-24—and the other for the so-called heat-sensitive
strains—types i-xviii (Hobbs et al., 1973).
Collee was unable to show neuraminidase production in cultures of four British typical
food-poisoning strains but, because culture supernates of two strains produced a myxovirus-
receptor-inactivating effect on red cells (Collee, 1965a), he concluded that " more extensive
investigation is required before it can be claimed that neuraminidase is never produced by
typical food-poisoning strains " (Collee, 19656).
Moss, Schekter and Cherry (1967), working in the United States, surveyed many strains
of C. welchii for neuraminidase activity. These workers confirmed that the reference British
heat-resistant food-poisoning strains examined by them did not produce neuraminidase, but
they showed that one of five American food-poisoning strains of C. welchii that could not
otherwise be differentiated from these strains was neuraminidase positive. American food-
poisoning strains generally include many that are haemolytic or heat-sensitive or both; the
majority of American food-poisoning strains examined by Moss et al. (1967) did produce
neuraminidase.
In the present study, the more sensitive neuraminidase-assay procedure
described by Fraser and Smith (1975) was used for a further investigation
of neuraminidase production in a range of heat-resistant and heat-sensitive
British food-poisoning strains of C. welchii.
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Materials and methods
Strains of C. welchii. Four classical haemolytic strains of C. welchii type A were used.
Strain L2Ab was described in the previous paper (Fraser and Smith, 1975); strain L3A was
also obtained from Professor C. L. Oakley, School ofMedicine, University of Leeds. Strains
CI and 032 were laboratory strains originally isolated from wound infections in Edinburgh.
Typical non-haemolytic, heat-resistant, food-poisoning strains of C. welchii type A of
Hobbs' types 1-4 (Nos. 8359, 8238, 8239 and 8247 respectively) were obtained from the
National Collection of Type Cultures, Colindale, London; strains of Hobbs' types 5-24 were
kindly provided by Dr Betty Hobbs, Central Public Health Laboratory, Colindale. Strains
029 and 153 were typical food-poisoning strains isolated from separate food-poisoning out¬
breaks in Edinburgh (Collee, 19656); they were submitted to Dr Hobbs, who reported that
they were both type-13 strains. Strains 611 and 4621 were provided by Dr Hobbs: these
were non-haemolytic type-13 strains but were not responsible for actual food-poisoning out¬
breaks; strain 611 was isolated post mortem from a patient with colitis and strain 4621 from
a patient who died during a food-poisoning outbreak attributed to a different strain of C.
welchii. Reference food-poisoning strains of C. welchii type A that do not produce heat-
resistant spores (types i-iii, v-xviii) were provided by Dr Hobbs, and are referred to as heat-
sensitive strains.
Media and method ofanaerobic culture. Cooked-meat broth and Proteose Peptone-water
medium (PPW5) were described in the previous paper (Fraser and Smith, 1975). Todd-
Hewitt Broth and Nutrient Broth (No. 2) were manufactured by Oxoid Ltd. Horse-blood
agar contained Columbia Agar Base with 10% (v/v) defibrinated horse blood (Oxoid).
Anaerobic culture methods were as previously described (Fraser and Smith, 1975) with a gas
mixture of 10% (v/v) CO2 and 90% H2 used as a routine.
Observation of haemolytic effect. Strains were grown anaerobically on horse-blood agar
for 18 h at 37°C with 10% CO2. Strains graded as haemolytic produced clear haemolysis,
with or without a surrounding zone of incomplete haemolysis. Non-haemolytic strains
produced no effect or only a small zone of faint, incomplete haemolysis.
Serial culture ofstrainsfor tests ofneuraminidaseproduction. In general, a 01 -ml inoculum
of an overnight anaerobic cooked-meat broth culture was added to 10 ml of pre-steamed
culture medium in a tube and incubated anaerobically for 48 h. Serial 48-h cultures were
made in this manner with a 01-ml inoculum for each passage. A 5-ml sample of centrifuged
supernate (800 g for 1 h at 4°C) from each passage was stored at — 20°C. Cultures were
incubated at 37°C unless otherwise indicated.
Disruption of washed cells. Five serial cultures were made in PPW5 broth, incubated on
each occasion for 48 h at 39°C. Cultures 1, 2 and 3 were made by transferring 01 ml of
culture into 10 ml of medium as for the serial cultures described above. For the fourth
culture, a 1-0-ml inoculum was added to 100 ml medium and, for the fifth, 10 ml was added to
500 ml. Samples (5 ml) of centrifuged supernates (800 g for 1 h at 4°C) from the first four
cultures were stored at — 20°C. After centrifugation (2000 g for 1 h at 4°C) the supernate of
the fifth serial culture was stored at — 20°C and the packed cells were resuspended in 20 ml
of sterile normal saline. The cells were washed three times in saline (2000 g for 1 h at 4°C)
and the washed cells were resuspended in 20 ml of saline. The resuspended washed cells and
samples of the supernate from each washing were held at — 20°C.
The washed cell suspension was later thawed and four 3-ml samples of each organism
were subjected to ultrasonic disruption (MSE-Mullard Ultrasonic Disintegrator) for 1 h
with the samples held at 0°-l°C in an ice bath. This produced a great decrease in turbidity
in the samples, and phase-contrast microscopy confirmed a reduction in the number of intact
cells to less than 1 % of the original. The treated samples were pooled and the centrifuged
supernate (20,000 g for 1 h at 4°C) was held at — 20°C.
Concentration and dialysis of culture supernates. Samples of culture supernate (100 ml)
were concentrated in 2-5-cm Visking cellophane tubing exposed to polyethylene glycol
(mol. wt. 6000) for 20 h at 4°C, and thereafter dialysed against large quantities of distilled
water for 72 h at 4°C.
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Assay for neuraminidase activity. The reagents and procedures are described in the
previous paper (Fraser and Smith, 1975). The assay was standardised with reaction mixtures
prepared as follows: test substance, 0-1 ml; sodium acetate buffer, pH 5-1, 0-15 ml; and
substrate FVII diluted in the acetate buffer, 0-25 ml. The original batch of substrate, FVII(5),
was used at a final concentration of 3-07 mg per ml in the 0-5-ml test volume and the second
batch, FVII(6), at 4 0 mg per ml. Separate enzyme and substrate controls were assayed and
used to correct the test results. Test and control mixtures were incubated at 37°C in a water
bath for the appropriate length of time before the assay for free N-acetyl neuraminic acid
(NANA). Duplicate mixtures were usually assayed, and the amount of NANA released is
indicated in terms of the corrected average extinction values at 549 nm (£549). In progress
experiments, the timing was such that all tests, including time-zero (To) control tests, were
assayed for NANA in one batch; To test values were used for correction of test readings
(Fraser and Smith, 1975).
Tests for the effects of culture materials on the NANA assay. These have been described
in the previous paper, in which control assays and calculations are detailed (Fraser and Smith,
1975). Mixtures were prepared as for the standard neuraminidase assay but with 10 fig of
pure NANA in 0-25 ml of distilled water in place of the substrate.
Results
Production of neuraminidase by classical strains of C. welchii grown in various
broth media
Four classical (haemolytic, heat-sensitive) strains of C. welchii type A were
cultured for 48 h in a range ofbroth media, and a second serial culture was made
from each in the same medium. The results of neuraminidase assays on the
supernates of the second serial cultures (table I) indicate that neuraminidase
production is poor in nutrient broth and generally good in PPW5 broth and
Todd-Hewitt medium. These results reflect our experience with many strains
of C. welchii', PPW5 broth and Todd-Hewitt medium give generally good
yields of neuraminidase, but yields may vary markedly even in successive
cultures of the same strain grown under apparently identical conditions in
Table I
Production of neuraminidase by four classical strains of Clostridium welchii type A
grown in four broth media
Strain
number
Result of neuraminidase assay on supernate from
second serial culture in stated medium (£549)*





















* The spectrophotometric value (£549) is an average result obtained from duplicate 15-min. assay
readings corrected by subtraction of the values for the substrate control and the corresponding
enzyme control.
NB = nutrient broth; CMB = cooked-meat broth; THB = Todd-Hewitt broth; PPW5 = 5%
Proteose Peptone water.
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Table II
Production of neuraminidase by heat-resistant and heat-sensitive reference food-poisoning
strains of C. welchii type A*
Serotype numbers of Serotype numbers of
Reference strains Haemolytic effect neuraminidase- neuraminidase-
on blood agarf positive strains} negative strains §
Hobbs' types 1-24 NH 13, 18, 21, 24 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,
(heat-resistant) 11, 12, 14, 15, 16, 17,
19, 20, 22, 23
Hobbs' types i-xviii NH i, ix xiii, xiv, xv
(heat-sensitive)
H ii, iii, v, vi, vii, x, xi, xii, viii
xvi, xvii, xviii
* Tests performed on supernates of second serial 48-h cultures in PPW5 broth.
t See Materials and Methods', H = haemolytic; NH = non-haemolytic.
t Tests incubated with substrate FVII at 37°C. Supernates ofmost cultures gave clearly positive
results in assays incubated for 15 min.; assays of supernates of strains belonging to serotypes 24
and i were incubated for 4 h to produce clearly significant assay values.
§ Tests incubated with substrate FVII at 37°C for 24 h gave negative results.
samples of medium prepared in a single batch (see fig. 1 below). On occasion,
cultures in PPW5 broth were unduly mucoid; this occurred rather more
frequently in Todd-Hewitt medium but was not correlated with variations
in neuraminidase production. The amount of neuraminidase present in the
supernate of cultures in PPW5 broth reaches a maximum within 24 h and
there is no significant increase or decrease in activity between 24 and 72 h.
In later studies we found that the production of neuraminidase by strain
L2Ab in 48-h cultures in PPW5 broth was markedly influenced by the temper¬
ature of incubation of the culture within the range 35-42°C; the maximum
Table III




Result of neuraminidase assay
on supernate from second serial







* See footnote to table I.
t Hobbs' type-13 reference strain.
t The negative result for the culture supernate of strain 4621 was confirmed when the period of
incubation of the test was extended to 24 h.
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Table IV
Neuraminidase activity in various culture products of strain L2Ab grown in PPW5 broth







Supernate 5 concentrate} 13-640
1st washing from bacillary deposit 5 0-433
2nd washing 0-032
3rd washing 0-021
Extract of sonicated washed deposit 5 1-428
* See Materials and Methods.
t See footnote to table I. (Samples diluted appropriately before assay).
} Concentrated to 22-1 % of the original volume.
yield obtained at 39-40°C may be up to twice that obtained at 35°C. Minor
differences in the temperature of incubation may contribute to the variation
in amount of neuraminidase produced in serial cultures.
Production of neuraminidase by food-poisoning strains of C. welchii
We chose to test the supernate of the second serial 48-h culture in PPW5
broth at 37°C as a routine procedure in the present studies. The results of
neuraminidase assays on 41 reference food-poisoning strains of C. welchii are
presented in table II. The culture supernates were first tested in a screening
assay incubated with FVII substrate for 1 h; thereafter, positive supernates
were assayed at appropriate dilutions by a standard 15-min. assay procedure.
Two supernates gave very low readings in the 1-h screening assay; these were
assayed in tests incubated for 4 h to produce clearly significant readings.
Supernates that were negative in the 1-h screening assay were then tested with
24-h incubation; all remained negative. Most of the typical non-haemolytic,
heat-resistant C. welchii strains were neuraminidase negative, but there was
good production of neuraminidase by the strains of Hobbs' types 13, 18 and 21
and the strain of Hobbs' type 24 produced a small amount of activity. Thirteen
of the 17 heat-sensitive food-poisoning strains produced neuraminidase, but
the remaining four strains were completely negative. It appears that in general
non-haemolytic strains do not produce neuraminidase whereas haemolytic
strains do, though there are clear exceptions to this general correlation.
A further four type-13 strains were tested for neuraminidase production
in this way. Strains 029 and 153 were isolated from food-poisoning outbreaks
in Edinburgh and strains 611 and 4621 were supplied by Dr Hobbs. The
results presented in table III show production of a moderate amount of neura¬
minidase by strain 611 and rather small amounts by the reference strain 10240
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Fig 1.—Corrected test results of 15-min. neuraminidase assays of supernates of serial cultures of
C. welchii strains in PPW5 broth: x x, strain L2Ab; A A- strain 153; • •.
strain 029. Strain L2Ab supernates were assayed at a dilution of 1 in 4 in acetate buffer, pH 5-1,
and the values corrected accordingly; supernates of strains 153 and 029 were assayed undiluted.
Fig. 2.—Release and destruction of NANA during neuraminidase assays on undiluted L2Ab cell
extract for up to 8 h. The relative amount of free NANA is plotted as the spectrophotometric
reading (E549) of single-tube assays corrected by subtraction of the value for the time-zero test.
The assay product for each test was diluted 1 in 5 in reagent 4 (acid butanol) before reading and
the results were corrected accordingly.
and by strains 029 and 153; nevertheless, activity was clearly demonstrable
after incubation of tests for 15 min. By contrast, there was no activity in the
supernate of strain 4621 even when the tests were incubated for 24 h. When
a sample of this supernate was incubated with NANA for 24 h under conditions
equivalent to those of the neuraminidase assay there was no significant reduc¬
tion in the assay value for NANA. Thus the negative result in the 24-h neura¬
minidase assay with the supernate of strain 4621 was not due to destruction
of NANA by N-acyl neuraminic acid-aldolase (NAN-aldolase : N-acyl neura-
minate lyase, EC 4.1.3.3).
Variability of neuraminidase production during serial culture
Five serial cultures of the classical strain L2Ab and the weakly
neuraminidase-positive food-poisoning strains 029 and 153 were made in
10-ml volumes of PPW5 broth. The results of the standard 15-min. assay for
neuraminidase activity in the supernates of these cultures are presented in
fig. 1. Strain L2Ab produced moderate but variable yields of neuraminidase
in all supernates. Initially, the two Edinburgh food-poisoning strains pro¬
duced small amounts of neuraminidase but this increased in serial cultures
until by the fifth culture the activity was comparable with that produced by
strain L2Ab. The presence of neuraminidase activity in the supernates of the
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first cultures in this series was confirmed by demonstrating that more NANA
was released when the period of incubation was extended. In tests in which
samples of supernate were incubated with a standard amount of NANA for
15 min., there was no significant breakdown of NANA. The values plotted
in fig. 1 therefore give a valid indication of the relative amounts of neuraminidase
produced by the three strains in this experiment. These results might suggest
that sequential culture in PPW5 broth of strains 029 and 153 produces a gradu¬
ally increased yield of neuraminidase. However, further experiments with
organisms derived from freeze-dried stocks and grown under apparently
identical conditions did not show this pattern; the initial cultures often pro¬
duced high amounts of the enzyme and variations in yield could not be attri¬
buted to any particular variable in experimental conditions.
Assays for cell-associated neuraminidase
Five serial cultures of the neuraminidase-positive classical strain L2Ab
and the neuraminidase-negative food-poisoning strain Hobbs' 2 were made
successively at 39°C in 10-, 10-, 10-, 100- and 500-ml volumes of PPW5 broth.
Samples (100 ml) of culture supernates from the fifth serial cultures were
concentrated approximately five-fold; the L2Ab culture was concentrated
to 22-1 % of its original volume, and the Hobbs' type-2 culture to 17-8%, after
dialysis (see Materials and Methods). The washed cells from the 500 ml of
the fifth serial cultures were resuspended in 20 ml saline and disrupted ultra-
sonically; the resultant suspension was then centrifuged free of cell debris
and is referred to as cell extract. Table IV presents the results of neuraminidase
assays on the culture products of strain L2Ab from this experiment. The 15-
min. neuraminidase assays show very high yields in the supernates , of all
Table V
Effect of incubating N-acetyl neuraminic acid {NANA) with culture supernates of
strain L2Ab and the Hobbs'' type-2 strain for up to 24 h
Reaction mixture*
NANA alone
NANA+supernate of 5th serial
culture of strain L2Ab
NANA+supernate of 5th serial
culture of Hobbs' type-2 strain
NANA+concentrated supernate of
5th serial culture of Hobbs' type-2
strain
Result of assay for NANA (£549)! after incubation of
mixture for stated time (h)
0 1 2 3 22 24
0-514 0-514 0-506 0-530 0-531 0-537
0-516 0-502 0-474 0-474 0-299
0-503 0-500 0-494 0-511 0-511 0-500
0-548 0-524 0-523 0-523 0-493 0-476
* A standard amount of NANA, 10 g-g in 0-5-ml final volume, was tested,
t Spectrophotometric reading (£549) of single-tnbe assays corrected by subtraction of the value
for the corresponding time-zero enzyme control.
... = Not done.
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five serial cultures and concentration of a sample of the fifth culture supernate
produced a proportional increase in activity. The amount of neuraminidase
in the successive washings fell rapidly to trace amounts, but there was release
of a significant amount of neuraminidase after ultrasonic treatment of the
suspension of L2Ab cells. By contrast, neuraminidase activity was not detected
in any of the equivalent samples from the cultures of strain Hobbs' 2, although
the tests were incubated for 24 h.
Table V shows the amount of NANA that was destroyed during incubation
with samples of the fifth culture supernates for periods up to 24 h under con¬
ditions equivalent to those of the neuraminidase assay. The supernate of
the fifth culture of strain L2Ab produced slight destruction of NANA after
incubation for 24 h; this suggests that there is slight NAN-aldolase activity
in the culture supernate (although too little to interfere significantly with the
15-min. neuraminidase assay). There was, however, no destruction of NANA
by the supernate of the fifth culture of the strain of Hobbs' type 2 and even
with this product concentrated five-fold there was only a very slight reduction
in the assay value for NANA after incubation for 24 h. This confirms that
the results of neuraminidase assays on culture supernates of the strain of
Hobbs' type 2 are valid, i.e. that this strain produced no demonstrable extra¬
cellular neuraminidase.
Disruption of the washed cells of strain L2Ab and the strain of Hobbs'
type 2 liberated NAN-aldolase into the supernate. The results presented
in table VI show that in each case the supernate from the third washing of
the cells in saline produced no destruction of NANA but that the supernate
after disruption of the cells was able to destroy the test dose of NANA during
incubation for 24 h. The amount of NAN-aldolase activity in the cell extracts
of the two strains appears to be comparable, as judged by the similar rate of
NANA destruction during the first 3 h of the test.
Table VI
Effect of incubating NANA with cell extracts of strain L2Ab and the
Hobbs'' type-2 strain for up to 24 h
Reaction mixture*
Result of assay for NANA (£549)1 after incubation of
mixture for stated time (h)
r
0 i . 1 2 3 24
NANA+3rd washing of strain L2Ab 0-477 0-467 0-481 0-474 0-470 0-461
NANA+cell extract of strain L2Ab 0-460 0-334 0-250 0-125 0-086 0-020
NANA+3rd washing of Hobbs'
type-2 strain 0-485 0-502 0-494 0-487 0-489 0-492
NANA+cell extract of Hobbs' type-2
strain 0-480 0-372 0-300 0-163 0-113 0-008
* A standard amount of NANA, lOgg in 0-5-ml final volume, was tested.
t Spectrophotometric reading (£549) of single-tube assays corrected by subtraction of the value
for the corresponding time-zero enzyme control.
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Fig. 3.-—Results of neuraminidase assays incubated for periods up to 3 h in the presence of cell
extract of the Hobbs' type-2 strain. The test mixtures (final volume 0-6 ml) contained: 0-25 ml
FVII substrate; 0-15 ml sodium-acetate buffer, pH 5-1; 0T ml L2Ab cell extract diluted in the
acetate buffer; and either 0-1 ml acetate buffer or 0-1 ml undiluted cell extract from the Hobbs'
type-2 strain.
2% (v/v) L2Ab cell extract+buffer, X X ; 2% L2Ab cell extract+cell extract from the
Hobbs' type-2 strain, 9 ©; 1% L2Ab cell extract-(-buffer, A A; 1% L2Ab cell
extract-(-cell extract from the Hobbs' type-2 strain, V V- Results corrected by subtraction
of the value for the corresponding time-zero test.
Fig. 2 shows the effect of the NAN-aldolase in the L2Ab cell extract when
the neuraminidase assay is done at intervals up to 8 h. The amount of NANA
released increases rapidly to reach a peak at 1 h and thereafter there is a pro¬
gressive fall in assay value; thus the result of the 15-min. neuraminidase assay
on the L2Ab cell extract given in table IV is liable to be an underestimate.
Because the cell extract prepared from the Hobbs' type-2 strain contains a
similar amount of NAN-aldolase activity, the negative result in the 24-h neura¬
minidase assay on this sample might have been due to subsequent destruction
of the NANA released; however, further studies showed no detectable release of
NANA even during the first 3 h of incubation of assay mixtures containing
cell extract of this strain.
To give an indication of the amount of neuraminidase that we could
expect to detect in the Hobbs' type-2 cell extract despite its NANA-destroying
activity, dilutions of L2Ab cell extract were assayed in the presence and absence
of undiluted cell extract. The results are presented in fig. 3. The assay values
for neuraminidase were reduced by the Hobbs'-2 cell extract in tests incubated
for 2-3 h, but even 1 % of the amount of neuraminidase released by ultra¬
sonic treatment of strain-L2Ab cells could clearly be detected in the presence
of the cell extract prepared from the Hobbs' type-2 strain.
Discussion
Neuraminidase-positive strains of C. welchii type A produce small amounts
of neuraminidase when grown in nutrient broth but large amounts, and
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sometimes very large amounts, in the PPW5 broth that we chose for these
studies. We found considerable variation in the amount of neuraminidase pro¬
duced by strain L2Ab in serial cultures incubated under apparently identical
conditions, even when the PPW5 broth was prepared in a single batch and
when we assayed the supernates of the serial cultures in a single experiment.
Collee (19656) found that four non-haemolytic, heat-resistant food-poisoning
strains were neuraminidase negative and Moss et al. (1967) confirmed that 12
reference British food-poisoning strains (Hobbs' types 1-3 and 5-13) were
neuraminidase negative. It seemed that it might be generally true that non-
haemolytic, heat-resistant food-poisoning strains did not produce neura¬
minidase, but Moss et al. (1967) went on to demonstrate an exception with
one American isolate that was otherwise indistinguishable from the Hobbs'
reference strains. Most of the American food-poisoning isolates that these
workers examined differed in one or more characters from the non-haemolytic,
heat-resistant Hobbs' strains, and the majority of these American strains
did produce neuraminidase. We have now studied 41 of the current British
reference food-poisoning strains and found that, whereas 12 of 17 so-called
heat-sensitive strains were neuraminidase positive, 20 of 24 heat-resistant
strains were neuraminidase negative. Our findings show that, in British as
in American food-poisoning strains, the ability to cause food-poisoning is
not correlated with lack of neuraminidase production, although the majority
of non-haemolytic heat-resistant isolates are neuraminidase negative.
The four heat-resistant strains that we found to be clearly neuraminidase positive include
the reference strain of Hobbs' type 13, which was found to be neuraminidase negative by
Moss et al. (1967). We found that three other type-13 strains produced neuraminidase,
including strains 029 and 153, which were amongst the strains reported as neuraminidase
negative by Collee (19656). It is possible that our strains might have altered as a result of
prolonged storage and subculture, although their characteristics were carefully re-checked to
confirm that they were still non-haemolytic and produced heat-resistant spores. PPW5
medium is generally much better for the production of neuraminidase than the media used
by Collee in 1965 and it is unlikely that the less sensitive assay procedure then in use, with
egg-white as substrate, would have detected the small amounts of neuraminidase produced in
some cultures of these strains even in PPW5 broth—for example, in the experiment illustrated
in fig. 1. Although the data from this experiment suggest that sequential subculture in PPW5
broth might result in a gradually increased yield of the enzyme, this pattern was not found in
subsequent experiments. We have found considerable variation in the amount of neuramini¬
dase produced by strains 029 and 153 in PPW5 broth, but all cultures that we have examined
contain neuraminidase activity that is clearly demonstrable by our present methods. We
think that our ability to show neuraminidase production by strains 029 and 153 is now prob¬
ably attributable to developments in our culture and assay procedures; however, even after
incubation of tests for 24 h, we found no evidence of neuraminidase production by one other
type-13 strain. It thus appears that there is true variation in the ability to produce neuramini¬
dase among strains of a single Hobbs' serotype of C. welchii.
Our finding that any neuraminidase-positive strainmay vary considerably in its production
of the enzyme despite apparently identical conditions of culture led us to assay the supernates
of five sequential cultures in tests of an apparently neuraminidase-negative Hobbs' type-2
strain. When strain L2Ab was grown in PPW5 broth at the optimum temperature for neura¬
minidase production it produced very high yields of the enzyme, which was essentially extra¬
cellular; some further neuraminidase could be released by ultrasonic disintegration of the
washed cells. When the Hobbs' type-2 strain was grown in parallel under identical conditions,
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no activity was demonstrable in culture supernates even after five-fold concentration, and
no neuraminidase was released by ultrasonic disintegration of the cells.
As our assay depends upon the detection of NANA liberated by the neuraminidase, the
presence of NAN-aldolase might produce a false negative result. However, there was insigni¬
ficant NAN-aldolase activity in the culture supernate of the Hobbs' type-2 strain; this con¬
firms the validity of our 24-h neuraminidase assay as a sensitive test for neuraminidase
activity and demonstrates that the Hobbs' type-2 strain produces no extracellular neuramini¬
dase (i.e. less than 0 01 % of the neuraminidase produced by strain L2Ab). When the
neuraminidase-positive L2Ab cells were disrupted, the NAN-aldolase released produced
some interference with the neuraminidase assay. A similar amount of NAN-aldolase was
released from the neuraminidase-negative Hobbs' type-2 strain, but our further experiments
showed that this would not prevent the demonstration of quite small amounts of neuramini¬
dase—as little as 1 % of that associated with L2Ab cells. Thus we now have clear evidence
that British food-poisoning strains of C. welchii include some that are neuraminidase positive
and some that still cannot be shown to produce neuraminidase despite considerable advances
in our ability to detect the enzyme.
Whilst it is unlikely that neuraminidase is concerned in the mechanism of
pathogenicity of C. welchii in the gut, it is possible that the enzyme plays
a part in gas gangrene. Hauschild and Thatcher (1968) found that whereas
non-haemolytic, heat-resistant food-poisoning strains did not produce experi¬
mental gas gangrene in animals, and that this was correlated with production
of very low amounts of the lethal a-toxin, some non-haemolytic but heat-
sensitive food-poisoning strains did produce gas gangrene if injected in large
numbers. There was a clear but imperfect correlation between virulence
and in-vitro production of a-toxin. Although the mechanism of pathogenicity
of C. welchii in wound infection has long been associated with the organism's
ability to produce a-toxin (Evans, 1945; MacLennan, 1962), Bullen (1970)
has developed an interesting argument to suggest that other factors may be
more important. It might be argued that the neuraminidase, which is pro¬
duced in close association with the a-toxin by many strains, plays a hitherto
undetected role as an aggressin (Collee, 1965b) and that anti-neuraminidase in
C. welchii antitoxin (see Warren and Spearing, 1963) may contribute to its
protective effect. Under these circumstances, the organism's infectivity and
virulence might depend upon its early production of neuraminidase in vivo.
Our ability to define neuraminidase-negative strains might now be exploited
to test this suggestion.
Summary
The production of neuraminidase by a classical strain of Clostridium
welchii (C. perfringens) type A was studied. Good yields were produced in
5% Proteose Peptone-water medium (PPW5); the enzyme was essentially
extracellular but some further neuraminidase could be released by ultrasonic
disintegration of the cells. This also released N-acyl neuraminic acid-aldolase
(NAN-aldolase) and the degree to which this interferes with the assay for
neuraminidase was evaluated.
Forty-one British reference food-poisoning strains of C. welchii type A
were examined for extracellular neuraminidase production in PPW5. Twelve
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of 17 strains that produce so-called heat-sensitive spores were neuraminidase
positive whereas 20 of 24 strains that are non-haemolytic and produce very
heat-resistant spores were neuraminidase negative. Variation was found in
the ability to produce neuraminidase among strains of a single Hobbs' serotype;
four Hobbs' type-13 strains produced neuraminidase but a fifth did not. Dis¬
ruption of the cells of a Hobbs' type-2 strain that did not produce any extra¬
cellular neuraminidase released NAN-aldolase but there was no evidence
of cell-associated neuraminidase. British food-poisoning strains of C. welchii
type A thus include some that are clearly neuraminidase positive and some
that still cannot be shown to produce neuraminidase. There is no correlation
between lack of neuraminidase production and the ability to cause food
poisoning, although the majority of non-haemolytic heat-resistant strains
do not produce neuraminidase. It remains possible that neuraminidase may
play a part in C. welchii gas gangrene; it is suggested that the ability to define
neuraminidase-negative strains may now be of value in investigating this
possibility.
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NEURAMINIDASE PRODUCTION BY CLOSTRIDIA
A. G. Fraser
Department ofBacteriology, Medical School, University ofEdinburgh,
Teviot Place, Edinburgh EH8 9AG
The assay for neuraminidase (EC 3.2.1.18) developed by Fraser and Smith
(1975) was used by Fraser and Collee (1975) to investigate the production of the
enzyme by a variety of strains of Clostridium perfringens (C. welchii) type A.
Sensitive assay procedures were developed that allowed definition of truly
neuraminidase-negative strains. Many classical haemolytic strains of C.
perfringens type A produced neuraminidase and most non-haemolytic food-
poisoning strains did not.
It has been suggested that neuraminidase might play a part in the production
of gas gangrene by C. perfringens and other Clostridia (Collee, 19656; Gadalla
and Collee, 1968; Muller, 1974). Our previous studies of C. perfringens have
now been extended to investigate the production of neuraminidase by a range of
other pathogenic and non-pathogenic Clostridia.
Materials and methods
Bacterial strains. The strains used and their sources are detailed in tables I—III. All
strains were held as lyophilised stock, with periodic subculture in cooked-meat broth (CMB)
and re-lyophilisation. The source of strains that were recently obtained from the National
Collection of Type Cultures, Colindale, London, is shown as NCTC. Other strains were
originally obtained from the NCTC and have been held for many years in the collection of
Professor J. G. Collee in this department; their NCTC numbers are quoted. The remainder
of the strains, including some NCTC strains and clinical isolates from a variety of infections,
were obtained from various sources and have been held here, sometimes for many years and
with many subcultures. Donors of these strains included Dr Nancy Hayward, Monash
University Medical School, Australia, the late Professor C. L. Oakley, Leeds University
Medical School, Dr B. Watt, Central Microbiological Laboratories, Western General
Hospital, Edinburgh, and colleagues in the diagnostic laboratories in this Department.
For the present studies, all strains were freshly grown in CMB from lyophilised stock and
their purity and identity were carefully rechecked in cultural and biochemical studies. Some
strains were further checked by immunofluorescence microscopy.
Media and method ofanaerobic culture. CMB medium and proteose peptone water broth
(PPW5) were prepared as described by Fraser and Smith (1975). The PPW5 broth was
clarified by filtering through Whatman no. 1 paper before autoclaving. To improve the
growth of strains of C. novyi, L-cysteine (Koch Light) and dithiothreitol (BDH) were added
(Moore, 1968); the supplemented broth is referred to as PPW5S. A freshly-prepared con¬
centrated (x 50) solution containing cysteine and dithiothreitol was passed through a
membrane filter {0-2-pm pore) and added aseptically to the sterile PPW5 broth to give final
concentrations of the two substances of 1 mg per ml and 90 y.g per ml respectively; the
PPW5S was presteamed and cooled to 37°C, just before inoculation with the test organism.
Received 24 Nov. 1977; accepted 3 Jan. 1978.
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Todd Hewitt broth (THB) was prepared according to the manufacturer's recommenda¬
tions (Oxoid). In early experiments thepH was adjusted to 7-4 before autoclaving but it was
found that the pH of THB sometimes rose considerably on storage. In later experiments the
pH was adjusted after autoclaving, by the addition of membrane-filtered 1-0m HC1 to the
sterile broth before use.
Anaerobic culture methods were as previously described (Fraser and Smith, 1975).
Cultures were prepared from lyophilised stock and maintained in CMB medium. An
inoculum (0-1 ml) of an overnight anaerobic culture in CMB incubated at 37°C was added
to 10 ml presteamed medium and incubated anaerobically at 37°C for 48 h. A second serial
48-h culture was made with an inoculum of 0-1 ml from the first 48-h culture. The purity of
growth in the second serial culture was carefully checked. When an organism did not grow
or grew very poorly in a particular medium, a further attempt was made with an inoculum of
1-0 ml, incubating each serial culture for 96 h.
Growth was estimated visually and recorded as follows: + + + , dense turbidity; + +,
moderate turbidity; +, light turbidity or faint turbidity with many cells seen by microscopy
in a wet film; ±, faint turbidity with few cells present on microscopy; —, no turbidity, or no
cells seen on microscopy.
The supernates of the second serial cultures were tested for neuraminidase activity. The
cultures were centrifuged (800 g for 60 min. at 4°C) and 5-ml samples of the centrifuged
supernates were stored at — 20°C before assay. In addition, the centrifuged supernates of
C. botulinum cultures were passed through a membrane filter (0-2-p.m pore) to ensure the
removal of all organisms.
Preparation ofcell extracts. Cell extracts were prepared from the centrifuged cell deposits
of the second serial cultures of a number of strains grown in PPW5 or CMB medium.
Cooked-meat particles were allowed to settle and the broth was removed for centrifugation.
All the supernate was removed from the packed cell deposit after centrifugation (1200 g for
90 min. at 4°C) and the cells were resuspended in 2 ml sterile normal saline. The resuspended
cells were subjected to ultrasonic disintegration for 15-30 min. in an ice bath until the sample
was no longer turbid (Fraser and Collee, 1975). These uncentrifuged cell extracts were stored
at — 20°C until assayed for neuraminidase.
Substrate for neuraminidase assays. Two batches of human glycoprotein substrate FVII
(Fraser and Smith, 1975) were used. Batch FVII(6) was used at a final concentration in the
0-5-ml test volume of 4-0 mg FVII per ml as previously (Fraser and Collee, 1975); this batch
contained about 4-2% of A-acetyl neuraminic acid (NANA) and the final concentration of
releasable NANA in the reaction mixture was thus c. 168 pg per ml. The concentration of
NANA-rich glycoprotein may vary in different batches of FVII and it is preferable to express
the concentration of substrate used in assays in terms of the amount of NANA that can be
released from the substrate. Batch FVII(7) was used at a final concentration of 140 pg
NANA per ml.
Assay for neuraminidase activity. The standard assay was as described by Fraser and
Collee (1975). Initial assays for neuraminidase activity in culture products were incubated
for 60 min. before assay for free NANA. Test spectrophotometric readings at 549 nm were
corrected by subtraction of the sum of the values for separate enzyme and substrate controls.
When the 60-min. assay clearly showed neuraminidase activity, the assay was repeated with
a 15-min. incubation period. When the 60-min. assay showed little or no activity, tests were
incubated for 24 h in order to demonstrate the presence or absence of detectable neura¬
minidase activity.
Tests that gave low corrected spectrophotometric readings (£549) were further examined
with a Pye-Unicam SP8000A spectrophotometer to determine whether the absorption peak
was at 549 nm. In order to demonstrate clearly whether a low assay value was or was not due
to the presence of NANA, it was occasionally necessary to read the absorption curve of the
test mixture against a time-zero (To) control test (Fraser and Smith, 1975), rather than the
enzyme control, as reference sample.
The corrected results of neuraminidase assays have been graded as follows: + + + ,
clearly detectable in 15-min. assays (£549>0-1); ++, low spectrophotometric values in
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15-min. assays (<0-l) but NANA release clearly demonstrable in 60-min. assays; +, not
demonstrable in 60-min. assays but high values (>0-5) in 24-h assays; ±, low values (<0-5)
in 24-h assays but absorption peak clearly shown at 549 nm; —, no peak at 549 nm demon¬
strable in 24-h assays.
Tests for the effects ofculture products on the NANA assay. Tests to demonstrate whether
false negative results might be attributable to destruction of NANA by iV-acetyl neuraminic
acid-aldolase (NAN-aldolase EC 4.1.3.3) were performed on all culture supernates or cell
extracts that gave low positive (+ or ±) or negative results in the 24-h assay for neura¬
minidase (see Fraser and Smith, 1975). Culture products that did not reduce the assay value
for 10 /tg NANA (E549 c. 0-5) by 0-1 or more during incubation for 24 h were regarded as
having insignificant NANA-destroying activity.
Effect of Ca2+ and EDTA on neuraminidase assays. CaCl2 . 2H2O (BDH, Analar) or
EDTA (ethylenediaminetetra-acetic acid disodium salt, BDH, Analar) were added to the
acetate buffer used in the neuraminidase assay. The final concentrations of added Ca2+ or
EDTA in the reaction mixtures were 3mM Ca2+, ImM Ca2+, ImM EDTA or 5mM EDTA. The
enzyme preparation (0-1 ml) and the acetate buffer containing Ca2+or EDTA (0-15 ml) were
mixed and held at 37°C for 30 min. before addition of the substrate FVII (0-25 ml) and the
start of incubation of the neuraminidase assay. Separate enzyme and substrate control tubes
contained the equivalent volumes of acetate buffer in place of the substrate and enzyme
respectively. Enzyme control assays also contained the appropriate amount of added Ca2+
or EDTA.
The C. perfringens neuraminidase tested was a dialysed preparation (P9D3) of supernate
from a bulk culture of strain L2Ab in PPW5 broth (P9) prepared as for the standard prepara¬
tion (P9D2) used by Fraser and Smith (1975). Vibrio cholerae Receptor-Destroying Enzyme
(Wellcome; RDE) was used as V. cholerae neuraminidase.
Results
Neuraminidase production by Clostridium perfringens, Clostridium
septicum, Clostridium chauvoei and Clostridium tertium
Table I gives the data for production of neuraminidase by various strains
and species of Clostridia examined in this study. Strain L2Ab, a classical
neuraminidase-producing strain of C. perfringens type A, grew well in both
PPW5 and THB media, producing large amounts of neuraminidase in the
culture supernates. Cell-associated neuraminidase was also demonstrable with
the PPW5 culture, but the enzyme is predominantly extracellular. Good
production of neuraminidase was also found in PPW5 culture supernates of
strains of C. perfringens types B, C, D and E.
The production of large amounts of neuraminidase by strains of C. septicum
is also easily shown by these techniques and the results for strain NCTC547 are
typical of those obtained with other strains of C. septicum.
The two strains of C. chauvoei tested did not grow well in PPW5 broth and
they failed to grow in THB medium. Nevertheleless, strain CC2 produced
moderate amounts of neuraminidase in the PPW5 culture supernate. Neura¬
minidase production by strain NCTC8070 was demonstrated when the incuba¬
tion time of the assay was prolonged to 24 h; the enzyme was predominantly
extracellular. The low values for neuraminidase activity in the culture supernate
and the cell extract were not due to NAN-aldolase activity.
Two strains of C. tertium produced small amounts of neuraminidase; more
enzyme was produced in PPW5 culture supernates although the organisms grew
better in THB medium.
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Table I
Production ofneuraminidase by Clostridium perfringens, C. septicum, C. chauvoei, C. tertium,






Relative amount of neuraminidase








L2Ab + + + + ++ + + + + + + + + + See Fraser and
Smith (1975)
C. septicum
NCTC547 + + + +++ + + + ++ + See Gadalla and
Collee (1967)
C. chauvoei
CC2 + t -t + + Collee
NCTC8070 -ft -t + ± NCTC
C. tertium
CT1 + + + -f ± ± Watt
NCTC541 + ++ + -t NCTC
C. sordellii
1734 + + + + ++ + -f -f -f Oakley
P3 + + + + + + + -f -f -f Oakley
CB2 -f -f -f + + ++ -f -f -f Collee
CB3 ++ + + + ± + Collee
CB4 + + -f -f + ± ++ + Watt
NCTC1340 ++ + + + -j—1—1~ NCTC
NCTC2914 + + + ++ NCTC
NCTC6800 + ++ + + NCTC
NCTC6801 + ++ + + + + + NCTC
NCTC6927 ++ ++ + + + NCTC
NCTC6929 + + + + + + + + NCTC
NCTC8780 +++ j- + + + -f + -f NCTC
C. bifermentans
B4 -f -f -f +++ — — — Oakley
1617 +++ + ++ — — — Oakley
NCTC506 +++ ++ — — — Collee
NCTC1341 ++ + + — — NCTC
NCTC6928 ++ + + + — — NCTC
* See Methods for assessment of growth. PPW5 = Proteose peptone water; THB = Todd
Hewitt broth.
f Culture supernate or cell extract from second serial culture in stated medium was tested.
See Methods for grading of neuraminidase activity; ... = not tested,
t 96-h culture; 1 ml inoculum.
Studies with Clostridium sordellii and Clostridium bifermentans
Most of the 12 strains of C. sordellii grew well in PPW5 broth and the
supernates of all these cultures contained neuraminidase (table I). These
cultures in PPW5 broth gave high enzyme-control readings (£'549) due to the
formation of a chromogen with a peak absorption at 530 nm (Fraser and Smith,
1975) and it was occasionally necessary to use a time-zero (T0) control test as
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reference sample (see Methods). The enzyme was predominantly extracellular
in the two strains tested for intracellular enzyme. Several strains grew rather
poorly in THB medium but neuraminidase activity was still clearly demonstrable
in the culture supernates. Enzyme control values (E549) were low in THB
culture supernates and there was no difficulty in demonstrating the absorption
peak at 549 nm of the chromogen formed in neuraminidase assays.
By contrast, the five strains of the closely related C. bifermentans examined
could not be shown to produce neuraminidase activity in culture supernates of
either medium. The values for enzyme control tests were high in assays with
PPW5 culture supernates but comparison with T0 control tests confirmed that
there was no increase in value in tests incubated for 24 h. No cell-associated
enzyme activity was shown in 24-h assays with the cell extracts of PPW5
cultures of three strains. These negative results were shown not to be due to
presence of NAN-aldolase activity.
Studies with Clostridium novyi (oedematiens)
No neuraminidase was demonstrable in cultures of 10 strains of C. novyi,
types A to D. Table II shows that some strains grew poorly in the test media,
although the PPW5 broth was supplemented with cysteine and dithiothreitol
(PPW5S), and a large inoculum and prolonged incubation time were used. No
Table II
Growth of Clostridium novyi obtained in three fluid media
Test organism


































* See Methods for assessment of growth; ... = not tested. PPW5S = Proteose peptone water
supplemented with cysteine and dithiothreitol; THB = Todd Hewitt broth; CMB = cooked-meat
broth.
t 96-h culture; 1 ml inoculum.
j Source, NCTC. For the source of all organisms, except those marked i, see Rutter and Collee
(1969).
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neuraminidase activity could be shown in culture supernates in PPW5S or THB
media even in assays incubated for 24 h. Culture supernates and cell extracts
of four strains grown in CMB medium were also neuraminidase-negative. No
significant NANA destruction was found with the majority of these culture
supernates or cell extracts; the remainder produced a small reduction in the
assay value for NANA after incubation for 24 h, but in no instance was this fall
in reading (-E549) greater than 0-15 and this would not have obscured significant
neuraminidase activity.
Table III





















































































NCTC7423 ±t + + Collee
C. sphenoides
NCTC507 + + + + NCTC
C. fallax
NCTC8380 +++ + + NCTC
C. tetanomorphum
NCTC2909 + + ++ + NCTC
C. subterminale
CS1 + + ++ + Watt
* See Methods for assessment of growth. PPW5 ='Proteose peptone water; THB = Todd
Hewitt broth.
t 96-h culture; 1 ml inoculum.
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Studies with other neuraminidase-negative Clostridia
Table III shows the other strains of Clostridia that did not produce neura¬
minidase; no activity was demonstrable in 24-h assays in any of the culture
supernates. A few strains that grew poorly in one of the test media showed
better growth in the other. None of the culture supernates contained significant
NANA-destroying activity.
Effect of Ca2+ and EDTA on neuraminidase assays
Table IV compares the effect of varying the concentration of Ca2+ in the
assays of neuraminidase from C. perfringens and V. cholerae. Assays of pure
NANA were not affected by the presence of these amounts of Ca2+ or EDTA.
The V. cholerae enzyme is very calcium-dependent and its activity in our assay
can be almost doubled by the addition of 3mM Ca2+ to the reaction mixture.
By contrast, the activity of the C. perfringens enzyme is not increased by the
addition of 3mM Ca2+; 5mM EDTA reduced the assay value by c. 21 % only.
The calcium dependence of the neuraminidase produced by other Clostridia
was assessed under our standard assay conditions with no added Ca2+ and with
added 3mM Ca2+. Neuraminidase-containing PPW5 culture supernates of the
following strains were tested (see table I): C. perfringens L2Ab; C. septicum
NCTC547; C. chauvoei CC2 and NCTC8070; C. tertium CT1 and NCTC541;
C. sordellii CB3 and NCTC8780. Culture supernates with strong neuraminidase
activity were diluted in the acetate buffer before testing in 15-min. assays and the
time of incubation of assays of supernates with weak neuraminidase activity was
prolonged in order to give assay results in the range OT-O-6. In no instance was
there increased activity in the presence of the added Ca2+.
Table IV
Effect of Ca2+ and EDTA on the assay of neuraminidase from
Clostridium perfringens and Vibrio cholerae
Concentration of added Ca2+ or
EDTA in reaction mixture*
Result of neuraminidase assay on stated
preparation (£549)!
C. perfringens (P9D3) V. cholerae (RDE)
3mM Ca2+ 0-348 0-576
ImM Ca2+ 0-315 0-436
None added 0-351 0-318
ImM EDTA 0-313 0-202
5mM EDTA 0-277 0-012
* See Methods.
t The spectrophotometric value (£549) is an average result obtained from duplicate 15-min. assay
readings corrected by subtraction of the values for the corresponding substrate and enzyme controls.
For tested enzyme preparations P9D3 and RDE, see Methods.
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Further tests were performed with the PPW5 and THB culture supernates of
C. bifermentans strains B4, NCTC506, NCTC1341 and NCTC6928 that could
not be shown to contain neuraminidase in standard assays (see table I). The
24-h assays remained negative in the presence of added 3mM Ca2+.
Discussion
The neuraminidase of C. perfringens type A was one of the first to be
discovered (McCrea, 1947) and has been well characterised (Cassidy, Jourdian
and Roseman, 1966). Collee (1965a) reported that the enzyme was also
produced by strains of types B, C, D and E and this was confirmed during the
present studies. Although most classical strains of C. perfringens type A
produce large amounts of neuraminidase, some produce only small amounts
and a number of food-poisoning strains are neuraminidase-negative (Fraser and
Collee, 1975).
An organism that is shown to produce the enzyme is clearly neuraminidase-
positive; it is more difficult to be certain that an organism is truly neuraminidase-
negative and can never produce it. The assay procedures developed by Fraser
and Collee (1975) to define true neuraminidase-negative strains of C. perfringens
were used in the present study. Neuraminidase-positive Clostridia were shown
to produce the enzyme in culture supernates in both PPW5 and THB media
although there were often considerable differences in the relative amounts
produced and these did not correlate clearly with differences in the relative
amounts of growth in the two media. Neuraminidase-negative strains could not
be shown to produce the enzyme in either medium, even when assays were
incubated for 24 h. Clostridial neuraminidase is essentially extracellular but
several neuraminidase-negative strains were further tested to confirm that no
cell-associated enzyme could be detected after disruption of the cells.
ThepH optimum of a particular neuraminidase may vary considerably when
tested with different substrates (Rafelson, Schneir and Wilson, 1963), with
different buffer ions (Cassidy et al., 1966; Fraser and Smith, 1975) or at
different ionic strengths (Rosenberg and Schengrund, 1976). Optimal
values quoted for bacterial neuraminidases are usually in the range 4-5-6-5
(Drzeniek, 1972); in the present studies, acetate buffer atpH 5-1 was used as this
was found to be optimal for C. perfringens neuraminidase in earlier studies with
FVII substrate (Fraser and Smith, 1975).
Neuraminidases from different sources vary in their calcium dependence and
their sensitivity to EDTA (Boschman and Jacobs, 1965; Drzeniek, 1972). C.
perfringens neuraminidase is not calcium-dependent (Cassidy et al., 1966) and
the present studies showed that the enzyme produced by other clostridial species
is also calcium-independent. Ca2+ was not added to our assays as a routine, but
culture products of C. bifermentans and C. novyi retested with the addition of
Ca2+ remained negative. It is thus unlikely that our inability to demonstrate
neuraminidase production by other Clostridia was due to lack of Ca2+ in the
reaction mixtures.
The assay for C. perfringens neuraminidase may be complicated by the
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presence of NAN-aldolase which may destroy the NANA that is released, but
this does not usually prevent detection of quite small amounts of neuraminidase
in our assay (Fraser and Collee, 1975). In the present studies, none of the
culture products assayed contained sufficient NANA-destroying activity to
interfere significantly with the assays for neuraminidase; negative results are
thus not attributable to destruction of released NANA by NAN-aldolase.
The clostridial species that produced neuraminidase in the present study
were C. perfringens, C. septicum, C. chauvoei, C. tertium and C. sordellii-, all
strains tested were neuraminidase-positive. The other clostridial species tested
were all neuraminidase-negative.
C. septicum and C. chauvoei are usually regarded as separate species but the
differences between them are very small; Willis (1969) discussed the arguments
for regarding them as two types of a single species. Warren and Spearing (1963)
noted the presence of neuraminidase activity in a lyophilised preparation of C.
septicum toxin. Gadalla and Collee (1968) found that the enzyme was produced
by all of 15 strains studied. Miiller and Schallehn (1972) detected the enzyme in
two strains of C. chauvoei (C. feseri) by electrophoretic methods. The present
study confirmed that strains of C. septicum generally produce large amounts of
neuraminidase whereas the two strains of C. chauvoei produced rather small
amounts under the same test conditions.
Howe et al. (1957) reported that C. tertium produced an enzyme that
destroyed myxovirus receptor substances. Muller and Werner (1974) demon¬
strated neuraminidase production by a strain of C. tertium and the present study
confirmed that small amounts of the enzyme were produced by two other
strains.
C. sordellii and C. bifermentans are very closely related and there has been
considerable debate as to whether or not they should be regarded as separate
species (see Willis, 1969). Pathogenic strains of C. sordellii produce the /3-toxin
whereas C. bifermentans is non-toxigenic, but this is not an adequate criterion
for classification as non-toxigenic strains of C. sordellii also occur. Nakamura
et al. (1975) used numerical taxonomy and DNA homology in a reinvestigation
of this problem. They scored for 162 features (not including neuraminidase
activity) and concluded that the two species could be reliably differentiated by
only a few biochemical tests—fermentation of mannose and sorbitol, urease
activity, arginine deamination and growth inhibition by mannose. Warren and
Spearing (1963) noted neuraminidase activity in a preparation of C. sordellii
toxin, and White and Mellanby (1969) separated the neuraminidase from the
toxic activity in the culture supernate of a strain of C. sordellii. The present
finding that all of 12 strains of C. sordellii produced neuraminidase but that none
of five strains of C. bifermentans did so suggests that this may be another
character that distinguishes the two species. Soloviev et al. (1972) have
suggested that tests for neuraminidase production may be of value in studies of
vibrio taxonomy and it now appears that they may also be of interest in certain
aspects of clostridial taxonomy.
C. sordellii is a rare cause of wound infection in man and animals (Willis,
1969). The finding that neuraminidase production is one of the few features
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that distinguish this organism from the non-pathogenic C. bifermentans might
suggest that neuraminidase plays a part in the pathogenicity of C. sordellii.
White and Mellanby (1969) were unable to show an enhancing effect when C.
sordellii neuraminidase was added to /3-toxin in guinea-pig skin tests, but they
did not study actual infection with the organism.
It has been suggested that neuraminidase may play a part in the pathogenesis
of clostridial infections (Collee, 19656; Gadalla and Collee, 1968; Midler,
1970a and 6; Midler and Schallehn, 1972; Fraser and Collee, 1975) although
there is little direct evidence for this. Neuraminidase action has been shown to
alter a wide range of properties and functions of important proteins and cells
(tabulated by Rosenberg and Schengrund, 1976). Midler (1974) reviewed the
possible role of neuraminidase in bacterial infections. He argued that there is a
correlation between virulence and the ability to produce large amounts of
neuraminidase in vivo for a variety of strains and species of bacteria and he
suggested that neuraminidase-producing organisms are more likely to be
successful in a wide range of infections.
Gadalla and Collee (1968) showed that neuraminidase is produced in vivo
during experimental infections with C. septicum, and similar findings have been
made in tissues taken from guinea-pigs with experimental C. perfringens gas
gangrene (unpublished results). Midler (19706) demonstrated changes attri¬
butable to neuraminidase in the glycoproteins of the wound exudate from a
patient with a C. septicum infection and this also shows that neuraminidase is
produced and active in vivo.
Neuraminidase might conceivably influence an organisms's invasiveness, or
its ability to gain access to a target site or receptor. C. septicum and classical
strains of C. perfringens type A both produce large amounts of neuraminidase
and are important causes of gas gangrene in man, in whom they are invasive
pathogens when infection is established. However, C. novyi type A, the other
important cause of gas gangrene, is also invasive and is neuraminidase-negative.
Of the other neuraminidase-positive species, C. chauvoei is pathogenic for
animals (blackquarter) but not for man and C. tertium is regarded as non¬
pathogenic. C. tetani and C. botulinum, both neuraminidase-negative, are
important non-invasive and essentially toxic human pathogens. C. sporogenes,
which is closely related to C. botulinum, is neuraminidase-negative and essen¬
tially non-pathogenic, but C. histolyticum and C. fallax are neuraminidase-
negative histotoxic Clostridia with invasive potential. The other Clostridia found
to be neuraminidase-negative in this study are regarded as non-pathogenic (see
Willis, 1969 and 1977).
It is clear that there is no strict correlation between neuraminidase produc¬
tion and the ability of various clostridial species to cause wound infection.
However, several pathogenic species produce neuraminidase in addition to
recognised toxins and it is possible that this may contribute to their virulence.
Further studies are in progress to determine whether there is any correlation
between virulence and neuraminidase production in strains of those species that
produce the enzyme.
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Summary
The production of neuraminidase (EC 3.2.1.18) by a range of clostridial
species was investigated with techniques previously developed to distinguish
neuraminidase-negative and neuraminidase-positive strains of Clostridium
perfringens (welchii). Large amounts of extracellular neuraminidase were
produced by representative strains of C. perfringens and C. septicum in the test
media. Under similar conditions, two strains each of C. chauvoei and C. tertium
were found to produce small amounts of the enzyme. All of 12 strains of C.
sordellii were clearly shown to produce neuraminidase, often in large amounts,
but none of five strains of the closely related but non-pathogenic C. bifermentans
had demonstrable neuraminidase activity. No neuraminidase was produced by
C. novyi (oedematiens) types A-D (10 strains), C. tetani (6), C. botulinum types
A, B, C or E (4), C. sporogenes (4), C. histolyticum (4) or by single strains of five
other clostridial species.
Clostridial neuraminidase was predominantly extracellular and was not
calcium-dependent. The investigation took account of variations in growth and
enzyme production in different media. It was necessary to prolong the
neuraminidase-assay reaction time to 24 h and to monitor for the presence of
NAN-aldolase (EC 4.1.3.3) to define true negatives. It is suggested that
neuraminidase production may be of value in taxonomic studies and that its
production by several pathogenic species of Clostridia may be of interest in
studies of pathogenicity and virulence.
The invaluable technical assistance of Mr Robert Brown and his colleagues and the
constant advice and encouragement of Professor J. G. Collee are gratefully acknowledged. I
am indebted to Dr J. G. Watt, Scottish National Blood Transfusion Service, Protein Frac¬
tionation Centre, Ellen's Glen Road, Edinburgh EH17 7QT for supplies of FVII substrate.
REFERENCES
Boschman, T. A. C. and Jacobs, J. 1965. The influence of ethylenediaminetetraacetate on
various neuraminidases. Biochem. Z., 342, 532.
Cassidy, J. T., Jourdian, G. W. and Roseman, S. 1966. Sialidase from Clostridium per¬
fringens. In Methods in enzymology, edited by S. P. Colowick and N. O. Kaplan, New
York and London, vol. 8, p. 680.
Collee, J. G. 1965a. A myxovirus receptor-inactivating agent occurring in cultures of
Clostridium welchii. J. Path. Bact., 90, 1.
Collee, J. G. 19656. The relationship of the haemagglutinin of Clostridium welchii to the
neuraminidase and other soluble products of the organism. J. Path. Bact., 90, 13.
Drzeniek, R. 1972. Viral and bacterial neuraminidases. Curr. Top. Microbiol. Immun., 59,
35.
Fraser, A. G. and Collee, J. G. 1975. The production of neuraminidase by food-poisoning
strains of Clostridium welchii (C. perfringens). J. med. Microbiol., 8, 251.
Fraser, A. G. and Smith, J. K. 1975. Preparation of a glycoprotein fraction from pooled
human plasma and its evaluation as a substrate for the assay of Clostridium welchii (C.
perfringens) neuraminidase. J. med. Microbiol., 8, 235.
Gadalla, M. S. A. and Collee, J. G. 1967. The nature and properties of the haemag¬
glutinin of Clostridium septicum. J. Path. Bact., 93, 255.
Gadalla, M. S. A. and Collee, J. G. 1968. The relationship of the neuraminidase of
Clostridium septicum to the haemagglutinin and other soluble products of the organism.
J. Path. Bact., 96, 169.
280 A. G. FRASER
Howe, C., Maclennan, J. D., Mandl, I. and Kabat, E. A. 1957. Enzymes of Clostridium
tertium. Effects on blood group and virus receptor substances. J. Bact., 74, 365.
McCrea, J. F. 1947. Modification of red-cell agglutinability by CI. welchii toxins. Aust. J.
exp. Biol. med. Sci., 25, 127.
Moore, W. B. 1968. Solidified media suitable for the cultivation of Clostridium novyi type B.
J. gen. Microbiol., 53, 415.
Muller, H. E. 1970a. Die Neuraminidase als pathogenetischer Faktor bei Gasodem-
Infektionen durch Clostridium perfringens. Dt. med. Wschr., 95, 513.
Muller, H. E. 19706. The in-vitro identification and the in-vivo action of Clostridium
septicum neuraminidase. Zentbl. Bakt. ParasitKde, I. Abt. Orig., 215, 530.
Muller, H. E. 1974. Neuraminidases of bacteria and protozoa and their pathogenetic role.
Behring Institute Mitteilungen, No. 55, p. 34.
Muller, H. E. and Schallehn, G. 1972. The occurrence of neuraminidase and acyl-
neuraminate lyase in Clostridium chauvoei (Clostridium feseri). Zentbl. Bakt. ParasitKde,
I. Abt. Orig. A, 222, 64.
Muller, H. E. and Werner, H. 1974. Occurrence of neuraminidase and acylneuraminate
lyase in Clostridium beijerinckii and Clostridium tertium. Zentbl. Bakt. ParasitKde, I.
Abt. Orig. A, 229, 134.
Nakamura, S., Shimamura, T., Hayashi, H. and Nishida, S. 1975. Reinvestigation of the
taxonomy of Clostridium bifermentans and Clostridium sordellii. J. med. Microbiol., 8,
299.
Rafelson, M. E. jr, Schneir, M. andWilson, V. W. jr 1963. Studies on the neuraminidase
of influenza virus. II. Additional properties of the enzymes from the Asian and PR8
strains. Archs Biochem. Biophys., 103, 424.
Rosenberg, A. and Schengrund, C.-L. 1976. Sialidases. In Biological roles of sialic acid,
edited by A. Rosenberg and C.-L. Schengrund, New York and London, p. 295.
Rutter, J. M. and Collee, J. G. 1969. Studies on the soluble antigens of Clostridium
oedematiens (CI. novyi). J. med. Microbiol., 2, 395.
Soloviev, V. D., Domaradsky, I. V., Shimanyuk, N. Ya., Bichul, K. G. and Kurennaya,
I. I. 1972. Function of neuraminidase in Vibrio taxonomy. Bull. exp. Biol. Med.
U.S.S.R., 73, No. 2, 61.
Warren, L. and Spearing, C. W. 1963. Sialidase (neuraminidase) of Corynebacterium
diphtheriae. J. Bact., 86, 950.
White, A. B. and Mellanby, J. 1969. The separation of neuraminidase activity from other
pathological activities of a culture filtrate of Clostridium sordellii CN 3903. J. gen.
Microbiol., 56, 137.
Willis, A. T. 1969. Clostridia of wound infection, London.
Willis, A. T. 1977. Anaerobic bacteriology: clinical and laboratory practice, 3rd ed.,
London.
FOOD POISONING CAUSED BY
CLOSTRIDIUM PERFRINGENS (C. WELCHII) TYPE A
A. G. Fraser and J.G. Collee*
Although Clostridium perfringens (C.
perfringens) type A occurs regularly as a
commensal in the gut of man and anim¬
als, some strains are able to cause food
poisoning in man if ingested in large num¬
bers. An association between diarrhoea
and C. perfringens was first suggested in
1895 but despite sporadic reports there¬
after the difficulty of discriminating
food-poisoning strains from commensal
organisms in the faeces prevented the
general recognition of the disease1.
The work of Hobbs and her colleagues2
in Britain finally established C. perfrin¬
gens as a definite cause of food poison¬
ing. These studies identified "typical
food-poisoning strains" that grow as
non-haemoiytic coionies on horse-blood
agar and produce unusually heat-resistant
spores. Such organisms have been class¬
ified as type-A2, to distinguish them
from so-called classical strains of type-
A13. Although type-A2 strains are the
more likely to survive cooking pro¬
cedures, because of the marked heat re¬
sistance of their spores, later studies in
Britain and America established that
food poisoning can also be caused by
classical type-Ai strains that produce re¬
latively heat-sensitive spores4.5.6.
The term "typical food-poisoning
strain" has probably outlived its useful¬
ness. It is now clear that the food-poison¬
ing potential of a strain of C. perfringens
rests upon its ability to produce a speci¬
fic enterotoxin during sporulation in the
gut (see below). Enterotoxin may be
produced by either haemolytic or non-
haemolytic strains. Classical strains are
haemolytic on horse-blood agar because
of the production of theta (0) toxin.
Strains that do not produce d toxin are
defined as non-haemolytic-though they
♦Department of Bacteriology, University Med¬
ical School, Teviot Place, Edinburgh EH8 9AG.
may produce a weak haemolytic effect
due to the action of their alpha (a) toxin.
The spores produced by classical type-
Ai strains of C. perfringens are not very
heat-resistant and are usually inactivated
by boiling at 100°C within a few min¬
utes, whereas type-A2 food-poisoning
strains form markedly heat-resistant
spores can survive boiling in cooked-
meat broth or food for several horns2.
Markedly heat-resistant spores are typic¬
ally produced by strains that are virtu¬
ally non-haemolytic, but not all non-
haemo lytic strains produce heat-resistant
spores.
Techniques for detecting enterotoxin
produced during sporulation in labora¬
tory media have only recently been deve¬
loped and few epidemiological studies
have differentiated between strains of C.
perfringens on this basis. However, the
recognition of the enterotoxin is amajor
step forward in our understanding of the
mechanism of pathogenicity of this dis¬
ease and raises the possibility of improved
methods for its diagnosis.
The occurrence of Clostridium per¬
fringens
C. perfringens occurs very widely in
nature. The spores are able to survive
under adverse conditions and can be re¬
covered from soil and dust, water, mud
and grass. The ecology of this organism
has not been fully studied. C. perfringens
type A occurs regularly in the faecal
flora of man and animals and can be
found in human faeces in numbers that
range from relatively few to about 104
to 105 per gram wet weight of faeces7.
Although the organism does not readily
sporulate in routine culture media, it
does so in the human gut and consider¬
able numbers of spores of C. perfringens
type Ai may occur in faeces. Sutton8.9
studied the carrier rate of type-A2 strains
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and related high carrier rates (15-25%) to
communal feeding and to poor hygiene.
Many opportunities arise for spores of
C. perfringens to contaminate meat and
meat products at the abattoir, in transit
to shops and market places, and in cater¬
ing establishments and in the home. As
the organism is encountered so frequent¬
ly and so widely, it is not usual to
attempt to trace the ultimate source in
an outbreak of food poisoning but rather
to determine the circumstances or con¬
ditions that allowed the almost inevitable
contamination to be boosted during pro¬
cessing of the food concerned.
Growth of C. perfringens in food
It can be argued that the organism
has taken advantage of changing habits
in food production because bulk food
processing and communal eating, partic¬
ularly of meat foods, produces the con¬
ditions necessary to deliver high challenge
doses of C. perfringens to man. The bulk
cooking of meat allows circumstances in
which heat gain is slow and subsequent
cooling may be prolonged. Dissolved
oxygen is driven off and the meat main¬
tains an anaerobic environment. Spores of
C. perfringens contaminating the meat
may be activated and germinate readily
under these conditions!0. They they mul¬
tiply very rapidly at temperatures up to
45°C. A portion of such food may taste
normal but will contain many hundreds
of millions of viable C. perfringens org¬
anisms which pass the acid barrier of the
stomach in such a meal and sporulate in
the human gut, producing the enterotox-
in.
The heat-resistance of type-A2 spores
allows them to survive the whole cook¬
ing procedure, whereas type-Ai spores
are not likely to cause trouble unless
they are introduced by faulty catering
practice during the period between cook¬
ing and serving.
C. perfringens food poisoning and its
incidence
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The signs and symptoms of C. perfrin¬
gens food poisoning include abdominal
cramping pain and diarrhoea, usually
beginning within about 9-14 hours after
ingestion of the infected food and per¬
sisting for a day or so. The patient is
usually not,, fevered and vomiting is not
characteristic. The effective challenge
dose is about 108 - 109 viable organisms;
the numbers of organisms in the faeces
of those involved in an outbreak range
from 105 108 per gram with many
spores present. In an outbreak, only a
proportion of those at risk report that
they have been significantly unwell and
it seems that there is a considerable vari¬
ation in host susceptibility.
Pre-cooked meat and poultry foods are
most commonly involved in this form
of food poisoning, but fish dishes, milk
foods and leguminous seeds are some¬
times associated with outbreaks. The
numbers of cases of C. perfringens food
poisoning reported in England and Wales
in recent years are disturbingly high (see
Table). C. perfringens was the second
most common cause of food poisoning,
being responsible for approximately 25%
of general outbreaks in 1973-512. As the
condition is associated with bulk-cooked
foods, the numbers of people affected in
an outbreak are usually large - often 50-
300, and up to 13,500 persons have been
affected in a single episode13. Salmonel-
lae are the commonest cause of food
poisoning in Britain, but salmonella out¬
breaks tend to affect smaller numbers
of people and there are many more lim¬
ited family outbreaks and sporadic cases.
It is disappointing that the numbers of
cases of C. perfringens food poisoning
continue to be so high, because the occur¬
rence of C. perfringens food poisoning
is a direct indictment of the food-proces¬
sing procedures of the institution involv¬
ed and the condition is clearly prevent¬
able by observing simple fundamental
rules of hygiene in food processing14.
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The prevalence of C. perfringens food
poisoning in many countries of the world
is not known, because notification is
either inadequate or non-existent, but
there are many indications in the liter¬
ature that C. perfringens food poisoning
is under-reported even in those countries
in which the condition is well recognised
and where there are laboratory facilities
for its detection13.
(C.perfringens Enterotoxin)
Our understanding of the role of en¬
terotoxin in C. perfringens food poison¬
ing stems largely from the systematic
studies of two groups, Duncan and col¬
leagues in Wisconsin, and Hauschild and
colleagues in Ottawa13. These workers
established valid animal models for the
study of C. perfringens food poisoning,
similar to those developed over the pre¬
vious decade to demonstrate the central
role of Vibrio cholerae enterotoxin in
the pathogenesis of cholera16. Hauschild,
Niilo & Dorward17.18 worked with
lambs and showed that, when suitably
administered, human food-poisoning
strains caused experimental diarrhoea
and produced fluid accumulation in lig-
ated intestinal loops. Independently,
Duncan and colleagues produced similar
results with infant rabbits19.20. Living
organisms were used in the initial ligated
loop experiments, but a cell-free entero¬
toxin was soon demonstrated by Dun¬
can & Strong21 in studies with rabbits
and by Hauschild, Niilo & Dorward22.23
in lambs. The enterotoxin could be speci¬
fically neutralised by experimental anti-
sera and was quite distinct from the a
toxin and other toxins of C. perfringens
type A.
A good correlation was found in these
and other studies between the production
of enterotoxin able to cause fluid accu¬
mulation in ligated loops of rabbit or lamb
intestine and the ability to cause exper-
mental food poisoning when suitably
administered to man or monkeys24. 23
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Enterotoxin-negative strains did not pro¬
duce experimental food poisoning.
Enterotoxin production and sporulation
The production of food-poisoning
symptoms in human volunteers requires
the ingestion of large numbers of veget¬
ative cells of a food-poisoning strain of
C. perfringens type A26. 3. 24. Culture
filtrates or heat-killed cutures of the
organism are seldom effective. The
reason for this became clear when it
was found that enterotoxin production
is linked to sporulation. It is unique in
this, as other clostridial toxins are pro¬
duced as exotoxins during vegetative
growth. Enterotoxin is not found in the
medium until the cells lyse although it
can be released by sonic disintegration
during the early stages of sporulation21.
22, 23, 27. Strains of C. perfringens type
A do not generally spore readily in the
laboratory, although spores are common¬
ly formed in the gut and are regularly
present in faeces. A few unusual strains
produce many spores in laboratory
media, but this is quite uncommon. The
introduction of Duncan and Strong's
improved sporulation medium (DS med¬
ium) has proved a great advance as many
strains of C. perfringens sporulate well
in it28, 29, 30 Sporulation is essential
for enterotoxin production; it should be
borne in mind that not all strains that
sporulate readily are enterotoxin pro¬
ducers.
C. perfringens in poisoned food is pre¬
sent predominantly as actively growing
vegetative cells and these release the
enterotoxin when they sporulate in the
intestine. The amount of free enterotoxin
present in food or in culture filtrates of
C. perfringens is usually inadequate to
cause symptoms when taken orally,
Hauschild, Walcroft & Campbell31 pro¬
duced vomiting and diarrhoea in mon¬
keys dosed with purified enterotoxin,
and Skjelkvale & Uemura in 1977 pro¬
duced diarrhoea in human volunteers by
giving very large oral doses (8-12 pg) of
C. perfringens enterotoxin32
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Enterotoxin as a spore-specific product
Duncan, Strong & Sebald's studies with
mutants of C. perfringens showed that
enterotoxin is a sporulation-specific
gene product but its precise role in sporu-
lation remains obscure33. Later studies
confirmed that enterotoxin production
is an early event (c. stage IV) in sporu-
lation34. 35 and suggested that theentero¬
toxin is also one of the normal struetural
proteins of the spore coat33, 37. it
may be that food - poisoning strains
over-produce this spore-coat protein,
which accumulates in the cytoplasm of
the sporulating cells; enterotoxin produc¬
tion my be the result of poor control
of this stage in sporulation36. During
sporulation, some enterotoxin-producing
strains form a paracrystalline inclusion
which may represent an aggregation of
enterotoxin in the cytoplasm of sporul¬
ating cells38. Niilo used direct micro¬
scopy with fluorescent antibody to con¬
firm the production of enterotoxin in
the cytoplasm of sporulating cells but
did not demonstrate antibody on the sur¬
face of washed spores39, perhaps because
it lies in the deeper layers of the spore
coats.
Properties of enterotoxin and methods
of assay
The enterotoxin is a simple heat-labile
acidic protein of M.W. c. 36,000 which
has been purified and characterised by
various techniques40,41,42,43,44,45.
In addition to its local action on the
gut, it also has a lethal effect if injected
intravenously into mice, guinea pigs,
rabbits or lambs, but only when large
doses are given46,47. When injected into
the skin of rabbits or guinea pigs, it pro¬
duces an erythematous reaction48. 49
and this provides a more convenient assay
than mouse lethality or the use of ligated
intestinal loops5 0,47,51.
More recently, immunological tech¬
niques have been developed for sensitive
in-uitro assays52. Duncan & Somers53
introduced electroimmunodiffusion, and
Uemura, Sakaguchi & Riemann2? deve¬
loped a reversed passive haemagglutin-
ation (RPHA) assay. Naik & Duncan
found the RPHA technique rather vari¬
able although it is very sensitive, detect¬
ing as little as 0.001 pg enterotoxin per
ml; these workers recommended a count-
erimmunoelectrophoresis assay for rapid
detection and quantitation of enterotoxin
(limit 0.2 pg per ml)5 4.
Relationship to other bacterial enterotox-
ins
The C. perfringens type A enterotoxin
is clearly distinct from the enterotoxins
produced by Vibrio cholerae, Escherichia
coli, Staphylococcus aureus, Bacillus
cereus, Salmonellae and shigellae5 5. How¬
ever, Skjelkvale & Duncan56, 57 studied
other types of C. perfringens and found
that type-C strains also produce an enter¬
otoxin which is biochemically and imm¬
unologically indistinguishable from that
of the type-A strains; this raises the ques¬
tion whether the enterotoxin may play
a part in the pathogenesis of C. perfrin¬
gens type C necrotic enteritis.
Pathogenesis of C. perfringens food
poisoning
Since the disease is very rarely fatal,
little is known of the response of the
human gut during the illness. In experi¬
mental animals the small bowel is most
sensitive to the effect of enterotoxin5 8
and it is presumed that this is also the
site of in man. There is, however, little
direct information on the site of repli¬
cation, sporulation and enterotoxin
production by C. perfringens in the
human gut.
ii is known that in a variety of gut in¬
fections adhesive factors play an import¬
ant part in assisting colonisation of the
intestinal mucosa at an appropriate level
in the gut, e.g. K88 and K99 antigens in
Escherichia coli enteritis in pigs and cat¬
tle, and similar factors may be important
in cholera59. Arbuckle noted that type-
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C strains of C. perfringens which cause a
form of enteritis in piglets can attach to
the intestinal epithelium of the area of
the gut that they affect60. No adhesive
factor or antigen has been identified for
enteropathogenic strains of C. perfringens
type A so far.
It is clear that the enterotoxin is the
factor responsible for producing fluid
accumulation in ligated segments of small
intestine in experimental animals. This is
a local effect and it is not thought that
there is significant absorption of entero¬
toxin during the clinical illness. Large
doses have to be given parenterally in
order to produce systemic effects4 6. Cir¬
culating antibody to enterotoxin is pre¬
sent in many healthy people 61, but it
appears to give no protection against fur¬
ther attacks in man or experimental an¬
imals2 6. 24, 62, 3 2.
There are clear differences in the mode
of action of the enterotoxins of C. per¬
fringens and V. cholerae. The enterotoxin
of V.cholerae does not damage the
intestinal epithelium, but binds to it and
stimulates active secretion of fluid and
electrolytes into the gut lumen, with
cyclic AMP as the mediator of this effect
16. Like V. cholerae, C. perfringens does
not invade the intestinal epithelium, but
the C. perfringens enterotoxin does cause
some damage to the epithelium at the tips
of the ileal villi in rabbits. The biochem¬
ical changes suggest a general pattern of
cell degeneration and metabolic inhibiti¬
on and cyclic AMP has not been found
to be involved in-the clostridial model63.
64,65.
Diagnosis of C. perfringens food poison¬
ing
Careful bacteriological investigations
are required to confirm the clinical and
epidemiological impression that an out¬
break of food poisoning is due to C. per¬
fringens type A. Detailed recommendati¬
ons for laboratory procedures are given
by Hobbs66, Hobbs et al§l, Hauschild13
and Willis68. Hauschild et a/69, have
compared various media for the enumer¬
ation of C. perfringens in foods and a
further study of media for the examinati¬
on of faeces is in progress.
Samples of suspect foods should be
examined if possible but they are often
not available by the time the diagnosis
is suggested. The organism will be present
as vegetative cells in food and the samples
should not be heated before culture.
Faecal specimens from affected people
should be examined for spores of C. per¬
fringens. If faecal samples are boiled be¬
fore culture, heat-resistant strains will be
isolated but the spores of many entero-
toxin-producing strains will be killed by
this treatment. Mild heating is, however,
of value in recovery of heat-sensitive.
C. perfringens from faeces as heat shock
activates the spores and increases the rate
of germination.
The simple demonstration of C. per¬
fringens in the faeces of affected people
is of limited value. The qualitative evi¬
dence requires to be substantiated by
quantitative evidence, because many
foods are contaminated with C. perfrin¬
gens and the organism occurs regularly
in the faeces of normal people. It should
be appreciated that the count of organ¬
isms in remnants of suspect food will
depend on the conditions under which
the food has been kept and little reliance
can be put upon high counts unless the
food was held in the refrigerator after
serving. Under normal circumstances,
median counts of the organism do not
usually exceed 105 per gram of food or
faeces, whereas in C. perfringens food
poisoning the affected food may contain
very high counts of C. perfringens (up to
109 per gram) and the faeces of affected
people may contain C. perfringens in
counts of 10s - 108 per gram for some
days after the food-poisoning incident.
These counts fall within a few weeks so
that a temporary convalescent carrier
state persists. Sutton9 was able to distin¬
guish between recent cases and carriers
of food-poisoning strains of C.perfringens
in this way.
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When significant numbers of C. per-
fringens have been found in the faeces of
a number of affected people, these should
be compared for haemolytic activity and
heat resistance in order to show whether
they appear similar to each other and to
any isolate from the suspect food. The
identity of the strains can then be con¬
firmed by serotyping in a reference lab¬
oratory. Several isolates from each sample
should be sent as more than one serotype
may be found.
Serotyping of C. perfringens
Various attempts have been made to
develop serotyping methods for C. per¬
fringens''0. Two sets of antisera were
developed to identify type-A2 or type-Ai
food-poisoning strains2.07, but there was
considerable overlap between the two
groups and recent studies have aimed at
producing a unified set of antisera for all
C. perfringens type A strains, regardless
of haemolytic activity or the heat resis¬
tance of the spores71. It is hoped soon
to produce an internationally standard¬
ised scheme.
There does not appear to be a constant
relationship between specific serotypes
and enterotoxin production, but the
demonstration that substantial numbers
of the same serotype are present in a
suspect food and the faeces of affected
people is the best evidence to incriminate
C. perfringens type A in an outbreak of
food poisoning.
Lecithinase-negative strains
Clostridium perfringens type A is iden¬
tified primarily by its production of
toxins (seeWillis70. 68), notably the lethal
a-toxin, a lecithinase or phospholipase C
which is not involved in the pathogenesis
of food poisoning. Strains of C. perfrin¬
gens type A vary in the amount of a-toxin
produced, but type-A2 strains are usually
only weakly toxigenic2. It is difficult to
identify strains of C. perfrihgens that do
not produce lecithinase, because this is
the cornerstone of our identification
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system; but such lecithinase-negative
strains do occur72 and it has recently
been shown that such strains may occasi¬
onally be responsible for food poisoning
73.
Further approaches
It has only recently become practicable
to test isolates directly for enterotoxin
production and it seems desirable that this
should now be used to supplement the
standard epidemiological and serological
techniques. Uemura, Sakaguchi & Riem-
ann27 found increased in-vitro producti¬
on of enterotoxin after strains had been
subjected to heat treatment, and this was
confirmed by Skjelkvale & Duncan 56
with type-A and type-C strains. The pre¬
cise mechanism of this enhancement is
uncertain but Uemura74 recommended
that heat treatment should be performed
on three successive cultures of each isol¬
ate before testing for enterotoxin produc¬
tion.
The significance of the detection of
enterotoxin-positive strains in the faeces
of an individual is not yet clear. Most
strains isolated from outbreaks of tood
poisoning produce enterotoxin in DS
medium, while few studies have shown
enterotoxin-positive strains in healthy
human subjects or the natural environ¬
ment7 5. The ecology of these strains has
not been properly studied and the ultim¬
ate source of food-poisoning strains has
seldom been traced. It is not known
whether enterotoxin-producing strains
are particularly liable to contaminate and
grow in food, or whether the conditions
found in bulk-cooked meat dishes select
or induce enterotoxin production. How¬
ever, using triple heat treatment, Uemura
was able to demonstrate enterotoxin-pro-
duction by strains of C. perfringens type
A from 11 of 35 (31%) healthy human
subjects7 4. This observation underlines
the continuing importance of quantitative
epidemiological studies.
Recent studies in India have shown a
higher incidence of enterotoxin-positive
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strains of C. perfringens in faeces of
patients with diarrhoea than in non-diar-
rhoeal controls76. 77 but there is little
information on the incidence or epidemi¬
ology of C. perfringens food poisoning
in India.
The development of very sensitive im¬
munological assays such as RPHA also
raises the possibility of making the diag¬
nosis by detecting enterotoxin directly
in faeces. This approach is recommended
by Skjelkvale & Uemura32 who were able
to detect amounts of 0.2-16 pg entero¬
toxin per gram of faeces after oral admi¬
nistration of purified enterotoxin to vol¬
unteers.
Conclusion
C.perfringens type A has been increas¬
ingly recognised as a commoncauseofout¬
breaks pf food poisoning in Britain and
America during the past 25 years. Its in¬
cidence in developing countries is not
known, but it seems likely to become
commoner wherever there is a move to-
TABLE
Numbers of cases of C. perfringens type A
food poisoning in England and Wales. 1969-75*








*from Vernon & Tillett 78 and Vernon12
wards centralised catering in canteens
and institutions. Typical outbreaks affect
fairly large numbers of people who have
eaten cold or reheated meat dishes that
have been cooked in bulk but not held
under proper conditions before serving.
The recognition over the last 10 years
that the symptoms are produced by an
enterotoxin has greatly advanced our
understanding of the pathogenesis of the
disease although the ecology of entero-
toxin-producing strains remains unclear.
C. perfringens type A is a normal com¬
mensal in the gut of man and of animals
and its spores are widely distributed in
nature. Meat and other foods are almost
inevitably contaminated with the organ¬
ism, which can multiply rapidly if bulk-
cooked food is not adequately cooled
and held refrigerated before serving.
Prevention depends upon careful attenti¬
on to fundamental rules of good catering
practice.
The diagnosis of C. perfringens type1A
food poisoning is complicated by the need
to distinguish food-poisoning from com¬
mensal strains in the faeces. Strains that
produce particularly heat-resistant spores
are most likely to survive cooking and
cause trouble, but outbreaks may also be
due to enterotoxin-producing strains that
form relatively heat-sensitive spores. Care¬
ful epidemiological studies must be fol¬
lowed by prompt qualitative and quanti¬
tative bacteriological examination of the
faeces of affected people and, where
possible, of suspect foods also. The devel¬
opment of sensitive methods for detecti¬
on of enterotoxin production during
sporulation in the laboratory should lead
to further improvements inourprocedures
for recognition of the condition.
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NEURAMINIDASE PRODUCTION BY BACTEROIDACEAE
A. G. Fraser and R. Brown
Department of Bacteriology, Medical School, University of Edinburgh, Teviot Place,
Edinburgh EH8 9AG
Summary. The production of neuraminidase (EC 3.2.1.18) by 77 strains
of Bacteroidaceae was investigated by techniques previously used to
study neuraminidase production by Clostridia. Conditions for culture
and assay of Bacteroidesfragilis neuraminidase were characterised. The
enzyme is predominantly cell associated; it is not calcium dependent and
the pH optimum for its production is c. 4-5.
Most neuraminidase-positive Bacteroides strains produced the
enzyme well in the test media but a few strains failed to produce it
consistently in one or other of the media. Because of these occasional
variations, strains were grown and tested in at least two media before
being defined as neuraminidase negative.
Within the B. fragilis group of species, B. fragilis, B. vulgatus, B.
distasonis, B. ovatus, B. thetaiotaomicron and B. variabilis were neura¬
minidase positive while B. eggerthii, B. uniformis and B. splanchnicus
were negative. Two subspecies of B. melaninogenicus (ss. melanino-
genicus and ss. levii) were positive but the other (ss. intermedius) was
negative. Strains ofB. oralis and B. bivius produced the enzyme while B.
ruminicola, B. disiens, B. asaccharolyticus and B. corrodens did not. The
microaerophilic B. ochraceus were also positive. None of the Fusobac-
terium or Leptotrichia species tested produced neuraminidase.
Our results for neuraminidase production are consistent for all
strains ofeach species examined and we suggest that tests for neuramini¬
dase production would be a valuable addition to biochemical tests
currently used in taxonomic studies of the Bacteroidaceae.
Introduction
The importance of the Bacteroides-Fusobacterium group of gram-negative
anaerobic bacilli as significant pathogens in various infections has become
increasingly apparent with recent improvements in methods for their isolation
and identification (Finegold, 1977). Little is known of their mechanisms of
pathogenicity, and the biochemical attributes of the different species are still
being defined.
Neuraminidases (EC 3.2.1.18) are produced bymany species ofaerobic and
Received 23 Mar. 1980; revised version accepted 10 Jul. 1980.
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anaerobic bacteria (see Miiller, 1974). The enzyme is thought to play a
significant role in infection with influenza virus and other myxoviruses
(Drzeniek, 1972; Rosenberg and Schengrund, 1976) and it has been suggested
that it may also be a virulence factor for some pathogenic bacteria (Collee,
1965; Miiller, 1974).
Miiller andWerner (1910a and b) reported production ofneuraminidase by
some Bacteroides species and argued that the enzyme had a role in patho¬
genesis. We have previously reported studies of production of neuraminidase
by Clostridia (Fraser and Collee, 1975; Fraser, 1978) and have now extended
these studies to a range of well characterised strains representing the major
species of gram-negative non-sporing anaerobic bacilli.
Materials and methods
Bacterial strains. Many of the strains were characterised in detail in this laboratory and
described by Duerden, Holbrook, Collee and Watt (1976) or Deacon, Duerden and Holbrook
(1978). The other strains studied were as follows: Bacteroides eggerthWHCTCX 1155, B. splanch-
nicus NCTC10825 and NCTC10826, B. asaccharolyticus NCTC9337 and Fusobacterium varium
NCTC10560; these were obtained from the National Collection of Type Cultures, Central
Public Health Laboratory, Colindale Avenue, London NW9 5HT. B. uniformis VPI11227, B.
variabilis VPI11368 and B. melaninogenicus ss. levii VPI3300 were obtained from Dr Lillian V.
Holdeman, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060,
USA. B. oralis VPI8906D and VPI9958, B. bivius VPI5540, VPI6318, VPI6822 and VPI7880,
and B. disiens VPI7852 and VPI8057 were provided by Dr Ella M. Barnes, Agricultural Research
Council, Food Research Institute, Colney Lane, Norwich NOR 70F. B. ruminicola strains
B38024, B38080 and B56029 were provided by Dr T. Mitsuoka, Animal Pathology Laboratory,
Institute of Physical and Chemical Research, Wako, Saitama 351, Japan. B. corrodens strains
143A and 151RV were provided by Dr A.L. James, Department of Chemistry, Faculty of
Science and Technology, Newcastle upon Tyne Polytechnic. The GNAB andWPH strains were
isolated from various sites in healthy adults in this laboratory, or from clinical material by
colleagues in the diagnostic laboratories in the Bacteriology Departments of the Royal Infirm¬
ary and the Western General Hospital, Edinburgh. All strains were identified to species level by
the methods described by Duerden et al. (1976).
Culture media and method of anaerobic culture. Cooked-meat broth (CMB), 5% proteose
peptone water broth (PPW5) and Todd-Hewitt broth (THB) were prepared as described by
Fraser (1978). Thioglycollate broth (TGB) was prepared according to the manufacturer's
recommendations (Thioglycollate Medium, fluid, without dextrose or Eh indicator, code 11727;
BBL, Becton Dickinson UK Ltd, York House, Empire Way, Wembley, Middlesex HA9 OPS)
with the addition of 0-25% yeast extract (Oxoid) and 0-25% sodium succinate (BDH) to improve
growth of Bacteroides strains. Digest broth (DB) was prepared as described by Cruickshank et
al. (1975) but with best beef steak in place of horse flesh; the NaHCCL was omitted and the final
pH adjusted with NaOH to 7-4-7-6 before sterilisation by autoclaving. PPY broth medium was
as described by Deacon et al. (1978). The BM broth medium used in this study was prepared as
described by Deacon et al. (1978) but 0-25% sodium succinate was added and horse serum
omitted.
CMB was used without added growth factors but all other media were supplemented with
haemin and menadione as a routine; in addition, cysteine hydrochloride and NajCCL were
added to PPY and BM media. Solutions of these supplements were sterilised by filtration and
added aseptically to the steamed media just before inoculation as described by Deacon et al.
(1978). The final concentrations were: haemin, 5 pg/ml; menadione, 1 pg/ml; cysteine hydro¬
chloride, 0-075% (w/v); and Na2CC>3, 0-04% (w/v).
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Anaerobic culture methods were those described by Fraser and Smith (1975). Cultures were
prepared from lyophilised stock and maintained in CMB. For standard tests, an inoculum of0-2
ml of a 48-h anaerobic culture in CMB incubated at 37°C was added to 10 ml ofsteamed medium
and incubated anaerobically at 37°C for 48 h. Growth was estimated visually and recorded as
+ + +,++,+, + or — as described by Fraser (1978). Incubation was continued to 96 h to
improve growth when there was < + turbidity at 48 h.
Preparation ofcell extracts. The 48-h or 96-h cultures were centrifuged (800 g for 60 min at
4°C). If the culture supernates were to be tested, 5-ml samples of the centrifuged supernates were
removed and stored at — 20°C. The rest of the supernate was then removed from the packed cell
deposit and the cells from the 10 ml culture were resuspended in 2 ml of sterile normal saline. The
resuspended cells were subjected to ultrasonic disintegration for 15-20 min in an ice bath (Fraser
and Collee, 1975) and these uncentrifuged cell extracts were stored at —20°C until assayed for
neuraminidase.
A more concentrated bulk cell extract was prepared for tests of the effects ofpH and Ca2+ on
neuraminidase activity of B.fragilis NCTC9344. An inoculum of 2 ml of a 48-h CMB culture
was added to 200 ml of PPW5 broth and incubated anaerobically at 37°C for 48 h. After
centrifugation, the packed cell deposit was resuspended in 5 ml of sterile normal saline and
disrupted by ultrasonic vibration; the uncentrifuged cell extract was stored at — 20°C.
Assay for neuraminidase activity. Human glycoprotein substrate FVII (Fraser and Smith,
1975) was used at a final concentration of 140-170 pg N-acetyl neuraminic acid (NANA)/ml
reaction mixture (Fraser, 1978).
The standard assay procedures used by Fraser (1978) were followed. Tests for neuramini¬
dase activity were first incubated for 60 min before assay for free NANA; when the 60-min assay
showed little or no activity, tests were incubated for 24 h to demonstrate the presence or absence
of detectable neuraminidase. Test spectrophotometric readings (£549) were corrected by sub¬
traction of the sum of the values for separate enzyme and substrate controls.
The corrected results of neuraminidase assays were graded as follows: + + +, high values in
60-min assays (£549 >0-5); ++, moderate NANA release clearly demonstrable in 60-min
assays (£549 >0-1); +, neuraminidase not demonstrable in 60-min assays but high values
(£549> 0-5) in 24-h assays; ±, low values (£549 < 0-5 but > 0 05) in 24-h assays and absorption
peak clearly shown at 549 nm; —, no peak at 549 nm demonstrable in 24-h assays.
Tests that gave low values (£549 < 0-5) in 24-h neuraminidase assays were routinely examined
to confirm that the absorption peak was at 549 nm (Fraser, 1978) and at least one test from each
neuraminidase-positive species was also examined in this manner, whether the assay values were
high or low. Culture products that gave very low values or negative results in 24-h neuramini¬
dase assays (£549 <0-5) were further examined to determine whether destruction of NANA by
N-acetyl neuraminic acid-aldolase (NAN-aldolase, EC 4.1.3.3) might be interfering with the
24-h neuraminidase assay (Fraser, 1978).
Studies of the effect ofpH on the neuraminidase of B. fragilis. Neuraminidase assays were
performed in a range of sodium-acetate buffers as described by Fraser and Smith (1975). The
reaction mixture of 1 0-ml volume consisted of: 0-1 ml of the bulk cell extract of B. fragilis
NCTC9344 (see above) diluted 1 in 40 in distilled water; 0-65 ml of the appropriate acetate
buffer; and 0-25 ml of substrate FVII diluted in distilled water to give a final concentration in the
reactionmixture of 160 pg NANA/ml. Separate enzyme and substrate controls were prepared at
each p\\ value. Tests and controls were incubated at 37°C before the assay for NANA.
The pH values shown in the figure are the initial values for the buffers added to the tests.
Separate measurements were made of the initial pH values in sample reaction mixtures prepared
with equivalent proportions but in 3-ml total volumes.
Effect of Ca2+ and EDTA on the neuraminidase ofB.fragilis. Neuraminidase assays in the
presence of added Ca2+ or EDTA were performed as described by Fraser (1978). The test
enzyme preparation was the bulk cell extract of B.fragilis NCTC9344 (see above) diluted 1 in 40
in acetate buffer, pH 51. Samples of the enzyme were mixed with buffer containing Ca2+ or
EDTA and held at 37°C for 30 min before addition of substrate FVII and the start of the
neuraminidase assay. Separate enzyme and substrate control tubes also contained Ca2+ or
EDTA.
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Results
Production ofneuraminidase by Bacteroidesfragilis NCTC9344
Table I records the production of neuraminidase by B. fragilis strain
NCTC9344 in 48-h cultures in various fluid media. The culture supernates
contained small amounts of enzyme activity that could be detected when the
incubation time of the assays was prolonged to 24 h. Cell extracts prepared
from the same cultures contained larger amounts of neuraminidase that gave
high assay values (£549) in 60-min assays. Neither the culture supernates nor
the cell extracts had significant NAN-aldolase activity that might interfere with
the assay for NANA released by neuraminidase.
The organism grew adequately in all the media tested. Growth was least
good in TGB and there were difficulties in centrifuging this culture because it
contains a low concentration of agar. DB, PPW5 and BM broth media were
chosen for further studies of neuraminidase production by Bacteroides species.
Effect ofpH and Ca2+ on neuraminidase ofB. fragilis NCTC9344
A more concentrated bulk cell extract was prepared from a 200-ml PPW5
culture of B. fragilis strain NCTC9344 for studies of the effect ofpH and Ca2+
on the enzyme. The figure shows the results of 30-min neuraminidase assays in
acetate buffers at different pH values. The assay values were corrected by
subtraction of the values obtained in separate substrate and enzyme controls at
each /?H value; the enzyme controls were constant but the substrate controls
were higher at low pW values.
The figure shows the />H optimum for B. fragilis neuraminidase with
substrate FVII to be about 4-2. Acetate buffer atpW 5-1 is used in the standard
assay (Fraser, 1978); this pH allows good neuraminidase activity and this
Table I







activity in culture productp
culture supernate cell extract
DB + + + + + +
PPW5 + + + + + +
BM + + + + + +
CMB + + + + + + +
PPY + + + + + +
TGB + + + + +
THB + + + + + + +
* DB = Digest broth; PPW5 = proteose peptone water; BM = BM medium; CM B = cooked-meat broth;
PPY = PPY medium; TGB = thioglycollate broth; THB = Todd-Hewitt broth,
f See Methods for assessment of growth.
t Supernates of 48-h cultures tested in 24-h assays; cell extracts from the same cultures tested in 60-min
assays. See methods for grading of neuraminidase activity
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Fig.—Effect of pH on the assay for the neuraminidase of B. fragilis. Cell extract of B. fragilis strain
NCTC9344 incubated with substrate FVII in sodium-acetate buffers.
buffer at this /?H was therefore used in our tests for neuraminidase production
by other Bacteroidaceae. Direct measurement of pH in equivalent test mix¬
tures showed that the actual pH values might be 0-2-0-3 units higher, but they
did not vary during incubation of the tests; thus thepH optimum for B. fragilis
neuraminidase is likely to be about 4-5.
Table II shows that the addition of Ca2+ did not affect the assay for B.
fragilis neuraminidase. The addition of ImM EDTA did not inhibit the enzyme
and even 5 mM EDTA reduced the assay value by about one third only. Ca2+
was not added as a routine to our assays for neuraminidase production by
Bacteroides strains.
Production ofneuraminidase by species of the Bacteroidesfragilis group
Table III shows the results of measuring neuraminidase produced by
various species of the B. fragilis group. The strains were grown for 48 h in DB
and PPW5 broths and cell extracts were tested for neuraminidase activity. In
general these organisms grew better in DB than PPW5 broth but neuramini-
dase-positive strains usually produced greater activity in PPW5. All the strains
of B. fragilis and B. vulgatus produced large amounts ofneuraminidase in both
media, and the strains of B. distasonis and B. ovatus were also clearly positive.
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Table II
Effect ofCa2+ and EDTA on the assay ofneuraminidase from B.fragilis NCTC9344
Concentration of added Ca2 + or
EDTA in reaction mixture*
Result of neuraminidase assay
(£549)t
3mM Ca2 + 0 186




* See Methods for reaction mixtures.
t The spectrophotometric value (£549) is an average result obtained from duplicate 15-min assay
readings corrected by subtraction of the values for the corresponding substrate and enzyme controls.
All strains of B. thetaiotaomicron produced neuraminidase well in PPW5
but production in DB varied. Strain NCTC10582 was cultured in DB on four
occasions; neuraminidase assays were twice positive (+ and + + ) and twice
negative. Variable results were also obtained with strain GNAB16 which was
once positive (+ ) and twice negative. By contrast, three separate cultures of
each organism in PPW5 broth were consistently positive.
Results with B. variabilis also varied. Strain GNAB18 consistently pro¬
duced neuraminidase. Strain VPI11368 twice produced moderate amounts
(+ +) in PPW5 but failed, however, to produce detectable activity in one other
PPW5 culture and in three cultures in DB medium.
All the strains of B. uniformis, B. eggerthii and B. splanchnicus grew
adequately but did not produce detectable neuraminidase in either medium.
Neuraminidase production by other Bacteroides species
The results of testswith other Bacteroides species are shown in table IV. All
strains grew adequately in DB and most also grew well in BM medium. Many
of these strains grew very poorly or not at all in PPW5 broth and so were not
tested for neuraminidase production in this medium.
The three strains of B. melaninogenicus ss. melaninogenicus and the single
strain of B. melaninogenicus ss. levii produced neuraminidase. Production by
strain WPH67 varied; it twice gave + + activity in DB medium but was
negative on another occasion and was twice negative in BM medium. The
other strains were consistently positive in both media. By contrast the five
strains of B. melaninogenicus ss. intermedius were negative in both media.
The strains of B. oralis and B. bivius were neuraminidase positive while B.
ruminicola, B. disiens, B. asaccharolyticus and B. corrodens were all negative in
both media. The B. corrodens strains did not grow well in BM broth; they were
also grown and found to be negative in PPW5 medium.
Four strains of B. ochraceus produced neuraminidase well in DB, but
production was very unreliable in BM and PPW5 media. Strain 79B produced
trace amounts on three occasions in DB and once in BM broth. Strain
VP 12845 produced a trace of activity in only one of three cultures in DB and
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Table III




Relative amount of neuraminidase
activity in culture productf
DB PPW5 DB PPW5
B. fragilis
NCTC9343 + + + + + + + + + +
NCTC9344 + + + + + + + + + + + +
WPH1 + + + + + + + + + + + +
WPH12 + + + + + + + + + + + +
WPH21 + + + + + + + + + + + +
B. vulgatus
NCTC10583 + + + + + + + + + + + +
GNAB9 + + + + + + + + + + +
GNAB29 + + + + + + + + + + +
B. distasonis
ATCC8503 + + + + + +
GNAB26 + + + + + + + +
GNAB39 + + + + + + + +
B. ovatus
ATCC8483 + + + + + + + + +
WPH207 + + + + + + + + +
B. thetaiotaomicron
NCTC10582 + + + + + V + + +J
GNAB1 + + + + + + + + + +
GNAB2 + + + + + + + + + +
GNAB7 + + + + + ± + + +
GNAB11 + + + + + + + + + +
GNAB16 + + + V + +t
GNAB20 + + + + + + + + + +
B. variabilis
VPI11368 + + + + + -t V
GNAB18 + + + + + +t + + +i
B. uniformis
ATCC8492 + + + + + + — —
VPI 11227 + + + + + — —
GNAB42 + + + + + + — —
B. eggerlhii
NCTC11155 + + + — —
GNAB21 + + + + — —
GNAB23 + + + + + — —
GNAB24 + + + — —
GNAB41 + + + — —
GNAB43 + + + + + — —
B. splanchnicus
NCTC 10825 + + + + + + — —
NCTC10826 + + + + + + — —
* See Methods for assessment of growth. DB = Digest broth; PPW5 = Proteose peptone water,
t Cell extract from 48-h culture in stated medium was tested. See Methods for grading of neuraminidase
activity. V = variable results in different experiments (see text),
t Result confirmed in repeat culture.
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Table IV




Relative amount of neuraminidase
activity in culture productf
DB BM DB BM
B. melaninogenicus
ss. melaninogenicus
ATCC15930 + + + + + + + + +
VPI4196 + + + + + + + +
WPH67 + + + + + + V _ *
B. melaninogenicus
ss. levii
VPI3300 + + + + + + + + + + + +
B. melaninogenicus
ss. intermedius
NCTC9336 + + + + + — —
NCTC9338 + + + — —
WPH4 + + + + + + — —
WPH26 + + + + + — —
WPH31 + + + + — —
B. oralis
VPI8906D + + + + + + + +
VPI9958 + + + + +
GNAB46 + + +
GNAB54 + +
B. bivius
VP15540 + + + + + +
VPI6318 + +
VPI6822 + + + +
VPI7880 + + + +
B. ruminicola
NP333 + + + + — —
B38024 + + + + — —
B38080 + + — —
B56029 + + — —
B. disiens
VPI7852 + + + + — —
VPI8057 + + + + + + — —
B. asaccharolyticus
NCTC9337 + + + + — —
WPH15 + + + — —
WPH30 + + + + — —
WPH57 + + + — —
B. corrodens
143A + + — —
151RV + ± —
B. ochraceus
VPI2845 + + + V -t
10 + + + + +
73 + + + + + + +
79B + + + + ±t V
1956C + + + + + + + —
2467B + + + + + + + —
* See Methods for assessment of growth. . . . = not tested; DB = digest broth; BM = BM broth,
t Cell extract from culture in stated medium was tested. See Methods for grading of neuraminidase
activity; . .. = not tested. V = variable results in different experiments (see text).
I Result confirmed in repeat culture.
NEURAMINIDASE PRODUCTION BY BACTEROIDES 71
was consistently negative in BM and PPW5 cultures. The difficulty in demon¬
strating neuraminidase activity in these cultures may be partly explained by the
presence of small amounts of NANA-destroying activity in the cell extract of
several of the B. ochraceus cultures.
Production ofneuraminidase by Fusobacterium and Leptotrichia species
Table V shows the results when eight strains of Fusobacterium species and
one of Leptotrichia buccalis were grown in DB and PPW5 media. In general
they grew well in DB and less well in PPW5. The two strains that grew poorly
in PPW5 were also grown and tested in BM medium. Cell extracts of all
cultures were neuraminidase negative.
Table V





Relative amount of neuraminidase
activity in culture productf
DB PPW5 DB PPW5
F. necrophorum
NCTC10575 + + + + + — —
NCTC10576 + + + — —
NCTC10577 + + + — —
F. polymorphum
(F. nucleatum)
NCTC10562 + + + + — —
WPH142 + + + — —
WPH160 + + ± —
F. necrogenes
NCTC 10723 + + — —
F. varium
NCTC10560 + + + _ _
L. buccalis
NCTC 10249 + + — —
* See Methods for assessment of growth. db = digest broth; ppw5 = proteose peptone water,
t Cell extract from culture in stated medium was tested. See Methods for grading of neuraminidase
activity. .. . =Not tested.
Discussion
Neuraminidase is produced as an extracellular enzyme in culture super-
nates by Vibrio cholerae and Clostridium perfringens, but is cell-associated in
other species, e.g., Klebsiella aerogenes and Pasteurella multocida (see Rosen¬
berg and Schengrund, 1976). Our previous studies confirmed that clostridial
neuraminidases are essentially extracellular, although some more enzyme
could be released by ultrasonic disintegration of the cells (Fraser and Collee,
1975; Fraser, 1978). By contrast, the results presented in table I show that the
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neuraminidase of B. fragilis is predominantly cell associated, with only small
amounts detectable in the supernates of 48-h cultures.
We have adapted our clostridial neuraminidase-assay techniques for use
with cell extracts of B. fragilis and other Bacteroidaceae. Thep\\ optimum for
neuraminidasesmay vary considerably with different buffer systems and differ¬
ent substrates (Fraserand Smith, 1975; Rosenberg and Schengrund, 1976) but
our standard assay with human glycoprotein substrate FVII with acetate
buffer at pH 5 1 also gave good results with the B. fragilis enzyme (see the
figure). The neuraminidase produced by certain species, e.g., V. cholerae, is
calcium dependent but added Ca2+ is not required in our assays for the enzyme
produced by Clostridia (Fraser, 1978) or Bacteroides species (table II).
Many of the Bacteroidaceae are nutritionally fastidious and do not gener¬
ally grow well in fluid media even with growth supplements and meticulous
anaerobic technique. The three media used in the present study were chosen
for their ability to support good enzyme production by neuraminidase-positive
species and also to allow good growth of a wide range of gram-negative
anaerobes. DB medium allowed adequate growth of all species tested but did
not always allow the best production of neuraminidase. Some of the B. fragilis
group of organisms produced more enzyme in PPW5 broth; however, this
medium did not support adequate growth of several other species, even when
incubation was extended to 96 h. A few of these strains produced more
enzyme in BM broth than in DB medium, but there were also clear exceptions.
Neuraminidase-positive strains generally produced the enzyme in each of the
two media in which they were grown, but production by a few varied or did not
take place in one or other (see tables III and IV). The purity of all cultures was
carefully tested by subculture from the test culture. Neuraminidase produc¬
tion has been shown to be inducible in certain species (Nees and Schauer, 1974;
Rosenberg and Schengrund, 1976) but we have not been able to identify
specific inducing conditions that might explain the variations observed in this
study between different media or different batches of the same medium.
Because no single medium consistently supported optimum production by
neuraminidase-positive strains, other strains were tested in at least two media
that supported adequate growth. All cell extracts were tested in assays incu¬
bated for 24 h before being classed as neuraminidase negative.
The neuraminidase assay depends upon detection ofNANA released from
the glycoprotein substrate by the enzyme. Some organisms also produce an
aldolase (NAN-aldolase) that may destroy the released NANA and this might
give false negative results in neuraminidase assays. The NAN-aldolase of
Clostridia remains cell associated and does not interfere with assays for neura¬
minidase in culture supernates, although it may reduce the sensitivity of assays
with cell extracts (Fraser and Collee, 1975). Muller and Werner (19706), using
a paper chromatographic method, reported the presence of NAN-aldolase in
several species of Bacteroides, including B. fragilis, and Muller (1973) also
found that a strain of Fusobacterium polymorphum produced the aldolase. We
have not assayed directly for NAN-aldolase (Brunetti, Swanson and Roseman,
1963; Nees et ah, 1976) but we have shown that there is negligible NANA-
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destroying activity in the cell extracts of the neuraminidase-positive B.fragilis
NCTC9344 and in the cell extracts of the various cultures that gave low values
or negative results in neuraminidase assays. Very few of these cell extracts
reduced the assay value for added NANA by as much as 10-20% during 24-h
incubation under conditions equivalent to those of the neuraminidase assay.
This amount ofNANA destruction would not appreciably reduce the ability of
the assay to detect small amounts of neuraminidase. Several of the B. ochra-
ceus cell extracts reduced the addedNANA by about 40% in 24 h and this could
have contributed to our difficulty in demonstrating neuraminidase production
consistently in this group.
The classification of the Bacteroidaceae has been much refined in the past
decade. Current schemes ofclassification are based mainly on the biochemical
activities of the organisms (Holdeman and Moore, 1974; Holdeman, Cato and
Moore, 1977). The strains used in the present study have been characterised
carefully by the methods used in this laboratory, including gas-liquid chroma¬
tography (Duerden etal., 1976; Deacon etal., 1978; Duerden ef al., 1980). The
former subspecies of B. fragilis are now given separate species status, and B.
thetaiotaomicron is further subdivided into the species B. thetaiotaomicron, B.
eggerthii, and B. uniformis. Strain ATCC8492, originally the reference strain
ofB. thetaiotaomicron, is now classified as B. uniformis. Werner (1974) demon¬
strated that sugar fermentation tests discriminated reliably between the var¬
ious species in this group; he further distinguished B. variabilis from B.
uniformis by differences in fermentation of rhamnose and trehalose.
The classification of the B. oralis-B. melaninogenicus group has been
considerably revised in recent years, with less emphasis placed on pigment
production as the criterion for classifying strains as B. melaninogenicus.
Because of the basic difference in sugar utilisation, B. melaninogenicus ss.
asaccharolyticus has been given separate species status as B. asaccharolyticus,
while B. melaninogenicus is now divided into the subspecies melaninogenicus,
levii and intermedius. There has been some debate about the classification of
B. oralis strains. Strain ATCC15930, originally a reference strain of B. oralis,
is now reclassified as B. melaninogenicus ss. melaninogenicus (Holbrook and
Duerden, 1974). Strain NP333, previously described as B. oralis, is now
reallocated to B. ruminicola. Strains ofB. ochraceus differ from other Bacteroi¬
daceae in that they require C02 for growth but are not strict anaerobes
(Holbrook, Duerden and Deacon, 1977). It has recently been proposed that
they should be reclassified in the new genus Capnocytophaga (Newman et al.,
1979; Williams, Hollis and Holdeman, 1979).
Our results for neuraminidase production by Bacteroides are consistent
within each species and tend to confirm the present classification. Within the
B. fragilis group, B. fragilis, B. vulgatus, B. distasonis and B. ovatus were all
neuraminidase positive. Seven strains of B. thetaiotaomicron were positive
while six strains of the closely related B. eggerthii were negative. The B.
variabilis strains were distinguished from the B. uniformis strains by their
production of the enzyme. Within the B. oralis-B. melaninogenicus group, B.
oralis and B. melaninogenicus ss. melaninogenicus were neuraminidase positive
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while ss. intermedins and B. ruminicola were negative; the single strain of B.
melaninogenicus ss. levii tested was neuraminidase positive. B. bivius produced
the enzyme, while the closely related B. disiens did not. The asaccharolytic
species, B. asaccharolyticus and B. corrodens, were both negative. The six
strains of B. ochraceus tested could all produce neuraminidase although it was
difficult to define conditions allowing reliable production.
Production of neuraminidase by Bacteroides species was studied by Muller
and Werner (1970/?; Werner and Muller, 1971). These studies depended
primarily on observing the electrophoretic changes in serum proteins in the
culture medium after incubation for 2-19 days, but were also supported by
paper chromatography ofneuramin-lactose and its split products. They found
that all of 24 strains of B. fragilis produced the enzyme, but only six of 11 B.
vulgatus, three of five B. distasonis and six of eight B. thetaiotaomicron. With
our assay procedures, testing cell extracts of the cultures, all the strains of these
species examined were neuraminidase positive. At least one of their negative
B. thetaiotaomicron strains (ATCC8492) is now reallocated to B. uniformis\
this strain was negative in our assays also. Their findings with other Bacter¬
oides species are in broad agreement with our present results: B. ovatus
ATCC8483, three strains of B. oralis (including ATCC15930) and one strain of
Leptotrichia innominata var. ochracea (B. ochraceus) were positive, and single
strains of B. asaccharolyticus (NCTC9337) and of B. putredinis were negative.
Muller and Werner (1970a) also studied pus from a B. fragilis abscess and
showed that neuraminidase was produced in vivo. They suggested that the
neuraminidase might play a role in the pathogenicity ofB. fragilis, demonstrat¬
ing that it is produced in greater amounts and has a broader spectrum ofaction
against serum glycoproteins than the enzyme produced by other Bacteroides
species. B. fragilis is now an accepted pathogen; although it is only a minor
component of the anaerobic gut or vaginal flora it is much the most common
Bacteroides species isolated from clinical infections (Duerden, 1980a and b).
The pathogenic potential of other Bacteroides species is much less clearly
understood at present; it will be interesting to note whether there is any
correlation with their ability to produce neuraminidase.
Fukui, Fukui and Moriyama (1971) failed to detect neuraminidase in four
strains ofFusobacterium species and two of Leptotrichia buccalis isolated from
themouth, nor could we detect the enzyme in cell extracts of the strains that we
examined. However, Werner and Muller (1971) detected weak neuraminidase
activity against plasma proteins in two of 10 strains of Sphaerophorus necro-
phorum (F. necrophorum), two of three S. varium (F. varium) including
NCTC10560, and one of seven other Fusobacterium strains. Muller (1973)
isolated a strain ofF. polymorphum from the throat of a patient with actinomy¬
cosis; it showed strong neuraminidase activity when first isolated but this
declined to a low level during subsequent laboratory passage. Muller (1973,
1974) has argued that neuraminidase plays a role in the pathogenicity of
various organisms and that in some cases its production may be induced in
vivo. The Fusobacterium strains that we found to be neuraminidase negative
have been maintained in laboratory culture for some years and it remains
NEURAMINIDASE PRODUCTION BY BACTEROIDES 75
possible that they have lost the ability to produce the enzyme during storage.
Solovev et al. (1972) found tests for neuraminidase production of value for
studies of vibrio taxonomy and our previous studies suggested that they might
also help to differentiate some closely related Clostridia, e.g., C. sordellii and C.
bifermentans (Fraser, 1978). The taxonomy of the fusobacteria is still being
debated (see Duerden et al., 1980) and our failure to demonstrate neuramini¬
dase in any of the strains tested is unlikely to be of assistance. However, the
results of our tests in Bacteroides species are consistent and conform with the
latest classifications (Holdeman et al., 1977; Duerden et al., 1980). They help
to discriminate between several closely related species that are otherwise
distinguished only by a small number of sugar fermentation reactions, e.g.,
between the species previously included in B. thetaiotaomicron, and between
various species of the B. oralis-B. melaninogenicus group. Tests for neura¬
minidase production would therefore be a valuable addition to the range of
biochemical tests currently used in classification of Bacteroides organisms.
We thank Professor J. G. Collee for constant advice and encouragement; Miss M. Byrne, Mr
G. Hay and Mr G. Henderson for skilled technical assistance; and Dr J. G. Watt, Scottish
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Current Approaches to the Classification, Characterisation and
Typing of Pathogenic Anaerobic Bacteria
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ABSTRACT. Characterisation systems based on the demonstration of soluble antigens and toxins
are of much practical value but have clear taxonomic limitations. This is illustrated by reference to
our work with some of the pathogenic Clostridia. The definition and classification of the anaerobic
cocci is a difficult and continuing challenge. Systems for the classification and characterisation of
the gram-negative non-sporing anaerobic bacilli are evolving well, though there are still some very
difficult areas. A selection of the most helpful tests is indicated. Biotyping systems are compared
with serotyping systems; the results of serological approaches to characterisation are encouraging.
The further exploration of bacteriocin typing seems to be merited. The challenge of characterisa¬
tion and classification of anaerobic spirochaetes commonly involved in human infections must now
be taken up.
INTRODUCTION
So much work is being done on the anaerobic bacte¬
ria that it is helpful to consider practical aspects of
classification and characterisation in 1981, to up¬
date our views expressed in 1979 (1). In this paper,
we review significant trends and we consider results
of our recent studies of various pathogenic anaer¬
obes, with special reference to practical approaches
to their prompt characterisation and effective clas¬
sification in relation to medical and dental bacteri¬
ology.
MATERIALS AND METHODS
Organisms: the strains studied are detailed in recent pa¬
pers published by past and present members of our re¬
search team; the relevant references are given in the text.
Biochemical tests were as described previously (5, 6). Gas
liquid chromatography: The procedures used were de¬
scribed by Deacon and colleagues (4). Neuraminidase as¬
says were performed as described by Fraser and Brown
(8. 9). Bacteriocin studies were as outlined by Watt and
Collee (22).
RESULTS AND DISCUSSION
The Clostridia. Two organisms provide interesting
examples of challenges to our existing systems of
classification and characterisation. These are Clos¬
tridium perfringens and C. difficile.
C. perfringens. Although strains of types A1 and
A2 replicate very rapidly at 44-45°C with mean
generation times of less than 10 min (2, 3) we found
that production of lecithinase (phospholipase-C) is
suppressed at these temperatures. As detection of
this enzyme is important in current primary identifi¬
cation tests, the organism's potential for very rapid
growth has not been exploited significantly in the
diagnostic laboratory.
C. perfringens-like organisms, including C. ab-
sonttm, C. paraperfringens and C. sardiniensis, dif¬
fer in relatively minor characteristics from typical
C. perfringens (14, 15). It is important to keep in
touch with developments in this area.
Any approach that might help to sub-divide the
C. perfringens complex merits exploration as our
present dependence on animals for toxin neutralisa¬
tion tests in the typing of the organism is a great
disadvantage. The use of agglutination tests for the
typing of strains involved in food-poisoning has
been very helpful (10).
C. difficile. Our experience with this organism
has recently been reviewed by Poxton (17). We
characterise the organism on the basis of its micro¬
scopic morphology, its ability to grow on CCFA
medium, its performance in biochemical tests, the
characteristic profile of end-products detected by
gas-liquid chromatography (GLC), and the detec¬
tion of characteristic antigens in crossed immuno-
electrophoresis systems when tested against rabbit
antiserum raised against whole cells of the type
strain (NCTC 11223). Antigenic cross-reactions
with the C. sordellilbifermentans complex can be
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absorbed out. Some strains do not produce the typi¬
cal cytotoxin and it is clear that more work is need¬
ed on the debated role of the cytotoxin in the en-
teropathogenicity of this organism. Some of our
strains showed minor variations in the presently
accepted range of biochemical tests used for char¬
acterisation; several showed significant differences,
and two strains showed marked departures from the
recognised pattern for C. difficile published in the
VPI manual (12). Differences of this degree would
certainly qualify for separate species rank in the
Bacteroides genus (see below). We are anxious to
determine whether the variation offers a basis for
biotyping which may be of epidemiological value in
tracing infective strains.
Neuraminidase production as an aid to clostridial
taxonomy
The possible association of neuraminidase produc¬
tion with pathogenic potential is debated, but the
enzyme may be of taxonomic use (8). Table I lists
the neuraminidase-positive and neuraminidase-neg-
ative Clostridia. This appears to distinguish clearly
between C. sordelli and C. bifermentans and com¬
plements the case for regarding these as separate
species.
Amino acid utilization and production in relation to
taxonomy
Studies to explore the metabolism of amino acids by
Clostridia as an aid to our understanding of the
proteolytic group deserve our attention (7).
Bacteroides-Fusobacterium group. Presumptive





















identification at genus level can be made by obser¬
vations on Gram smears, colonial morphology and a
few other tests. GLC analysis of short chain fatty
acid end-products of metabolism can also identify
to genus level, but further tests are required to
establish the species or sub-species of Bacteroides
and Fusobacterium (4). We select the observations
and tests indicated in Table II as the currently rec¬
ommended range (4, 5, 6, 11).
The experience of others (12, 13) encourages us
to replace mannitol with salicin, and we note prom¬
ising results with xylan (19). The range of organisms
indicated in Table II is not complete and is inten¬
tionally restricted to those species that might merit
specific recognition in the clinical laboratory. Den¬
tal bacteriologists may soon press for the inclusion
of Bacteroides gingivalis as an important species.
The restriction to genus level for Fusobacterium
species is unwise and merely reflects our present
lack of extensive experience with this group.
We now restrict the tolerance tests to taurocho-
late and to one dye only, in view of practical diffi¬
culties with Victoria blue. The two tests give infor¬
mation that helps significantly to compensate in a
laboratory that might not be able to afford the ex¬
pense of a GLC system.
Serological characterisation. In studies that ex¬
ploit the species-specific antigenicity of the cell sur¬
face outer membrane (OM) complex and the sensi¬
tivity of an indirect enzyme-linked immunosorbent
assay (ELISA), we are now able to identify many
Bacteroides strains to species and sub-species level
(16, 18). Table III summarises results obtained with
OM preparations from representative reference lab¬
oratory and freshly isolated strains with species
reference antisera that we prepared against whole
cells and tested in an indirect ELISA system. The
outer membrane preparations are obtained by treat¬
ment of bacterial suspensions with 10 mM EDTA at
45° C for 30 min and then holding in an ultrasonic
bath for 60 s. The antisera are raised in rabbits
against whole live bacterial suspensions. Heterolo¬
gous cross-reacting antibody can be removed by
absorption of the antiserum with whole cells. We
find very significant correlation between serotype
and biotype in this work. Results were clear-cut
with the B. fragilis complex, the asaccharolytic
group, and with B. melaninogenicus intermedins.
The results with the B. melaninogenicus-ruminicola
complex reflect the confusion that also afflicts con¬
ventional biotyping systems.
St and J Infect Dis, Suppl. 35
Classification and characterisation of anaerobes 19
Table II. A practical approach to the characterisation of commonly encountered gram-negative non-
sporing anaerobic bacilli of clinical interest
+ = > 95% of strains give positive result. - = > 95% of strains give negative result, v = variation 30-70%, +(—
) = positive with most strains. -( + ) = negative with most strains. For details see Duerden. Holbrook, Collee & Watt.
1976. J appl Bacteriol 40: 163-188. The characterization of clinically important gram-negative anaerobic bacilli by
conventional bacteriological tests.
3
CQ CQ 0; CQ CQ Q5 eg 05 05 CQ 55 CQ CQ [Q
Pigment - - - - + + - - - + - -
Indole — — — + + + — — — — - +(-) — V
Aesculin hydrolysis + V + + + - V +(-) + - - — - -(+)
Fermentation of
Glucose + + + + + + + + + + + - — V
Lactose + + + + + -(+) + + + + - - - -(+)
Sucrose + + + + + + + + + - - — - -(+)
Rhamnose - + +(-) + + - -(+) V +(-) - - - - -
Trehalose - - + + + -(+)
Xylose + (-) + + + + - - - + - - - -
Salicin - -(+) + -(+) + - — -(+) +(-) - — - — -(+)
Significant FA
Produced'' v
Succinic + + + + (+) + -(+)
Acetic + + + + + + + +
N-Butyric - - + + — + +
Tolerance of
Sod. Taurocholate + - - - V
Gentian Violet - - - - +
Resistance to1'
Neomycin 1000 pg R S S/R S S
Kanamycin 1000 pg R R R s S
Penicillin 2 units R S/R S s S
Rifampcin 15 pg S S S S/R S/R
" Alternative reactions in this column relate to species
differences as well as strain variations.
fcGLC: + = l-10 pmol/ml, ++ = > 10 pmol/ml,
(+) = variable amount of minor product.
' Tolerance: Taurocholate 0.5%, Gentian violet 1 in
100000. + = tolerant, - = inhibited.
J Antibiotic resistance: R = resistant, S = sensitive,
S/R = variation (30-70%).
Neuraminidase studies. Table IV lists the neura-
minidase-negative and positive Bacteroides species
and may help in classifying the melaninogenicus-
ruminicola-oralis complex and the bivius-disiens
group. The few Fusobacterium species that we
have tested do not produce neuraminidase (9). Our
neuraminidase tests helped to discriminate between
closely related Bacteroides species that are present¬
ly differentiated by a small number of sugar fermen¬
tation reactions. As the results are consistent for all
strains of each of the species that we examined, the
findings might be of taxonomic value (9). In view of
the technical difficulties of neuraminidase assays, it
will be necessary to develop a simple test; for exam¬
ple, the enzyme's ability to confer panagglutinabi-
lity on human red cells might be exploited.
Bacteriocin typing. Bacteriocin-like substances
produced by Bacteroides species offer a possible
approach to typing and sub-classification (22). It
was first necessary to develop detailed characteri¬
sation studies and now it seems worthwhile to re¬
examine the "bacteroidicins" in which we were
interested some years ago, but now to recognise
them as fragilicins, etc. It has been possible to ana¬
lyse our earlier results in the light of our subsequent
characterisation of the organisms that we tested
Scand J Infect Dis, Suppl. 35
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Table III. Results of serological studies with outer-
















NCTC9344 12800 34 (35)
B. vulgatus
NCTC10583 25600 11 (11)
B. distasonis
ATCC8503 12 800"
GNAB26 12 800 6(8)
B. thio.
NCTC 10582 25 600"
GNAB11 3 200 8 (10)
B. mel. intermed.
NCTC9338 12 800 11 (11)
B. mel. mel.
ATCC15930 12800"







NCTC9337 25 600 24 (25)
a The autologous titre denotes the titre obtained with the
strain used as antigen. When two antisera were prepared
for a species, the combined results are given.
Table IV. Results of neuraminidase studies with
organisms of the Bacteroides-Fusobacterium group
Neuraminidase-positive Bacteroides spp.
B. mel. ss. melaninogenicus









(B. ochraceus = Capnocytophaga)
Neuraminidase-negative Bacteroides spp.
B. eggerthii B. mel. ss. intermedius
B. uniformis B. ruminicola








(Table V). The indications are that most strains of
B. fragilis are both good producers and indicators,
whereas strains of B. thetaiotaomicron studied by
us were poor in this respect. Our experience with
the B. melaninogenicus group is presently inad¬
equate. The results obtained with the B. asaccharo¬
lyticus strains seem to be promising, as the produc¬
ers showed their effect only against B. asaccharoly¬
ticus indicators. These are retrospective analyses
and a note of caution is needed; the agents responsi¬
ble for these effects have not been formally charac¬
terised as bacteriocins and a systematic study is
now indicated with a range of characterised strains.
The anaerobic cocci
We certainly confirm that "the clinical microbiolo¬
gist attempting to isolate and characterise the obli-
gately anaerobic cocci, and the clinician attempting
to treat infections caused by these organisms, both
suffer from a lack of useful data" (24). We accept
the provisional definition of Watt and Jack (23) that
anaerobic cocci grow under satisfactory conditions
of anaerobiosis and do not grow on suitable solid
media in 10% COj in air even after incubation for 7
days at 37° C. These workers found that metronida¬
zole sensitivity is a reliable index; obligately anaer¬
obic cocci are all sensitive to metronidazole.
The detailed descriptions provided by Smith and
Holdeman (20) provide a helpful starting point for a
review of classification of this difficult group. We
find the inclusion of Streptococcus confusing. The
division of the streptococci into truly anaerobic and
facultative groups might be taxonomically proper,
but facultative strains are encountered in clinical
specimens that cannot be isolated initially unless
Table V. Results ofpreliminary studies ofbacterio-
cin-like effects with gram-negative anaerobic bacilli
Producers Indicators
Number Number Number Number
Species Positive Tested Positive Tested
B. fragilis 34 37 28 34
B. thio. 1 6 1 6
B. vulgatus 0 5 4 4
B. distasonis 0 1 0 1
B. mel. ss.
intermed. 2 2 0 2
B. mel. ss. mel. 1 1 1 1
B. asaccharolyticus 4 4 4 4
B. ruminicola 0 1 0 1
Fusobacterium spp. 2 5 0 3
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taerobic culture procedures are undertaken (20).
his may be explained on the basis of carbon diox-
le dependence and other exacting considerations
lat merit further work. Thus, apparently anaerobic
Dcci that are not true anaerobes still feature in our
allections. and sometimes in our clinical reports,
he anaerobic state and sensitivity to metronida-
Dle is of clinical importance, but it is inevitable that
le rules of convenience must bow to the stricter
ties of a system that might well include obligate
naerobes and facultative organisms in one genus,
ccordingly, the clinical bacteriologist must be on
uard: we make the lighthearted but significant
omment that some of our organisms at the primary
olation stage have not read the textbook.
he anaerobic spirochaetes
/e are again indebted to Smith and Holdeman (20)
>r a helpful outline. In addition to the well-known
uman pathogenic associations of the anaerobic
secies in the genera Spirochaeta, Borrelia and Tre-
onema, the association of spirochaetes with other
rganisms in periodontal disease is of much inter-
st. The occurrence of spirochaetes in the human
olon. especially noted in male homosexuals, also
lerits further study. Smith takes the view that it is
oubtful whether any of the cultivable treponemes
re significantly pathogenic in the mouth. The in-
rease in number of these organisms in areas of
ingival pathology has been recognised for years,
ut the correlation of these organisms with degrees
f tissue destruction has stimulated interest among
ental bacteriologists and dental practitioners con-
erned with periodontal disease (21). There is
athogenic synergy in these infections and, while it
lay be that the spirochaetes are not a significant
omponent of the initial microbial attack and may
e merely secondary opportunists exploiting condi-
ons that encourage their growth, many of us have
een slow to develop adequate investigations of
eriodontal disease. It is likely that the significant
rimary pathogens will include bacteroides organ-
ms and fusobacteria and perhaps Capnocyto-
haga-like organisms which abound in these Ie-
ons. Recent developments in the classification
nd characterisation of these organisms should now
How us to make significant progress in this impor-
tnt field.
ONCLUSION
ur aim in this paper has been to consider the
degrees of precision regarded as necessary and
practical in the characterisation and classification of
some representative anaerobic bacteria of clinical
importance. It is paradoxical that the label of C.
perfringens presently applies to a remarkably wide
range of human and animal pathogens that can only
be distinguished by difficult toxigenic analyses,
whilst new species rank is afforded to relatively
minor variant biotypes. In this case, serological
analyses of soluble antigens have so far helped only
in typing food-poisoning strains. On the other hand,
C. difficile seems to embrace many biotypes; pre¬
sent confusion concerning the significance of the
cytotoxin and the enterotoxin in its identification
encourages us to develop somatic serological stud¬
ies. Further studies of amino acid metabolism might
also be helpful. The successful biotyping of the
Bacteroides-Fusobacterium group has been ex¬
tended to the point at which minor biochemical
variants qualify for species rank, and this seems to
be supported by serological analyses of species-
specific outer membrane antigens. Other possible
approaches include bacteriocin typing and this may
have epidemiological value. In contrast, the classifi¬
cation of the anaerobic cocci is still poorly devel¬
oped, and the oral spirochaetes merit more system¬
atic study.
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